OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	question_answered_by_this_work

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1168874	7/2005	S68-PMC1168874	['OUR FINDING is IN AGREEMENT with the CONCLUSION of the european network of the teratology information services, whose data set DID NOT PROVIDE EVIDENCE for an INCREASED RISK of major cas ASSOCIATED with high Vitamin A intake (10,000 iu per day or more) during the Organogenetic period of Embryo26.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 127), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 187)]	6	[('CHEBI_27300', 'vitamin D', 208, 'vitamin A'), ('GO_0048513', 'animal organ development', 264, 'organogenetic'), ('UBERON_0000922', 'embryo', 288, 'embryo26')]
PMC2606998	6/2007	S84-PMC2606998	['from this perspective, the most STRIKING result from THIS STUDY was the CONSIDERABLY lower than RECOMMENDED intakes of Folate and Vitamin\u2009D, both before and during Pregnancy, EVEN when PROBABLE UNDERREPORTING was taken INTO ACCOUNT.']	[('ANOMALY_CURIOUS_FINDING', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('ANOMALY_CURIOUS_FINDING', 72), ('FUTURE_WORK', 96), ('ANOMALY_CURIOUS_FINDING', 175), ('PROBABLE_UNDERSTANDING', 185), ('PROBLEM_COMPLICATION', 194), ('INCOMPLETE_EVIDENCE', 219)]	8	[('CHEBI_30863', '5-azaorotic acid', 119, 'folate'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC2606998	6/2007	S120-PMC2606998	['ACCORDING TO the PRESENT STUDY there is a NEED to expand this FOCUS and include Selenium, Folate and Vitamin\u2009D too.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('FUTURE_WORK', 42), ('IMPORTANT_CONSIDERATION', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 62)]	5	[('CHEBI_27568', 'selenium atom', 80, 'selenium'), ('CHEBI_30863', '5-azaorotic acid', 90, 'folate'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC2606998	6/2007	S124-PMC2606998	['in the PRESENT STUDY Selenium, Calcium and Vitamin\u2009C density were higher, and iron was lower at mid-Gestation compared with the densities of these Nutrients before Gestation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7)]	1	[('CHEBI_27568', 'selenium atom', 21, 'selenium'), ('CHEBI_22313', 'alkaline earth metal atom', 31, 'calcium'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin C'), ('GO_0007565', 'female pregnancy', 100, 'gestation'), ('CHEBI_33284', 'nutrient', 147, 'nutrients'), ('GO_0007565', 'female pregnancy', 164, 'gestation')]
PMC2290997	4/2008	S86-PMC2290997	['“moreover, there is an inflammatory component to atherosclerosis, and Vascular Smooth Muscle Cells have a Vitamin D receptor and relax in the presence of 1,25(Oh)D, SUGGESTING a multitude of mechanisms by which Vitamin D MAY BE cardioprotective.”\nTO DETERMINE the POTENTIAL LINK betwen sun exposure and the PROTECTIVE effect in preventing hypertension, rolfdieter krause of the free university of berlin department of natural medicine and colleagues exposed a group of hypertensive Adults to a Tanning Bed that emitted full-spectrum uvr similar to summer sunlight.']	[('INCOMPLETE_EVIDENCE', 165), ('INCOMPLETE_EVIDENCE', 221), ('QUESTION_ANSWERED_BY_THIS_WORK', 247), ('INCOMPLETE_EVIDENCE', 264), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 307)]	6	[('CL_0000359', 'vascular associated smooth muscle cell', 70, 'vascular smooth muscle cells'), ('UBERON_0004237', 'blood vessel smooth muscle', 70, 'vascular smooth muscle'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 158, '(OH)D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('UBERON_0007023', 'adult organism', 482, 'adults'), ('UBERON_0002544', 'digit', 494, 'tanning'), ('UBERON_0002531', 'paired fin bud', 502, 'bed')]
PMC2290997	4/2008	S192-PMC2290997	['in short, there is no real specificity for ambient uvr.”\nresearchers also ASSESS history of time in the sun at various ages, history of sunburns, dietary and supplemental Vitamin D intake, and OTHER PROXY measures.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC2396486	6/2008	S2-PMC2396486	['because the Nucleus Accumbens HAS BEEN IMPLICATED in neuropsychiatric disorders, in THE CURRENT STUDY we EXAMINED protein Expression in this region in Adult Rats exposed to Dvd deficiency\n\nmethods\nfemale sprague dawley Rats were maintained on a Vitamin D deficient diet for 6 weeks, Mated and allowed to Give Birth, after which a diet containing Vitamin D was reintroduced.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 84), ('QUESTION_ANSWERED_BY_THIS_WORK', 105)]	4	[('UBERON_0001882', 'nucleus accumbens', 12, 'nucleus accumbens'), ('GO_0010467', 'gene expression', 122, 'expression'), ('UBERON_0007023', 'adult organism', 151, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 157, 'rats'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 173, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 219, 'rats'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('GO_0007618', 'mating', 283, 'mated'), ('GO_0007631', 'feeding behavior', 304, 'give'), ('GO_0007567', 'parturition', 309, 'birth'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC2396486	6/2008	S133-PMC2396486	['combined with OTHER experimental findings, THE CURRENT STUDY LENDS FURTHER CREDIBILITY to the NOTION that developmental Vitamin D deficiency IMPACTS adversely on normal Brain Development[30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007420', 'brain development', 169, 'brain development'), ('UBERON_0000955', 'brain', 169, 'brain')]
PMC2581757	11/2008	S36-PMC2581757	['in VIEW of the CONTRADICTORY REPORTS and the SERIOUSNESS of preeclampsia, the PRESENT STUDY included the determination of the activities of catalase, sod, Gpx and Grx in the Blood of normal and Preeclamptic women with and without vitamin treatment, along-with the contents of mda, Gsh, gssg, gssg/Gsh, no and Uric Acid, TO collectively EVALUATE the ROLES of Vitamins C and e in the Regulation of these factors.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 320), ('QUESTION_ANSWERED_BY_THIS_WORK', 336), ('SUPERFICIAL_RELATIONSHIP', 349)]	8	[('PR_000008210', 'glutathione peroxidase 1', 155, 'GPx'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 163, 'GRx'), ('UBERON_0000178', 'blood', 174, 'blood'), ('GO_0007565', 'female pregnancy', 194, 'preeclamptic'), ('CHEBI_16856', 'glutathione', 281, 'GSH'), ('CHEBI_16856', 'glutathione', 297, 'GSH'), ('CHEBI_27226', 'uric acid', 309, 'uric acid'), ('CHEBI_27300', 'vitamin D', 358, 'vitamins C'), ('GO_0065007', 'biological regulation', 382, 'regulation')]
PMC2582131	11/2008	S12-PMC2582131	['conclusions\nFINDINGS from the PRESENT STUDY SUGGEST that maternal Vitamin D deficiency in early Pregnancy is significantly ASSOCIATED with an elevated RISK for gdm.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 151)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]
PMC2582131	11/2008	S26-PMC2582131	['in the PRESENT STUDY, we EVALUATED the ASSOCIATION between maternal Plasma Vitamin D concentrations in early Pregnancy and subsequent risk of gdm based ON a prospective cohort study of Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 152)]	4	[('UBERON_0001969', 'blood plasma', 68, 'plasma'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('GO_0007565', 'female pregnancy', 185, 'pregnant')]
PMC2582131	11/2008	S100-PMC2582131	['OUR FINDINGS are also GENERALLY CONSISTENT with a relatively large body of LITERATURE documenting a significant and inverse ASSOCIATION of circulating Vitamin D concentrations with measurements of glycemia or presence of type 2 dm among non-Pregnant women, ALTHOUGH the majority of THESE FINDINGS are based ON cross-sectional/RETROSPECTIVE data.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 124), ('ANOMALY_CURIOUS_FINDING', 257), ('INCOMPLETE_EVIDENCE', 282), ('ANOMALY_CURIOUS_FINDING', 307), ('INCOMPLETE_EVIDENCE', 326)]	9	[('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnant')]
PMC2582131	11/2008	S119-PMC2582131	['in CONCLUSION, OUR STUDY provides data INDICATING that maternal Vitamin D deficiency in early Pregnancy (i.e.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 39)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC4516488	9/2009	S188-PMC4516488	['ALTHOUGH this FINDING WAS NOT discussed or followed-up, it is IN LINE WITH the Vitamin D dependency of Pea-15 OUTLINED in OUR STUDY.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 110), ('QUESTION_ANSWERED_BY_THIS_WORK', 122)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_39015', 'apolipoprotein', 103, 'PEA'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 103, 'PEA-15')]
PMC2779500	11/2009	S130-PMC2779500	['IN ORDER TO account for the fact that injection Drug users (idus) MAY have a smaller Vitamin C intake, we set the amount of dietary Vitamin C absorbed in groups hiv(-), hiv(+)p and hiv(+)v to be 80 mg/day which yields λa= 2.74 × 1013molecules μ l-1day-1.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 66)]	2	[('CHEBI_23888', 'drug', 48, 'drug'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin C')]
PMC4188019	1/2010	S2-PMC4188019	['OBJECTIVES : THIS was a PRELIMINARY EXPLORATION of the Vitamin D status in Pregnant women visiting the Antenatal clinic in the antwerp university hospital.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 36)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnant'), ('GO_0007567', 'parturition', 103, 'antenatal'), ('UBERON_0001760', 'frontal sinus', 103, 'antenatal')]
PMC4188019	1/2010	S25-PMC4188019	['THIS PILOT STUDY AIMS at determining the prevalence of Vitamin D deficiency in the antwerp population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4188019	1/2010	S74-PMC4188019	['in the population studied, the non-covered women had higher mean Serum concentrations of Vitamin D compared TO partially covered women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 108)]	1	[('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4188019	1/2010	S83-PMC4188019	['in THIS PILOT STUDY, we FOUND that low Vitamin D levels in the antwerp population are frequent and that there is an EFFECT of the seasonal moment of the year and degree of sun exposure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 116)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC2821652	2/2010	S16-PMC2821652	['due TO the limited dietary sources of Vitamin D, Serum Vitamin D levels are PRIMARILY determined by sunlight exposure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBABLE_UNDERSTANDING', 76)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0001977', 'blood serum', 49, 'serum'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC2821652	2/2010	S45-PMC2821652	["the PURPOSES of THIS STUDY were to define parameters for measuring adherence to Vitamin D supplementation by measures of Serum Metabolite, which could then be applied to other medication regimens, and TO EXAMINE the ASSOCIATION between adherence as determined by Serum Metabolites and adherence as determined by patients' pill counts."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('SUPERFICIAL_RELATIONSHIP', 216)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_39382', 'flufenoxuron', 127, 'metabolite'), ('UBERON_0001977', 'blood serum', 263, 'serum'), ('CHEBI_25212', 'metabolite', 269, 'metabolites')]
PMC2821652	2/2010	S119-PMC2821652	['in THIS TRIAL, we SOUGHT TO DETERMINE WHETHER there was a significant ASSOCIATION between adherence to Vitamin D supplementation as measured by pill count and assessment of a NOVEL measure of adherence BASED UPON Serum levels of Vitamin D Metabolites in a Pregnant population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('SUPERFICIAL_RELATIONSHIP', 70), ('FULL_UNKNOWN', 175), ('QUESTION_ANSWERED_BY_THIS_WORK', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	8	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0001977', 'blood serum', 213, 'serum'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_25212', 'metabolite', 239, 'metabolites'), ('GO_0007565', 'female pregnancy', 256, 'pregnant')]
PMC3257641	3/2010	S6-PMC3257641	['in THIS REVIEW, we OUTLINE the RESEARCH EVIDENCE TO DATE RELATING to Vitamin D status and Pregnancy, including a range of POSSIBLE health outcomes from pre-Conception to later Life (figure 1).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 122)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007620', 'copulation', 156, 'conception'), ('UBERON_0000104', 'life cycle', 176, 'life')]
PMC3257641	3/2010	S162-PMC3257641	['in this situation, the timing of low Vitamin D’s EFFECT over the Life Course will HAVE TO BE carefully determined, using specific Life Course analytic techniques [125], TO ASSESS WHETHER any low Prenatal Vitamin D status is INDEPENDENTLY ASSOCIATED with health outcomes INDEPENDENTLY of the mother’s Vitamin D status before Pregnancy and the offspring’s Vitamin D status during Postnatal Life.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 224), ('SUPERFICIAL_RELATIONSHIP', 238), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0001281', 'hepatic sinusoid', 65, 'life course'), ('UBERON_0001281', 'hepatic sinusoid', 130, 'life course'), ('GO_0007565', 'female pregnancy', 195, 'prenatal'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0007567', 'parturition', 378, 'postnatal'), ('UBERON_0000104', 'life cycle', 388, 'life')]
BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
PMC2872349	4/2010	S143-PMC2872349	['this SUPPORTS the general NEED for a programme of interventional research aimed at improving general dietary quality among women before Conception and during Pregnancy, in addition to studies that EVALUATE the TARGETING of specific Micronutrients such as Vitamin D and Calcium.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 26), ('INCOMPLETE_EVIDENCE', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 197), ('QUESTION_ANSWERED_BY_THIS_WORK', 197), ('FUTURE_WORK', 210)]	6	[('GO_0007620', 'copulation', 136, 'conception'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_33839', 'macromolecule', 232, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 269, 'calcium')]
PMC2872349	4/2010	S144-PMC2872349	['the maternal Vitamin D in osteoporosis study (mavidos) is a randomized controlled trial TO INVESTIGATE WHETHER supplementation of Vitamin D during Pregnancy serves to optimize offspring Skeletal Development, and commenced recruitment in 2008.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	2	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('GO_0001501', 'skeletal system development', 186, 'skeletal development'), ('UBERON_0004288', 'skeleton', 186, 'skeletal')]
PMC2872349	4/2010	S145-PMC2872349	['the STUDY AIMS TO TEST the HYPOTHESIS that Vitamin D supplementation of Pregnant women who have low levels of Vitamin D will result in improved neonatal bone Mineral content.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 27)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_46662', 'mineral', 158, 'mineral')]
PMC2872349	4/2010	S146-PMC2872349	['this is an IDEAL platform on which TO INVESTIGATE epigenetic Modulation Of Placental Calcium Transport, PARTICULARLY the ROLE of Vitamin D. this SHOULD improve our understanding of the processes INVOLVED in developing osteoporosis, and POTENTIALLY provide a focus for interventions to avert DETRIMENTAL processes by INFLUENCING maternal dietary habits.']	[('IMPORTANT_CONSIDERATION', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('IMPORTANT_CONSIDERATION', 104), ('SUPERFICIAL_RELATIONSHIP', 121), ('FUTURE_WORK', 145), ('SUPERFICIAL_RELATIONSHIP', 195), ('INCOMPLETE_EVIDENCE', 236), ('IMPORTANT_CONSIDERATION', 291), ('SUPERFICIAL_RELATIONSHIP', 316)]	9	[('GO_0061724', 'lipophagy', 61, 'modulation of'), ('GO_0006813', 'potassium ion transport', 75, 'placental calcium transport'), ('UBERON_0001987', 'placenta', 75, 'placental'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC2873552	4/2010	S133-PMC2873552	['TO ASSESS this POSSIBILITY, we looked into the entropy of the vdr Gene, a Vitamin D receptor.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15)]	2	[('SO_0000704', 'gene', 66, 'gene'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC2889879	5/2010	S1-PMC2889879	['our AIM was TO EVALUATE the ASSOCIATION between the Intake of different fish species, Pufa and Vitamin D and the prevalence of psychotic-like symptoms in a population-based study among swedish women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 28)]	3	[('GO_0007631', 'feeding behavior', 52, 'intake'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 86, 'PUFA'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC2889879	5/2010	S14-PMC2889879	['conclusion\nOUR FINDINGS RAISE a POSSIBILITY that Adult women with a high Intake of fish, Omega-3 or Omega-6 Pufa and Vitamin D have a lower rate of psychotic-like symptoms.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('EXPLICIT_QUESTION', 24), ('INCOMPLETE_EVIDENCE', 32)]	3	[('UBERON_0007023', 'adult organism', 49, 'adult'), ('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_79370', 'ibho#10', 89, 'omega-3'), ('CHEBI_79370', 'ibho#10', 100, 'omega-6'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 108, 'PUFA'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC2889879	5/2010	S37-PMC2889879	['the main PURPOSE of the PRESENT STUDY was TO EVALUATE the ASSOCIATION between the dietary Intake of different fish species, the dietary Intake of Pufas (Omega-3 and Omega-6) and Vitamin D and the prevalence of positive psychotic-like symptoms in a population-based study among swedish women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('GO_0007631', 'feeding behavior', 90, 'intake'), ('GO_0007631', 'feeding behavior', 136, 'intake'), ('CHEBI_86926', 'S a S b S', 146, 'PUFAs'), ('CHEBI_30823', 'oleate', 153, 'omega'), ('CHEBI_79370', 'ibho#10', 165, 'omega-6'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC2889879	5/2010	S127-PMC2889879	['caption (table-wrap): table 4\n\nrelative risk of positive psychotic-like symptoms in relation to estimated dietary intake of vitamin Ddietary intake g/day·mjpositive psychotic-like symptomsamedianinterquintile rangelow level groupmiddle level grouphigh level group energy adjustedmultivariatebenergy adjustedmultivariatebvitamin dno.no.rr95% cirr95% cino.rr95% cirr95% ci 0.4(0.01-0.5)4132ref.36682400.6(0.5-0.6)447634620.870.82-0.930.88a0.82-0.931850.710.58-0.860.72a0.59-0.880.7(0.6-0.8)459033930.840.79-0.890.84a0.79-0.901710.640.53-0.790.65a0.52-0.800.9(0.8-4.0)462033430.830.78-0.880.82a0.77-0.881750.660.54-0.810.63a0.50-0.78\naadjusted for age, total energy intake, country of Birth, bmi and dietary intake of Vitamin B12\n\ndiscussion\nwe report HERE results from the FIRST STUDY that has evaluated the dietary Intake of Fish, Pufa and Vitamin D in RELATION to the experience of positive psychotic-like symptoms in a large cohort of over 30 000 swedish women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 749), ('INCOMPLETE_EVIDENCE', 771), ('SUPERFICIAL_RELATIONSHIP', 852)]	3	[('GO_0051215', 'RNAi-mediated antiviral immunity against DNA virus', 132, 'DDietary'), ('GO_0007567', 'parturition', 682, 'birth'), ('CHEBI_33279', 'vitamin D5', 715, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 715, 'vitamin B12'), ('GO_0007631', 'feeding behavior', 814, 'intake'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 824, 'fish'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 830, 'PUFA'), ('CHEBI_27300', 'vitamin D', 839, 'vitamin D')]
PMC2889879	5/2010	S135-PMC2889879	['OUR FINDINGS INDICATED a PROTECTIVE EFFECT of Vitamin D for the risk of psychotic-like symptoms.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 36)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC2898025	5/2010	S4-PMC2898025	['THIS PAPER reviews the PLAUSIBILITY of evidence FOCUSING on the seasonal INTERRELATION of farming, allergies, Viruses, Vitamin D, diet, Birth weight, and handedness.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('NCBITaxon_1', 'root', 110, 'viruses'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007567', 'parturition', 136, 'birth')]
PMC3032617	5/2010	S3-PMC3032617	['the AIM of the study was TO INVESTIGATE, in a ugandan rural Pregnant women cohort, the preventive EFFECTS of Vitamin C supplementation on hospital admission.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('GO_0007565', 'female pregnancy', 60, 'pregnant'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin C')]
PMC3032617	5/2010	S5-PMC3032617	['the primary outcome measure of this study was TO ASSESS the PREVENTION of hospitalization during Pregnancy in the group of women supplemented with Vitamin C compared to the controls.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin C')]
PMC3032617	5/2010	S8-PMC3032617	['conclusion\nthe results of THIS STUDY SUGGEST including Vitamin C in the GUIDELINES of multivitamin PREVENTION for Pregnant women, ESPECIALLY in developing countries where seasonal availability of fruits and Vegetables COULD result in adverse clinical outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 72), ('PROBABLE_UNDERSTANDING', 72), ('SUPERFICIAL_RELATIONSHIP', 99), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('GO_0007565', 'female pregnancy', 114, 'pregnant'), ('CHEBI_33267', 'elemental nitrogen', 207, 'vegetables')]
PMC3032617	5/2010	S37-PMC3032617	['all this considerations led us TO INVESTIGATE, in an open-label cohort randomized study, the preventive EFFECTS of regular Vitamin C supplementation on overall hospitalization rate in the Pregnant women population attending a ugandan rural health centre for Antenatal assessment.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 104)]	2	[('CHEBI_27300', 'vitamin D', 123, 'vitamin C'), ('GO_0007565', 'female pregnancy', 188, 'pregnant'), ('GO_0007567', 'parturition', 258, 'antenatal')]
PMC3032617	5/2010	S38-PMC3032617	['the primary outcome measure of this study was TO ASSESS the PREVENTION of hospitalization during Pregnancy in the group of women supplemented with Vitamin C compared to the controls, and the secondary outcome measures were to compare the overall mother-to-child health benefits in the two groups, such as: overall hospitalization rate, weight gain during Pregnancy (normal <16kg), term Pregnancy (≥37 Gestational weeks), Preterm Delivery, Miscarriage (<24 Gestational weeks) and child low Birth weight (<2500g) and Gestational systolic Blood pressure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin C'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('GO_0007565', 'female pregnancy', 386, 'pregnancy'), ('GO_0007565', 'female pregnancy', 401, 'gestational'), ('GO_0007565', 'female pregnancy', 421, 'preterm'), ('GO_0007567', 'parturition', 429, 'delivery'), ('GO_0046660', 'female sex differentiation', 439, 'miscarriage'), ('GO_0007565', 'female pregnancy', 456, 'gestational'), ('GO_0007567', 'parturition', 489, 'birth'), ('GO_0007565', 'female pregnancy', 515, 'gestational'), ('UBERON_0000178', 'blood', 536, 'blood')]
PMC2874518	6/2010	S115-PMC2874518	['in a randomised controlled trial TO ASSESS the EFFECT of Vitamin E and C supplementation during Pregnancy on the incidence of pre-eclampsia, poston et al.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin E'), ('CHEBI_18245', 'carboxylato group', 71, 'C'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]
PMC3075531	7/2010	S8-PMC3075531	['also, OUR STUDY SHOWED significant DISCREPANCY between the two groups ACCORDING TO the rate of deficiency, insufficiency and normal range of Vitamin D categories (p=0.021).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3075531	7/2010	S12-PMC3075531	['there are DIFFERENCES in OPTIMAL level of 25-Hydroxy Vitamin D BUT nowadays internationally ACCEPTED normal range is between 75 nmol/l and 200 nmol/l, and we CONSIDER Serum level below 75 nmol/l and below 2 nmol/l as insufficiency and deficiency, respectively.42325even it SEEMS to achieve the prevention of Autoimmune diseases, the Serum level of Vitamin D MUST BE higher than the level required to reduce osteoporosis (higher than 75 nmol/l).4in attention to high prevalence of ms in iran and especially in isfahan which is ABOUT 43.5/100,0002627and GIVEN that iran is located in an latitude of 32° 50’ and longitude of 51° 43’ with enough sun exposure and BECAUSE nobody INVESTIGATED the RELATIONSHIP between Vitamin D, AS an environmental agent, and ms disease in iran before, we DECIDED to compare the Serum level of 25-Hydroxy Vitamin D in ms patients and healthy control group in isfahan region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 158), ('ANOMALY_CURIOUS_FINDING', 273), ('IMPORTANT_CONSIDERATION', 358), ('INCOMPLETE_EVIDENCE', 526), ('PROBABLE_UNDERSTANDING', 552), ('PROBABLE_UNDERSTANDING', 659), ('QUESTION_ANSWERED_BY_THIS_WORK', 674), ('SUPERFICIAL_RELATIONSHIP', 691), ('PROBABLE_UNDERSTANDING', 723), ('QUESTION_ANSWERED_BY_THIS_WORK', 784)]	14	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 42, '25-hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum'), ('UBERON_0001442', 'skeleton of manus', 308, 'autoimmune'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 712, 'vitamin D'), ('UBERON_0001977', 'blood serum', 807, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 822, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 841, 'D')]
PMC3075531	7/2010	S55-PMC3075531	['in a pooled analysis of data from canada, uk, denmark, and sweden including more than 40,000 Individuals with ms, significantly fewer (8.5%) People with ms were Born in november and significantly more (9.1%) were Born in may.39THIS FINDING SUGGESTS that Prenatal exposures or exposures in the first months of Life COULD BE IMPORTANT in ms etiology, BUT the LINK to Vitamin D is UNCLEAR.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 314), ('IMPORTANT_CONSIDERATION', 323), ('ANOMALY_CURIOUS_FINDING', 349), ('SUPERFICIAL_RELATIONSHIP', 357), ('FULL_UNKNOWN', 378)]	8	[('NCBITaxon_1', 'root', 93, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 141, 'people'), ('GO_0007567', 'parturition', 161, 'born'), ('GO_0007567', 'parturition', 213, 'born'), ('GO_0007565', 'female pregnancy', 254, 'prenatal'), ('UBERON_0000104', 'life cycle', 309, 'life'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC3075531	7/2010	S61-PMC3075531	['conclusions\nin conclusion, THIS STUDY SHOWED that Serum Vitamin D deficiency MIGHT be a POTENTIAL environmental predisposing FACTOR for developing multiple sclerosis in our region, and NEED to follow FACTORS that cause THIS PROBLEM including dietary, Genetic, and other ones.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 185), ('SUPERFICIAL_RELATIONSHIP', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 219), ('IMPORTANT_CONSIDERATION', 224)]	9	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('SO_0000704', 'gene', 251, 'genetic')]
PMC2963768	10/2010	S3-PMC2963768	['THEREFORE, to gain PRELIMINARY INSIGHTS into the Vitamin D status of infants in rural bangladesh, 25(Oh)D was ASSESSED in a group of community-sampled control participants in a pneumonia case-control study in rural sylhet, bangladesh (25°n) during the winter dry season (january-february).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 110)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D')]
PMC2963768	10/2010	S13-PMC2963768	['HOWEVER, SINCE Vitamin D status has become READILY estimable BASED on Serum/Plasma 25-Hydroxyvitamin D concentration [25(Oh)D] (2), epidemiologic RESEARCH aimed at identifying PREVIOUSLY-UNCHARACTERIZED AT-risk populations and characterizing NOVEL disease ASSOCIATIONS with Vitamin D status HAS BEEN greatly facilitated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('PROBABLE_UNDERSTANDING', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('FUTURE_WORK', 146), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 203), ('FULL_UNKNOWN', 242), ('SUPERFICIAL_RELATIONSHIP', 256), ('INCOMPLETE_EVIDENCE', 291)]	11	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 83, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC2963768	10/2010	S21-PMC2963768	['HERE, we AIMED to describe the Vitamin D status of the source population and briefly review the POTENTIAL DETERMINANTS of low infant 25(Oh)D in this setting.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 133, '25 ... OH ... D')]
PMC2963768	10/2010	S34-PMC2963768	['maternal Intake of Foods from Animal sources, which included POTENTIAL sources of Vitamin D and rich sources of Calcium, was ASSESSED based on the reported frequency of consumption of Food items/categories over the seven days preceding enrollment.']	[('INCOMPLETE_EVIDENCE', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 125)]	2	[('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_33290', 'food', 19, 'foods'), ('NCBITaxon_33208', 'Metazoa', 30, 'animal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 112, 'calcium'), ('CHEBI_33290', 'food', 184, 'food')]
PMC2963768	10/2010	S83-PMC2963768	["cement, brick, or tin)\xa0\xa0floor03 (6)0.221\xa0\xa0walls6 (25)16 (32)0.537\xa0\xa0roof20 (83)45 (90)0.411child is/was usually swaddled during the first 6 months of Life24 (100)46 (92)0.154child was deliberately exposed to sunlight before Learning to crawl/walk18 (75)36 (72)0.786mother's clothing practices when outdoors\xa0\xa0head usually covered23 (96)50 (100)0.146\xa0\xa0Face usually covered00-\xa0\xa0Arms usually covered24 (100)48 (96)0.321\xa0\xa0usually wears burka in public21 (91)47 (94)0.672number of meals at which mother reportedly Consumed Food items from Animal source during the past week (median±iqr)any type of fish13.0±514.5±120.158\xa0\xa0small fish with Bones6.0±76±80.561\xa0\xa0milk0±00±70.119\xa0\xa0meat0±0.50±20.415\xa0\xa0Eggs0±1.50±20.247\xa0\xa0Liver0±00±00.324\nfigures in parentheses indicate percentages;\niqr=interquartile range;\nsd=standard deviation\n\ndiscussion\nTHIS PRELIMINARY STUDY in sylhet during the winter dry season REVEALED that the Vitamin d status of young infants in rural bangladesh MIGHT be POOR enough to put many AT RISK of rickets and other POTENTIAL Vitamin D-RELATED health consequences."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 827), ('QUESTION_ANSWERED_BY_THIS_WORK', 832), ('QUESTION_ANSWERED_BY_THIS_WORK', 832), ('INCOMPLETE_EVIDENCE', 889), ('INCOMPLETE_EVIDENCE', 961), ('IMPORTANT_CONSIDERATION', 970), ('IMPORTANT_CONSIDERATION', 994), ('INCOMPLETE_EVIDENCE', 1023), ('SUPERFICIAL_RELATIONSHIP', 1043)]	9	[('UBERON_0008878', 'palmar part of manus', 149, 'life24'), ('GO_0007612', 'learning', 223, 'learning'), ('UBERON_0001456', 'face', 349, 'Face'), ('UBERON_0001460', 'arm', 374, 'Arms'), ('GO_0007631', 'feeding behavior', 507, 'consumed'), ('CHEBI_33290', 'food', 516, 'food'), ('NCBITaxon_33208', 'Metazoa', 532, 'animal'), ('UBERON_0001474', 'bone element', 631, 'bones6'), ('CL_0000059', 'ameloblast', 687, 'Eggs0'), ('UBERON_0001773', 'sclera', 706, 'Liver0'), ('CHEBI_33229', 'vitamin (role)', 907, 'vitamin'), ('CHEBI_27300', 'vitamin D', 1033, 'vitamin D')]
PMC2963768	10/2010	S85-PMC2963768	['TO OUR KNOWLEDGE, THIS is the FIRST report of Vitamin D status in young infants in bangladesh.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC2963768	10/2010	S113-PMC2963768	['inferences regarding the DETERMINANTS of infant/toddlers’ Vitamin D status in THIS STUDY were LIMITED, largely BECAUSE of the SMALL sample-size and substantial uniformity with respect to selected maternal clothing and dietary practices.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 94), ('PROBLEM_COMPLICATION', 111), ('INCOMPLETE_EVIDENCE', 126)]	5	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC2963768	10/2010	S141-PMC2963768	['if Vitamin D deficiency is CONFIRMED AS a RISK FACTOR for pneumonia, INTERVENTIONS to improve maternal-infant Vitamin D status COULD reduce THE GLOBAL BURDEN of alri, the single most IMPORTANT cause of early childhood death in the world (58).']	[('INCOMPLETE_EVIDENCE', 27), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('FUTURE_WORK', 69), ('INCOMPLETE_EVIDENCE', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 140), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 183)]	8	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC2963768	10/2010	S152-PMC2963768	['conclusions\nTHIS STUDY provides initial OBSERVATIONS on the Vitamin D status of young infants in northeastern rural bangladesh.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 40)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC2996405	11/2010	S9-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATIONS with Vitamin D. we FOUND in a set of vitamin d related Genes a significant enrichment of both lrgs and of Genes INVOLVED in schizophrenia.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 234)]	9	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('SO_0000704', 'gene', 177, 'genes'), ('SO_0000704', 'gene', 228, 'genes')]
PMC2996405	11/2010	S59-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATION with Vitamin D, which had been PREVIOUSLY ASSOCIATED, separately, to both of them.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 163)]	9	[('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC2996405	11/2010	S60-PMC2996405	['OUR FINDINGS SUGGEST a molecular LINK among latitude, schizophrenia and Vitamin D.\n\nresults\na set of Snps showing high levels of latitude-DEPENDENT population differentiation was selected by using a two-step approach.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 138)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('SO_0000694', 'SNP', 101, 'SNPs')]
PMC2996405	11/2010	S153-PMC2996405	['TO TEST this LINK at a Genomic level, we created a hand-curated list of Genes that, at different levels, are RELATED to Vitamin D (see results; additional file4).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 109)]	3	[('SO_0001026', 'genome', 23, 'genomic'), ('SO_0000704', 'gene', 72, 'genes'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D')]
PMC2996405	11/2010	S168-PMC2996405	['ACCORDING TO our HYPOTHESIS that Vitamin D COULD BE the LINK between latitude and schizophrenia, we FOCUSED on the 9 lrgs present in both the lists of Vitamin D and schizophrenia RELATED Genes (figure1).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('SUPERFICIAL_RELATIONSHIP', 179)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('SO_0000704', 'gene', 187, 'genes')]
PMC2798111	12/2010	S1-PMC2798111	['TO EXAMINE the EFFECTIVENESS of oral Vitamin D3(400\u2009iu) supplementation on the nutritional Vitamin D status of breastfeeding infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('CHEBI_33279', 'vitamin D5', 37, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 37, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC2798111	12/2010	S23-PMC2798111	['as part of an ongoing Vitamin D supplementation trial of fully Lactating women and their infants, we SOUGHT TO DETERMINE WHETHER a dosing regimen that utilizes an oil emulsion of one drop per day to Deliver 400\u2009iu/day is effective in raising infant 25(Oh)D levels from baseline.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('QUESTION_ANSWERED_BY_THIS_WORK', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 63, 'lactating'), ('GO_0007567', 'parturition', 199, 'deliver'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 249, '25(OH)D')]
PMC2798111	12/2010	S90-PMC2798111	['discussion\nbecause the PRELIMINARY results of this arm of the trial are IMPORTANT for decision-making in the current clinical environment, we report HERE the interim results of an ONGOING Vitamin D supplementation TRIAL of Lactating women and their infants.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 72), ('QUESTION_ANSWERED_BY_THIS_WORK', 149), ('IMPORTANT_CONSIDERATION', 180), ('INCOMPLETE_EVIDENCE', 214)]	5	[('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 223, 'lactating')]
PMC2798111	12/2010	S96-PMC2798111	['another IMPORTANT finding in THIS STUDY is that the majority of infants enrolled in this cohort of exclusively Breastfed infants had Vitamin D deficiency (defined as circulating 25(Oh)D levels <20\u2009ng/ml) at one month of age.']	[('IMPORTANT_CONSIDERATION', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 29)]	2	[('GO_0007567', 'parturition', 111, 'breastfed'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 181, 'OH)D')]
PMC2798111	12/2010	S99-PMC2798111	['THUS, OUR FINDINGS in THIS STUDY and our earlier studies [4,32] SUPPORT the RECENT aap RECOMMENDATION of starting Vitamin D supplementation in all breastfed infants within the first few days after Delivery [26].']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 76), ('FUTURE_WORK', 87)]	6	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'delivery')]
PMC2798111	12/2010	S104-PMC2798111	['OUR FINDINGS SUPPORT the PREMISE that an oil emulsion delivered as a single drop is well-tolerated and absorbed with a CONSISTENT increase in circulating 25(Oh)d on the Vitamin D supplementation during a three-month interval that was sustained during the next three-month interval.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 119)]	4	[('CHEBI_30778', 'gallic acid', 154, '25(OH)'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC2798111	12/2010	S116-PMC2798111	['clearly, the 400\u2009iu/day group of infants (presented HERE) had improved Vitamin D status BASED ON their therapy that was not seen in the 2400\u2009iu group of infants, who were receiving placebo and whose only source of Vitamin D was maternal Breast Milk that has significantly lower levels than that of the 6400 iu group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 237, 'breast milk')]
PMC3004407	12/2010	S22-PMC3004407	['AS a result of the CONCERN regarding the prevalence of Vitamin D deficiency among Pregnant women receiving care at community health centers, and TO CLARIFY earlier scientific STUDIES which REPORTED that a majority of african-american and hispanic women are Vitamin D deficient [34–40], a cross-sectional study of Pregnant women presenting at a community health center network in south carolina at latitude 32°n was designed and implemented.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('PROBLEM_COMPLICATION', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 145), ('FUTURE_WORK', 148), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'pregnant')]
PMC3004407	12/2010	S23-PMC3004407	['the AIM of THIS STUDY was to define the prevalence of Vitamin D deficiency in a large and ethnically diverse cross-sectional sample of Pregnant women living in a sun-rich environment with ample access to sunlight during most of the year.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 135, 'pregnant')]
PMC3004407	12/2010	S101-PMC3004407	['multinomial logistic regression models for the three Vitamin D categories (deficient, insufficient, and sufficient) were constructed TO EVALUATE the ASSOCIATION between Vitamin D status and age, gravidity, race, and season of measurement.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 133), ('SUPERFICIAL_RELATIONSHIP', 149)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC3004407	12/2010	S158-PMC3004407	['studies TO EXAMINE the BENEFIT of higher doses of Vitamin D during Pregnancy SUGGEST that the dose of Vitamin D FOUND in MOST Prenatal Vitamins—400\u2009iu—is INADEQUATE to meet the NEEDS of the Pregnant woman and her growing fetus [11,32,34,39,60–67].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 112), ('PROBABLE_UNDERSTANDING', 121), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 177)]	7	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 135, 'vitamins'), ('GO_0007565', 'female pregnancy', 190, 'pregnant')]
PMC3034879	12/2010	S3-PMC3034879	['we EVALUATED the ROLE of Prenatal and Postnatal Vitamin D status on bone parameters in early infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 17)]	2	[('GO_0007565', 'female pregnancy', 25, 'prenatal'), ('GO_0007567', 'parturition', 38, 'postnatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC3034879	12/2010	S28-PMC3034879	['BASED ON these results, it was CONCLUDED that maternal Vitamin D status AFFECTS bone Mineral accrual and INFLUENCES bone size during the Intrauterine Period [10].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 72), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_46662', 'mineral', 85, 'mineral'), ('UBERON_0006351', 'principal vein of forelimb', 137, 'intrauterine period')]
PMC3034879	12/2010	S30-PMC3034879	['the first was to follow WHETHER the Vitamin D-ASSOCIATED Skeletal EFFECTS observed at Birth persist during the first year of Life, and the second was TO EVALUATE the IMPACT of Postnatal Vitamin D status on bone growth and development in early infancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 166)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0004288', 'skeleton', 57, 'skeletal'), ('GO_0007567', 'parturition', 86, 'birth'), ('UBERON_0000104', 'life cycle', 125, 'life'), ('GO_0007567', 'parturition', 176, 'postnatal'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC3034879	12/2010	S145-PMC3034879	['we CONSIDER this as a random finding because it is UNLIKELY that higher maternal Vitamin D status would contribute to this and SEVERAL STUDIES have witnessed that Vitamin D deficiency is RELATED to delayed age of walking [24,25].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 187)]	4	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3034879	12/2010	S176-PMC3034879	['all subjects in the present study received supplementation, compared TO a representative study cohort in finland, in which 85% of 1-year-old infants and 70% of 2-year-old infants were reported to receive Vitamin D supplementation [37].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 69)]	1	[('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC3034879	12/2010	S192-PMC3034879	['optimally, Vitamin D sufficiency SHOULD BE guaranteed during fetal Life AS the FINDINGS of the PRESENT STUDY SUGGEST that the CONSEQUENCES of POOR Vitamin D status during the fetal period cannot be totally reverted by Postnatal Vitamin D supplementation.']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 126), ('IMPORTANT_CONSIDERATION', 142)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 218, 'postnatal'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC3034879	12/2010	S198-PMC3034879	['HOWEVER, the strength of THIS STUDY was a prospective study design with Antenatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 25)]	2	[('GO_0007567', 'parturition', 72, 'antenatal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC3103150	3/2011	S2-PMC3103150	['THEREFORE, we undertook THIS STUDY TO DETERMINE the prevalence of Vitamin D deficiency and insufficiency [Serum 25 Hydroxyvitamin D (25Ohd) ≤ 15 ng/ml and 15-20 ng/ml, respectively] among healthy term Breastfed 3 month old infants and their mothers, evaluate for clinical and radiological rickets in those infants having 25Ohd < 10 ng/ml, and check for seasonal variation and PREDICTORS of infants’ Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('SUPERFICIAL_RELATIONSHIP', 376)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 112, '25 hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 133, '25OHD'), ('GO_0007567', 'parturition', 201, 'breastfed'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 321, '25OHD'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D')]
PMC3103150	3/2011	S10-PMC3103150	['interpretation & conclusions:\nprevalence of Vitamin D deficiency and insufficiency was FOUND TO BE high in breastfed infants and their mothers, with radiological rickets in a third of infants with 25Ohd < 10 ng/ml in THIS STUDY.']	[('ANOMALY_CURIOUS_FINDING', 87), ('QUESTION_ANSWERED_BY_THIS_WORK', 217)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 197, '25OHD')]
PMC3103150	3/2011	S21-PMC3103150	['THIS STUDY was UNDERTAKEN TO DETERMINE the prevalence of Vitamin D deficiency and insufficiency [Serum 25 Hydroxyvitamin D (25Ohd) < 15 ng/ml and 15-20 ng/ml, respectively] among healthy breastfed term infants at the age of 3 months and their mothers and the prevalence of radiological rickets among those infants with 25Ohd <10 ng/ml.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 26)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_37972', 'phosphorus-32 atom', 103, '25'), ('CHEBI_67825', '17beta,21beta-epoxyhopan-3-one', 106, 'hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 124, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 319, '25OHD')]
PMC3103150	3/2011	S128-PMC3103150	['in CONCLUSION, the PRESENT STUDY FOUND a very high prevalence of Vitamin D deficiency in healthy term Born infants at the age of 3 months and their mothers in winter as well as summer.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('INCOMPLETE_EVIDENCE', 33)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'born')]
PMC3103150	3/2011	S131-PMC3103150	['LARGER STUDIES and meta-analysis SHOULD BE conducted to CONFIRM the FINDINGS of the PRESENT study and develop RECOMMENDATIONS for Vitamin D supplementation for Pregnant and Lactating women and young infants.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 33), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 68), ('QUESTION_ANSWERED_BY_THIS_WORK', 84), ('FUTURE_WORK', 110)]	6	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnant'), ('GO_0007594', 'puparial adhesion', 173, 'lactating')]
PMC3107676	4/2011	S39-PMC3107676	['the PURPOSE of OUR STUDY was (1) TO describe the prevalence and PATTERNS of Nitrosatable Drug use among u.s. women during the first Trimester of Pregnancy, including type of Drug (secondary or tertiary Amine, amide) and indication of use; (2) TO EXAMINE maternal factors ASSOCIATED with Nitrosatable Drug use; and (3) TO INVESTIGATE the prevalence of supplemental Vitamin C use among women who took Nitrosatable Drugs in early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 64), ('QUESTION_ANSWERED_BY_THIS_WORK', 243), ('SUPERFICIAL_RELATIONSHIP', 271), ('QUESTION_ANSWERED_BY_THIS_WORK', 318)]	7	[('CHEBI_75872', '(R)-sarin', 76, 'nitrosatable drug'), ('GO_0009294', 'DNA mediated transformation', 132, 'trimester'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('CHEBI_23888', 'drug', 174, 'drug'), ('CHEBI_32952', 'amine', 202, 'amine'), ('CHEBI_7587', 'nitroalkane', 287, 'nitrosatable'), ('CHEBI_23888', 'drug', 300, 'drug'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin C'), ('CHEBI_7496', 'nelfinavir', 399, 'nitrosatable drugs'), ('GO_0007565', 'female pregnancy', 427, 'pregnancy')]
PMC3107676	4/2011	S71-PMC3107676	['because Vitamin C supplement use varied CONSIDERABLY by month during the first trimester, we EXAMINED prevalence of supplement use (none, less than daily, daily) separately during the first, second, and third months of Pregnancy by Nitrosatable Drug use during the first trimester.']	[('ANOMALY_CURIOUS_FINDING', 40), ('QUESTION_ANSWERED_BY_THIS_WORK', 93)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin C'), ('GO_0007565', 'female pregnancy', 219, 'pregnancy'), ('CHEBI_75872', '(R)-sarin', 232, 'nitrosatable drug')]
PMC3107676	4/2011	S115-PMC3107676	['by the third month of Pregnancy, APPROXIMATELY 80% reported taking Supplements that MOST LIKELY contained Vitamin C.\ncompared with prevalence ESTIMATES in PREVIOUSLY PUBLISHED STUDIES, the PRESENT STUDY has the highest REPORTED prevalence of Nitrosatable Drug use during early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 84), ('PROBABLE_UNDERSTANDING', 89), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155), ('QUESTION_ANSWERED_BY_THIS_WORK', 189), ('INCOMPLETE_EVIDENCE', 219)]	7	[('GO_0007565', 'female pregnancy', 22, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 67, 'supplements'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin C'), ('CHEBI_75872', '(R)-sarin', 242, 'nitrosatable drug'), ('GO_0007565', 'female pregnancy', 277, 'pregnancy')]
PMC3309463	6/2011	S45-PMC3309463	['we SPECULATE that Prenatal Vitamin D deficiency would be one of many DIFFERENT exposures that COULD decanalize Brain Development and lead TO an increased susceptibility to schizophrenia.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('INCOMPLETE_EVIDENCE', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 138)]	4	[('GO_0007565', 'female pregnancy', 18, 'prenatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007420', 'brain development', 111, 'brain development'), ('UBERON_0000955', 'brain', 111, 'brain')]
PMC3171895	9/2011	S3-PMC3171895	['the PRESENT PAPER summarises the CURRENT understanding of selected Micronutrient antioxidants Selenium, copper, zinc, manganese, and Vitamins C and e in Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 33)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('CHEBI_27568', 'selenium atom', 94, 'selenium'), ('CHEBI_27300', 'vitamin D', 133, 'vitamins C'), ('PR_000004900', 'complement C3', 142, 'C'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy')]
PMC3171895	9/2011	S36-PMC3171895	['methods\na number of Micronutrients and Vitamins are KNOWN to serve as antioxidants or be essential Cofactors for antioxidant enzymes; these include Selenium, copper, zinc, manganese, and Vitamins C and e. THE PRESENT PAPER summarises CURRENT UNDERSTANDING of the IMPORTANCE of these Micronutrient antioxidants in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 52), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('INCOMPLETE_EVIDENCE', 234), ('IMPORTANT_CONSIDERATION', 263)]	5	[('CHEBI_33839', 'macromolecule', 20, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 39, 'vitamins'), ('CHEBI_23357', 'cofactor', 99, 'cofactors'), ('CHEBI_27568', 'selenium atom', 148, 'selenium'), ('CHEBI_27300', 'vitamin D', 187, 'vitamins C'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 283, 'micronutrient'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy')]
PMC3235789	12/2011	S1-PMC3235789	['TO INVESTIGATE ASSOCIATIONS among Serum 25-Hydroxy-Vitamin D (25-Oh-D), Folate, Omega-6/Omega-3 Fatty Acid ratio and bacterial vaginosis (bv) during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_70487', '(-)-sanguinolignan C', 40, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 62, '25-OH-D'), ('CHEBI_30863', '5-azaorotic acid', 72, 'folate'), ('CHEBI_79370', 'ibho#10', 80, 'omega-6'), ('CHEBI_79370', 'ibho#10', 88, 'omega-3'), ('CHEBI_35366', 'fatty acid', 96, 'fatty acid'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy')]
PMC3235789	12/2011	S32-PMC3235789	['THIS STUDY involved the biochemical assessment of Vitamin D, Folate, and polyunsaturated Fatty Acid status from stored edta Plasma samples collected during the Delivery admission and comparison of Vitamin D, Folate, and polyunsaturated Fatty Acid nutriture for women with and without a diagnosis of bv during the Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 61, 'folate'), ('CHEBI_35366', 'fatty acid', 89, 'fatty acid'), ('UBERON_0001969', 'blood plasma', 124, 'plasma'), ('GO_0007567', 'parturition', 160, 'delivery'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 208, 'folate'), ('CHEBI_35366', 'fatty acid', 236, 'fatty acid'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy')]
PMC3235789	12/2011	S99-PMC3235789	['in the case of Vitamin D deficiency, OUR FINDINGS are CONSISTENT with a RECENT cohort of Pregnant women, which FOUND a dose-response RELATIONSHIP between 25-Oh-D and the PREVALENCE of Bv during Pregnancy [29], and a nationally representative cross-sectional study of women in the united states, which found that 25-Oh-D <30\u2009ng/ml significantly increased the odds of bv during Pregnancy (aor 2.87, 95% ci: 1.13–7.28) [30].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 133), ('IMPORTANT_CONSIDERATION', 170)]	6	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant'), ('CHEBI_17808', 'IDP', 157, 'OH-D'), ('PR_000004696', 'apoptosis facilitator Bcl-2-like protein 14', 184, 'BV'), ('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 312, '25-OH-D'), ('GO_0007565', 'female pregnancy', 376, 'pregnancy')]
PMC3277098	12/2011	S4-PMC3277098	['THIS REVIEW explores the FINDINGS of epidemiological, clinical and laboratory research, and the POTENTIAL ROLE of Vitamin D in promoting the inappropriate Immune Responses which UNDERPIN the rise in a broad range of Immune diseases.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 178)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006955', 'immune response', 155, 'immune responses'), ('UBERON_0002405', 'immune system', 155, 'immune'), ('UBERON_0002405', 'immune system', 216, 'immune')]
PMC3277098	12/2011	S11-PMC3277098	['we AIM to review the CURRENT EVIDENCE on Vitamin D in RELATION to Immune mechanisms and FOCUS on the EFFECT of Pregnancy and Early Life exposure on Allergy Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0002405', 'immune system', 66, 'immune'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('UBERON_0001847', 'lobule of pinna', 125, 'early life'), ('GO_0060021', 'roof of mouth development', 148, 'allergy development')]
PMC3277098	12/2011	S199-PMC3277098	['most of these OBSERVATIONAL studies DID NOT have direct serological measures of 25(Oh)D levels to ACCURATELY CONFIRM Vitamin D status and cross sectional study designs involving older children and Adults fail TO provide EVIDENCE on aetiological FACTORS.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 109), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('UBERON_0007023', 'adult organism', 197, 'adults')]
PMC3271033	1/2012	S0-PMC3271033	['EFFECTS of ethnicity and Vitamin D supplementation on Vitamin D status and changes in bone Mineral content in infants\n\nabstract\n\nabstract\n\nbackground\nTO EVALUATE the EFFECTS on Serum 25(Oh)D and Bone mineralization of supplementation of Breast-Fed hispanic and non-hispanic caucasian infants with Vitamin D in infants in houston, texas.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 166)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_46662', 'mineral', 91, 'mineral'), ('UBERON_0001977', 'blood serum', 177, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 186, 'OH)D'), ('GO_0007567', 'parturition', 195, 'bone'), ('UBERON_0000310', 'breast', 237, 'breast'), ('GO_0007631', 'feeding behavior', 244, 'fed'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
PMC3271033	1/2012	S17-PMC3271033	['THIS STUDY was CONDUCTED TO EVALUATE early Life bone Mineral content (bmc) and the EFFECTS of three months of Vitamin D supplementation in Breast-Fed hispanic and non-hispanic caucasian (henceforth, "caucasian") infants on Vitamin D levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('UBERON_0000104', 'life cycle', 43, 'life'), ('CHEBI_46662', 'mineral', 53, 'mineral'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('UBERON_0000310', 'breast', 139, 'breast'), ('GO_0007631', 'feeding behavior', 146, 'fed'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D')]
PMC3271033	1/2012	S21-PMC3271033	['furthermore, FEW DATA have EVALUATED hispanic infants who MAY BE at high-risk for low Vitamin D status DUE TO POOR maternal Vitamin D intake [4].']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 58), ('PROBABLE_UNDERSTANDING', 103), ('PROBLEM_COMPLICATION', 110)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3271033	1/2012	S146-PMC3271033	['HOWEVER, the FINDINGS in OUR STUDY APPEAR MEANINGFUL in that the provision of Vitamin D at a dose of 400 iu/day LED TO mean values that were above 30 ng/ml REGARDLESS OF starting value or ethnicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ANOMALY_CURIOUS_FINDING', 35), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 156)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3271033	1/2012	S159-PMC3271033	['OUR FINDINGS SUPPORT current GUIDELINES to begin Vitamin D supplementation of 400 iu/day to all Breast-Fed infants in the first week of Life and to FURTHER ENCOURAGE the provision of adequate Vitamin D to Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 29), ('FUTURE_WORK', 148), ('FUTURE_WORK', 156)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'breast'), ('UBERON_0000310', 'breast', 96, 'breast'), ('GO_0007631', 'feeding behavior', 103, 'fed'), ('UBERON_0000104', 'life cycle', 136, 'life'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('GO_0007565', 'female pregnancy', 205, 'pregnant')]
PMC3296991	2/2012	S22-PMC3296991	['the PURPOSE of the PRESENT STUDY was TO INVESTIGATE the RELATIONSHIPS among maternal and Cord Vitamin D status, pth, balp, and Whole Body bmc (wbbmc) in newborns in a multiethnic population in oakland, california and TO EVALUATE the predictive value of the biochemical indices as indicators of neonatal wbbmc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 217)]	5	[('UBERON_0002240', 'spinal cord', 89, 'cord'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0000468', 'multicellular organism', 127, 'whole body')]
PMC3296991	2/2012	S85-PMC3296991	['in the PRESENT STUDY, total maternal daily Vitamin D intake >600 iu/day was ASSOCIATED with significantly higher Cord, and a TREND towards higher maternal, Serum 25(Oh)D at Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 125)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 113, 'cord'), ('UBERON_0001977', 'blood serum', 156, 'serum'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 162, '25(OH ... D'), ('GO_0007567', 'parturition', 173, 'delivery')]
PMC3296991	2/2012	S100-PMC3296991	['conclusion\nTHIS STUDY PROVIDES EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, cord pth and balp, and neonatal wbbmc, THOUGH neither Cord nor maternal 25(Oh)D were directly CORRELATED with wbbmc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 135), ('SUPERFICIAL_RELATIONSHIP', 190)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 150, 'cord'), ('CHEBI_33010', 'chromide(1-)', 170, '(OH)D')]
PMC3513049	2/2012	S4-PMC3513049	['methods\nTO INVESTIGATE POTENTIAL RELATIONSHIPS between household pet exposure and Cord Blood Vitamin D concentrations, we analyzed information from a large, geographically-based, general risk birth cohort.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('UBERON_0002240', 'spinal cord', 82, 'cord'), ('UBERON_0000178', 'blood', 87, 'blood'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC3347028	3/2012	S16-PMC3347028	['it is with these CAUTIONS and confessions that we approach THIS review about Vitamin D’s ROLE during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC3347028	3/2012	S17-PMC3347028	['in the sections ahead, we will FOCUS on one Micronutrient—Vitamin D—and will discuss WHAT we KNOW and what we surely do NOT KNOW in the context of the Pregnant woman and her developing fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('EXPLICIT_QUESTION', 85), ('INCOMPLETE_EVIDENCE', 93), ('FULL_UNKNOWN', 120)]	4	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 44, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnant')]
PMC3347028	3/2012	S36-PMC3347028	['general Vitamin D Metabolism\nIN ORDER TO understand the DIFFERENCES between the nonpregnant and Pregnant states and their EFFECTS on Vitamin D Metabolism, it is ESSENTIAL to understand the nonpregnant state first.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 122), ('IMPORTANT_CONSIDERATION', 161)]	4	[('CHEBI_28384', 'vitamin K', 8, 'Vitamin D'), ('GO_0046443', 'FAD metabolic process', 8, 'Vitamin D Metabolism'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 8, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 133, 'vitamin D metabolism'), ('PR_000006444', 'diacylglycerol kinase delta', 141, 'D')]
PMC3347028	3/2012	S110-PMC3347028	['in addition, BASED on rickets and osteoporosis data, it APPEARS that bone health, which is LINKED with Renal production of 1,25(Oh)2D and Calcium Metabolism is maintained at significantly lower levels of circulating Vitamin D concentrations COMPARED to OTHER health factors such as Immune function, which is dependent on delivery of 25(Oh)D to cells of the target Tissue.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ANOMALY_CURIOUS_FINDING', 56), ('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	5	[('UBERON_0002113', 'kidney', 103, 'renal'), ('CHEBI_37958', 'dye', 123, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 125, '25(OH)2D'), ('CHEBI_22313', 'alkaline earth metal atom', 138, 'calcium'), ('GO_0018884', 'carbazole metabolic process', 138, 'calcium metabolism'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('UBERON_0002405', 'immune system', 282, 'immune'), ('CHEBI_71657', 'versiconol acetate', 333, '25(OH)D'), ('UBERON_0000479', 'tissue', 364, 'tissue')]
PMC3347028	3/2012	S157-PMC3347028	['the FEW STUDIES that HAVE BEEN conducted have FOCUSED more on discernible neonatal EFFECTS of Vitamin D during Pregnancy, RATHER than the long-latency and later health EFFECTS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 168)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy')]
PMC3347028	3/2012	S163-PMC3347028	['WHILE we await the results of numerous clinical trials now underway TO determine IF there is a discernible EFFECT of Vitamin D in altering RISK for various disease states to understand the ROLE of Vitamin D in health, it is IMPORTANT not TO discount the MOUNTING EVIDENCE from laboratory studies and prospective observation trials [103,104,105] that Vitamin D—as a preprohormone—is ESSENTIAL in maintaining the Immune System with PROFOUND IMPLICATIONS [19,138,139,140].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 139), ('SUPERFICIAL_RELATIONSHIP', 189), ('IMPORTANT_CONSIDERATION', 224), ('QUESTION_ANSWERED_BY_THIS_WORK', 238), ('INCOMPLETE_EVIDENCE', 254), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 430), ('IMPORTANT_CONSIDERATION', 439)]	12	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('UBERON_0002405', 'immune system', 411, 'immune system')]
PMC3338544	4/2012	S12-PMC3338544	['moreover, there is now CONVINCING EXPERIMENTAL EVIDENCE BASED ON a MODEL in sprague-dawley Rats that developmental Vitamin D (Dvd) deficiency is ASSOCIATED with a range of schizophrenia-related neurochemical, neuroanatomical, and behavioural phenotypes[4],[5].']	[('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 23), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 56), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 145)]	7	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 91, 'rats'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD')]
PMC3347007	4/2012	S1-PMC3347007	['the AIMS of the PRESENT STUDY were to ESTIMATE the intake and sources of Vitamin D in danish Pregnant women and TO EXAMINE POTENTIAL DETERMINANTS of Vitamin D intake of the recommended level (10 µg per day).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 133)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnant'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC3347007	4/2012	S27-PMC3347007	['the danish national Birth cohort (dnbc) offers information on Vitamin D intake in danish Pregnant women as well as information on socio-demographic and lifestyle factors, and is THEREBY an excellent OPPORTUNITY TO investigate POTENTIAL DETERMINANTS of Vitamin D intake.']	[('PROBABLE_UNDERSTANDING', 178), ('FUTURE_WORK', 199), ('QUESTION_ANSWERED_BY_THIS_WORK', 211), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 236)]	5	[('GO_0007567', 'parturition', 20, 'Birth'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
PMC3347007	4/2012	S30-PMC3347007	['the AIMS of the PRESENT STUDY, conducted within the danish national Birth cohort, were: (1) to ESTIMATE the Vitamin D intake among danish Pregnant women; (2) TO INVESTIGATE the sources of Vitamin D; and (3) TO EXAMINE POTENTIAL DETERMINANTS of sufficient total Vitamin D intake among danish Pregnant women, including Gestational, lifestyle, and dietary factors.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('QUESTION_ANSWERED_BY_THIS_WORK', 207), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 228)]	7	[('GO_0007567', 'parturition', 68, 'Birth'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('GO_0007565', 'female pregnancy', 291, 'pregnant'), ('GO_0007565', 'female pregnancy', 317, 'gestational')]
PMC3347007	4/2012	S85-PMC3347007	['IN ORDER TO INVESTIGATE the sources of Vitamin D, total Vitamin D intake was divided into quartiles, and mean intake of dietary Vitamin D and Vitamin D from Supplements in each quartile was calculated.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 157, 'supplements')]
PMC3347007	4/2012	S95-PMC3347007	['we wanted TO EXAMINE WHETHER the women with sufficient total Vitamin D intake DIFFERED from the women with insufficient total Vitamin D intake (table 4).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC3347007	4/2012	S183-PMC3347007	['HOWEVER, we BELIEVE that the DETERMINANTS of Vitamin D intake SEEN in THIS STUDY MAY adequately reflect the ones of the background population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('INCOMPLETE_EVIDENCE', 81)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3347007	4/2012	S190-PMC3347007	['we PROPOSE that clinicians SHOULD ENCOURAGE Vitamin D supplementation among Pregnant women, with a SPECIAL FOCUS on vulnerable groups, such as younger, smoking and multiparous women, IN ORDER to improve maternal and fetal health both during and after Pregnancy.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 27), ('FUTURE_WORK', 34), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 107), ('QUESTION_ANSWERED_BY_THIS_WORK', 183)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnant'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
PMC3348565	4/2012	S27-PMC3348565	['a cross-sectional survey during the high-risk winter months in 2005 SHOWED that greater than 95% of children younger than 5 years in a socioeconomically deprived part of kabul had Serum Calcifediol levels of less than 37·5 nmol/l.12\nON THE BASIS OF findings that Vitamin D is an immunomodulator, that deficiency is a risk factor for pneumonia, and that quarterly supplementation had better compliance than daily or weekly supplementation,13,14we AIMED TO TEST the HYPOTHESIS that quarterly 100\u2008000 iu Vitamin D supplementation WOULD reduce the incidence of radiologically confirmed pneumonia by 35% in our study population.']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 233), ('QUESTION_ANSWERED_BY_THIS_WORK', 446), ('QUESTION_ANSWERED_BY_THIS_WORK', 452), ('INCOMPLETE_EVIDENCE', 464), ('FUTURE_PREDICTION', 527)]	6	[('UBERON_0001977', 'blood serum', 180, 'serum'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 186, 'calcifediol'), ('CHEBI_27300', 'vitamin D', 263, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 501, 'vitamin D')]
PMC3356951	4/2012	S11-PMC3356951	['in THIS REVIEW, we will summarize the mechanisms that are PRESUMED to underlie the RELATIONSHIP between Vitamin D and understand its biology and clinical IMPLICATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 154)]	4	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC3356951	4/2012	S19-PMC3356951	['[7] in THIS REVIEW, we will FOCUS on the biology of Vitamin D and summarize the mechanisms that are PRESUMED to underlie the RELATIONSHIP between Vitamin D and its clinical IMPLICATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('PROBABLE_UNDERSTANDING', 100), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 173)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC3427192	4/2012	S3-PMC3427192	['additionally, a GROWING body of LITERATURE SUGGESTS that there is a RELATIONSHIP between Vitamin D status and Respiratory symptoms, PRESUMABLY through immunomodulatory EFFECTS of Vitamin D. this review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on Human studies.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 228), ('QUESTION_ANSWERED_BY_THIS_WORK', 278)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 110, 'respiratory'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 287, 'human')]
PMC3427192	4/2012	S9-PMC3427192	['indeed, numerous dietary hypotheses HAVE BEEN PROPOSED.13-15among the Nutrients and antioxidants included in this HYPOTHESIS, Vitamin D is of particular INTEREST SINCE Vitamin D concentrations decrease with increased time spent indoors, decreased exposure to sunlight, less exercise, obesity, and inadequate Calcium intake.16additionally, a GROWING BODY of literature SUGGESTS that there is a RELATIONSHIP between Vitamin D status and asthma-RELATED Respiratory symptoms,17-22PRESUMABLY through the immunomodulatory EFFECTS of Vitamin D.23,24this brief review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on EMERGING Human STUDIES over the past decade.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 153), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 341), ('INCOMPLETE_EVIDENCE', 368), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 442), ('ANOMALY_CURIOUS_FINDING', 474), ('SUPERFICIAL_RELATIONSHIP', 516), ('SUPERFICIAL_RELATIONSHIP', 586), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 645)]	14	[('CHEBI_33284', 'nutrient', 70, 'nutrients'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 308, 'calcium'), ('CHEBI_27300', 'vitamin D', 414, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 450, 'respiratory'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 570, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 654, 'human')]
PMC3427192	4/2012	S38-PMC3427192	['due to higher levels of Melanin, african americans have the highest prevalence of Vitamin D deficiency, with the highest prevalence in those living in urban environments.43,76at the same time, asthma is also more PREVALENT in african american children.10,11only ONE STUDY TO DATE has FOCUSED on Vitamin D status in school-aged african american asthmatic children.']	[('IMPORTANT_CONSIDERATION', 213), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 272), ('QUESTION_ANSWERED_BY_THIS_WORK', 284)]	4	[('CHEBI_25179', 'melanins', 24, 'melanin'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC3427192	4/2012	S60-PMC3427192	['studies of Vitamin D status in Adults with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsblack80200514,091 (55)> 20 ycross-sectionalgeneral us populationlung functionhigher Serum 25(Oh)D ASSOCIATED with increased Lung functionkeet8120116857 (49)23.6cross-sectionalgeneral us populationwheeze, history of asthma, and asthma exacerbationhigher serum 25(Oh)D ASSOCIATED with decreased odds of current wheezing and asthma as well as emergency visits for asthma and asthma exacerbationsli822011435 (38)48.57cross-sectionalnewly diagnosed asthmaticslung function, total Serum igehigher 25(Oh)D ASSOCIATED with greater Lung function with no associations NOTED for igeoren832008290 (26)43cross-sectionalobese patientsasthma and allergic rhinitis25(Oh)D deficiency (< 25 ng/ml) ASSOCIATED with increased odds of atopic dermatitis BUT no associations with asthmasutherland84201054 (43)38.3cross-sectionalpersistent asthmalung function, Airway hyper-responsiveness, Glucocorticoid responsivenessdecreased 25(Oh)D ASSOCIATED with decreased Lung function, increased Airway hyperresponsiveness, and reduced Glucocorticoid responses\n\ngenetics of Vitamin D and asthma\nSOME STUDIES have FOCUSED on Genetic ASSOCIATIONS between Vitamin D and asthma in larger populations.']	[('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 388), ('SUPERFICIAL_RELATIONSHIP', 620), ('ANOMALY_CURIOUS_FINDING', 679), ('SUPERFICIAL_RELATIONSHIP', 801), ('ANOMALY_CURIOUS_FINDING', 853), ('SUPERFICIAL_RELATIONSHIP', 1034), ('INCOMPLETE_EVIDENCE', 1184), ('QUESTION_ANSWERED_BY_THIS_WORK', 1202), ('SUPERFICIAL_RELATIONSHIP', 1221)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0007023', 'adult organism', 31, 'adults'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 211, '25(OH)D'), ('UBERON_0002048', 'lung', 245, 'lung'), ('CHEBI_71657', 'versiconol acetate', 380, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 380, '25(OH)D'), ('UBERON_0001977', 'blood serum', 596, 'serum'), ('CHEBI_71657', 'versiconol acetate', 612, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 612, '25(OH)D'), ('UBERON_0002048', 'lung', 644, 'lung'), ('CHEBI_33010', 'chromide(1-)', 771, '(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 775, 'D'), ('UBERON_0001005', 'respiratory airway', 958, 'airway'), ('CHEBI_24261', 'glucocorticoid', 987, 'glucocorticoid'), ('CHEBI_71657', 'versiconol acetate', 1026, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 1029, 'OH ... D'), ('UBERON_0002048', 'lung', 1060, 'lung'), ('UBERON_0001005', 'respiratory airway', 1085, 'airway'), ('CHEBI_24261', 'glucocorticoid', 1125, 'glucocorticoid'), ('CHEBI_28384', 'vitamin K', 1163, 'Vitamin D'), ('SO_0000704', 'gene', 1213, 'genetic'), ('CHEBI_27300', 'vitamin D', 1242, 'vitamin D')]
PMC3395583	7/2012	S1-PMC3395583	["we AIMED TO INVESTIGATE WHETHER season of Birth INFLUENCES the risk of rheumatoid arthritis, crohn's disease, ulcerative colitis and systemic lupus erythematosus in addition to multiple sclerosis, and TO EXPLORE the CORRELATION between the risk of id and predicted ultraviolet b (uvb) light exposure and Vitamin D status during Gestation."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('GO_0007567', 'parturition', 42, 'birth'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('GO_0007565', 'female pregnancy', 328, 'gestation')]
PMC3395583	7/2012	S24-PMC3395583	['since all these conditions HAVE BEEN LINKED to Vitamin D deficiency [23,24], we also TESTED WHETHER the risk of disease by month of Birth follows the same seasonal distribution of predicted ultraviolet b (uvb) light radiation and 25-Hydroxyvitamin D (25-Oh-D) levels during Gestation.']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 37), ('QUESTION_ANSWERED_BY_THIS_WORK', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007567', 'parturition', 132, 'birth'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 230, '25-hydroxyvitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 251, '25-OH-D'), ('GO_0007565', 'female pregnancy', 274, 'gestation')]
PMC3395583	7/2012	S56-PMC3395583	['we next INVESTIGATED WHETHER the monthly risk of id inversely CORRELATED with PREDICTED Gestational Uvb exposure and Vitamin D status during different Trimesters of Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('GO_0007565', 'female pregnancy', 88, 'gestational'), ('CHEBI_37043', "pyrimidine 2'-deoxyribonucleoside 5'-triphosphate", 100, 'UVB'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 151, 'trimesters'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy')]
PMC3395583	7/2012	S85-PMC3395583	['furthermore, the seasonal variation of 25-Oh-D levels WAS NOT INVESTIGATED AND NO other STUDIES have tried to answer the same QUESTION in id OTHER than ms. we FOUND that the risk of id was inversely ASSOCIATED with PREDICTED second trimester Uvb exposure and third trimester Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 54), ('FULL_UNKNOWN', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('EXPLICIT_QUESTION', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 215)]	8	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 39, '25-OH-D'), ('CHEBI_37043', "pyrimidine 2'-deoxyribonucleoside 5'-triphosphate", 242, 'UVB'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3407995	7/2012	S13-PMC3407995	['a review of current literature was UNDERTAKEN to summarize the POTENTIAL benefits of maternal supplementation with Dha, Vitamin D, Folic Acid and Iodine during Pregnancy and/or Breast feeding for Foetal and/or infant Brain Development and/or function.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('INCOMPLETE_EVIDENCE', 63)]	2	[('CHEBI_17874', 'dihydrozeatin', 115, 'DHA'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_30751', 'formic acid', 131, 'folic acid'), ('CHEBI_24859', 'iodine atom', 146, 'iodine'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy'), ('UBERON_0000310', 'breast', 177, 'breast'), ('GO_0000009', 'alpha-1,6-mannosyltransferase activity', 196, 'foetal ...'), ('GO_0007420', 'brain development', 217, 'brain development'), ('UBERON_0000955', 'brain', 217, 'brain')]
PMC3407995	7/2012	S436-PMC3407995	['a RECENT cochrane review ASSESSED the EFFECTS and SAFETY of Vitamin D supplementation in Pregnancy and EXAMINED WHETHER supplementation with Vitamin D alone OR in combination with Calcium and other Vitamins and Minerals given to women during Pregnancy COULD SAFELY improve Pregnancy outcomes [175].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 252), ('IMPORTANT_CONSIDERATION', 258)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 180, 'calcium'), ('CHEBI_33277', 'gamma-tocotrienol', 198, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 211, 'minerals'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
PMC3424155	8/2012	S10-PMC3424155	['conclusion\nTHESE FINDINGS DEMONSTRATE that maternal Vitamin D deficiency accompanies changes in the Renal Expression of IMPORTANT FACTORS that MAY retard the Maturation Of Glomeruli by EXTENDING the period of Nephrogenesis.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('IMPORTANT_CONSIDERATION', 120), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 185)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002113', 'kidney', 100, 'renal'), ('GO_0010467', 'gene expression', 106, 'expression'), ('GO_0009902', 'chloroplast relocation', 158, 'maturation of glomeruli'), ('UBERON_0000074', 'renal glomerulus', 172, 'glomeruli'), ('GO_0001822', 'kidney development', 209, 'nephrogenesis')]
PMC3424155	8/2012	S23-PMC3424155	['THIS STUDY investigates the EFFECTS of maternal Vitamin D deficiency on Glomerular Development in early Postnatal Life and its EFFECTS on Renal structure at maturity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 127)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0032835', 'glomerulus development', 72, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 72, 'glomerular'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('UBERON_0000104', 'life cycle', 114, 'life'), ('UBERON_0002113', 'kidney', 138, 'renal')]
PMC3424155	8/2012	S24-PMC3424155	['THIS STUDY FOCUSES on the f1 and f2 generations after f0 maternal Vitamin D restriction.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3424155	8/2012	S167-PMC3424155	['in the PRESENT STUDY, maternal Vitamin D deficiency in Mice LED TO significant changes in Kidney Development in the offspring, such as retardation of Glomerular Maturation and an increase in the number of Glomeruli.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 55, 'mice'), ('GO_0001822', 'kidney development', 90, 'kidney development'), ('UBERON_0002113', 'kidney', 90, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 150, 'glomerular'), ('GO_0007618', 'mating', 161, 'maturation'), ('UBERON_0000074', 'renal glomerulus', 205, 'glomeruli')]
PMC3424155	8/2012	S208-PMC3424155	['the MAJOR AIM of the study was TO INVESTIGATE Glomerular Development and Renal structure at Birth, 10 days and Adulthood in Mice Born to mothers Fed a diet restricted in Vitamin D. ALTHOUGH, we EXAMINED OTHER variables, such as body mass and 24 h Urine, the PRESENT STUDY was NOT DESIGNED TO investigate Renal functional and Metabolic CONSEQUENCES BUT RATHER was DESIGNED TO answer the QUESTION of WHETHER there were structural, Glomerular alterations or transgenerational EFFECTS.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 203), ('QUESTION_ANSWERED_BY_THIS_WORK', 258), ('INCOMPLETE_EVIDENCE', 276), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 363), ('EXPLICIT_QUESTION', 386), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 398), ('SUPERFICIAL_RELATIONSHIP', 473)]	15	[('GO_0032835', 'glomerulus development', 46, 'glomerular development'), ('UBERON_0000074', 'renal glomerulus', 46, 'glomerular'), ('UBERON_0002113', 'kidney', 73, 'renal'), ('GO_0007567', 'parturition', 92, 'birth'), ('UBERON_0000113', 'post-juvenile adult stage', 111, 'adulthood'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'mice'), ('GO_0007567', 'parturition', 129, 'born'), ('GO_0007631', 'feeding behavior', 145, 'fed'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('UBERON_0001088', 'urine', 247, 'urine'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('GO_0008152', 'metabolic process', 325, 'metabolic'), ('UBERON_0000074', 'renal glomerulus', 429, 'glomerular')]
PMC3427250	8/2012	S2-PMC3427250	['the AIM of THIS STUDY was to estimate the prevalence of Vitamin D deficiency among belgian Pregnant women and TO ASSESS the determinants of Vitamin D status in the first and third Trimester of Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 110)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnant'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 180, 'trimester'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
PMC3427250	8/2012	S34-PMC3427250	['THEREFORE the AIM of THIS STUDY was to carry out the FIRST national representative random sample survey on Vitamin D status in Pregnant women in a european country and TO ASSESS the determinants of Vitamin D status in the first and third Trimester of Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 168)]	5	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 238, 'trimester'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
PMC3427250	8/2012	S97-PMC3427250	['however, the PRESENT STUDY is the FIRST national survey on Vitamin D status among Pregnant women in belgium.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 34)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant')]
PMC3427250	8/2012	S103-PMC3427250	['ethnicity was also a major DETERMINANT of Vitamin D status in the PRESENT STUDY, as PREVIOUSLY reported in the Adult population[32]and in Pregnant women[29],[48],[49].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 66), ('INCOMPLETE_EVIDENCE', 84)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 138, 'pregnant')]
PMC3472720	8/2012	S2-PMC3472720	['TO answer THIS question, we ASSESSED f2females whose f1parents (males or females) were Vitamin D-deprived when developing in the Uterus of f0females.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 28)]	3	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0000995', 'uterus', 129, 'uterus')]
PMC3472720	8/2012	S12-PMC3472720	['IN ORDER TO TEST the HYPOTHESIS that low Vitamin D status during Gestation is a RISK FACTOR for ms, we explored a well-DESCRIBED developmental Vitamin D (dvd) deficiency Rodent MODEL, [11,12].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 177)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestation'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 170, 'rodent')]
PMC3472720	8/2012	S31-PMC3472720	['the QUESTION we have ADDRESSED was WHETHER one’s parents’ season of Birth (AS a PROXY-measure of developmental Vitamin D status) COULD BE an additional RISK FACTOR for ms patients?']	[('EXPLICIT_QUESTION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('EXPLICIT_QUESTION', 35), ('PROBABLE_UNDERSTANDING', 75), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 152), ('EXPLICIT_QUESTION', 179)]	9	[('GO_0007567', 'parturition', 68, 'birth'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 119, 'D')]
PMC3472720	8/2012	S105-PMC3472720	['conclusions\nwe SHOW HERE for the FIRST TIME that a maternal Vitamin D deficiency induces inverted transgenerational EFFECTS on the Immune System of offspring: the f2generation is more sensitive to Myelin peptide immunization WHILE, as PREVIOUSLY DEMONSTRATED, the f1generation is less sensitive.']	[('INCOMPLETE_EVIDENCE', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('INCOMPLETE_EVIDENCE', 235)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002405', 'immune system', 131, 'immune system'), ('UBERON_0000345', 'myelin', 197, 'myelin')]
PMC3476426	8/2012	S92-PMC3476426	['in the PRESENT STUDY, autistic children had significantly lower Serum levels of 25-Hydroxy Vitamin D than healthy children, p< 0.001, with 40% and 48% being Vitamin D deficient and insufficient, respectively.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7)]	1	[('UBERON_0001977', 'blood serum', 64, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 80, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC3476426	8/2012	S102-PMC3476426	['in the PRESENT WORK, Serum 25-Hydroxy Vitamin D levels had significant negative CORRELATIONS with cars ( p< 0.001) which signifies the POSSIBLE LINK between the extent of Vitamin D deficiency and the degree of the severity of autism.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 144)]	4	[('UBERON_0001977', 'blood serum', 21, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 27, '25-hydroxy vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC3476426	8/2012	S115-PMC3476426	['THUS, the results of OUR STUDY DID NOT signify the reduced duration of sun exposure AS a causal factor of 25 Hydroxy Vitamin D deficiency in autistic children.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 31), ('PROBABLE_UNDERSTANDING', 84)]	4	[('CHEBI_45557', 'sec-butyl group', 106, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3458940	9/2012	S160-PMC3458940	['THUS, the ROLES for the tra/rar target Genes IDENTIFIED in THIS STUDY in the aforementioned Renal anomalies ASSOCIATED to post-Natal Vitamin A deficiency DESERVE FURTHER studies.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('SUPERFICIAL_RELATIONSHIP', 108), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 154), ('FUTURE_WORK', 162)]	8	[('SO_0000704', 'gene', 39, 'genes'), ('UBERON_0002113', 'kidney', 92, 'renal'), ('GO_0007567', 'parturition', 127, 'natal'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A')]
PMC3470091	9/2012	S0-PMC3470091	['the EFFICACY and SAFETY of a high dose of Vitamin D in mothers with Gestational diabetes mellitus: a randomized controlled clinical TRIAL\n\nabstract\nbackground: during Pregnancy and Lactation outstanding changes occur in mother’s Vitamin D Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('IMPORTANT_CONSIDERATION', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 132)]	3	[('CHEBI_28384', 'vitamin K', 42, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 42, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'Gestational'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy'), ('GO_0007595', 'lactation', 181, 'lactation'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 229, 'vitamin D metabolism')]
PMC3470091	9/2012	S1-PMC3470091	['THIS STUDY was carried out TO EVALUATE the efficacy of 300,000 iu Vitamin D given intramuscularly on body status in new cases of Gestational diabetes mellitus (gdm).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 27)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'gestational')]
PMC3470091	9/2012	S21-PMC3470091	['a dose of 600,000 iu Vitamin D resulted in hypercalcemia, THEREFORE, it can not be REGARDED a SAFE dose.17there is NO STUDY to evaluate Vitamin D status in mothers with previous gdm, and present oral Vitamin D products are not fully EFFECTIVE,16THEREFORE, THIS STUDY was DESIGNED TO EVALUATE the EFFECT of intramuscular injection of 300,000 iu during a three-month period.']	[('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 83), ('IMPORTANT_CONSIDERATION', 94), ('FULL_UNKNOWN', 115), ('SUPERFICIAL_RELATIONSHIP', 233), ('PROBABLE_UNDERSTANDING', 245), ('QUESTION_ANSWERED_BY_THIS_WORK', 256), ('QUESTION_ANSWERED_BY_THIS_WORK', 271), ('QUESTION_ANSWERED_BY_THIS_WORK', 280), ('SUPERFICIAL_RELATIONSHIP', 296)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC3470091	9/2012	S69-PMC3470091	['this INDICATES the efficacy of THIS procedure in dramatic improvement of Vitamin D status in the mothers, especially in the region with high Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 31)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3470091	9/2012	S77-PMC3470091	['such a change results in the inhibition of pth secretion from Parathyroid Cells.27\nthe increase of Serum calcium in the ig in the PRESENT STUDY is SIMILAR TO that REPORTED in the OTHER STUDIES.15,17-20,22-25,27,28the mechanism of increasing Serum Calcium by Vitamin D is that Vitamin D attaches optionally to receptors X Of Retinoic Acid (rxr), and composes a heteromeric Complex with a certain sequence on the dna, known as reacting elements to Vitamin D. this LEADS to the transcription of a special mrna, which results in the Translation Of several Proteins such as Epithelial calcium channels and the proteins attached to calcium.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 130), ('INCOMPLETE_EVIDENCE', 147), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 462)]	5	[('CL_0000512', 'paracrine cell', 62, 'parathyroid cells'), ('UBERON_0001132', 'parathyroid gland', 62, 'parathyroid'), ('UBERON_0001977', 'blood serum', 99, 'serum'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 247, 'calcium'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_30341', 'silver monochloride', 319, 'X of'), ('GO_0000805', 'X chromosome', 319, 'X'), ('CHEBI_26536', 'retinoic acid', 324, 'retinoic acid'), ('GO_0032991', 'protein-containing complex', 372, 'complex'), ('CHEBI_27300', 'vitamin D', 446, 'vitamin D'), ('GO_0006415', 'translational termination', 529, 'translation of ... proteins'), ('UBERON_0000483', 'epithelium', 569, 'epithelial')]
PMC3470091	9/2012	S84-PMC3470091	['OUR STUDY REVEALED that a single high dose injection of Vitamin D is more economic and effective PARTICULARLY in Lactating mothers who refrain from Consuming oral daily doses due to Postpartum care, unwillingness or depression.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('ANOMALY_CURIOUS_FINDING', 97)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 113, 'lactating'), ('GO_0007631', 'feeding behavior', 148, 'consuming'), ('GO_0007565', 'female pregnancy', 182, 'postpartum')]
PMC3470091	9/2012	S87-PMC3470091	['moreover, ANOTHER STUDY,18SHOWED that a single dose of 200,000 iu of Vitamin D in the healthy youths was ASSOCIATED with a peak in Vitamin D concentration after two weeks of treatment, BUT lower than that of OUR STUDY at three months after treatment.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 208)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3465343	10/2012	S2-PMC3465343	['THE CURRENT STUDY SEEKS TO elucidate the EFFECT of maternal Vitamin A deficiency and the production of congenital Spinal deformities in the offsping.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 41)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('UBERON_0001130', 'vertebral column', 114, 'spinal')]
PMC3465343	10/2012	S143-PMC3465343	['TO verify the reduction of Vitamin A in Mice receiving vad diet, we measured the Vitamin A level of mothers before Mating and their offspring at Postnatal day 1, and confirmed the vad status during Pregnancy in the vad group as previously described[33].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 40, 'mice'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A'), ('GO_0007618', 'mating', 115, 'mating'), ('GO_0007567', 'parturition', 145, 'postnatal'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy')]
PMC3465343	10/2012	S175-PMC3465343	['HOWEVER, in OUR STUDY, we used the modified ain-93g diet without any source of Vitamin A and the mean Serum Retinol concentration in the Adult females in the vad group was 0.51±0.57 µmol/l, which was significantly lower than that of the control group (p<0.01).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_26536', 'retinoic acid', 108, 'retinol'), ('UBERON_0007023', 'adult organism', 137, 'adult')]
PMC3485340	10/2012	S124-PMC3485340	['DESPITE this adjustment, hippocampal volumes were consistently lower in Prenatally deficient compared TO non-deficient counterparts at all time points (p<0.05 or less) (figure 2).10.1371/journal.pone.0048488.g002\n\ncaption (fig): figure 2\npersistently lower hippocampal volume corrected for Brain weight in Prenatally Vitamin C-depleted Animals.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 102)]	2	[('GO_0019230', 'proprioception', 72, 'prenatally'), ('UBERON_0000955', 'brain', 290, 'brain'), ('GO_0019230', 'proprioception', 306, 'prenatally'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin C'), ('NCBITaxon_33208', 'Metazoa', 336, 'animals')]
PMC3501517	11/2012	S7-PMC3501517	['ex vivo Neutrophil Chemotaxis was EVALUATED, using Neutrophils from Vitamin D sufficient and deficient Mice exposed to the chemoattractants, Kc/Cxcl1 and C5A, and to Bronchoalveolar lavage Fluid from Lps-exposed Mice.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 34)]	1	[('CL_0000775', 'neutrophil', 8, 'neutrophil'), ('GO_0007567', 'parturition', 8, 'neutrophil'), ('GO_0006935', 'chemotaxis', 19, 'chemotaxis'), ('CL_0000775', 'neutrophil', 51, 'neutrophils'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 103, 'mice'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 141, 'KC'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 144, 'CXCL1'), ('PR_000002319', 'catenin beta-1 isoform 1', 154, 'C5a'), ('UBERON_0002183', 'lobar bronchus', 166, 'bronchoalveolar'), ('UBERON_0006314', 'bodily fluid', 189, 'fluid'), ('CHEBI_16412', 'lipopolysaccharide', 200, 'LPS'), ('NCBITaxon_10088', 'Mus <genus>', 212, 'mice')]
PMC3501517	11/2012	S30-PMC3501517	['TO TEST THIS HYPOTHESIS, we developed a Murine MODEL of Vitamin D deficiency through diet modification to compare the temporal pattern of inflammation and resolution in response to Lps exposure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 47)]	4	[('NCBITaxon_39107', 'Murinae', 40, 'murine'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 181, 'LPS')]
PMC3501517	11/2012	S153-PMC3501517	['Lung inflammation and injury 10 days after Lps\nTO INVESTIGATE the EFFECT of Vitamin D deficiency on resolution of Lung injury, we evaluated Mice at day 10 after Lps or pbs instillation[34].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('UBERON_0002048', 'lung', 0, 'Lung'), ('CHEBI_16412', 'lipopolysaccharide', 43, 'LPS'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0002048', 'lung', 114, 'lung'), ('NCBITaxon_10088', 'Mus <genus>', 140, 'mice'), ('CHEBI_16412', 'lipopolysaccharide', 161, 'LPS')]
PMC3501517	11/2012	S179-PMC3501517	['discussion\nour GOAL in THIS STUDY was TO INVESTIGATE the ROLE of Vitamin D in Lps-induced acute Lung injury and its resolution.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 78, 'LPS'), ('UBERON_0002048', 'lung', 96, 'lung')]
PMC3501517	11/2012	S181-PMC3501517	['the PRIMARY findings of this study are that Vitamin D level has minimal IMPACT on acute inflammation and injury following Lps and on subsequent resolution of inflammation and injury.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 122, 'LPS')]
PMC3501517	11/2012	S225-PMC3501517	['a LIMITATION of THIS STUDY is that normal levels of Vitamin D in Mice are not well established.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 65, 'mice')]
PMC3509518	11/2012	S1-PMC3509518	['we INVESTIGATED ASSOCIATIONS between maternal intakes of Β-Carotene, Vitamin C, Vitamin E, copper and zinc, and infant allergic outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('CHEBI_28064', 'cyanidin 3-O-rutinoside', 57, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin E')]
PMC3509518	11/2012	S11-PMC3509518	['IN SUMMARY, THIS STUDY SUGGESTS that maternal diet of fresh Foods rich in Vitamin C is ASSOCIATED with reduced risk of infant wheeze, and that copper intake is ASSOCIATED with reduced RISK of several allergic outcomes.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 87), ('SUPERFICIAL_RELATIONSHIP', 160), ('IMPORTANT_CONSIDERATION', 184)]	6	[('CHEBI_33290', 'food', 60, 'foods'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin C')]
PMC3509518	11/2012	S24-PMC3509518	['THEREFORE, the AIM of THIS STUDY was TO PROSPECTIVELY ASSESS the EFFECTS of Maternal intakes of selected Antioxidants (Β-Carotene, Vitamin C, Vitamin E, copper and zinc) in Pregnancy on early infant allergic outcomes, namely eczema, Immunoglobulin e (Ige)-mediated Food allergy, allergic sensitisation and wheeze in a population at high risk of developing allergic disease BASED ON familial ASSOCIATION.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 373), ('SUPERFICIAL_RELATIONSHIP', 391)]	7	[('GO_0007618', 'mating', 76, 'maternal'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 105, 'antioxidants'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 119, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin E'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('GO_0019815', 'B cell receptor complex', 233, 'Immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 251, 'IgE'), ('CHEBI_33290', 'food', 265, 'food')]
PMC3509518	11/2012	S93-PMC3509518	['SINCE many mothers did not meet the rdi for Vitamin E and Zinc [18], we INVESTIGATED ASSOCIATIONS between Vitamin E and zinc intakes dichotomized as exposure at the minimum rdi (yes/no) and allergic outcomes.']	[('PROBLEM_COMPLICATION', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 72), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 58, 'Zinc'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin E')]
PMC3509518	11/2012	S117-PMC3509518	['this is CONSISTENT with the FINDINGS in the PRESENT STUDY that SUGGEST a reduced risk of wheeze with higher maternal dietary Vitamin C intake, ALTHOUGH the inverse linear trend fell short of the significance level.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('INCOMPLETE_EVIDENCE', 63), ('ANOMALY_CURIOUS_FINDING', 143)]	5	[('CHEBI_27300', 'vitamin D', 125, 'vitamin C')]
PMC3509518	11/2012	S122-PMC3509518	['in the PRESENT STUDY, the MAJORITY of mothers reported dietary Vitamin C intakes above the rdi of 60 mg Vitamin C daily, thereby well meeting the expected needs [18].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('PROBABLE_UNDERSTANDING', 26)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin C')]
PMC3509518	11/2012	S148-PMC3509518	['conclusions\nIN SUMMARY, THIS STUDY SUGGESTS an ASSOCIATION between Maternal Consumption of Foods rich in SOME antioxidant factors, namely Vitamin C and copper, and reduced risk of allergic outcomes in infancy in a population PREDISPOSED to allergic disease.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 225)]	6	[('GO_0007618', 'mating', 67, 'maternal'), ('GO_0007631', 'feeding behavior', 76, 'consumption'), ('CHEBI_33290', 'food', 91, 'foods'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin C')]
PMC3515887	11/2012	S218-PMC3515887	['Ascorbic Acid\nthe RATIONALE for Ascorbic Acid (Vitamin C) supplementation in large doses is that it blocks binding to da receptors and POSSIBLY corrects redox balance, leading to correction of Metabolic stress that MAY CONTRIBUTE to autism symptoms.']	[('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 219)]	5	[('CHEBI_2878', 'Aspecioside', 0, 'Ascorbic Acid'), ('CHEBI_22652', 'ascorbic acid', 32, 'ascorbic acid'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin C'), ('GO_0008152', 'metabolic process', 193, 'metabolic')]
PMC3515553	12/2012	S2-PMC3515553	['in THIS STUDY we ASSESSED the EFFECT of Vitamin B-12 status in well-nourished Pregnant women on the Cognitive ability of their offspring in a uk birth cohort (alspac).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 30)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 40, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('GO_0050890', 'cognition', 100, 'cognitive')]
PMC3515553	12/2012	S7-PMC3515553	['OUR FINDINGS SUGGEST that maternal Vitamin B-12 MAY not have an IMPORTANT EFFECT on offspring Cognitive ability.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 64), ('SUPERFICIAL_RELATIONSHIP', 74)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin B'), ('PR_000004770', 'Polycomb complex protein BMI-1', 43, 'B-12'), ('GO_0050890', 'cognition', 94, 'cognitive')]
PMC3515553	12/2012	S18-PMC3515553	['ONE WAY to avoid PROBLEMS of residual CONFOUNDING in OBSERVATIONAL epidemiology is to use Genetic variants that are KNOWN to be reliably RELATED to the modifiable risk factor of interest (here maternal Vitamin B-12) as PROXIES IN ORDER TO determine the causal EFFECT of the risk factor[9],[10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 17), ('PROBLEM_COMPLICATION', 38), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 219), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 236), ('SUPERFICIAL_RELATIONSHIP', 260)]	10	[('SO_0000704', 'gene', 90, 'genetic'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 202, 'vitamin B-12')]
PMC3515553	12/2012	S21-PMC3515553	['the AIM of THIS STUDY was TO EXAMINE the ASSOCIATION of maternal dietary Intake of Vitamin B-12 and also of Snps in Fut2 and tcn2 with offspring iq assessed at age 8 in a population of european origin.figure 1shows the framework for the HYPOTHESIS that we have EXAMINED HERE concerning the LINKS between maternal Vitamin B-12 during Pregnancy with offspring iq.10.1371/journal.pone.0051084.g001\n\ncaption (fig): figure 1\ndiagram showing the framework of the mendelian randomization approach used in this study.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 237), ('QUESTION_ANSWERED_BY_THIS_WORK', 261), ('QUESTION_ANSWERED_BY_THIS_WORK', 270), ('SUPERFICIAL_RELATIONSHIP', 290)]	8	[('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 83, 'vitamin B-12'), ('SO_0000694', 'SNP', 108, 'SNPs'), ('PR_000007719', 'frizzled-2', 116, 'FUT2'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin B'), ('GO_0007565', 'female pregnancy', 333, 'pregnancy')]
PMC3515553	12/2012	S49-PMC3515553	['potential confounders and mediators\nwe TESTED for the ASSOCIATION of POTENTIAL CONFOUNDERS with offspring iq, maternal dietary Vitamin B-12 intake and genotypes of Vitamin B-12 RELATED variants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 69), ('PROBLEM_COMPLICATION', 79), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_85855', 'diacylglycerol 46:7', 127, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 127, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 164, 'vitamin B-12')]
PMC3515553	12/2012	S53-PMC3515553	['in the observational analyses of maternal dietary Vitamin B-12 in Pregnancy, we also EXAMINED POSSIBLE MEDIATION by Gestational age, Birth-weight and breastfeeding (obtained from repeat Postnatal maternal completed questionnaires and derived as no breastfeeding, breastfeeding for <3 months, for 3 to 5 months, for ≥6 months).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 85), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 50, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007565', 'female pregnancy', 116, 'gestational'), ('GO_0007567', 'parturition', 133, 'birth'), ('GO_0007567', 'parturition', 186, 'postnatal')]
PMC3515553	12/2012	S65-PMC3515553	['we INVESTIGATED the ASSOCIATION of POTENTIAL CONFOUNDING FACTORS with maternal Vitamin B-12 intake, offspring iq, and maternal and offspring genotype using linear regression and chi square tests.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 35), ('PROBLEM_COMPLICATION', 45)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 79, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 89, '12')]
PMC3515553	12/2012	S127-PMC3515553	['discussion\n\nmain findings\nTO THE BEST OF OUR KNOWLEDGE THIS is the FIRST STUDY to EXAMINE the IMPACT of differential concentrations of circulating Vitamin B-12 on offspring iq through the use of records of Maternal Pregnancy Vitamin B-12 intake, as well as Vitamin B-12 RELATED Genetic variants.']	[('PROBABLE_UNDERSTANDING', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 67), ('QUESTION_ANSWERED_BY_THIS_WORK', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 147, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 147, 'vitamin B-12'), ('GO_0007618', 'mating', 206, 'maternal'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 225, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 235, '12'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 257, 'vitamin B-12'), ('SO_0000704', 'gene', 278, 'genetic')]
PMC3515553	12/2012	S151-PMC3515553	['HOWEVER, the MAJORITY of the children with Cord Blood Vitamin B-12 measures in OUR STUDY were not Vitamin B-12 deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 79)]	3	[('UBERON_0009472', 'axilla', 43, 'cord blood'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 54, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 98, 'vitamin B-12')]
PMC3515553	12/2012	S164-PMC3515553	['additionally, the Snps that we have used HERE as PROXIES for the unconfounded ASSOCIATION of maternal Vitamin B-12 with offspring iq explain ONLY a small proportion of the variance of Plasma Vitamin B-12[11],[39].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 141)]	4	[('SO_0000694', 'SNP', 18, 'SNPs'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 102, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 112, '12'), ('UBERON_0001969', 'blood plasma', 184, 'plasma'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 191, 'vitamin B-12')]
PMC3521768	12/2012	S1-PMC3521768	['objective\nTO ASSESS the INDEPENDENT and INTERACTION EFFECTS of Prenatal zinc and Vitamin A deficiencies on Birthweight in rural sidama, southern ethiopia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 40), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('GO_0007565', 'female pregnancy', 63, 'prenatal'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A'), ('GO_0007596', 'blood coagulation', 107, 'birthweight')]
PMC3521768	12/2012	S30-PMC3521768	['the PURPOSE of THE CURRENT STUDY is TO INVESTIGATE the INDEPENDENT and INTERACTION EFFECTS of Prenatal zinc and Vitamin A deficiencies on Birthweight in rural sidama, southern ethiopia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 83)]	6	[('GO_0007565', 'female pregnancy', 94, 'prenatal'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin A'), ('GO_0007596', 'blood coagulation', 138, 'birthweight')]
PMC3521768	12/2012	S32-PMC3521768	['DESPITE the existence of MANY rcts and OBSERVATIONAL studies which evaluated the EFFECT of Prenatal zinc and Vitamin A status on Birthweight, THE CURRENT STUDY is WORTH documentable as it HAS BEEN conducted in area with high prevalence of zinc and Vitamin A deficiencies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 142), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 188)]	8	[('GO_0007565', 'female pregnancy', 91, 'prenatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('GO_0007596', 'blood coagulation', 129, 'birthweight'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin A')]
PMC3521768	12/2012	S143-PMC3521768	['IN ORDER TO INVESTIGATE the POSSIBILITY of synergetic INTERACTION of the two deficiencies in causing lbw, the study subjects were categorized into four groups based on Vitamin A and zinc deficiency statuses and analyzed accordingly (table 3).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 168, 'vitamin A')]
PMC3534321	12/2012	S65-PMC3534321	['MANY STUDIES about PREVENTION of pe are BASED on primary INTERVENTIONS, when applied to whole population\u2009:\u2009bed rest, restriction of activity or regular exercise, nutritional measures as Reduced Salt intake, and antioxidants such as Vitamins C and e, garlic, marine oil.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_26567', 'N-ribosyl-N(6)-isopentenyladenine', 186, 'reduced salt'), ('CHEBI_27300', 'vitamin D', 232, 'vitamins C')]
PMC3552819	12/2012	S18-PMC3552819	['the AIM was to generate PRELIMINARY pharmacokinetic (pk) and safety data to inform the design of supplementation regimens for use in FUTURE larger-scale TRIALS of Antenatal Vitamin D supplementation in bangladesh.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 24), ('FUTURE_WORK', 133)]	3	[('GO_0007567', 'parturition', 163, 'antenatal'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3552819	12/2012	S218-PMC3552819	['these erratic PATTERNS COULD NOT EASILY BE EXPLAINED on THE BASIS OF KNOWN Vitamin D pharmacokinetics, but were MOST LIKELY ATTRIBUTABLE TO small-sample ARTIFACTS, biological variability in the absorption and Metabolism Of Vitamin D, and inherent imprecision in the laboratory assessment of [25(Oh)D].']	[('SUPERFICIAL_RELATIONSHIP', 14), ('DIFFICULT_TASK', 23), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 137), ('PROBLEM_COMPLICATION', 153)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 209, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 292, '25(OH)D')]
PMC3888066	12/2012	S12-PMC3888066	['this NOTION is BASED ON the KNOWN Teratogenic EFFECTS of Retinoic Acids on the Central Nervous System,1–3the CALCULATED dose of Retinol and Beta Carotene Ingested by the mother during early Pregnancy, and STRONG EVIDENCE that the fetus Metabolizes Beta Carotene to Retinoids and has LIMITED ability to store Beta Carotene in Fat Cells.4–7\nin 1995, rothman et al DEMONSTRATED that high maternal dietary intake of Vitamin A in the form of Retinol, ie, >10,000 iu/day, particularly in the first Trimester, MAY BE ASSOCIATED with Cranial-Neural-Crest Birth defects.8using a smooth regression curve, THIS study of 22,748 Pregnant women and their offspring IDENTIFIED 1 infant in 57 with malformations that COULD BE ATTRIBUTED to the intake of supplements of Preformed Vitamin A at a dose >10,000 iu/day.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 15), ('ANOMALY_CURIOUS_FINDING', 21), ('ANOMALY_CURIOUS_FINDING', 21), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 205), ('INCOMPLETE_EVIDENCE', 283), ('INCOMPLETE_EVIDENCE', 362), ('INCOMPLETE_EVIDENCE', 503), ('SUPERFICIAL_RELATIONSHIP', 510), ('QUESTION_ANSWERED_BY_THIS_WORK', 595), ('INCOMPLETE_EVIDENCE', 651), ('INCOMPLETE_EVIDENCE', 701), ('SUPERFICIAL_RELATIONSHIP', 710)]	16	[('CHEBI_50905', 'teratogenic agent', 34, 'teratogenic'), ('CHEBI_26536', 'retinoic acid', 57, 'retinoic acids'), ('UBERON_0001017', 'central nervous system', 79, 'central nervous system'), ('CHEBI_26536', 'retinoic acid', 128, 'retinol'), ('CHEBI_51438', 'D-isoascorbic acid', 140, 'beta carotene'), ('GO_0007631', 'feeding behavior', 154, 'ingested'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0008152', 'metabolic process', 236, 'metabolizes'), ('CHEBI_51438', 'D-isoascorbic acid', 248, 'beta carotene'), ('CHEBI_26537', 'retinoid', 265, 'retinoids'), ('CHEBI_51438', 'D-isoascorbic acid', 308, 'beta carotene'), ('CL_0000136', 'fat cell', 325, 'fat cells'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 437, 'retinol'), ('GO_0009294', 'DNA mediated transformation', 492, 'trimester'), ('UBERON_0001456', 'face', 526, 'cranial'), ('UBERON_0002342', 'neural crest', 534, 'neural-crest'), ('GO_0007567', 'parturition', 547, 'birth'), ('GO_0007565', 'female pregnancy', 616, 'pregnant'), ('GO_0007565', 'female pregnancy', 753, 'preformed'), ('CHEBI_27300', 'vitamin D', 763, 'vitamin A')]
PMC3659910	1/2013	S11-PMC3659910	['THIS REVIEW discusses Vitamin D Metabolism, dietary REQUIREMENTS and RECOMMENDATIONS and IMPLICATIONS of Vitamin D deficiency during Pregnancy and Lactation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 52), ('FUTURE_WORK', 69), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 22, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0007595', 'lactation', 147, 'lactation')]
PMC3809191	1/2013	S0-PMC3809191	['frequency of Vitamin D deficiency in Pregnant diabetics at baskent university hospital, istanbul\n\nabstract\nobjective: TO FIND out the frequency of Vitamin D deficiency and its RELATION with Glucose parameters and the incidence of Gestational diabetes (gdm).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('SUPERFICIAL_RELATIONSHIP', 176)]	2	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_17234', 'glucose', 190, 'glucose'), ('GO_0007565', 'female pregnancy', 230, 'gestational')]
PMC3809191	1/2013	S60-PMC3809191	['first, Serum 25 (Oh) D concentrations determined in late trimester MAY not show the status of maternal Vitamin D during the whole Pregnancy Period and HENCE to IDENTIFY the ASSOCIATION of Gdm Development and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 151), ('QUESTION_ANSWERED_BY_THIS_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('UBERON_0001977', 'blood serum', 7, 'serum'), ('CHEBI_71657', 'versiconol acetate', 13, '25 (OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 21, 'D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('UBERON_0018298', 'stylocone', 130, 'pregnancy period'), ('GO_0072147', 'glomerular parietal epithelial cell fate commitment', 188, 'GDM development'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D')]
PMC3901983	1/2013	S106-PMC3901983	['reported on five cases with SEVERE Intracranial bleeding and Skeletal malformations similar TO Warfarin fetopathy ( rhizomelic chondrodysplasia punctata ), which were caused by Vitamin K deficiency of mothers following bariatric surgery.']	[('IMPORTANT_CONSIDERATION', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 92)]	2	[('UBERON_2000442', 'supraneural bone', 35, 'intracranial'), ('UBERON_0004288', 'skeleton', 61, 'skeletal'), ('CHEBI_10033', 'warfarin', 95, 'warfarin'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin K')]
PMC3901983	1/2013	S108-PMC3901983	['to avoid SEVERE malnutrition and Vitamin K depletion, the authors of THIS PAPER RECOMMEND close followup with specialized team.']	[('IMPORTANT_CONSIDERATION', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('FUTURE_WORK', 80)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin K')]
PMC3705320	3/2013	S18-PMC3705320	['THEREFORE, to guide the design of clinical trials of Antenatal Vitamin D supplementation in bangladesh, we CONDUCTED a randomized open-label pilot trial of two Antenatal Vitamin d3 supplementation doses that were several fold higher than those in typical Prenatal supplements.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 107)]	2	[('GO_0007567', 'parturition', 53, 'antenatal'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 160, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 170, 'vitamin'), ('GO_0007565', 'female pregnancy', 255, 'prenatal')]
PMC3705320	3/2013	S204-PMC3705320	['the most direct application of the present OBSERVATIONS is to guide the design of FUTURE TRIALS of Vitamin D3 (at doses up to 35,000 iu per week) AIMED at CONFIRMING SAFETY and establishing the health benefits of Antenatal Vitamin D supplementation in south asia, where many POTENTIALLY Vitamin D-responsive outcomes (e.g., infant growth and infectious disease morbidity) are MAJOR PUBLIC HEALTH PRIORITIES.']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 146), ('PROBABLE_UNDERSTANDING', 155), ('IMPORTANT_CONSIDERATION', 166), ('INCOMPLETE_EVIDENCE', 275), ('IMPORTANT_CONSIDERATION', 376), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 396)]	9	[('CHEBI_33279', 'vitamin D5', 99, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 99, 'vitamin D3'), ('GO_0007567', 'parturition', 213, 'antenatal'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D')]
PMC3616124	4/2013	S139-PMC3616124	['hp phenotype, Prenatal/multivitamin use at randomization, and Plasma Ascorbate\nhp phenotype INFLUENCES Plasma Ascorbate concentration[35], PROVIDING a POTENTIAL mechanism by which hp phenotype MIGHT INFLUENCE treatment response to Vitamin C and E. we EXAMINED the RELATIONSHIP between hp phenotype and Plasma Ascorbate in a pre-planned analysis.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('PROBABLE_UNDERSTANDING', 139), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 199), ('QUESTION_ANSWERED_BY_THIS_WORK', 251), ('SUPERFICIAL_RELATIONSHIP', 264)]	7	[('GO_0007565', 'female pregnancy', 14, 'Prenatal'), ('UBERON_0001969', 'blood plasma', 62, 'Plasma'), ('CHEBI_2874', 'Asimicin', 69, 'Ascorbate'), ('UBERON_0001969', 'blood plasma', 103, 'plasma'), ('CHEBI_22651', 'ascorbate', 110, 'ascorbate'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 245, 'E'), ('UBERON_0001969', 'blood plasma', 302, 'plasma'), ('CHEBI_22651', 'ascorbate', 309, 'ascorbate')]
PMC3616124	4/2013	S173-PMC3616124	['THEREFORE, we EXAMINED the POTENTIAL for hp phenotype to INFLUENCE the effectiveness of Vitamin C and E in preventing Preeclampsia and SERIOUS COMPLICATIONS of pah.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 143)]	6	[('CHEBI_27300', 'vitamin D', 88, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 102, 'E'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia')]
PMC3629265	4/2013	S4-PMC3629265	['objective\nthe OBJECTIVE of THIS report is to bring ATTENTION to the risk of SEVERE Vitamin D deficiency in high risk, formula Fed infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('IMPORTANT_CONSIDERATION', 51), ('IMPORTANT_CONSIDERATION', 76)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0007631', 'feeding behavior', 126, 'fed')]
PMC3629265	4/2013	S8-PMC3629265	["while these infants had several RISK FACTORS for Vitamin D deficiency, they were all receiving Cow's milk based formula supplemented with 400 iu/l of vitamin D.\n\nconclusion\nTHIS report SUGGESTS that CURRENT practice with regards to Vitamin D supplementation MAY BE INADEQUATE, especially for high-risk infants."]	[('SUPERFICIAL_RELATIONSHIP', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 173), ('INCOMPLETE_EVIDENCE', 185), ('INCOMPLETE_EVIDENCE', 199), ('INCOMPLETE_EVIDENCE', 258), ('IMPORTANT_CONSIDERATION', 265), ('PROBLEM_COMPLICATION', 265)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 95, 'cow'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC3635901	4/2013	S35-PMC3635901	['this ROLE of Vitamin D SEEMS to be so IMPORTANT that ads show seasonality (due TO DIFFERENT levels of uv exposure), and EVEN the month of Birth MAY INFLUENCE the risk of onset of an ad, as SHOWN by disanto et al .']	[('SUPERFICIAL_RELATIONSHIP', 5), ('ANOMALY_CURIOUS_FINDING', 23), ('IMPORTANT_CONSIDERATION', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 148), ('INCOMPLETE_EVIDENCE', 189)]	9	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007567', 'parturition', 138, 'birth')]
PMC3641012	4/2013	S161-PMC3641012	['given the substantial inter-Individual VARIABILITY in the response to Vitamin D supplementation (figure\xa03), we EXPLORED the ROLE of the following POTENTIAL MODIFIERS of the magnitude of the change in 25(Oh)D (δ25(Oh)D) from baseline to Delivery (selected a priori ): maternal weight at baseline, maternal age, Gestational age, maternal body mass index at baseline (bmi), gravidity, parity, baseline Pth status, season and baseline Vitamin D status.']	[('DIFFICULT_TASK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 111), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('NCBITaxon_1', 'root', 28, 'individual'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 206, 'D'), ('CHEBI_33010', 'chromide(1-)', 212, '(OH)D'), ('GO_0007567', 'parturition', 236, 'delivery'), ('GO_0007565', 'female pregnancy', 310, 'gestational'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 399, 'PTH'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D')]
PMC3641012	4/2013	S226-PMC3641012	['in comparison to the lc-ms/ms method used HERE, the immunoassay used in the pilot study (diasorin liaison total) MAY have UNDER-estimated 25(Oh)D because of raised dbp concentrations in Pregnancy [29] OR relative imprecision at the higher 25(Oh)D range attained in the Vitamin D group [30,31].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('INCOMPLETE_EVIDENCE', 113), ('IMPORTANT_CONSIDERATION', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 201)]	4	[('CHEBI_71657', 'versiconol acetate', 138, '25(OH)D'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 239, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC3773018	4/2013	S21-PMC3773018	['THIS STUDY FURTHER extends and strengthens our PREVIOUS work by EXAMINING the risk of fs in RELATION to the longitudinal trajectory of Vitamin D status from Birth to early childhood in the same Birth cohort.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 64), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007567', 'parturition', 157, 'birth'), ('GO_0007567', 'parturition', 194, 'birth')]
PMC3773018	4/2013	S22-PMC3773018	['HEREIN, we EXAMINED the INTERACTION of a Promoter polymorphism (rs2243250: c-590t) in the Il4 Gene and the longitudinal trajectory of Vitamin D status from Birth to early childhood on the risk of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 24)]	3	[('SO_0000167', 'promoter', 41, 'promoter'), ('PR_000008989', 'interleukin-1 family member 7', 90, 'IL4'), ('SO_0000704', 'gene', 94, 'gene'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007567', 'parturition', 156, 'birth')]
PMC3773018	4/2013	S38-PMC3773018	['we also conducted the above regression analyses stratified by the genotypes of rs2243250, and then EXAMINED the statistical significance for the multiplicative INTERACTION between low Vitamin D status and rs2243250.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 160)]	2	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC3773018	4/2013	S61-PMC3773018	['discussion\nTHIS is the FIRST STUDY TO EXAMINE the EFFECTS of longitudinal trajectory Vitamin D status, by measurement of Plasma 25(Oh)D concentrations from Birth to early childhood, on the development of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 121, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 128, '25(OH ... D'), ('GO_0007567', 'parturition', 156, 'birth')]
PMC3773018	4/2013	S63-PMC3773018	['OUR FINDINGS SUGGEST that both Prenatal and early Postnatal Vitamin D levels APPEAR TO play an IMPORTANT ROLE in the development of fs, ESPECIALLY among those with specific genotypes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 77), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 136)]	6	[('GO_0007565', 'female pregnancy', 31, 'prenatal'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3773018	4/2013	S74-PMC3773018	['the FINDINGS from THIS extended STUDY EMPHASIZE the IMPORTANT ROLE of Postnatal Vitamin D status in the development of fs.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 52), ('SUPERFICIAL_RELATIONSHIP', 62)]	6	[('GO_0007567', 'parturition', 70, 'postnatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC3773018	4/2013	S79-PMC3773018	['furthermore, OUR FINDINGS REMAINED SIMILAR after controlling for season of Birth or stratification by season of Birth, INDICATING that Birth season is UNLIKELY to MEDIATE the ASSOCIATIONS between persistently low Vitamin D and risk of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 151), ('SUPERFICIAL_RELATIONSHIP', 163), ('SUPERFICIAL_RELATIONSHIP', 175)]	8	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007567', 'parturition', 135, 'birth'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC3773018	4/2013	S82-PMC3773018	['OF NOTE, OUR FINDINGS from the stratified analyses SUGGESTED stronger ASSOCIATIONS between low Vitamin D status and high RISK of fs among children Born Preterm, which NEEDS to be FURTHER explored in a larger sample.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 121), ('IMPORTANT_CONSIDERATION', 167), ('FUTURE_WORK', 179), ('INCOMPLETE_EVIDENCE', 179)]	8	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007567', 'parturition', 147, 'born'), ('GO_0007565', 'female pregnancy', 152, 'preterm')]
PMC3773018	4/2013	S105-PMC3773018	['overall, THIS STUDY UNDERSCORES THE NEED to simultaneously CONSIDER both Cord Blood and Postnatal Vitamin D levels, along with Genetic susceptibility, in the development of fs and Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 32), ('FUTURE_WORK', 36), ('FUTURE_WORK', 59), ('IMPORTANT_CONSIDERATION', 59)]	6	[('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('GO_0007567', 'parturition', 88, 'postnatal'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic'), ('CHEBI_33290', 'food', 180, 'food')]
PMC3651971	5/2013	S0-PMC3651971	['cognitive and motor skills in school-aged children following maternal Vitamin A supplementation during Pregnancy in rural nepal: a follow-up of a placebo-controlled, randomised cohort\n\nabstract\n\nobjective\nTO DETERMINE the EFFECTS of maternal Vitamin A supplementation from Preconception through Postpartum on Cognitive and Motor Development of children at 10–13\u2005years of age in rural nepal.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('SUPERFICIAL_RELATIONSHIP', 222)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin A'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin A'), ('GO_0007565', 'female pregnancy', 273, 'preconception'), ('GO_0007565', 'female pregnancy', 295, 'postpartum'), ('GO_0050890', 'cognition', 309, 'cognitive ...'), ('GO_0009653', 'anatomical structure morphogenesis', 323, 'motor development')]
PMC3651971	5/2013	S11-PMC3651971	['caption (boxed-text)\narticle summary\n\narticle focus\nTHIS ARTICLE EXAMINES the EFFECTS of early Vitamin A supplementation on Cognitive and motor skills in school-aged children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 103, 'A'), ('GO_0050890', 'cognition', 124, 'cognitive')]
PMC3651971	5/2013	S18-PMC3651971	['THIS STUDY SUGGESTS no benefit of maternal Vitamin A supplementation on Cognitive or motor skills in 10-year-old to 13-year-old offspring.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin A'), ('GO_0050890', 'cognition', 72, 'cognitive')]
PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]
PMC3651971	5/2013	S27-PMC3651971	['THIS STUDY is the FIRST TO EXAMINE EFFECTS of routine, maternal Vitamin A supplementation before, during and following Pregnancy, provided via a randomised, placebo-controlled trial, on child Cognitive and motor ability.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 35)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin A'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('GO_0050890', 'cognition', 192, 'cognitive')]
PMC3651971	5/2013	S38-PMC3651971	['objective and outcomes\nTHIS STUDY HYPOTHESISED that, by school age, children Born to mothers routinely supplemented with Vitamin A would perform better on tests of Cognitive and motor ability than children Born to Placebo-supplemented women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 34), ('QUESTION_ANSWERED_BY_THIS_WORK', 34)]	3	[('GO_0007567', 'parturition', 77, 'born'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin A'), ('GO_0050890', 'cognition', 164, 'cognitive'), ('GO_0007567', 'parturition', 206, 'born'), ('CHEBI_26130', 'biological pigment', 214, 'placebo')]
PMC3651971	5/2013	S157-PMC3651971	['the post hoc analyses REPORTED in THIS PAPER HINTED AT differences in motor skills after in utero Vitamin A supplementation, but did so ONLY after excluding children who never attended school and those who repeated a grade.']	[('INCOMPLETE_EVIDENCE', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('INCOMPLETE_EVIDENCE', 45), ('ANOMALY_CURIOUS_FINDING', 136), ('INCOMPLETE_EVIDENCE', 136)]	5	[('CHEBI_27300', 'vitamin D', 98, 'vitamin A')]
PMC3668200	5/2013	S10-PMC3668200	['HOWEVER, measuring 1,25-Oh2-D levels AS a PREDICTOR of Vitamin D status CAN LEAD TO ERRONEOUS CONCLUSIONS BECAUSE, compared with 25(Oh)D levels, 1,25-Oh2-D levels CAN be normal or EVEN elevated DESPITE Vitamin D deficiency due to secondary hyperparathyroidism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 72), ('PROBABLE_UNDERSTANDING', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 194)]	14	[('CHEBI_78731', '9(R)-HPETE', 21, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 129, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D'), ('CHEBI_78731', '9(R)-HPETE', 147, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3672018	5/2013	S2-PMC3672018	['the PRESENT STUDY includes an in-depth examination of the INFLUENCE of exposure to Vitamin D early in Life for development of fractures of the Wrist, Arm and Clavicle; obesity, and type 1 diabetes (t1d) during child- and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000104', 'life cycle', 102, 'life'), ('UBERON_0004452', 'carpal region', 143, 'wrist'), ('UBERON_0001460', 'arm', 150, 'arm'), ('UBERON_0001105', 'clavicle bone', 158, 'clavicle'), ('UBERON_0000113', 'post-juvenile adult stage', 221, 'adulthood')]
PMC3672018	5/2013	S4-PMC3672018	['apart from determining the INFLUENCES of exposure prior to Conception and during Prenatal Life, we will EXAMINE the IMPORTANCE of Vitamin D exposure during specific seasons and trimesters, by comparing disease incidence among Individuals Born before and after fortification.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 104), ('IMPORTANT_CONSIDERATION', 116)]	3	[('GO_0007620', 'copulation', 59, 'conception'), ('GO_0007565', 'female pregnancy', 81, 'prenatal'), ('UBERON_0000104', 'life cycle', 90, 'life'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('NCBITaxon_1', 'root', 226, 'individuals'), ('GO_0007567', 'parturition', 238, 'born')]
PMC3672018	5/2013	S12-PMC3672018	['THE PRESENT STUDY addresses these ISSUES in RELATION to Vitamin D.\n\nVitamin D\nvitamin D is a fat-soluble Vitamin that is NECESSARY for the Human body.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBLEM_COMPLICATION', 34), ('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 121)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 68, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 86, 'D'), ('CHEBI_33229', 'vitamin (role)', 105, 'vitamin'), ('NCBITaxon_9606', 'Homo sapiens', 139, 'human')]
PMC3672018	5/2013	S48-PMC3672018	['objectives and HYPOTHESIS\nthe PRESENT STUDY relies on a unique societal experiment in which all Margarine and low fat Milk products Consumed by the danish population were fortified with vitamin D, during two distinct time periods: in 1961–1985 fortifying Margarine with Vitamin D was mandatory in denmark and in 1972–1976 low fat milk fortification was allowed.']	[('INCOMPLETE_EVIDENCE', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	2	[('CHEBI_6784', 'mestranol', 96, 'margarine'), ('UBERON_0001913', 'milk', 118, 'milk'), ('GO_0007631', 'feeding behavior', 132, 'consumed'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 194, 'D'), ('CHEBI_6784', 'mestranol', 255, 'margarine'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3672018	5/2013	S51-PMC3672018	['initially the PRESENT STUDY will include an in-depth examination of the INFLUENCE of exposure to Vitamin D during Pregnancy for development of fractures of the Wrist, forearm, upper Arm and Shoulder, as well as fractures of Ankle; development of obesity; and development of t1d during child- and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 72)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy'), ('UBERON_0004452', 'carpal region', 160, 'wrist'), ('UBERON_0001460', 'arm', 182, 'arm'), ('UBERON_0001467', 'shoulder', 190, 'shoulder'), ('UBERON_0004454', 'tarsal region', 224, 'ankle'), ('UBERON_0000113', 'post-juvenile adult stage', 296, 'adulthood')]
PMC3672018	5/2013	S65-PMC3672018	['databases\nin a first effort, we will EXAMINE INFLUENCE of additional early exposure to Vitamin D on subsequent development of fractures, obesity, and t1d.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC3672018	5/2013	S148-PMC3672018	['the use of 50,000-100,000 Individuals from adjacent Birth years in the general population studies of events like fractures and diagnosis of t1d, a pivotal strength of THIS STUDY, makes it possible to detect EVEN minor EFFECTS of Vitamin D.\nFood disappearance statistics SHOW that Margarine Intake decreased and low fat milk slightly increased during the period covered.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('ANOMALY_CURIOUS_FINDING', 207), ('SUPERFICIAL_RELATIONSHIP', 218), ('INCOMPLETE_EVIDENCE', 270)]	4	[('NCBITaxon_1', 'root', 26, 'individuals'), ('GO_0007567', 'parturition', 52, 'birth'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('CHEBI_33290', 'food', 240, 'Food'), ('CHEBI_6784', 'mestranol', 280, 'margarine'), ('GO_0007631', 'feeding behavior', 290, 'intake')]
PMC3672018	5/2013	S177-PMC3672018	['conclusion\nthe PRESENT STUDY relies on a unique societal experiment in which Vitamin D fortification of all Margarine Consumed by the danish population was mandatory during two distinct time periods.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15)]	1	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_6784', 'mestranol', 108, 'margarine'), ('GO_0007631', 'feeding behavior', 118, 'consumed')]
PMC3717170	5/2013	S0-PMC3717170	['Vitamin D: beyond bone\n\nabstract\nin RECENT YEARS, Vitamin D HAS BEEN received INCREASED ATTENTION due TO the resurgence of Vitamin D deficiency and rickets in developed countries and the IDENTIFICATION of Extraskeletal EFFECTS of Vitamin D, SUGGESTING UNEXPECTED benefits of Vitamin D in health and disease, beyond bone health.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 219), ('INCOMPLETE_EVIDENCE', 241), ('ANOMALY_CURIOUS_FINDING', 252)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 205, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC3717170	5/2013	S3-PMC3717170	['THIS REPORT summarizes RECENT RESEARCH on the ROLES for Vitamin D in cancer, Immunity and Autoimmune diseases, Cardiovascular and Respiratory health, Pregnancy, obesity, Erythropoiesis, diabetes, muscle function, and Aging.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007566', 'embryo implantation', 77, 'immunity'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('UBERON_0004535', 'cardiovascular system', 111, 'cardiovascular'), ('UBERON_0001004', 'respiratory system', 130, 'respiratory'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0030218', 'erythrocyte differentiation', 170, 'erythropoiesis'), ('GO_0007568', 'aging', 217, 'aging')]
PMC3717170	5/2013	S18-PMC3717170	['IN ORDER TO DETERMINE mechanisms INVOLVED in inhibition of Breast tumor growth, christakos’ lab SHOWED that C/Ebpα, a transcription factor that HAS BEEN SHOWN to play a CRITICAL ROLE in growth arrest of other cell types, is induced by 1,25(Oh)2D3In mcf-7 Human Breast cancer cells.2c/Ebpα was found to induce transcription of the Vitamin D receptor in mcf-7 cells.2since the levels of the vdr CORRELATE with the antiproliferative effects of 1,25(Oh)2D3, and since it HAS BEEN SUGGESTED that C/Ebpα CAN be considered a POTENTIAL tumor suppressor, these FINDINGS SUGGEST mechanisms whereby 1,25(Oh)2D3May act to inhibit Growth Of Breast cancer Cells.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 144), ('IMPORTANT_CONSIDERATION', 169), ('SUPERFICIAL_RELATIONSHIP', 178), ('SUPERFICIAL_RELATIONSHIP', 393), ('INCOMPLETE_EVIDENCE', 467), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 552), ('INCOMPLETE_EVIDENCE', 561)]	13	[('UBERON_0000310', 'breast', 59, 'breast'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 108, 'C/EBPα'), ('CHEBI_37958', 'dye', 235, '1,'), ('CHEBI_45409', 'ritonavir', 237, '25(OH)2D3in'), ('NCBITaxon_9606', 'Homo sapiens', 255, 'human'), ('UBERON_0000310', 'breast', 261, 'breast'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 284, 'EBPα'), ('CHEBI_27300', 'vitamin D', 330, 'vitamin D'), ('CHEBI_37983', 'sulfur-35 atom', 441, '1'), ('CHEBI_17996', 'chloride', 442, ','), ('CHEBI_73394', 'Ala-Ser', 443, '25(OH)2D3'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 491, 'C/EBPα'), ('CHEBI_37958', 'dye', 588, '1,'), ('CHEBI_83462', 'metolachlor OXA', 590, '25(OH)2D3may'), ('GO_0048468', 'cell development', 618, 'growth of ... cells'), ('UBERON_0000310', 'breast', 628, 'breast')]
PMC3717170	5/2013	S66-PMC3717170	['collectively, these data DEMONSTRATE that the Vitamin D system—specifically, the ligand-bound vdr—plays an IMPORTANT ROLE in the maintenance of Cardiovascular health and SUGGEST that Vitamin D repletion MAY have IMPORTANT PUBLIC HEALTH IMPLICATIONS in Controlling the prevalence of, and morbidity ASSOCIATED with, Cardiovascular disease.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 222), ('SUPERFICIAL_RELATIONSHIP', 297)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 144, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0065007', 'biological regulation', 252, 'controlling'), ('UBERON_0004535', 'cardiovascular system', 314, 'cardiovascular')]
PMC3717170	5/2013	S68-PMC3717170	['Vitamin D during Pregnancy and Lactation\nVitamin D as a preprohormone has EFFECTS that extend beyond Calcium Metabolism and Homeostasis throughout Life but which are most vivid during Pregnancy when Vitamin D Metabolism is disengaged from its usual constraints.12at no other time during the Lifecycle is 25(Oh)D3Linked directly to 1,25(Oh)2d3production, the latter rising more than 2.5 times above nonpregnant levels.12this elevation of 1,25(oh)2d3likely serves the purpose of Immune Regulation, THOUGH there HAVE BEEN ONLY a FEW STUDIES that have evaluated the EFFECT of Vitamin D status on Immune function during Pregnancy to SUPPORT THIS HYPOTHESIS.']	[('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 484), ('ANOMALY_CURIOUS_FINDING', 496), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 628), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 641)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('GO_0007595', 'lactation', 31, 'lactation'), ('CHEBI_28384', 'vitamin K', 41, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 101, 'calcium metabolism'), ('GO_0042592', 'homeostatic process', 124, 'homeostasis'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 199, 'vitamin D metabolism'), ('UBERON_0000104', 'life cycle', 291, 'lifecycle'), ('CHEBI_77914', '3-methylbut-1-ene', 304, '25(OH)D3linked'), ('CHEBI_63056', 'zinc cation', 333, '25(OH'), ('CHEBI_17996', 'chloride', 438, ','), ('GO_0002521', 'leukocyte differentiation', 477, 'immune regulation'), ('UBERON_0002405', 'immune system', 477, 'immune'), ('CHEBI_27300', 'vitamin D', 572, 'vitamin D'), ('UBERON_0002405', 'immune system', 592, 'immune'), ('GO_0007565', 'female pregnancy', 615, 'pregnancy')]
PMC3717170	5/2013	S125-PMC3717170	['they have INITIATED a randomized controlled trial of 25(Oh)D3Repletion in Vitamin D–deficient hemodialysis patients TO EVALUATE efficacy and SAFETY and the EFFECTS on inflammation and esa REQUIREMENTS.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 116), ('IMPORTANT_CONSIDERATION', 141), ('SUPERFICIAL_RELATIONSHIP', 156), ('IMPORTANT_CONSIDERATION', 188)]	5	[('CHEBI_76706', 'EC 6.1.* (C-O bond-forming ligase) inhibitor', 53, '25(OH)D3repletion'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 53, '25(OH'), ('PR_000006494', 'disrupted in schizophrenia 1 protein', 59, 'D3repletion'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3717170	5/2013	S144-PMC3717170	['THEREFORE, CONFIRMATION of a POTENTIAL beneficial EFFECT of Vitamin D in type 2 diabetes IS NEEDED in trials conducted in well-defined populations (e.g., pre-diabetes and early diabetes) SPECIFICALLY DESIGNED TO TEST the COMPELLING BUT YET UNPROVEN HYPOTHESIS that Vitamin D status is a direct CONTRIBUTOR to the pathogenesis of type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 50), ('FUTURE_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('ANOMALY_CURIOUS_FINDING', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 294)]	14	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC3717170	5/2013	S185-PMC3717170	['Vitamin D dietary reference intakes\ndaniel bikle (university of california and va medical center, san francisco) addressed the RECENT institute of medicine (iom) RECOMMENDATIONS for dietary Intake of Vitamin D and EVALUATED WHETHER they were sufficient in the context of EMERGING DATA about the ROLES of Vitamin D and the prevalence of deficiency.']	[('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 162), ('QUESTION_ANSWERED_BY_THIS_WORK', 214), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 190, 'intake'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D')]
PMC3679329	6/2013	S82-PMC3679329	['in the PRESENT STUDY, among Pregnant women, the proportion of women with an Intake of Vitamin C (from diet alone) below the ear was significantly higher among Supplement non-users (68%) than among users (44%).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7)]	1	[('GO_0007565', 'female pregnancy', 28, 'pregnant'), ('GO_0007631', 'feeding behavior', 76, 'intake'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin C'), ('CHEBI_16158', 'steroid sulfate', 159, 'supplement')]
PMC3685533	6/2013	S10-PMC3685533	['conclusions\nthe PRESENT STUDY SHOWS a high prevalence of Vitamin D insufficiency and deficiency in newborns with significant differences observed to be DUE TO ethnicity, skin colour and maternal supplementation during the Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 152)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'pregnancy')]
PMC3685533	6/2013	S35-PMC3685533	['IN ORDER TO understand the DIFFERENCES in Vitamin D levels depending on skin colour and ethnic differences, we evaluated 25Ohd levels at Birth in Cord Blood and in the first three days of Life from ethnically diverse infants Born within our hospital.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 121, '25OHD'), ('GO_0007567', 'parturition', 137, 'birth'), ('UBERON_0002240', 'spinal cord', 146, 'cord'), ('UBERON_0000178', 'blood', 151, 'blood'), ('UBERON_0000104', 'life cycle', 188, 'life'), ('GO_0007567', 'parturition', 225, 'born')]
PMC3685533	6/2013	S100-PMC3685533	['discussion\nthe PRESENT STUDY DEMONSTRATES a high prevalence of Vitamin D deficiency and insufficiency both in Cord Blood and in neonatal Serum, with lower concentrations in infants Born from immigrant mothers.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 29)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0009472', 'axilla', 110, 'cord blood'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('GO_0007567', 'parturition', 181, 'born')]
PMC3685533	6/2013	S119-PMC3685533	['we have also INVESTIGATED the ROLE of supplementation in Pregnancy on Vitamin D Cord Blood and Serum levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 80, 'cord'), ('UBERON_0000178', 'blood', 85, 'blood'), ('UBERON_0001977', 'blood serum', 95, 'serum')]
PMC3685533	6/2013	S136-PMC3685533	['conclusions\nthe PRESENT STUDY DEMONSTRATES a high prevalence of Vitamin D deficiency and insufficiency both in Cord Blood and in neonatal Serum with significant differences DUE TO ethnicity, skin colour and presence or absence of supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 30), ('PROBLEM_COMPLICATION', 173)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0009472', 'axilla', 111, 'cord blood'), ('UBERON_0001977', 'blood serum', 138, 'serum')]
PMC3691177	6/2013	S1-PMC3691177	['we EXAMINED the EFFECT of Prenatal Vitamin D on childhood wheezing in an interventional study.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC3691177	6/2013	S22-PMC3691177	['we assessed children whose mothers had taken part in a randomised controlled trial of Prenatal Vitamin D supplementation, TO DETERMINE WHETHER supplementation PREVENTED wheezing or allergic disease in the first 3 years of Life[19].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('GO_0007565', 'female pregnancy', 86, 'prenatal'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0000104', 'life cycle', 222, 'life')]
PMC3691177	6/2013	S35-PMC3691177	['women were given instructions to swallow the tablets whole and to avoid other multivitamin supplements containing Vitamin D. this trial was CONDUCTED before national guidance on routinely providing advice on Vitamin D intake during Pregnancy was introduced in march 2008[14].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 140)]	1	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('GO_0007565', 'female pregnancy', 232, 'pregnancy')]
PMC3691177	6/2013	S107-PMC3691177	['discussion\nin THIS randomised CONTROLLED TRIAL of Vitamin D supplementation in late Pregnancy in a relatively deficient mixed race population, daily supplementation with 800 iu Ergocalciferol or a single bolus dose of 200,000 iu Cholecalciferol from 27 weeks Gestation did not prevent wheezing, allergic disease or influence measures of Lung function or allergic inflammation in offspring in the first three years of Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_4910', 'etomidate', 177, 'ergocalciferol'), ('CHEBI_52550', 'theopalauamide', 229, 'cholecalciferol'), ('GO_0007565', 'female pregnancy', 259, 'gestation'), ('UBERON_0002048', 'lung', 337, 'lung'), ('UBERON_0000104', 'life cycle', 417, 'life')]
PMC3691177	6/2013	S134-PMC3691177	['the FINDINGS of OUR STUDY are specific to a population of Vitamin D deficient women (half had baseline 25(Oh)D levels below 25 nmol/l) and two specific forms of Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 103, '25(OH)D'), ('GO_0007565', 'female pregnancy', 161, 'prenatal'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC3702245	6/2013	S9-PMC3702245	['SEVERAL REPORTS in the literature HAVE SHOWN that INADEQUATE or lack of sunlight exposure without appropriate corrective Vitamin D intake or supplements accounts FOR the high prevalence of Vitamin D deficiency in women.11–18\nafter synthesis in the skin, Vitamin D attaches to Vitamin D-binding protein and is transported to the Liver, where it undergoes a process of hydroxylation to form 25-Hydroxyvitamin D [25(Oh)D].9the Serum concentration of 25(Oh)D is the MOST reliable MARKER of Vitamin D nutritional status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 162), ('PROBABLE_UNDERSTANDING', 462), ('SUPERFICIAL_RELATIONSHIP', 476)]	7	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 284, 'D'), ('UBERON_0002107', 'liver', 328, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 389, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('UBERON_0001977', 'blood serum', 424, 'serum'), ('CHEBI_71657', 'versiconol acetate', 447, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 486, 'vitamin D')]
PMC3702245	6/2013	S45-PMC3702245	['CONSISTENT with THIS report, a systematic review and meta-analysis of seven observational studies performed between 2008 and 2011 FOUND Serum 25(Oh)D < 50 nmol/l to be ASSOCIATED with Gestational diabetes BUT with an overall lower odds ratio of 1.61 (ci 1.19–2.17).86another meta-analysis of maternal Vitamin D status and Pregnancy outcomes,87which included 24 studies up to 2012, FOUND an overall INCREASED RISK of Preeclampsia (odds ratio 2.09; ci 1.50–2.90) and Gestational diabetes (odds ratio 1.38; ci 1.12–1.70).']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 205), ('INCOMPLETE_EVIDENCE', 381), ('IMPORTANT_CONSIDERATION', 398)]	7	[('UBERON_0001977', 'blood serum', 136, 'serum'), ('CHEBI_71657', 'versiconol acetate', 142, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 142, '25(OH)D'), ('GO_0007565', 'female pregnancy', 184, 'gestational'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 322, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 416, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 465, 'gestational')]
PMC3702245	6/2013	S51-PMC3702245	['further, there is a SUGGESTION of an ASSOCIATION between Vitamin D and Periodontal disease,90and maternal Serum 25(Oh)D < 75 nmol/l during Early Pregnancy HAS BEEN ASSOCIATED with a two-fold INCREASED risk of Periodontal disease.91in a RECENT randomized controlled TRIAL of Vitamin D supplementation from south carolina, Vitamin D supplementation of 4000 iu/day during Pregnancy was ASSOCIATED with a reduction in the risk of combined morbidities, such as Maternal infection, Preterm labor, and Preterm Birth.92\nIN VIEW of the POSSIBLE ASSOCIATION between maternal Vitamin D status and the pattern of fetal growth, pre-eclampsia, Gestational diabetes mellitus, and maternal infection, and the significant POTENTIAL for Perinatal morbidities ASSOCIATED with these conditions, evaluation of Vitamin D nutrition in early Pregnancy and the EFFECT of appropriate supplementation SEEMS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 164), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 512), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 527), ('SUPERFICIAL_RELATIONSHIP', 536), ('INCOMPLETE_EVIDENCE', 705), ('SUPERFICIAL_RELATIONSHIP', 741), ('SUPERFICIAL_RELATIONSHIP', 836), ('ANOMALY_CURIOUS_FINDING', 874), ('FUTURE_WORK', 874)]	16	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001758', 'periodontium', 71, 'periodontal'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 112, '25(OH ... D'), ('GO_0051318', 'G1 phase', 139, 'early'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('UBERON_0001758', 'periodontium', 209, 'periodontal'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D'), ('GO_0007565', 'female pregnancy', 369, 'pregnancy'), ('GO_0007618', 'mating', 456, 'maternal'), ('GO_0007565', 'female pregnancy', 476, 'preterm'), ('GO_0007565', 'female pregnancy', 495, 'preterm'), ('GO_0007567', 'parturition', 503, 'birth'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D'), ('GO_0007565', 'female pregnancy', 630, 'gestational'), ('GO_0036268', 'swimming', 719, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 719, 'perinatal'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('GO_0007565', 'female pregnancy', 818, 'pregnancy')]
PMC3702245	6/2013	S57-PMC3702245	['regarding Neurocognitive Development, WHILE ONE STUDY FOUND no association between maternal Vitamin D status during Pregnancy and Neurocognitive function,76a RECENT larger-sized STUDY LINKED maternal Serum 25(Oh)D levels during Pregnancy with Language Development in the offspring.98the results of the above studies SUGGEST that childhood infections, atopy, and Neurocognitive development NEED TO BE included as outcomes of interest following Vitamin D supplementation in Pregnancy, and that clinical trials SHOULD include a RELEVANT group of subjects CONSIDERED to be replete for Vitamin D.\ntaken TOGETHER, the high prevalence of Vitamin D deficiency in Pregnancy and the POSSIBLE multiple POTENTIAL adverse EFFECTS on mother and offspring IDENTIFIED in SEVERAL epidemiologic STUDIES UNDERSCORE the URGENT NEED FOR large randomized controlled TRIALS to identify the amount of Vitamin D supplementation that optimizes Vitamin D status during Pregnancy, and to DETERMINE the EFFECT of supplementation on POTENTIAL adverse conditions ASSOCIATED with Vitamin D deficiency and any POSSIBLE Vitamin D excess.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 184), ('INCOMPLETE_EVIDENCE', 316), ('FUTURE_WORK', 389), ('FUTURE_WORK', 508), ('IMPORTANT_CONSIDERATION', 525), ('IMPORTANT_CONSIDERATION', 552), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 691), ('SUPERFICIAL_RELATIONSHIP', 709), ('INCOMPLETE_EVIDENCE', 741), ('INCOMPLETE_EVIDENCE', 755), ('IMPORTANT_CONSIDERATION', 785), ('IMPORTANT_CONSIDERATION', 800), ('FUTURE_WORK', 807), ('INCOMPLETE_EVIDENCE', 807), ('FUTURE_WORK', 844), ('QUESTION_ANSWERED_BY_THIS_WORK', 960), ('SUPERFICIAL_RELATIONSHIP', 974), ('INCOMPLETE_EVIDENCE', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1077)]	26	[('GO_0007399', 'nervous system development', 10, 'neurocognitive development'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0050905', 'neuromuscular process', 130, 'neurocognitive'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 206, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 243, 'language development'), ('GO_0050905', 'neuromuscular process', 362, 'neurocognitive'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('GO_0007565', 'female pregnancy', 472, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 581, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 631, 'vitamin D'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 877, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 918, 'vitamin D'), ('GO_0007565', 'female pregnancy', 942, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1048, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1086, 'vitamin D')]
PMC3702245	6/2013	S58-PMC3702245	['Vitamin D REQUIREMENT during Pregnancy\nin ORDER TO DETERMINE the Vitamin D REQUIREMENT during Pregnancy, one NEEDS to define the target Serum 25(Oh)D concentration considered as “normal” or “optimal”.']	[('IMPORTANT_CONSIDERATION', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('IMPORTANT_CONSIDERATION', 75), ('FUTURE_WORK', 109), ('IMPORTANT_CONSIDERATION', 109)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('UBERON_0001977', 'blood serum', 136, 'serum'), ('CHEBI_71657', 'versiconol acetate', 142, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 148, 'D')]
PMC3702245	6/2013	S75-PMC3702245	['because of CONTROVERSY surrounding Vitamin D REQUIREMENTS during Pregnancy, investigators from south carolina performed a comprehensive, large, randomized controlled study of Vitamin D supplementation in Pregnancy to achieve optimal Vitamin D status, DEFINED as a Serum 25(Oh)D concentration ≥80 nmol/l at Delivery.18BASED on the pharmacokinetics of Vitamin d, the authors INVESTIGATED the SAFETY and EFFECTIVENESS of high-dose Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('IMPORTANT_CONSIDERATION', 45), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 315), ('QUESTION_ANSWERED_BY_THIS_WORK', 373), ('IMPORTANT_CONSIDERATION', 390), ('SUPERFICIAL_RELATIONSHIP', 401)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('UBERON_0001977', 'blood serum', 264, 'serum'), ('CHEBI_71657', 'versiconol acetate', 270, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 270, '25(OH)D'), ('GO_0007567', 'parturition', 306, 'delivery'), ('CHEBI_33229', 'vitamin (role)', 350, 'vitamin'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
PMC3702245	6/2013	S93-PMC3702245	['another RECENT STUDY from the united arab emirates among Pregnant arab women with a high prevalence of Vitamin D deficiency also CONFIRMED that 4000 iu/day of Vitamin D supplementation was SAFE and more EFFECTIVE than 2000 iu/day and 400 iu/day in optimizing Vitamin D status during Pregnancy and in achieving Vitamin D sufficiency at Birth in mothers and offspring.106in the united arab emirates study, the increment from baseline to Delivery was about four-fold higher than expected BASED ON previous pharmacokinetic STUDIES, POSSIBLY RELATED to low baseline Vitamin D status.100this INDICATES that baseline Vitamin D status SHOULD BE taken INTO CONSIDERATION when evaluating Vitamin D supplementation.100,107\nthe FINDINGS of these RECENT intervention STUDIES INDICATE an URGENT NEED for more randomized controlled trials in diverse geographic locations with large sample sizes to identify the Vitamin D intake REQUIRED to optimize Vitamin D status, and TO ASSESS the EFFECT on Pregnancy-related and infant-related COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 189), ('SUPERFICIAL_RELATIONSHIP', 203), ('PROBABLE_UNDERSTANDING', 485), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 528), ('SUPERFICIAL_RELATIONSHIP', 537), ('INCOMPLETE_EVIDENCE', 586), ('FUTURE_WORK', 627), ('IMPORTANT_CONSIDERATION', 643), ('FUTURE_WORK', 648), ('INCOMPLETE_EVIDENCE', 716), ('INCOMPLETE_EVIDENCE', 734), ('INCOMPLETE_EVIDENCE', 762), ('IMPORTANT_CONSIDERATION', 774), ('FUTURE_WORK', 781), ('IMPORTANT_CONSIDERATION', 913), ('QUESTION_ANSWERED_BY_THIS_WORK', 956), ('SUPERFICIAL_RELATIONSHIP', 970), ('PROBLEM_COMPLICATION', 1017)]	21	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('GO_0007567', 'parturition', 335, 'birth'), ('GO_0007567', 'parturition', 435, 'delivery'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 896, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 934, 'vitamin D'), ('GO_0007565', 'female pregnancy', 980, 'pregnancy')]
PMC3702339	6/2013	S0-PMC3702339	['prevalence and CORRELATES of Prenatal Vitamin A deficiency in rural sidama, southern ethiopia\n\nabstract\na cross-sectional study was CONDUCTED TO ASSESS the prevalence and CORRELATES of Prenatal Vitamin A deficiency (vad) in rural sidama, southern ethiopia.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('QUESTION_ANSWERED_BY_THIS_WORK', 142), ('SUPERFICIAL_RELATIONSHIP', 171)]	4	[('GO_0007565', 'female pregnancy', 29, 'Prenatal'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 38, 'Vitamin A'), ('GO_0007565', 'female pregnancy', 185, 'prenatal'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin A')]
PMC3695234	7/2013	S1-PMC3695234	['in THIS STUDY, we INVESTIGATED the ASSOCIATION between Serum Vitamin D status and the clinical manifestation of ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC3695234	7/2013	S22-PMC3695234	['in THIS STUDY, we INVESTIGATED the ASSOCIATION between Serum Vitamin D status and the clinical manifestation of ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC3695234	7/2013	S49-PMC3695234	['discussion\nACCORDING TO the results of the 2005-2006 national Health and nutrition examinations survey (nhanes), Vitamin D deficiency is ASSOCIATED with higher levels of Ige sensitization in children and adolescents.6to ASSESS the RELATIONSHIP between Vitamin D levels and Respiratory outcomes, other analyses were performed on the same survey data.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 137), ('QUESTION_ANSWERED_BY_THIS_WORK', 220), ('SUPERFICIAL_RELATIONSHIP', 231)]	4	[('UBERON_0000925', 'endoderm', 62, 'Health'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 170, 'IgE'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 273, 'respiratory')]
PMC3695234	7/2013	S50-PMC3695234	['a PROTECTIVE EFFECT for Vitamin D against wheezing and asthma was found to be strongest for non-atopic and older subjects, SUGGESTING that Vitamin D modifies the risk of allergic and Respiratory disease through multiple mechanisms.7\nalthough Vitamin D deficiency is DEFINED AS a Serum level <20 ng/ml of 25(Oh)d3, there is also an increasing CONCERN about Vitamin D INSUFFICIENCY, which is characterized by levels of 25(Oh)D3Between 20 and 29 ng/ml.8in THIS STUDY, we FOUND that most participants with ad COULD BE categorized as having Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 266), ('PROBABLE_UNDERSTANDING', 274), ('IMPORTANT_CONSIDERATION', 342), ('IMPORTANT_CONSIDERATION', 366), ('QUESTION_ANSWERED_BY_THIS_WORK', 453), ('INCOMPLETE_EVIDENCE', 468), ('INCOMPLETE_EVIDENCE', 505)]	10	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 183, 'respiratory'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0001977', 'blood serum', 279, 'serum'), ('CHEBI_30778', 'gallic acid', 304, '25(OH)'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin D'), ('CHEBI_52744', 'fort orange 600', 417, '25(OH)D3between 20'), ('CHEBI_27300', 'vitamin D', 536, 'vitamin D')]
PMC3695234	7/2013	S51-PMC3695234	['ALTHOUGH there was no healthy control group, OUR FINDINGS SHOWED lower normal levels of Serum Vitamin D (15.61±5.67 ng/ml) irrespective of ad severity, which SUGGESTS a CORRELATION between ad and the absorption and Metabolism Of Vitamin D.\nthis Metabolism begins with two processes: absorption into the skin as Vitamin D3And via the Gut as either Vitamin D2Or Vitamin D3.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 169)]	5	[('UBERON_0001977', 'blood serum', 88, 'serum'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 215, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D'), ('GO_0008152', 'metabolic process', 245, 'metabolism'), ('CHEBI_61991', 'maltotriose trisaccharide', 311, 'vitamin D3and'), ('PR_000027594', 'histone H3', 311, 'vitamin D3and'), ('UBERON_0001555', 'digestive tract', 333, 'gut'), ('CHEBI_27329', 'xanthosine phosphate', 347, 'vitamin D2or'), ('PR_000017209', 'utrophin', 347, 'vitamin D2or'), ('CHEBI_33279', 'vitamin D5', 360, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 360, 'vitamin D3')]
PMC3695234	7/2013	S54-PMC3695234	['THEREFORE, the RELATIONSHIP between Vitamin D and ad HAS been INVESTIGATED both HERE and in PREVIOUS STUDIES.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('IMPORTANT_CONSIDERATION', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('INCOMPLETE_EVIDENCE', 92)]	6	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3695234	7/2013	S59-PMC3695234	['BASED ON the RELATIONSHIP between Vitamin D deficiency and ad, trials of Vitamin D supplementation in atopic populations or high-risk groups HAVE BEEN conducted.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 141)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC3695234	7/2013	S74-PMC3695234	['AS OUR STUDY is LIMITED by its retrospective cross-sectional design, we COULD NOT analyze the RELATIONSHIP between sun exposure and Vitamin D concentration.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 16), ('DIFFICULT_TASK', 72), ('ANOMALY_CURIOUS_FINDING', 78), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3695234	7/2013	S77-PMC3695234	['in conclusion, the results of THIS STUDY SUGGEST that Vitamin D deficiency MIGHT be RELATED to the severity of ad that is ASSOCIATED with Food sensitization.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 84), ('SUPERFICIAL_RELATIONSHIP', 122)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_33290', 'food', 138, 'food')]
PMC3713405	7/2013	S46-PMC3713405	['GIVEN that Vitamin D deficiency is common (1) during winter and spring, (2) at high latitudes (holick et al., 1995), (3) in urban environments (mcgrath et al., 2001) and (4) in dark skinned Individuals (clemens et al., 1982;holick et al., 1995), these ecological data led TO the HYPOTHESIS that low maternal Vitamin D COULD BE a modified risk FACTOR for schizophrenia.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 272), ('INCOMPLETE_EVIDENCE', 279), ('INCOMPLETE_EVIDENCE', 318), ('SUPERFICIAL_RELATIONSHIP', 343)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 190, 'individuals'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]
PMC3713405	7/2013	S91-PMC3713405	['in the developing Brain, levels of Vitamin D Receptor (Vdr) Expression COINCIDE with increasing levels of Apoptosis and decreasing levels of mitosis (burket et al., 2003) SUGGESTING similar actions TO that SEEN in peripheral Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 171), ('QUESTION_ANSWERED_BY_THIS_WORK', 198), ('INCOMPLETE_EVIDENCE', 206)]	4	[('UBERON_0000955', 'brain', 18, 'brain'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 35, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 55, 'VDR'), ('GO_0010467', 'gene expression', 60, 'expression'), ('GO_0006915', 'apoptotic process', 106, 'apoptosis'), ('UBERON_0000479', 'tissue', 225, 'tissue')]
PMC3717763	8/2013	S0-PMC3717763	['a qualitative study of uptake of free Vitamins in england\n\nabstract\n\nobjective\nTO IDENTIFY reasons WHY eligible families are not accessing free ‘healthy start’ Vitamin supplementation (providing Vitamins A, C and d) in england.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('EXPLICIT_QUESTION', 99)]	2	[('CHEBI_33277', 'gamma-tocotrienol', 38, 'vitamins'), ('CHEBI_33229', 'vitamin (role)', 160, 'vitamin'), ('CHEBI_27300', 'vitamin D', 195, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 204, 'A'), ('PR_000004900', 'complement C3', 207, 'C')]
PMC3717763	8/2013	S9-PMC3717763	['this scheme provides low-income families in the uk with fixed-value Food vouchers and vitamin coupons for eligible women and young children.1vitamin coupons can be exchanged for branded hs vitamin tablets for women (70\u2005mg Vitamin C, 10\u2005µg Vitamin D and 400\u2005µg Folic Acid daily during Pregnancy, and one year Postpartum) and drops for children (233\u2005µg Vitamin A, 20\u2005µg Vitamin C, and 7.5\u2005µg Vitamin D3 daily between\n\ncaption (boxed-text)\nwhat is already known on THIS topic\ncurrent uk GUIDANCE is that vulnerable groups of Pregnant and breastfeeding women and young children SHOULD take Vitamin Supplements (including Vitamins A, c and d) to protect against the greater RISK of Birth defects and poor health outcomes in later Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 462), ('FUTURE_WORK', 484), ('FUTURE_WORK', 574), ('IMPORTANT_CONSIDERATION', 669)]	4	[('CHEBI_33290', 'food', 68, 'food'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('CHEBI_30751', 'formic acid', 260, 'folic acid'), ('GO_0007565', 'female pregnancy', 284, 'pregnancy'), ('GO_0007565', 'female pregnancy', 308, 'postpartum'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin C'), ('CHEBI_33279', 'vitamin D5', 390, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 390, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 522, 'pregnant'), ('CHEBI_33229', 'vitamin (role)', 586, 'vitamin'), ('CHEBI_33341', 'titanium atom', 594, 'supplements'), ('CHEBI_27300', 'vitamin D', 617, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 626, 'A'), ('GO_0007567', 'parturition', 677, 'birth'), ('UBERON_0000104', 'life cycle', 725, 'life')]
PMC3717763	8/2013	S18-PMC3717763	["in RECENT YEARS, there HAS BEEN particular CONCERN about Vitamin D levels among children in the uk, and the rise in Vitamin D deficiency disease, presenting as rickets, symptomatic hypocalcaemia and motor delay.5–12vitamin d is hard to source through diet alone; 90% comes from exposure to sunlight.13if the mother's Vitamin D status is low during Pregnancy, the infant will also have low levels.14estimates CONSISTENTLY SHOW that the MAJORITY of uk children aged between 1.5 and 3\u2005years do not get their daily reference Nutrient intake of Vitamin D.15–18one RECENT STUDY REPORTS that supplying hs Vitamins to all Pregnant women and young children resulted in a substantial reduction in symptomatic Vitamin D deficiency in children in one primary care trust (pct), where 75% of the population were from ethnic minority groups PARTICULARLY AT RISK of Vitamin D deficiency.19\nTHIS PAPER reports on research with parents and professionals with the AIM of understanding WHY the provision of free hs Vitamins has not resulted in higher levels of use among low income families in england."]	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 43), ('PROBABLE_UNDERSTANDING', 408), ('INCOMPLETE_EVIDENCE', 421), ('PROBABLE_UNDERSTANDING', 435), ('INCOMPLETE_EVIDENCE', 559), ('INCOMPLETE_EVIDENCE', 572), ('IMPORTANT_CONSIDERATION', 826), ('IMPORTANT_CONSIDERATION', 839), ('QUESTION_ANSWERED_BY_THIS_WORK', 874), ('QUESTION_ANSWERED_BY_THIS_WORK', 945), ('EXPLICIT_QUESTION', 966)]	13	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('GO_0007565', 'female pregnancy', 348, 'pregnancy'), ('CHEBI_33284', 'nutrient', 521, 'nutrient'), ('CHEBI_27300', 'vitamin D', 540, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 598, 'vitamins'), ('GO_0007565', 'female pregnancy', 614, 'pregnant'), ('CHEBI_27300', 'vitamin D', 699, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 850, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 995, 'vitamins')]
PMC3717763	8/2013	S109-PMC3717763	['reports SUGGEST that less than half the midwives and health visitors are aware of the current uk Vitamin D GUIDELINES for ages under 5 years, and RECOMMEND supplementation to parents.29–31additionally, THIS STUDY INDICATES that workload pressures and infrequent contact with mothers CAN also discourage them from promoting hs Vitamins.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 107), ('FUTURE_WORK', 146), ('QUESTION_ANSWERED_BY_THIS_WORK', 202), ('INCOMPLETE_EVIDENCE', 213), ('INCOMPLETE_EVIDENCE', 283)]	6	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 105, 'D'), ('CHEBI_33277', 'gamma-tocotrienol', 326, 'vitamins')]
PMC3739737	8/2013	S1-PMC3739737	['the AIM of THIS STUDY was TO INVESTIGATE the EFFECTS of Adult Vitamin D (avd) deficiency on behavioural tasks of relevance to neuropsychiatric disorders in male sprague-dawley Rats.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('UBERON_0007023', 'adult organism', 56, 'adult'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 176, 'rats')]
PMC3739737	8/2013	S111-PMC3739737	['discussion\noverall, our results clearly DEMONSTRATE that Adult Vitamin D (avd) deficiency in male sprague-dawley Rats was not associated with a gross neurochemical or behavioural phenotype.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 40)]	1	[('UBERON_0007023', 'adult organism', 57, 'adult'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 113, 'rats')]
PMC3739737	8/2013	S169-PMC3739737	['evidence from a RECENTLY published randomized controlled trial of Vitamin D supplementation for the treatment of parkinson’s disease (pd) SUPPORT THIS HYPOTHESIS[40].']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 138), ('QUESTION_ANSWERED_BY_THIS_WORK', 146), ('INCOMPLETE_EVIDENCE', 151)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3798907	8/2013	S1-PMC3798907	['we INVESTIGATED WHETHER these ASSOCIATIONS REFLECT direct EFFECTS of Vitamin E by INVESTIGATING the EFFECTS of supplementing cbmc cultures with physiological concentrations of Vitamin E. cbmc from seventy neonates were cultured supplemented with either nothing, Α-Tocopherol or Ascorbic Acid.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 100)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin E'), ('CHEBI_27725', 'butin', 262, 'α-tocopherol'), ('CHEBI_22652', 'ascorbic acid', 278, 'ascorbic acid')]
PMC3798907	8/2013	S21-PMC3798907	['these considerations RAISE the POSSIBILITY that the OBSERVED epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses MAY NOT be a direct ASSOCIATION BUT MERELY a consequence of CONFOUNDING by other Nutrients ASSOCIATED with Vitamin E.\nTO INVESTIGATE these ISSUES further, and to inform any intervention trial, we CONDUCTED an ex vivo study to test WHETHER the OBSERVED epidemiological ASSOCIATION between reduced maternal Vitamin E intake during Pregnancy and increased cbmc responses COULD BE EXPLAINED by a direct causal EFFECT.']	[('EXPLICIT_QUESTION', 21), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 159), ('ANOMALY_CURIOUS_FINDING', 163), ('SUPERFICIAL_RELATIONSHIP', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('ANOMALY_CURIOUS_FINDING', 195), ('ANOMALY_CURIOUS_FINDING', 195), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 250), ('QUESTION_ANSWERED_BY_THIS_WORK', 277), ('PROBLEM_COMPLICATION', 298), ('QUESTION_ANSWERED_BY_THIS_WORK', 355), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 390), ('INCOMPLETE_EVIDENCE', 402), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 527), ('PROBABLE_UNDERSTANDING', 536), ('SUPERFICIAL_RELATIONSHIP', 565)]	21	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_33284', 'nutrient', 240, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin E'), ('GO_0007565', 'female pregnancy', 488, 'pregnancy')]
PMC3798907	8/2013	S22-PMC3798907	['the approach was TO DETERMINE WHETHER the in vitro addition of Vitamin E to cbmc cultures altered proliferative and th cytokine responses against a panel of Mitogenic, Antigenic and Allergenic T-Cell stimuli.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin E'), ('CHEBI_59132', 'antigen', 157, 'mitogenic'), ('CHEBI_59132', 'antigen', 168, 'antigenic'), ('CHEBI_77514', '6-phenylundecane', 182, 'allergenic'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 182, 'allergenic T-cell'), ('CL_0000084', 'T cell', 193, 'T-cell'), ('GO_0085026', 'tubovesicular membrane network', 193, 'T-cell')]
PMC3798907	8/2013	S23-PMC3798907	['the prime AIM was TO DETERMINE WHETHER the in vitro addition of Vitamin E to cbmc cultures at a physiological concentration observed in Cord Blood altered proliferative and th-cell cytokine responses in a manner predicted by the original observation studies [12,13].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin E'), ('UBERON_0002240', 'spinal cord', 136, 'cord'), ('UBERON_0000178', 'blood', 141, 'blood')]
PMC3798907	8/2013	S25-PMC3798907	['given the REPORTED age RELATED DIFFERENTIAL responsiveness of Vitamin E on Human Th-Cell Responses [4,8], a secondary AIM of the study was TO INVESTIGATE the in vitro EFFECTS of Vitamins E and C on Adult Peripheral Blood Mononuclear Cell (Pbmc) responses.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('QUESTION_ANSWERED_BY_THIS_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 167)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin E'), ('NCBITaxon_9606', 'Homo sapiens', 75, 'human'), ('CL_0000545', 'T-helper 1 cell', 81, 'Th-cell'), ('GO_0001783', 'B cell apoptotic process', 81, 'Th-cell responses'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 193, 'C'), ('PR_000004900', 'complement C3', 193, 'C'), ('UBERON_0007023', 'adult organism', 198, 'adult'), ('CL_0000111', 'peripheral neuron', 204, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 204, 'peripheral blood'), ('GO_0031097', 'medial cortex', 221, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 239, 'PBMC')]
PMC3798907	8/2013	S100-PMC3798907	['discussion\nTHIS STUDY was BASED ON our novel OBSERVATION in a general population study, that low maternal Vitamin E intake during Pregnancy is INDEPENDENTLY ASSOCIATED with increased in vitro Proliferative Responses by cbmc and an increased LIKELIHOOD of asthma in children aged 5 years.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 45), ('SUPERFICIAL_RELATIONSHIP', 143), ('SUPERFICIAL_RELATIONSHIP', 157), ('PROBABLE_UNDERSTANDING', 241)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('GO_0001780', 'neutrophil homeostasis', 192, 'proliferative responses')]
PMC3798907	8/2013	S102-PMC3798907	['before embarking on a Vitamin E intervention study during Pregnancy we wanted TO TEST WHETHER in vitro Vitamin E supplementation COULD Modulate Neonatal Immune Responses, REASONING that the demonstration of a direct EFFECT would justify Vitamin E supplementation, WHEREAS FAILURE to demonstrate a direct EFFECT would justify ALTERNATIVE dietary STRATEGIES to increase Vitamin E intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 129), ('PROBABLE_UNDERSTANDING', 171), ('PROBABLE_UNDERSTANDING', 171), ('SUPERFICIAL_RELATIONSHIP', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('PROBLEM_COMPLICATION', 272), ('SUPERFICIAL_RELATIONSHIP', 304), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 325), ('FUTURE_WORK', 345)]	11	[('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('GO_0065007', 'biological regulation', 135, 'modulate'), ('GO_0007567', 'parturition', 144, 'neonatal'), ('GO_0006955', 'immune response', 153, 'immune responses'), ('UBERON_0002405', 'immune system', 153, 'immune'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin E')]
PMC3798907	8/2013	S109-PMC3798907	['a further POSSIBILITY raised by THE CURRENT STUDY is that isolated maternal Vitamin E supplementation during Pregnancy MAY have MIXED or EVEN adverse CONSEQUENCES for atopic sensitisation to different Allergens.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('ANOMALY_CURIOUS_FINDING', 137), ('PROBLEM_COMPLICATION', 150)]	6	[('CHEBI_27300', 'vitamin D', 76, 'vitamin E'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_33663', 'cyclic hydrocarbon', 201, 'allergens')]
PMC3798907	8/2013	S122-PMC3798907	['ALTHOUGH the main FOCUS of our work was the supplementation of cbmc, we included a parallel study of Adult pbmc TO EXAMINE the EFFECT of the same in vitro Vitamin E supplementation on Adult Pbmc IN LIGHT OF the REPORTS of age RELATED differential responsiveness.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 127), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 226)]	7	[('UBERON_0007023', 'adult organism', 101, 'adult'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin E'), ('UBERON_0007023', 'adult organism', 184, 'adult'), ('UBERON_2005026', 'primary head sinus', 190, 'PBMC')]
PMC3798907	8/2013	S125-PMC3798907	['we FOUND NO CONVINCING evidence of differential responsiveness of cbmc and Adult Pbmc to Vitamin E supplementation; HOWEVER the dose of Vitamin E used in THE current study was CONSIDERABLY LESS than that REPORTED in PREVIOUS work [4].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ANOMALY_CURIOUS_FINDING', 176), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 216)]	8	[('UBERON_0007023', 'adult organism', 75, 'adult'), ('UBERON_2005026', 'primary head sinus', 81, 'PBMC'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin E')]
PMC3798907	8/2013	S135-PMC3798907	['the population studied in the CURRENT study (children Born by elective caesarean section) DIFFERED from the general population from which the original ASSOCIATION between Vitamin E and cbmc responses was drawn [12], HOWEVER cbmc responses in a general population were not associated with mode of delivery (unpublished observations from [12]).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 216)]	4	[('GO_0007567', 'parturition', 54, 'born'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin E')]
PMC3798907	8/2013	S143-PMC3798907	['the mechanisms by which Vitamins E and C MEDIATED their COMPLEX EFFECTS on cbmc responses in THE CURRENT STUDY are UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 56), ('SUPERFICIAL_RELATIONSHIP', 64), ('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('FULL_UNKNOWN', 115)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 39, 'C'), ('PR_000004900', 'complement C3', 39, 'C')]
PMC3798907	8/2013	S148-PMC3798907	['in THE CURRENT STUDY, the EFFECTS of in vitro Vitamin E supplementation on cbmc and pbmc Effector cytokine responses did DIFFER, BUT the EFFECTS of in vitro Vitamin C supplementation were broadly SIMILAR in neonates and Adults.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 129), ('SUPERFICIAL_RELATIONSHIP', 137), ('SUPERFICIAL_RELATIONSHIP', 196)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin E'), ('CHEBI_35224', 'effector', 89, 'effector'), ('CHEBI_33229', 'vitamin (role)', 157, 'vitamin'), ('CHEBI_18245', 'carboxylato group', 165, 'C'), ('UBERON_0007023', 'adult organism', 220, 'adults')]
PMC3798907	8/2013	S151-PMC3798907	['conclusions\noverall, THIS WORK DEMONSTRATES that in vitro supplementation of cbmc with Vitamins E or C CAN INFLUENCE their Immune function but NOT in the simple and consistent manner predicted by models arising from observational epidemiological studies.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 107), ('ANOMALY_CURIOUS_FINDING', 143)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 101, 'C'), ('UBERON_0002405', 'immune system', 123, 'immune')]
PMC3798907	8/2013	S154-PMC3798907	['the FINDINGS of THE CURRENT STUDY have changed the direction of our Vitamin E based intervention away from supplementation, towards dietary intervention, with Vitamin E in its natural Food based form [33].']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin E'), ('CHEBI_33290', 'food', 184, 'food')]
PMC3760821	9/2013	S1-PMC3760821	['the second AIM of the study was TO INVESTIGATE POTENTIAL INTERACTIONS between maternal body mass index (bmi) and foetal Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC3760821	9/2013	S46-PMC3760821	['the second AIM of the study was TO INVESTIGATE POTENTIAL INTERACTIONS between maternal bmi and foetal Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC3760821	9/2013	S155-PMC3760821	['the FINDINGS of THE CURRENT STUDY that, in women with t1dm, low Vitamin D levels are EVIDENCED throughout Gestation are IN AGREEMENT with PREVIOUS GROUPS who HAVE reported compromised Vitamin D status in Pregnancy[5].']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 138), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'gestation'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy')]
PMC3760821	9/2013	S172-PMC3760821	['WHILE josefson et al ., REPORTED an IMPACT of maternal age and neonatal adiposity, directly measured by air displacement plethysmography, on Cord Vitamin D levels, in the CURRENT STUDY, ALTHOUGH neonatal bmi sds was significantly negatively CORRELATED with Cord 25Ohd in subjects with t1dm, regression analysis INDICATED that maternal age at Delivery and SURROGATE measures of neonatal adiposity (Subscapular Skinfold, Triceps Skinfold, and sds bmi) did not impact significantly on Cord Blood 25Ohd.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 171), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 186), ('SUPERFICIAL_RELATIONSHIP', 241), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 355)]	9	[('UBERON_0002240', 'spinal cord', 141, 'cord'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 257, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 262, '25OHD'), ('GO_0007567', 'parturition', 342, 'delivery'), ('UBERON_0007191', 'anterior paracentral gyrus', 397, 'subscapular skinfold'), ('UBERON_0005299', 'prepuce of clitoris', 419, 'triceps skinfold'), ('UBERON_0002240', 'spinal cord', 482, 'cord'), ('UBERON_0000178', 'blood', 487, 'blood'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 493, '25OHD')]
PMC3760821	9/2013	S173-PMC3760821	['a KEY FINDING of THE CURRENT STUDY is that in t1dm Pregnancy, maternal Vitamin D levels EXHIBIT an INDEPENDENT inverse RELATIONSHIP with hba1clevels.']	[('IMPORTANT_CONSIDERATION', 2), ('INCOMPLETE_EVIDENCE', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ANOMALY_CURIOUS_FINDING', 88), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 119)]	6	[('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC3760821	9/2013	S181-PMC3760821	['clearly, prospective clinical randomised controlled trials of Vitamin D supplementation ARE REQUIRED TO evaluate and CLARIFY the ASSOCIATION between Vitamin D status and Glycaemic Control in t1dm Pregnancy.']	[('FUTURE_WORK', 88), ('IMPORTANT_CONSIDERATION', 92), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('FUTURE_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 129)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 170, 'glycaemic control'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
PMC3760821	9/2013	S185-PMC3760821	['GIVEN the SAFETY of Vitamin D, the low cost of supplementation and its REQUIREMENT for OPTIMAL bone health (and POTENTIALLY other health outcomes) in both the mother and off-spring, the FINDINGS of THE CURRENT STUDY SUPPORT the case for determining Vitamin D status and, IF NECESSARY, administering Vitamin D in t1dm pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('IMPORTANT_CONSIDERATION', 71), ('IMPORTANT_CONSIDERATION', 87), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 198), ('INCOMPLETE_EVIDENCE', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 271), ('IMPORTANT_CONSIDERATION', 274)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC3814422	10/2013	S63-PMC3814422	['additional analyses\nTO TEST WHETHER ASSOCIATIONS were driven by a threshold effect of greater risk in those whose mothers had insufficient levels of Vitamin D, we EXAMINED ASSOCIATIONS of categories of 25(Oh)D levels (≥ 50 nmol/l; 27.5–49.99 nmol/l and < 27.5 nmol/l) with outcomes, we also repeated analyses using 75 nmol/l as a higher THRESHOLD for sufficiency as recommended in a more RECENT REVIEW23.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 163), ('SUPERFICIAL_RELATIONSHIP', 172), ('PROBABLE_UNDERSTANDING', 337), ('INCOMPLETE_EVIDENCE', 388)]	7	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 208, 'D')]
PMC3814422	10/2013	S137-PMC3814422	['ALTHOUGH Animal studies HAVE SHOWN that Vitamin D is INVOLVED in normal Fetal Lung Development31, OUR STUDY is IN GENERAL AGREEMENT with OTHER epidemiological STUDIES that have considered later offspring Lung function in the general population – two STUDIES HAVE REPORTED null ASSOCIATIONS of maternal 25(Oh)D13,32or dietary Vitamin D intake32with offspring Lung function.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 98), ('INCOMPLETE_EVIDENCE', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 277)]	11	[('NCBITaxon_33208', 'Metazoa', 9, 'animal'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007631', 'feeding behavior', 72, 'fetal'), ('GO_0030324', 'lung development', 78, 'lung development31'), ('UBERON_0002048', 'lung', 78, 'lung'), ('UBERON_0002048', 'lung', 204, 'lung'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 302, '25(OH)D13'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('UBERON_0002048', 'lung', 358, 'lung')]
PMC3827489	10/2013	S25-PMC3827489	['THUS, given the IMPORTANT ROLE of Vitamin D in childhood health, THIS REVIEW will FOCUS on the IMPACT of Vitamin D on health and disease in childhood and Adolescence.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 95)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 154, 'adolescence')]
PMC3827489	10/2013	S33-PMC3827489	['IN LINE WITH THESE data, a study FOCUSING on adolescents aged 12-13 years REPORTED that 98.9% of boys and 100% of girls showed Vitamin D insufficiency or deficiency; 5.3% had 25(Oh)D insufficiency (20.0-29.9 ng/ml), 94.2% had deficient concentrations (<20.0 ng/ml), and ONLY 1 boy (1.1%) had OPTIMAL concentrations of 25(Oh)d6).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('INCOMPLETE_EVIDENCE', 74), ('ANOMALY_CURIOUS_FINDING', 270), ('INCOMPLETE_EVIDENCE', 270), ('IMPORTANT_CONSIDERATION', 292)]	7	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 175, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 318, '25(OH')]
PMC3827489	10/2013	S64-PMC3827489	['in addition, Vitamin D HAS BEEN recognized as an anti-infective agent due TO its EFFECTS on Innate and Adaptive Immune Responses.']	[('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007631', 'feeding behavior', 92, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 103, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 112, 'immune')]
PMC4231606	10/2013	S2-PMC4231606	['the PURPOSE of THIS STUDY was TO DETERMINE the ASSOCIATION between Vitamin D (25(Oh)D) levels and s-ecc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 47)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 78, '25(OH)D')]
PMC4231606	10/2013	S112-PMC4231606	['discussion\nthe PURPOSE of THIS STUDY was TO DETERMINE WHETHER children with s-ecc have different nutritional profiles THAN their caries-free peers, specifically Vitamin D, calcium and albumin status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('EXPLICIT_QUESTION', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	5	[('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC4231606	10/2013	S155-PMC4231606	['THIS STUDY SUGGESTS a CLEAR RELATIONSHIP between Vitamin D levels and the caries status of preschool children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 22), ('SUPERFICIAL_RELATIONSHIP', 28)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3829803	11/2013	S256-PMC3829803	['THIS is the FIRST work to DEMONSTRATE the antiviral EFFECT of Vitamin A on Muv and MAY CONTRIBUTE to better treatment OPTIONS for Muv.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 87), ('FUTURE_WORK', 118)]	8	[('CHEBI_27300', 'vitamin D', 62, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 75, 'MuV'), ('NCBITaxon_10088', 'Mus <genus>', 130, 'MuV')]
PMC3991049	11/2013	S3-PMC3991049	['we CONDUCTED THIS STUDY TO DETERMINE the prevalence of Vitamin D deficiency among Pregnant women and TO EVALUATE the EFFECTIVENESS and level of weekly Oral 50,000 iu of Vitamin D supplementation for the mother and the newborn.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('SUPERFICIAL_RELATIONSHIP', 117)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('UBERON_0000165', 'mouth', 151, 'oral'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC3991049	11/2013	S24-PMC3991049	["a RECENT STUDY SHOWED that a daily supplement of 4000 iu of Vitamin D was REQUIRED to sustain normal Metabolism in Pregnancy and this dose was EFFECTIVE and SAFE.9\nin THIS STUDY we EVALUATED the prevalence of Vitamin D deficiency in Pregnant women and EVALUATED the EFFECT of weekly Oral 50,000 iu of Vitamin D on mothers' and newborn's level of Vitamin D.\n\nmethods\nTHIS is a prospective observational study conducted at a single center at hamad medical corporation in doha, qatar."]	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 143), ('IMPORTANT_CONSIDERATION', 157), ('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('QUESTION_ANSWERED_BY_THIS_WORK', 181), ('QUESTION_ANSWERED_BY_THIS_WORK', 252), ('SUPERFICIAL_RELATIONSHIP', 266), ('QUESTION_ANSWERED_BY_THIS_WORK', 366)]	10	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0008152', 'metabolic process', 101, 'metabolism'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('GO_0007565', 'female pregnancy', 233, 'pregnant'), ('UBERON_0000165', 'mouth', 283, 'oral'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC3991049	11/2013	S72-PMC3991049	['hypercalcemia, which is the most WORRYING toxicity, occurs with Vitamin D levels of more than 80 or 100\xa0ng/ml; and in OUR STUDY no one reached this level through out Pregnancy and in newborns with normal levels of calcium IN SPITE of supplementation.']	[('IMPORTANT_CONSIDERATION', 33), ('QUESTION_ANSWERED_BY_THIS_WORK', 118), ('ANOMALY_CURIOUS_FINDING', 222)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
PMC3991049	11/2013	S74-PMC3991049	['no adverse effects were observed in these mothers or their infants.33\nOUR STUDY DEMONSTRATED that low Vitamin D level is common in Pregnant mothers in qatar.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('INCOMPLETE_EVIDENCE', 80), ('QUESTION_ANSWERED_BY_THIS_WORK', 80)]	3	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnant')]
PMC3991049	11/2013	S80-PMC3991049	['we NEED rct of Vitamin D supplementation with measurement of 25-Hydroxyvitamin D to determine the baseline status, the level achieved on supplementation with appropriate design to avoid any CONFOUNDER, and TO ASSESS WHAT is the appropriate level of Vitamin D during Pregnancy and in newborns with no complications or toxicity through out.']	[('FUTURE_WORK', 3), ('PROBLEM_COMPLICATION', 190), ('QUESTION_ANSWERED_BY_THIS_WORK', 206), ('EXPLICIT_QUESTION', 216)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 61, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
PMC3873449	12/2013	S2-PMC3873449	['the PURPOSE of THIS STUDY was TO ASSESS the Vitamin D status of Pregnant women residing in beijing in winter AND EVALUATE the IMPACT of maternal factors on Serum 25-hydroxyvitamin d [25(Oh)D] levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 109), ('SUPERFICIAL_RELATIONSHIP', 126)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('UBERON_0001977', 'blood serum', 156, 'serum'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D')]
PMC3873449	12/2013	S42-PMC3873449	['the PURPOSE of THIS STUDY was TO ASSESS the Vitamin D status in Pregnant women residing in beijing in winter.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant')]
PMC3873449	12/2013	S53-PMC3873449	['Vitamin D intake in Food was not collected SINCE usually little Food in chinese diet contains reasonable amounts of Vitamin D. it should be NOTED that in china, dairy Products are not fortified with Vitamin D. the questionnaire also SOUGHT information about behavioral factors like daily duration of computer use and daily duration of sun exposure (duration-number of hours per day).']	[('PROBLEM_COMPLICATION', 43), ('ANOMALY_CURIOUS_FINDING', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 233)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_33290', 'food', 20, 'food'), ('CHEBI_33290', 'food', 64, 'food'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_38873', 'prothiofos', 167, 'products'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D')]
PMC3873449	12/2013	S65-PMC3873449	['for the analysis, in OUR STUDY we classified women into groups that defined Vitamin D status: severe Vitamin D deficiency: 25(Oh)D < 25 nmol/l; mild Vitamin D deficiency: 25 nmol/l ≤ 25(Oh)D < 50 nmol/l; Vitamin D insufficiency: 50 nmol/l ≤ 25(Oh)D < 75 nmol/l; and sufficiency: 25(Oh)D≥75 nmol/l.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21)]	1	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 241, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 279, '25(OH)D')]
PMC3873449	12/2013	S108-PMC3873449	['TO DETERMINE WHETHER education levels IMPACT Vitamin D status, women were grouped by better educated women (with associate degree or higher) and less educated women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC3873449	12/2013	S115-PMC3873449	['discussion\nthe PRESENT STUDY SHOWED a high prevalence of Vitamin D deficiency among Pregnant women in the beijing urban area (39.9 °n), northern china in winter.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 29)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnant')]
PMC3873449	12/2013	S171-PMC3873449	['in OUR STUDY nearly half of women did take multivitamins and these multivitamins did improve the Vitamin D level SOMEWHAT but DID NOT prevent Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 126)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC3873449	12/2013	S186-PMC3873449	['a hundred percent of Pregnant women had Vitamin D insufficiency in OUR STUDY.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 67)]	1	[('GO_0007565', 'female pregnancy', 21, 'pregnant'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC3873449	12/2013	S210-PMC3873449	['TO OUR KNOWLEDGE, THIS STUDY is the FIRST to report the INFLUENCE of maternal FACTORS on Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 78)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnant')]
PMC3873449	12/2013	S211-PMC3873449	['this design allowed us TO ASSESS the IMPACT of these factors on Vitamin D status in chinese Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 92, 'pregnant')]
PMC3882256	1/2014	S2-PMC3882256	['objective\nTO EXAMINE the RELATIONSHIP between Maternal Pregnancy dietary and supplement iron Intake and hemoglobin, with offspring’s Arterial stiffness (measured by Carotid-radial pulse wave velocity), Endothelial function (measured by Brachial Artery flow mediated dilatation), Blood pressure, and adiposity (measured by body mass index), test for mediation by cord ferritin, Birth weight, Gestational age, and child dietary iron intake, and for EFFECT modification by maternal Vitamin C intake and offspring sex.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 447)]	3	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('GO_0007631', 'feeding behavior', 93, 'intake'), ('UBERON_0001637', 'artery', 133, 'arterial'), ('UBERON_0005396', 'carotid artery segment', 165, 'carotid'), ('UBERON_0001986', 'endothelium', 202, 'endothelial'), ('UBERON_0001398', 'brachial artery', 236, 'brachial artery'), ('UBERON_0000178', 'blood', 279, 'blood'), ('GO_0007567', 'parturition', 377, 'birth'), ('GO_0007565', 'female pregnancy', 391, 'gestational'), ('CHEBI_27300', 'vitamin D', 479, 'vitamin C')]
PMC3882256	1/2014	S25-PMC3882256	['we EXAMINED WHETHER any observed ASSOCIATIONS were MEDIATED by Cord Blood ferritin levels, Gestational age, offspring’s birthweight, and dietary iron intake and explored WHETHER offspring sex and maternal Vitamin C intake moderate any ASSOCIATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 235)]	6	[('UBERON_0002240', 'spinal cord', 63, 'cord'), ('UBERON_0000178', 'blood', 68, 'blood'), ('GO_0007565', 'female pregnancy', 91, 'gestational'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin C')]
PMC3926113	1/2014	S2-PMC3926113	['in the PRESENT STUDY, we INVESTIGATED the developmental pattern and EFFECT of vitc deficiency on antioxidants, Vitamin E and Superoxide dismutase (sod), assessed oxidative damage by measuring Malondialdehyde (Mda), Hydroxynonenal (Hne) and Nitrotyrosine (Nt) and analysed Gene and protein Expression of Apoptosis marker Caspase-3 in the guinea pig foetal Brain at two Gestational (gd) time points, gd 45/pre-term and gd 56/near term following either a vitc sufficient (ctrl) or deficient (def) maternal dietary regime.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 68)]	3	[('CHEBI_27300', 'vitamin D', 111, 'vitamin E'), ('CHEBI_18421', 'superoxide', 125, 'superoxide'), ('CHEBI_16480', 'nitric oxide', 192, 'malondialdehyde'), ('CHEBI_34840', 'methyl methacrylate', 209, 'MDA'), ('CHEBI_5445', 'glyceraldehyde', 215, 'hydroxynonenal'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 231, 'HNE'), ('CHEBI_50654', 'but-2-enoate ester', 240, 'nitrotyrosine'), ('CHEBI_13389', 'NAD', 255, 'NT'), ('SO_0000704', 'gene', 272, 'gene'), ('GO_0010467', 'gene expression', 289, 'expression'), ('GO_0006915', 'apoptotic process', 303, 'apoptosis'), ('PR_000002319', 'catenin beta-1 isoform 1', 320, 'caspase-3'), ('UBERON_0000955', 'brain', 355, 'brain'), ('GO_0007565', 'female pregnancy', 368, 'gestational')]
PMC3926113	1/2014	S125-PMC3926113	['INTERACTION between Cytosolic Vitc and Membrane bound Vitamin E regenerates oxidized Vitamin E and results in an efficient antioxidant mechanism[9], which SUGGESTS that Vitc deficiency MAY alter Vitamin E levels HEREBY POSSIBLY disrupting Membrane integrity.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 212), ('INCOMPLETE_EVIDENCE', 219)]	5	[('GO_0005829', 'cytosol', 20, 'cytosolic'), ('PR_000017299', 'VIP peptides', 30, 'VitC'), ('GO_0016020', 'membrane', 39, 'membrane'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin E'), ('PR_000017299', 'VIP peptides', 169, 'VitC'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin E'), ('GO_0016020', 'membrane', 239, 'membrane')]
PMC4045304	2/2014	S275-PMC4045304	['recruitment for an OPEN LABEL clinical trial TO EVALUATE large doses of Vitamin D in autistic children as a new treatment modality, with target 25-Hydroxyvitamin D3 levels of 80\u2009ng/ml is UNDERWAY [99].']	[('FULL_UNKNOWN', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 187)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_63991', '15-epi-lipoxin B4', 144, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 162, 'D3')]
PMC3933171	3/2014	S0-PMC3933171	['Vitamin D status of early preterm infants and the EFFECTS of Vitamin D intake during hospital stay\n\nabstract\n\nobjectives\nTO EVALUATE Vitamin D (vitd) status in early preterm infants (eptis) at Birth and during Birth hospitalisation on current vitd intake.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 121)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007567', 'parturition', 193, 'birth'), ('GO_0007567', 'parturition', 210, 'birth')]
PMC3973641	4/2014	S36-PMC3973641	['considering that exposure to suboptimal nutrition during early development LEADS TO a long-term, age-DEPENDENT Metabolic response[26], we INVESTIGATED the EFFECTS of a Vitamin B-deficient diet during Pregnancy or Pregnancy/Lactation in Mice offspring.']	[('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 101), ('QUESTION_ANSWERED_BY_THIS_WORK', 138), ('SUPERFICIAL_RELATIONSHIP', 155)]	4	[('GO_0008152', 'metabolic process', 111, 'metabolic'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin B'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy'), ('GO_0007595', 'lactation', 223, 'lactation'), ('NCBITaxon_10088', 'Mus <genus>', 236, 'mice')]
PMC4018592	4/2014	S22-PMC4018592	['[17] in a study in nepal, multiple Micronutrient supplementations during Pregnancy did NOT reduce early infant mortality;[18] HOWEVER, it led TO improved folate status and reduced the prevalence of riboflavin, Vitamin B6, Vitamin B12, Folate and Vitamin D deficiencies.']	[('ANOMALY_CURIOUS_FINDING', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 142)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 35, 'micronutrient'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_33237', 'vitamin D4', 210, 'vitamin B6'), ('CHEBI_33279', 'vitamin D5', 222, 'vitamin B12'), ('CHEBI_30863', '5-azaorotic acid', 235, 'folate'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4051754	6/2014	S244-PMC4051754	['parameters measured were: the indexes of Acute Phase Reaction, such as the positive Acute Phase protein haptoglobin and ceruloplasmin; the negative Acute Phase protein Albumin, paraoxonase and the other index RELATED to the negative Acute Phase Protein reaction such as Cholesterol, Β-Carotene, and Vitamin A; Bilirubin; the Liver enzymes aspartate aminotransferase (ast or got ) and γ- glutamyl transpeptidase ( ggt ); Minerals (Calcium, magnesium, zinc, and Phosphorous); creatinine; and Vitamin e. the concentration of total proteins was analyzed also previously[10]and the data were re-analyzed in the PRESENT STUDY in order to calculate accurately the concentration of globulins which are ESTIMATED by the difference between total proteins and albumin.']	[('SUPERFICIAL_RELATIONSHIP', 209), ('QUESTION_ANSWERED_BY_THIS_WORK', 606), ('INCOMPLETE_EVIDENCE', 694)]	3	[('GO_0007354', 'zygotic determination of anterior/posterior axis, embryo', 41, 'acute phase reaction'), ('GO_0006953', 'acute-phase response', 84, 'acute phase'), ('GO_0006953', 'acute-phase response', 148, 'acute phase'), ('PR_000005908', 'alpha-crystallin B chain', 168, 'albumin'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 233, 'acute phase protein'), ('CHEBI_16113', 'cholesterol', 270, 'cholesterol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 283, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin A'), ('CHEBI_16990', 'bilirubin IXalpha', 310, 'bilirubin'), ('UBERON_0002107', 'liver', 325, 'liver'), ('CHEBI_46751', 'quinolizidine', 420, 'minerals'), ('CHEBI_22313', 'alkaline earth metal atom', 430, 'calcium'), ('CHEBI_30207', 'phosphorus(.)', 460, 'phosphorous'), ('CHEBI_33229', 'vitamin (role)', 490, 'vitamin')]
PMC4072587	6/2014	S10-PMC4072587	['OUR FINDINGS STRENGTHEN the EVIDENCE for giving Vitamin D supplementation during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy')]
PMC4072587	6/2014	S78-PMC4072587	['the association between maternal Vitamin D concentrations and each of the outcome variables was ASSESSED for linearity both visually and by comparing regression models with a categorized and pseudo-continuous form of maternal Vitamin D concentrations (quintile groupings) using the likelihood ratio test.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 96)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC4072587	6/2014	S113-PMC4072587	['OUR FINDINGS SHOW that low Vitamin D levels in late Pregnancy (<37.5 nmol/l) are ASSOCIATED with reduced infant Language Development at six months of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 112, 'language development')]
PMC4072587	6/2014	S120-PMC4072587	['ALTHOUGH Vitamin D concentration was significantly higher in the twice weekly multiple Micronutrient group compared TO daily iron Folic Acid group, (mean [sd] of 76.3 [23.8] versus 67.8 [20.6] nmol/l), the prevalence of Vitamin D deficiency (<37.5 nmol/l) was SIMILAR (4.9% (16/326) versus 3.1% (9/293).']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 116), ('SUPERFICIAL_RELATIONSHIP', 260)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 87, 'micronutrient'), ('CHEBI_30751', 'formic acid', 130, 'folic acid'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC4072587	6/2014	S149-PMC4072587	['TO OUR KNOWLEDGE, OUR STUDY is the largest and MOST COMPREHENSIVE study on maternal Vitamin D status to be conducted in vietnam.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('PROBABLE_UNDERSTANDING', 47)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC4072587	6/2014	S155-PMC4072587	['conclusions\nOUR STUDY INDICATES that low levels of Vitamin D during Pregnancy are of CONCERN in rural vietnam, and are ASSOCIATED with impaired Language Development at 6 months of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 22), ('PROBLEM_COMPLICATION', 85), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 144, 'language development')]
PMC4113768	7/2014	S55-PMC4113768	['conclusions: the PRESENT INVESTIGATION INDICATES that the Vitamin D status MAY function AS an INDEPENDENT positive PREDICTOR of sod, especially in non-obese, non-smoking elderly women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 115)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4113768	7/2014	S149-PMC4113768	['THEREFORE, in THIS STUDY, ASSOCIATIONS between sleep quality and Vitamin D status in uk dwelling south asian (a) and caucasian (c) women were INVESTIGATED.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 142)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S161-PMC4113768	['conclusion: THIS research PROVIDES PRELIMINARY EVIDENCE that Vitamin D MIGHT be ASSOCIATED with Sleep quality.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 80)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0030431', 'sleep', 96, 'sleep')]
PMC4113768	7/2014	S170-PMC4113768	['the OBJECTIVE of THIS SYSTEMATIC REVIEW was TO ASSESS the ASSOCIATION between Vitamin D RELATED MARKERS and Colorectal cancer prognosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('SUPERFICIAL_RELATIONSHIP', 58), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 96)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0012652', 'colorectum', 108, 'colorectal')]
PMC4113768	7/2014	S214-PMC4113768	['we THEREFORE AIMED TO DETERMINE WHETHER seasonal Vitamin D deficiency occurs in two healthy young Adult populations with moderate or dark skin pigmentation in cape town, WHETHER this had an EFFECT on the number and function of Circulating Blood Cells, their ability to Control to hiv-1 infection and WHETHER Vitamin D supplementation modifies the investigated responses.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 190), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 300)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adult'), ('CL_0000080', 'circulating cell', 227, 'circulating'), ('CL_0000081', 'blood cell', 239, 'blood cells'), ('UBERON_0000178', 'blood', 239, 'blood'), ('GO_0065007', 'biological regulation', 269, 'control'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]
PMC4113768	7/2014	S233-PMC4113768	['to account for seasonal variation in Vitamin D levels, as well as seasonality of infections, we EXAMINED the ASSOCIATION within different season strata.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 109)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4113768	7/2014	S244-PMC4113768	['conclusions: OUR FINDINGS SUGGEST that Vitamin D deficiency at Birth is ASSOCIATED with INCREASED RISK of lrti PARTICULARLY in infants Born to mothers without allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 72), ('IMPORTANT_CONSIDERATION', 88), ('ANOMALY_CURIOUS_FINDING', 111)]	5	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 63, 'birth'), ('GO_0007567', 'parturition', 135, 'born')]
PMC4113768	7/2014	S273-PMC4113768	['the AIM was to find POSSIBLE clinical INDICATORS of Vitamin D deficiency in swedish and immigrant women at a primary Health care center in sweden.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0000025', 'tube', 117, 'health')]
PMC4113768	7/2014	S369-PMC4113768	['HOWEVER this window-shot IDENTIFIES ongoing cross cultural Vitamin D deficiency in our community.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 25)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4113768	7/2014	S378-PMC4113768	['the national academies press : washington, dc, usa, 2011).we INVESTIGATED WHETHER DIFFERENT levels of habitual Calcium Intake INFLUENCED Serum 25(Oh)D and indices of Vitamin D activation and Catabolism during winter and in the context of both adequate and inadequate Vitamin D intakes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('EXPLICIT_QUESTION', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('SUPERFICIAL_RELATIONSHIP', 126)]	5	[('CHEBI_22313', 'alkaline earth metal atom', 111, 'calcium'), ('GO_0007631', 'feeding behavior', 119, 'intake'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_71657', 'versiconol acetate', 143, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 143, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0009056', 'catabolic process', 191, 'catabolism'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
PMC4113768	7/2014	S528-PMC4113768	['a multicenter randomized, controlled trial\n\nahmed, b.; kashif, w.; iqbal, r.; habib, a.; nasir, k.; mehmood, a.; sarwar, s.\nbackground: we INVESTIGATED the ROLE of Vitamin D (vd) and targeted physical activity in improving Musculoskeletal health among chronic Kidney diseases (ckd) patients.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 156)]	2	[('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 223, 'musculoskeletal'), ('UBERON_0002113', 'kidney', 260, 'kidney')]
PMC4113768	7/2014	S580-PMC4113768	['AIM: the PRESENT STUDY EXAMINED IF exposure to Vitamin D from fortified Margarine and milk during Prenatal Life INFLUENCED Birth weight.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 112)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_6784', 'mestranol', 72, 'margarine'), ('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('UBERON_0000104', 'life cycle', 107, 'life'), ('GO_0007567', 'parturition', 123, 'birth')]
PMC4113768	7/2014	S582-PMC4113768	['the INFLUENCE of Vitamin D exposure during Prenatal Life on Birth weight was INVESTIGATED among 59,411 danish children by comparing Birth weight among Individuals Born before, during, and after fortification.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 77)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('GO_0007567', 'parturition', 60, 'birth'), ('GO_0007567', 'parturition', 132, 'birth'), ('NCBITaxon_1', 'root', 151, 'individuals'), ('GO_0007567', 'parturition', 163, 'born')]
PMC4113768	7/2014	S602-PMC4113768	['the current analysis, based on two large cohort studies, EXAMINED the ASSOCIATION between peri-Pregnancy Vitamin D status in mothers, season of Birth of their offspring, and the risk of incident Peanut/Tree Nut (p/tn) allergy during childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 57), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007567', 'parturition', 144, 'birth'), ('NCBITaxon_10088', 'Mus <genus>', 195, 'peanut'), ('NCBITaxon_33208', 'Metazoa', 202, 'tree nut')]
PMC4113768	7/2014	S669-PMC4113768	['the PURPOSE of THIS STUDY was TO ASSESS Vitamin D status and its cross-sectional DETERMINANTS in this vulnerable population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4113768	7/2014	S690-PMC4113768	['methods: as part of a study examining the IMPACT of the introduction of the london low emission zone on children’s Respiratory health, we ASSESSED the feasibility and acceptability of a Finger prick dried Blood spot method for assessing Vitamin D status (pro-diagnostics, london, uk).']	[('SUPERFICIAL_RELATIONSHIP', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 138)]	2	[('UBERON_0001004', 'respiratory system', 115, 'respiratory'), ('UBERON_0002389', 'manual digit', 186, 'finger'), ('UBERON_0000178', 'blood', 205, 'blood'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC4113768	7/2014	S712-PMC4113768	['subjects in each cohort were classified as having optimal or suboptimal Vitamin D status BASED on a cut-off of 30 ng/ml AS recommended by many EXPERTS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 89), ('PROBABLE_UNDERSTANDING', 120), ('PROBABLE_UNDERSTANDING', 143)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4113768	7/2014	S808-PMC4113768	['we THEREFORE AIMED TO ESTABLISH WHETHER maternal Vitamin D and Vitamin D-binding protein (dbp) levels MIGHT RELATE to the Expression of amino acid transporters in Human Placenta.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0010467', 'gene expression', 122, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 163, 'human'), ('UBERON_0001987', 'placenta', 169, 'placenta')]
PMC4113768	7/2014	S826-PMC4113768	['methods: we CONDUCTED an audit TO DETERMINE the level of information given to Pregnant and breastfeeding women regarding Vitamin D and to gauge the knowledge of midwifery and medical staff on Postnatal wards.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 31)]	2	[('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007567', 'parturition', 192, 'postnatal')]
PMC4113768	7/2014	S852-PMC4113768	['most data regarding the EFFECTS of Vitamin D on non-Skeletal Tissues in young People HAS BEEN obtained from cross-sectional studies, with their ASSOCIATED LIMITATIONS.we have THEREFORE UNDERTAKEN a systematic review of randomised controlled trials (rcts) that has EXAMINED the IMPACT of Vitamin D on muscle strength and function in young People.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 144), ('INCOMPLETE_EVIDENCE', 155), ('PROBLEM_COMPLICATION', 155), ('PROBABLE_UNDERSTANDING', 175), ('QUESTION_ANSWERED_BY_THIS_WORK', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 264), ('SUPERFICIAL_RELATIONSHIP', 277)]	9	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0004288', 'skeleton', 52, 'skeletal'), ('UBERON_0000479', 'tissue', 61, 'tissues'), ('NCBITaxon_10088', 'Mus <genus>', 78, 'people'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 338, 'people')]
PMC4113768	7/2014	S875-PMC4113768	['conclusions: this systematic REVIEW FOUND that correcting Vitamin D deficiency in young People did not result in improved muscle strength.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 36)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 88, 'people')]
PMC4113768	7/2014	S926-PMC4113768	['methods: TO explore THIS issue we have reviewed clinical REPORTS of Vitamin D deficiency in neonates from 1930 onwards.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 57)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4113768	7/2014	S942-PMC4113768	['methods: to EXAMINE this VIEW reports of fractures at less than two years of age in rickets due to Vitamin D deficiency HAVE been reviewed.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 25), ('IMPORTANT_CONSIDERATION', 120)]	3	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4113768	7/2014	S963-PMC4113768	['logistic regression was used TO IDENTIFY environmental and Genetic factors independently ASSOCIATED with risk of Vitamin D deficiency DEFINED as Serum 25(Oh)D concentration <50 nmol/l.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('SUPERFICIAL_RELATIONSHIP', 89), ('PROBABLE_UNDERSTANDING', 134)]	3	[('SO_0000704', 'gene', 59, 'genetic'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 151, '25(OH ... D')]
PMC4113768	7/2014	S995-PMC4113768	['our AIM was to EXPLORE ASSOCIATIONS between maternal and Cord 25(Oh)D concentrations and Vitamin D supplementation during Pregnancy and infancy and Gross Motor Development in infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('SUPERFICIAL_RELATIONSHIP', 23)]	3	[('UBERON_0002240', 'spinal cord', 57, 'cord'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 65, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('GO_0008406', 'gonad development', 148, 'gross motor development')]
PMC4113768	7/2014	S1027-PMC4113768	['THIS STUDY was done TO EVALUATE the ASSOCIATION between maternal Vitamin D supplementation during Pregnancy, the risk of bacterial and Viral infections, and their POSSIBLE CONTRIBUTION to the risk of pre-term Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 163), ('SUPERFICIAL_RELATIONSHIP', 172)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('NCBITaxon_1', 'root', 135, 'viral'), ('GO_0007567', 'parturition', 209, 'birth')]
PMC4113768	7/2014	S1033-PMC4113768	['compared TO mothers who did not take Vitamin D supplements, risk of any infection was lower for mothers taking Vitamin D as a single Nutrient preparation (or 0.28, 95% ci 0.27–0.30, p< 1.0e−250) and for those using multivitamin only (0.53, 0.52–0.55, p = 1.1e−18).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_33284', 'nutrient', 133, 'nutrient')]
PMC4113768	7/2014	S1046-PMC4113768	['THEREFORE, we AIMED TO INVESTIGATE the ASSOCIATION between Serum levels of 25(Oh) Vitamin D and bone turnover MARKERS in a population-based sample of children with Serum calcium levels.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('UBERON_0001977', 'blood serum', 59, 'serum'), ('CHEBI_30778', 'gallic acid', 75, '25(OH)'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001977', 'blood serum', 164, 'serum')]
PMC4113768	7/2014	S1053-PMC4113768	['conclusions: THIS STUDY SHOWED ASSOCIATIONS between MARKERS of bone turnover and 25(Oh) Vitamin D which are DEPENDENT on Serum calcium level in school-aged children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 108)]	5	[('CHEBI_30778', 'gallic acid', 81, '25(OH)'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum')]
PMC4113768	7/2014	S1118-PMC4113768	['background: approximately one billion People worldwide have low Serum levels of Vitamin D. the AIM of THIS STUDY was TO EVALUATE the dose-response EFFECT in order TO DETERMINE the level of supplementation of Vitamin D REQUIRED in patients with deficiency in Vitamin D concentration (≤20 ng/ml).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 147), ('QUESTION_ANSWERED_BY_THIS_WORK', 163), ('IMPORTANT_CONSIDERATION', 218)]	6	[('NCBITaxon_10088', 'Mus <genus>', 38, 'people'), ('UBERON_0001977', 'blood serum', 64, 'serum'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC4113768	7/2014	S1136-PMC4113768	['conclusion: THIS study DEMONSTRATED a dose-response between Vitamin D administration and Plasma levels after monthly administrations of 25,000, 50,000 or 100,000 iu of Vitamin D (d-cure®ampoule).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 23)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 89, 'plasma'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4113768	7/2014	S1158-PMC4113768	['THIS STUDY AIMED to develop a risk profile that CAN be used to easily identify older Individuals at high RISK for Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 105)]	4	[('NCBITaxon_1', 'root', 85, 'individuals'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4113768	7/2014	S1173-PMC4113768	['THIS STUDY has two AIMS: (1) TO EXAMINE the ASSOCIATION between Vitamin D status and qus and bmd; and (2) TO EXAMINE WHETHER gender, age, physical activity or body mass index (bmi) MODIFY these ASSOCIATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('SUPERFICIAL_RELATIONSHIP', 44), ('QUESTION_ANSWERED_BY_THIS_WORK', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 194)]	8	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC4113768	7/2014	S1176-PMC4113768	['multiple linear regression was used TO ASSESS WHETHER Vitamin D status was RELATED to qus and bmd and WHETHER age (below vs. above the median age), gender, bmi (≤26.5 vs.>26.5 kg/m2) or physical activity (low vs. high) MODIFIED these RELATIONSHIPS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 234)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4113768	7/2014	S1288-PMC4113768	['for the present divids-2 study we followed up the children, now aged 3–6 years, to measure bone structure and strength by quantitative ultrasound (qus).the PURPOSE of THE STUDY was (1) TO DETERMINE the EFFECT of Vitamin D supplementation in infancy on bone structure and strength of children aged 3–6 years; (2) TO EVALUATE the ASSOCIATION of current Vitamin D status with bone structure and strength.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 156), ('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('QUESTION_ANSWERED_BY_THIS_WORK', 185), ('SUPERFICIAL_RELATIONSHIP', 202), ('QUESTION_ANSWERED_BY_THIS_WORK', 312), ('SUPERFICIAL_RELATIONSHIP', 328)]	6	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin D')]
PMC4113768	7/2014	S1376-PMC4113768	['we AIMED TO EXAMINE the ASSOCIATION between Vitamin D concentration and Insulin resistance in healthy, non-diabetic, overweight Individuals at high risk of Cardiovascular disease using gold-standard techniques for assessment of both Vitamin D concentration and Insulin resistance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 24)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('PR_000045358', 'insulin family protein', 72, 'insulin'), ('NCBITaxon_1', 'root', 128, 'individuals'), ('UBERON_0004535', 'cardiovascular system', 156, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('PR_000045358', 'insulin family protein', 261, 'insulin')]
PMC4113768	7/2014	S1393-PMC4113768	['the AIM of THIS STUDY was THEREFORE TO INVESTIGATE the EFFECTS of Vitamin D on the Gene Expression of IMPORTANT enzymes INVOLVED in Brain Steroidogenesis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 102), ('SUPERFICIAL_RELATIONSHIP', 120)]	7	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0010467', 'gene expression', 83, 'gene expression'), ('SO_0000704', 'gene', 83, 'gene'), ('UBERON_0000955', 'brain', 132, 'brain'), ('GO_0001501', 'skeletal system development', 138, 'steroidogenesis')]
PMC4113768	7/2014	S1448-PMC4113768	['THIS STUDY INVESTIGATED WHETHER Vitamin D status PREDICTS ed and OTHER cvd MARKERS in Ageing men.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('SUPERFICIAL_RELATIONSHIP', 75)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007568', 'aging', 86, 'ageing')]
PMC4113768	7/2014	S1544-PMC4113768	['we INVESTIGATE for the FIRST TIME WHETHER Vitamin D levels MAY alter cmv serology in a cohort of non-white Adults resident in the uk.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 59)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 107, 'adults')]
PMC4113768	7/2014	S1578-PMC4113768	['AS MOST studies examining Vitamin D status and disease progression to date have included Individuals receiving art, the AIMS of THIS STUDY are TO EVALUATE the EFFECT of vitamin d status over time on immunological outcomes, such as cd4+ cell count and cd4+ percentage in hiv-infected Individuals with hiv viraemia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 120), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('QUESTION_ANSWERED_BY_THIS_WORK', 143), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('NCBITaxon_1', 'root', 283, 'individuals')]
PMC4113768	7/2014	S1599-PMC4113768	['the AIM of THIS STUDY is TO EVALUATE Vitamin D, Calcium and Phosphate Metabolites and their IMPACT on bone Mineral density in hiv-infected Antiretroviral-experienced adults.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 92)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 48, 'calcium'), ('CHEBI_18367', 'phosphate(3-)', 60, 'phosphate'), ('CHEBI_25212', 'metabolite', 70, 'metabolites'), ('CHEBI_46662', 'mineral', 107, 'mineral'), ('CHEBI_65417', '(+)-aplysinillin', 139, 'antiretroviral')]
PMC4113768	7/2014	S1643-PMC4113768	['methods: we CONDUCTED a double-blind cluster-randomised placebo-controlled trial of high- vs. low-dose Vitamin D supplementation in residents and staff of sheltered accommodation schemes in london, uk.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12)]	1	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4113768	7/2014	S1674-PMC4113768	['OUR FINDINGS RAISE the POSSIBILITY that Vitamin D deficiency MAY BE a consequence, as well as a cause, of active tuberculosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('EXPLICIT_QUESTION', 13), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 61)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4113768	7/2014	S1679-PMC4113768	['the AIM of THIS STUDY was to compare the degree of Vitamin D insufficiency (vdi) and Vitamin D deficiency (vdd) in tb patients and delay in Sputum Conversion for afb.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0035041', 'sperm chromatin decondensation', 140, 'sputum conversion'), ('UBERON_0007311', 'sputum', 140, 'sputum')]
PMC4113768	7/2014	S1695-PMC4113768	['THIS STUDY was AIMED TO INVESTIGATE the prevalence of Vitamin D deficiency in Adult female of local population in pakistan and TO find out social and Genetic FACTORS that may CONTRIBUTE in hypovitaminosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('SUPERFICIAL_RELATIONSHIP', 158), ('SUPERFICIAL_RELATIONSHIP', 175)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0007023', 'adult organism', 78, 'adult'), ('SO_0000704', 'gene', 150, 'genetic')]
PMC4113768	7/2014	S1710-PMC4113768	['we THEREFORE CONDUCTED a study TO DETERMINE the prevalence of Vitamin D deficiency in a cohort of Adults with asthma who were screened for participation in a clinical trial in london, uk, and TO IDENTIFY CORRELATES of poor asthma Control and low Vitamin D status in this population.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 204)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adults'), ('GO_0065007', 'biological regulation', 230, 'control'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4113768	7/2014	S1713-PMC4113768	['multivariate logistic regression was performed TO IDENTIFY POTENTIAL DETERMINANTS of Vitamin D status and of six clinical MARKERS of asthma Control (asthma Control test score, british Thoracic society treatment step, number of exacerbations in preceding 12 months, % predicted fev1, exhaled Nitric Oxide concentration and degree of reversibility of Airway obstruction following administration of inhaled Salbutamol).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0065007', 'biological regulation', 140, 'control'), ('GO_0065007', 'biological regulation', 156, 'Control'), ('UBERON_0000915', 'thoracic segment of trunk', 184, 'Thoracic'), ('CHEBI_16480', 'nitric oxide', 291, 'nitric oxide'), ('UBERON_0001005', 'respiratory airway', 349, 'airway'), ('CHEBI_66163', 'samaderine Y', 404, 'salbutamol')]
PMC4113768	7/2014	S1726-PMC4113768	['we INVESTIGATED the EFFECT of dbp genotype on estimates of f25ohd (gc-f25ohd), and on their RELATIONSHIP with 25ohd3t1/2, a measure of 25ohd tissue usage, in populations KNOWN to differ in dbp genotype and Vitamin D supply.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 170)]	4	[('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
PMC4113768	7/2014	S1793-PMC4113768	['the AIM of the PRESENT STUDY was to follow up the study participants INVESTIGATING WHETHER the EFFECT of Vitamin D is restricted to the Prenatal period OR can also be SEEN in one or two year old infants INDEPENDENTLY from the maternal status during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 203)]	8	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'prenatal'), ('GO_0007565', 'female pregnancy', 249, 'pregnancy')]
PMC4113768	7/2014	S1805-PMC4113768	['conclusions: OUR STUDY DEMONSTRATES that in east germany region (latitude: 51.3667) the Vitamin D status of one year old children is sufficient DUE to a general rickets prophylaxis, WHEREAS levels of two years old infants drop back to levels similar SEEN for Pregnant mothers.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('IMPORTANT_CONSIDERATION', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 250)]	6	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnant')]
PMC4113768	7/2014	S1806-PMC4113768	['HOWEVER, according TO allergic outcomes our data RATHER POINT to a promoting THAN a protecting EFFECT of Vitamin D.\n\n2.82.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('INCOMPLETE_EVIDENCE', 56), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('SUPERFICIAL_RELATIONSHIP', 95)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4113768	7/2014	S1835-PMC4113768	['methods: IN ORDER TO ASSESS the POTENTIAL health EFFECTS of Consuming Vitamin D fortified Foods, we performed a registry based study, taking advantage of the extensive danish PUBLIC HEALTH registries.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 175)]	5	[('GO_0007631', 'feeding behavior', 60, 'consuming'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_33290', 'food', 90, 'foods')]
PMC4113768	7/2014	S1841-PMC4113768	['TO TEST the HYPOTHESIS of an ASSOCIATION between the Prenatal exposure to Vitamin D fortified Foods and the risk of the progeny developing schizophrenia later in Life, cox regression models were fit.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 29)]	3	[('GO_0007565', 'female pregnancy', 53, 'prenatal'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_33290', 'food', 94, 'foods'), ('UBERON_0000104', 'life cycle', 162, 'life')]
PMC4113768	7/2014	S1846-PMC4113768	['conclusion: the results of OUR STUDY SUGGEST that the Vitamin D fortification policy enacted in denmark until june 1st, 1985 had a PROTECTIVE EFFECT amongst children Born during the spring in regards to later development of schizophrenia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 142)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007567', 'parturition', 166, 'born')]
PMC4113768	7/2014	S1879-PMC4113768	['conclusions: THIS STUDY has IMPORTANT IMPLICATIONS for the FUTURE of Food fortification in helping to raise the Vitamin D status of the population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 38), ('FUTURE_WORK', 59)]	4	[('CHEBI_33290', 'food', 69, 'food'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4113768	7/2014	S1901-PMC4113768	['THIS simulation STUDY AIMED TO ASSESS the IMPACT of replacing non fortified Cow’s Milk with Vitamin D fortified gum in the diets of young uk children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 42)]	5	[('NCBITaxon_33208', 'Metazoa', 76, 'cow'), ('UBERON_0001913', 'milk', 82, 'milk'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4113768	7/2014	S1970-PMC4113768	['SINCE Vitamin D is also obtained from dietary sources and Vitamin D supplements; THIS STUDY INVESTIGATED the INFLUENCE of Food and Vitamin D supplements on the Serum 25-Hydroxy Vitamin D (25(Oh)D) concentration in children in the netherlands between october and april.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 92), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 122, 'food'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 160, 'serum'), ('CHEBI_43176', 'hydroxy group', 169, 'hydroxy'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D')]
PMC4113768	7/2014	S1984-PMC4113768	['the PRESENT STUDY AIMS TO EXAMINE the ASSOCIATIONS of Serum 25-Hydroxy Vitamin D levels [25(Oh)D, a BIOMARKER of Vitamin D in blood] with clrd and outcomes using data from a large-scale prospective cohort study in the u.s.\nmethods: a total of 15,772 (m: 7,414, f: 8,358) subjects aged ≥20 year old who participated in the u.s. third national health and nutrition examination survey, had measures of serum 25(Oh)D at baseline (1988–1994), and had been followed up through december of 2006 were analyzed.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 60, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 405, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 405, '25(OH)D')]
PMC4113768	7/2014	S1994-PMC4113768	['THIS STUDY adds NEW EVIDENCE to the research body of Vitamin D deficiency in RELATION to INCREASED RISKS of clrd, cvd and all-cause mortality.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 77), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4113768	7/2014	S2001-PMC4113768	['our AIM was TO EXAMINE the ASSOCIATION between Serum 25(Oh) Vitamin D and symptoms of depression and anxiety.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 27)]	3	[('UBERON_0001977', 'blood serum', 47, 'serum'), ('CHEBI_30778', 'gallic acid', 53, '25(OH)'), ('PR_000036060', 'pro-caspase-8:fadd:rip1:ticam1:ticam2:activated TLR4 complex (human)', 53, '25 ... OH ... vitamin D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC4113768	7/2014	S2043-PMC4113768	['the RECENT iom 2011 report on dietary reference intakes for Calcium and Vitamin D for north america is apt for the irish population by providing the most COMPREHENSIVE EVIDENCE-BASED REPORT on Vitamin D.\nmethods: since 2007, we have conducted studies of Vitamin D status by measuring Serum 25-Hydroxy Vitamin D (25Ohd) in: preterm infants shortly after Birth ( n = 274) and after 15 weeks ( n = 148); paired term infants and mothers at Birth ( n = 39); children and adolescents from age 1 to 18 years ( n = 252); mothers during Pregnancy and infants at Birth divided according to winter Birth ( n = 30) and summer Birth ( n = 30); Pregnant mothers and ethnicity ( n = 116); patients attending an osteoporosis clinic ( n = 100); patients with cystic fibrosis ( n = 114); patients with multiple sclerosis ( n = 331) compared with healthy relatives ( n = 229) during winter months in 3 different regions in ireland; and patients with psoriasis undergoing phototherapy during the winter months ( n = 29) compared with controls ( n = 29).']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 168), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('INCOMPLETE_EVIDENCE', 183)]	6	[('CHEBI_31341', 'calcium dihydroxide', 60, 'Calcium'), ('CHEBI_28384', 'vitamin K', 72, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 201, 'D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('UBERON_0001977', 'blood serum', 284, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 290, '25-hydroxy vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 312, '25OHD'), ('GO_0007567', 'parturition', 353, 'birth'), ('GO_0007567', 'parturition', 436, 'birth'), ('GO_0007565', 'female pregnancy', 528, 'pregnancy'), ('GO_0007567', 'parturition', 553, 'birth'), ('GO_0007567', 'parturition', 587, 'birth'), ('GO_0007567', 'parturition', 614, 'birth'), ('GO_0007565', 'female pregnancy', 631, 'pregnant')]
PMC4113768	7/2014	S2049-PMC4113768	['conclusions: Vitamin D status in ireland has improved immensely in ireland over the past 40 years, but TARGETED PUBLIC HEALTH policies of low-dose supplementation ARE NEEDED TO address AT-RISK groups, and mandated fortification to SAFE levels SHOULD maintain Vitamin D adequacy in the population.']	[('FUTURE_WORK', 103), ('IMPORTANT_CONSIDERATION', 112), ('FUTURE_WORK', 163), ('QUESTION_ANSWERED_BY_THIS_WORK', 174), ('IMPORTANT_CONSIDERATION', 185), ('IMPORTANT_CONSIDERATION', 231), ('FUTURE_WORK', 243)]	7	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC4113768	7/2014	S2052-PMC4113768	['ONLY a LIMITED NUMBER OF studies EXAMINED the RELATIONSHIP between Vitamin D status and the prevalence and severity of Respiratory infections in children.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 119, 'respiratory')]
PMC4113768	7/2014	S2053-PMC4113768	['the AIM of THIS STUDY was TO ASSESS Vitamin D status in a group of children and adolescents with Lower Respiratory Tract infections and TO EVALUATE the RELATIONSHIP between 25-hydroxy vitamin d (25-Oh-D) levels and the severity of infection.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 136), ('SUPERFICIAL_RELATIONSHIP', 152)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0004905', 'articulation', 97, 'lower respiratory tract'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 195, '25-OH-D')]
PMC4113768	7/2014	S2066-PMC4113768	['conclusions: the results of THIS STUDY SUGGEST an IMPORTANT ROLE for Vitamin D in the modulation of Immune response in children with Lower Respiratory Tract infections.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('UBERON_0004905', 'articulation', 133, 'lower respiratory tract')]
PMC4113768	7/2014	S2115-PMC4113768	['2008, 62 , 1079-1089) provides representative data TO ASSESS the current Vitamin D status of Adults in germany according to latitude of residence and to identify additional DETERMINANTS of Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 173)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0007023', 'adult organism', 93, 'adults'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC4113768	7/2014	S2144-PMC4113768	['in the PRESENT work we ASSESSED the INVOLVEMENT of these three Proteolytic systems in Vitamin D deficiency induced muscle wasting.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('GO_0006508', 'proteolysis', 63, 'proteolytic'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4113768	7/2014	S2155-PMC4113768	['conclusions: IN SUMMARY, THIS STUDY DEMONSTRATES that during Vitamin D deficiency induced muscle wasting, the activity of the Ubiquitin Proteasome Pathway is elevated.']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 36)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0031371', 'ubiquitin conjugating enzyme complex', 126, 'ubiquitin proteasome'), ('GO_0036169', '3-methoxy-4-hydroxy-5-decaprenylbenzoic acid decarboxylase activity', 126, 'ubiquitin proteasome pathway')]
PMC4113768	7/2014	S2161-PMC4113768	['we performed a systematic review and metaanalysis TO EXAMINE whether Vitamin D reduces Blood pressure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 50)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0000178', 'blood', 87, 'blood')]
PMC4113768	7/2014	S2182-PMC4113768	['we TESTED WHETHER high-dose intermittent oral Vitamin D therapy COULD reduce Blood pressure and Left Ventricular mass in patients with hypertension resistant to conventional treatment.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('INCOMPLETE_EVIDENCE', 64)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0000178', 'blood', 77, 'blood'), ('UBERON_0002084', 'heart left ventricle', 96, 'left ventricular')]
PMC4113768	7/2014	S2197-PMC4113768	['we TESTED WHETHER high-dose intermittent oral Vitamin D therapy COULD improve MARKERS of vascular health and fatigue in patients with chronic fatigue syndrome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4113768	7/2014	S2288-PMC4113768	['the PRESENT cross-sectional STUDY AIMS TO DETERMINE the prevalence and RISK FACTORS of Vitamin D deficiency among Premenopausal women visiting commercial centers in riyadh city.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 71)]	5	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0043277', 'apoptotic cell clearance', 114, 'premenopausal')]
PMC4113768	7/2014	S2303-PMC4113768	['in THIS cross-SECTIONAL case-CONTROL STUDY, we DESCRIBED the differences and ASSOCIATIONS in the Metabolic patterns of Adult saudis with and without hypothyroid dysfunction in RELATION to their Vitamin D status, pth, calcium and Lipid profile.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0008152', 'metabolic process', 97, 'metabolic'), ('UBERON_0007023', 'adult organism', 119, 'adult'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_18059', 'lipid', 229, 'lipid')]
PMC4113768	7/2014	S2334-PMC4113768	['in THIS PROSPECTIVE INTERVENTIONAL STUDY we INVESTIGATED the EFFECTS of Vitamin D3Supplementation on the Metabolic profiles of saudi t2dm subjects pre- and post-Vitamin D supplementation over an 18-month period.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	4	[('CHEBI_52915', 'phosphatediyl group', 72, 'vitamin D3supplementation'), ('PR_000006649', 'zinc finger protein neuro-d4', 80, 'D3supplementation'), ('GO_0008152', 'metabolic process', 105, 'metabolic'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
PMC4113768	7/2014	S2346-PMC4113768	['in THIS INTERVENTIONAL STUDY we measured the EFFECTS of improving Vitamin D status on bone biochemical MARKERS in overweight and obese Adult saudis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0007023', 'adult organism', 135, 'adult')]
PMC4113768	7/2014	S2358-PMC4113768	['in THIS FOLLOW-UP STUDY we DETERMINED seasonal differences in Serum 25(Oh)D Vitamin D levels, as well as parallel changes in Metabolic parameters, in a cohort of Adult overweight and obese saudis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 27)]	4	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_71657', 'versiconol acetate', 68, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0008152', 'metabolic process', 125, 'metabolic'), ('UBERON_0007023', 'adult organism', 162, 'adult')]
PMC4113768	7/2014	S2385-PMC4113768	['OUR FINDINGS implicate that Vitamin D supplementation becomes more IMPORTANT in older age groups and during wintertime.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 67)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4113768	7/2014	S2393-PMC4113768	['background: we performed a systematic review TO EXPLORE WHETHER (1) low maternal circulating 25(Oh)-Vitamin D (25(Oh)D) during Pregnancy is ASSOCIATED with impairment of offspring health; and (2) maternal supplementation with Vitamin D in Pregnancy MIGHT ameliorate these EFFECTS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 140), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 272)]	5	[('CHEBI_63056', 'zinc cation', 93, '25(OH'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 111, '25(OH)D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy')]
PMC4113768	7/2014	S2449-PMC4113768	['the AIM of THIS STUDY was TO DETERMINE the CONTRIBUTION from sunlight and diet to total Vitamin D in a mixed ethnicity population living in north-east scotland.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 43)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC4113768	7/2014	S2470-PMC4113768	['THIS STUDY AIMS to explore an ASSOCIATION between tb and Vitamin D levels in a rural afghan population and TO EXAMINE POSSIBLE factors RELATED to tb and Vitamin D levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 107), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 135)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4113768	7/2014	S2500-PMC4113768	['the AIM of THIS STUDY was TO INVESTIGATE the EFFECT of supplemental Vitamin D on bone Mineral accretion in adolescent female athletes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_46662', 'mineral', 86, 'mineral')]
PMC4113768	7/2014	S2543-PMC4113768	['background: AS Vitamin D is ESSENTIAL to calcium Regulation, the concern HAS BEEN RAISED that high levels of Vitamin D MAY lead TO hypercalcemia (Plasma levels exceeding 2.6 mmol/l) that, in turn, MAY increase the RISK of adverse health events such as Cardiac arrest, Renal failure, and Hepatic injuries.']	[('PROBABLE_UNDERSTANDING', 12), ('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 73), ('EXPLICIT_QUESTION', 82), ('INCOMPLETE_EVIDENCE', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 214)]	9	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0065007', 'biological regulation', 49, 'regulation'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 146, 'plasma'), ('UBERON_0000948', 'heart', 252, 'cardiac'), ('UBERON_0002113', 'kidney', 268, 'renal'), ('UBERON_0002107', 'liver', 287, 'hepatic')]
PMC4113768	7/2014	S2544-PMC4113768	['our OBJECTIVE is TO EXAMINE the INFLUENCE of Vitamin D supplementation on Serum calcium levels and the RISK for hypercalcimia in healthy volunteers in the pure north health program.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 32), ('IMPORTANT_CONSIDERATION', 103)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001977', 'blood serum', 74, 'serum')]
PMC4113768	7/2014	S2563-PMC4113768	['we AIMED TO EXAMINE the environmental and Genetic DETERMINANTS of change in 25 Hydroxy Vitamin D (25(Oh)D).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('SO_0000704', 'gene', 42, 'genetic'), ('CHEBI_45557', 'sec-butyl group', 76, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D')]
PMC4113768	7/2014	S2574-PMC4113768	['conclusion: THIS work SHOWS that Genetic FACTORS are ASSOCIATED with change in 25(Oh)D after Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('SO_0000704', 'gene', 33, 'genetic'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4113768	7/2014	S2593-PMC4113768	['THUS, OUR STUDY AIMED TO ASSESS IF Intake of Foods fortified with Vitamin D during Gestation had an EFFECT on the RISK of t1d later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 114)]	7	[('GO_0007631', 'feeding behavior', 35, 'intake'), ('CHEBI_33290', 'food', 45, 'foods'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'gestation'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC4113768	7/2014	S2594-PMC4113768	['THIS sub-study TESTED the HYPOTHESIS that seasonality of month of Birth in t1d is more pronounced among Individuals who were not exposed to Vitamin D fortification during Gestation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 26)]	3	[('GO_0007567', 'parturition', 66, 'birth'), ('NCBITaxon_1', 'root', 104, 'individuals'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007565', 'female pregnancy', 171, 'gestation')]
PMC4113768	7/2014	S2602-PMC4113768	['conclusions: TO ASSESS the IMPACT of exposure to Vitamin D during Gestation for later t1d risk we studied seasonality of month of Birth in a specific context of Food fortification practices in denmark.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 27)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'gestation'), ('GO_0007567', 'parturition', 130, 'birth'), ('CHEBI_33290', 'food', 161, 'food')]
PMC4113768	7/2014	S2616-PMC4113768	['we INVESTIGATED the EFFECT of Vitamin D supplementation on the Metabolic status of Individuals at increased risk of developing t2d.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0008152', 'metabolic process', 63, 'metabolic'), ('NCBITaxon_1', 'root', 83, 'individuals')]
PMC4113768	7/2014	S2666-PMC4113768	['THIS STUDY AIMED TO DETERMINE IF long-term high-dose Vitamin D over 18 months lowered bp.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30)]	4	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4113768	7/2014	S2782-PMC4113768	['we THEREFORE INVESTIGATED the Expression of components of Vitamin D (Vitamin D Receptor [Vdr], 25-Hydroxy Vitamin D3-1α-hydroxylase [Cyp27B1; 1α-ohase], 24-hydroxylase [Cyp24A1; 24-Ohase], rxr) and tlr (Tlr 1,2,4, Myd88 and cd14) signalling in Human Urinary Bladder Epithelial Cells.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13)]	2	[('GO_0010467', 'gene expression', 30, 'expression'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 69, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 89, 'VDR'), ('CHEBI_43141', '3-hydroxypropoxy group', 95, '25-hydroxy'), ('CHEBI_33279', 'vitamin D5', 106, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 106, 'vitamin D3'), ('PR_000006101', 'cytochrome P450 1A1', 133, 'CYP27B1'), ('PR_000006101', 'cytochrome P450 1A1', 169, 'CYP24A1'), ('CHEBI_50024', 'o-aminophenylarsonous acid', 178, '24-OHase'), ('PR_000001155', 'Toll-like receptor 4', 203, 'TLR 1'), ('PR_000010222', 'muscleblind-like protein 2', 209, '2'), ('PR_000017527', 'YEATS domain-containing protein 4', 211, '4'), ('PR_000010883', 'myozenin-2', 214, 'MyD88'), ('NCBITaxon_9606', 'Homo sapiens', 244, 'human'), ('CL_0002535', 'epithelial cell of cervix', 250, 'urinary bladder epithelial cells'), ('UBERON_0001255', 'urinary bladder', 250, 'urinary bladder'), ('UBERON_0000483', 'epithelium', 266, 'epithelial')]
PMC4113768	7/2014	S2798-PMC4113768	['conclusions: these data DEMONSTRATE that Urothelial Cells Express functional Vitamin D Signalling and are able to synthesize sufficient 1,25(Oh)2D3To stimulate a local immune response.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 24)]	1	[('CL_0000160', 'goblet cell', 41, 'urothelial cells'), ('UBERON_0000365', 'urothelium', 41, 'urothelial'), ('GO_0010467', 'gene expression', 58, 'express'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0048371', 'lateral mesodermal cell differentiation', 77, 'vitamin D signalling'), ('CHEBI_76917', 'methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate', 136, '1,25(OH)2D3to')]
PMC4113768	7/2014	S2817-PMC4113768	['the AIM of THIS STUDY was to validate a new ffq TO ASSESS habitual dietary Vitamin D intake, using the method of triads (ocké, m.c.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 48)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4113768	7/2014	S2930-PMC4113768	['conclusions: in CONCLUSION THIS STUDY INDICATES that Vitamin D deficiency promotes the development of dysplasia, increases Proliferation and inflammation, which is LIKELY promote the development of frank squamous Cell carcinoma, WHEREAS sufficiency retards this development.']	[('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('PROBABLE_UNDERSTANDING', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229)]	5	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0008283', 'cell proliferation', 123, 'proliferation'), ('CL_0000573', 'retinal cone cell', 213, 'cell')]
PMC4113768	7/2014	S3066-PMC4113768	['RISK FACTORS for Cardiovascular disease HAVE also BEEN ASSOCIATED with low Serum (25(Oh)D. we AIMED TO INVESTIGATE WHETHER high-dose Vitamin D supplementation CAN improve Glucose Metabolism in a population with impaired fasting Glucose and/or impaired Glucose tolerance.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 55), ('QUESTION_ANSWERED_BY_THIS_WORK', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 159)]	7	[('UBERON_0004535', 'cardiovascular system', 17, 'cardiovascular'), ('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('CHEBI_17234', 'glucose', 171, 'glucose'), ('GO_0006006', 'glucose metabolic process', 171, 'glucose metabolism'), ('CHEBI_17234', 'glucose', 228, 'glucose'), ('CHEBI_17234', 'glucose', 252, 'glucose')]
PMC4113768	7/2014	S3080-PMC4113768	['we EXAMINED the EFFECT of Prenatal Vitamin D on childhood wheezing in an interventional study.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4113768	7/2014	S3096-PMC4113768	['ALTHOUGH Vitamin D HAS BEEN ASSOCIATED with the development of tb in Adults, LITTLE RESEARCH has EXAMINED the IMPORTANCE of Vitamin D levels in children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('IMPORTANT_CONSIDERATION', 110)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0007023', 'adult organism', 69, 'adults'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4113768	7/2014	S3097-PMC4113768	['THE CURRENT STUDY was DESIGNED TO IDENTIFY the EFFECT of Vitamin D insufficiency and deficiency (vdid) and host Genetic Single Nucleotide Polymorphisms (Snps) that alter Vitamin d receptor Expression on the RISK for tb in hiv-infected and –exposed infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 207)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('SO_0000704', 'gene', 112, 'genetic'), ('SO_0000694', 'SNP', 120, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 153, 'SNPs'), ('CHEBI_33229', 'vitamin (role)', 170, 'Vitamin'), ('GO_0010467', 'gene expression', 189, 'expression')]
PMC4113768	7/2014	S3122-PMC4113768	['the OBJECTIVE of THIS RETROSPECTIVE case-CONTROL STUDY was TO FURTHER INVESTIGATE the POSSIBLE LINK between type i hypersensitivity and Vitamin D status in an inner-city population KNOWN to have a high prevalence of Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 181)]	7	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC4113768	7/2014	S3125-PMC4113768	['the EFFECT of Vitamin D deficiency on risk of Sensitisation to various common Allergens was ASSESSED using multiple logistic regression analysis.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 92)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 46, 'sensitisation'), ('CHEBI_33663', 'cyclic hydrocarbon', 78, 'allergens')]
PMC4113768	7/2014	S3136-PMC4113768	['DEPENDING ON the cutoff chosen, dietary intakes of Vitamin D MAY OR MAY NOT provide sufficient IMPACT upon Vitamin D status, in improving levels of 25(Oh)d. purpose: we SOUGHT TO EXAMINE WHETHER a supplemental dose of 10 mcg (400 iu) as found in fortified foods OR as a supplement, has a measurable IMPACT on Vitamin D status, as defined by improving status from below to above 50 nmol/l, or from less than 30 nmol/l to above 30 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('QUESTION_ANSWERED_BY_THIS_WORK', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187), ('SUPERFICIAL_RELATIONSHIP', 299)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 148, '25(OH'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D')]
PMC4113768	7/2014	S3181-PMC4113768	['purpose: TO DETERMINE Vitamin D status and its PREDICTORS among school children aged 11–18 years in ethiopia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4113768	7/2014	S3195-PMC4113768	['the OBJECTIVE of the PRESENT STUDY was TO INVESTIGATE the prevalence and PREDICTORS of Vitamin D deficiency throughout the year among a large representative sample of 85 year-old men and women living in the north east of england (55°n).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC4113768	7/2014	S3274-PMC4113768	['a pre-specified sub-group analysis was conducted TO DETERMINE whether effects of the intervention on co-primary outcomes were modified by the presence or absence of Vitamin D deficiency (Serum 25(Oh)D < 50 nmol/l) at baseline.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 49)]	1	[('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('UBERON_0001977', 'blood serum', 187, 'serum'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 193, '25(OH)D')]
PMC4113768	7/2014	S3316-PMC4113768	['background: since the publication of the ultraviolet b (uvb)-Vitamin D-cancer HYPOTHESIS BASED ON an ecological study of Colon cancer mortality rates with respect to annual solar radiation doses in the united states in 1980, the approach HAS BEEN extended to many types of cancer and various other health outcomes.']	[('INCOMPLETE_EVIDENCE', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 89), ('ANOMALY_CURIOUS_FINDING', 95), ('INCOMPLETE_EVIDENCE', 238)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001155', 'colon', 121, 'colon')]
PMC4113768	7/2014	S3336-PMC4113768	['; xiao, j.p.; zang, j.; fei, x.; zhu, y.; pei, j.j.\nbackground: thereare LITTLE DATA about the status of Vitamin D in Pregnant women and their newborns in china, and we EVALUATED the Vitamin D status in Pregnant women and their newborns all the year around in wuxi city (north latitude 32°), jiangsu province, china.']	[('FULL_UNKNOWN', 73), ('INCOMPLETE_EVIDENCE', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 169)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnant'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnant')]
PMC4113768	7/2014	S3367-PMC4113768	['our OBJECTIVES are (1) to conduct unbiased Genome-wide methylation profiling of Vitamin D in Human Peripheral Leukocytes; (2) to comprehensively search differential functional Methylation Sites UNDERLYING Vitamin D deficiency; (3) TO TEST the HYPOTHESIS that Vitamin D supplementation increases global Dna Methylation level by performing a randomized clinical trial (rct) in overweight/obese african americans with Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 194), ('QUESTION_ANSWERED_BY_THIS_WORK', 231), ('INCOMPLETE_EVIDENCE', 243)]	4	[('SO_0001026', 'genome', 43, 'genome'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 93, 'human'), ('CL_0000118', 'basket cell', 99, 'peripheral leukocytes'), ('SO_0000134', 'genomically_imprinted', 176, 'methylation sites'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0006306', 'DNA methylation', 302, 'DNA methylation'), ('CHEBI_27300', 'vitamin D', 415, 'vitamin D')]
PMC4161853	8/2014	S218-PMC4161853	['AS SEVERE malnutrition is one of the risk FACTORS to develop malaria-ibi co-infection, it is IMPORTANT TO evaluate the IMPACT of Vitamin A administration in the clinical management of children with malaria and ibi-co-infection in africa, EITHER as a therapeutic and/OR prophylactic measure, ESPECIALLY due to recent EVIDENCE of the positive IMPACT of Vitamin A and zinc supplementation on malaria morbidity in a study conducted in ghana [121,122].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 3), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('IMPORTANT_CONSIDERATION', 291), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 341)]	10	[('CHEBI_27300', 'vitamin D', 129, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin A')]
PMC4161944	9/2014	S148-PMC4161944	['full reviews on Micronutrient malnutrition and immunity can be found elsewhere (114–116) and ONLY select Micronutrients (Selenium, zinc, and Vitamin A) known to Modulate Immunity are highlighted HERE.']	[('INCOMPLETE_EVIDENCE', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 195)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 16, 'micronutrient'), ('CHEBI_33839', 'macromolecule', 105, 'micronutrients'), ('CHEBI_27568', 'selenium atom', 121, 'selenium'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('GO_0065007', 'biological regulation', 161, 'modulate'), ('GO_0007566', 'embryo implantation', 170, 'immunity')]
PMC4169453	9/2014	S2-PMC4169453	['THIS STUDY EVALUATED WHETHER Vitamin D supplementation during Lactation enhances the maternal and infant’s Vitamin D status, bone mass and body composition.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007595', 'lactation', 62, 'lactation'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4169453	9/2014	S103-PMC4169453	['the itt approach ASSESSES the EFFECTIVENESS of improving Vitamin D status via different oral Vitamin D supplementation, regardless of whether the subject adhered to the dosing regimen.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4169453	9/2014	S174-PMC4169453	['in OUR STUDY maternal median 25(Oh)D levels (∼15 ng/ml) at the baseline visit, INDICATING Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 79)]	2	[('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 29, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC4169453	9/2014	S188-PMC4169453	['KEEPING IN MIND RECENT LITERATURE, TO address the QUESTION of the lowest EFFECTIVE and SAFE Vitamin D dose NEEDED to observe health BENEFITS for both Lactating mother and Breastfed offspring, a higher Vitamin D doses would be chosen and evaluated in our rct (1500 iu/d vs. 2000 iu/d vs. 3000 iu/d).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('EXPLICIT_QUESTION', 50), ('SUPERFICIAL_RELATIONSHIP', 73), ('IMPORTANT_CONSIDERATION', 87), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 132)]	8	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 150, 'lactating'), ('GO_0007567', 'parturition', 171, 'breastfed'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4169453	9/2014	S239-PMC4169453	['conclusions\nIN SUMMARY, OUR STUDY SHOWED a very high prevalence (∼65%) of Postpartum Vitamin D deficiency among caucasian mothers and their newborn offspring living at latitude 52°n.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 34)]	3	[('GO_0007565', 'female pregnancy', 74, 'postpartum'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4380518	9/2014	S0-PMC4380518	['Prenatal Vitamin use and Vitamin D status during Pregnancy, differences by race and overweight status\n\nabstract\n\nobjective\nwe AIMED TO STUDY WHETHER Prenatal Vitamin (pnv) use PROTECTS against low 25(Oh)D levels in all women and PARTICULARLY in obese and black women who are both AT RISK of Vitamin D deficiency and poor pregnancy outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 176), ('IMPORTANT_CONSIDERATION', 229), ('IMPORTANT_CONSIDERATION', 280)]	6	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_33229', 'vitamin (role)', 9, 'Vitamin'), ('CHEBI_28384', 'vitamin K', 25, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 149, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 158, 'vitamin'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 203, 'D'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D')]
PMC4380518	9/2014	S2-PMC4380518	['we used multivariable logistic regression to ANALYZE ASSOCIATIONS of pnv use and odds of Vitamin D deficiency DEFINED as 25(Oh)D levels < 50 nmol/l.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 110)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 121, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 121, '25 ... OH ... D')]
PMC4380518	9/2014	S66-PMC4380518	['FUTURE ANALYSES of health EFFECTS of Vitamin D status in this population are PLANNED but beyond the scope of THIS analysis.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('FUTURE_WORK', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 109)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4193194	10/2014	S187-PMC4193194	['the study, called combined antioxidants and Preeclampsia prediction studies (capps), had the OBJECTIVE of determining WHETHER Vitamin C and E COULD reduce the frequency of Pregnancy related hypertension.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118), ('INCOMPLETE_EVIDENCE', 142)]	3	[('GO_0007128', 'meiotic prophase I', 44, 'Preeclampsia'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 140, 'E'), ('GO_0007565', 'female pregnancy', 172, 'pregnancy')]
PMC4193194	10/2014	S188-PMC4193194	['results from this STUDY SHOWED that the supplementation with Vitamin C and E in a low-risk cohort of women DEMONSTRATED no significant differences in maternal or newborn complications RELATED to hypertension during Pregnancy (roberts et al.,2010; weissgerber et al.,2013).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 75, 'E'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy')]
PMC4329404	10/2014	S1-PMC4329404	['we INVESTIGATED the EFFECT of early-Life Vitamin D deficiency on the development of Murine neonatal allergic Airways disease (aad).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('UBERON_0000104', 'life cycle', 36, 'life'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('NCBITaxon_39107', 'Murinae', 84, 'murine'), ('UBERON_0001005', 'respiratory airway', 109, 'airways')]
PMC4329404	10/2014	S30-PMC4329404	['Pregnant females were Fed a Vitamin D-deficient diet starting from day-16 Gestation (last trimester) to FOCUS on Immune-mediated mechanisms of disease development in offspring and to limit any EFFECTS of in utero Vitamin D deficiency on foetal Lung growth and Development (27).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 104), ('SUPERFICIAL_RELATIONSHIP', 193)]	2	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0007631', 'feeding behavior', 22, 'fed'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('UBERON_0002405', 'immune system', 113, 'immune'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0030324', 'lung development', 244, 'lung ... development'), ('UBERON_0002048', 'lung', 244, 'lung')]
PMC4329404	10/2014	S31-PMC4329404	['TO DETERMINE WHETHER Vitamin D deficiency exacerbates allergic Airways disease (aad), and the mechanisms underlying this, we used a neonatal MODEL of inhaled house dust Mite (hdm) exposure (28).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 141)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 63, 'airways'), ('CHEBI_46662', 'mineral', 169, 'mite'), ('NCBITaxon_10088', 'Mus <genus>', 169, 'mite')]
PMC4329404	10/2014	S87-PMC4329404	['Vitamin D insufficiency in utero and in early Life promotes Pulmonary th2 skewing and reduced Il-10+T Regulatory Cells\nto DETERMINE the ROLE of Vitamin D in T-Cell Differentiation, we analysed Th2 Cells and Il-10+T Regulatory Cells in the Lungs of pups.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 122), ('SUPERFICIAL_RELATIONSHIP', 136)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 46, 'life'), ('UBERON_0002048', 'lung', 60, 'pulmonary'), ('PR_000001470', 'interleukin-28B', 94, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 100, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 102, 'regulatory'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CL_0000084', 'T cell', 157, 'T-cell'), ('GO_0030217', 'T cell differentiation', 157, 'T-cell differentiation'), ('CL_0000546', 'T-helper 2 cell', 193, 'Th2 cells'), ('PR_000001470', 'interleukin-28B', 207, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 213, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 215, 'regulatory'), ('UBERON_0002048', 'lung', 239, 'lungs')]
PMC4329404	10/2014	S102-PMC4329404	['supplementation with Vitamin D after in utero and early-Life insufficiency reduces Serum Ige in pups at 6\xa0weeks of age, BUT NOT th2 cytokines\nwe measured Serum total and hdm-specific Ige TO ASSESS whether early-Life Vitamin D insufficiency AFFECTED sensitization to Allergen (fig.4a).']	[('ANOMALY_CURIOUS_FINDING', 120), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 240)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000104', 'life cycle', 56, 'life'), ('UBERON_0001977', 'blood serum', 83, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 89, 'IgE'), ('UBERON_0001977', 'blood serum', 154, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 183, 'IgE'), ('UBERON_0000104', 'life cycle', 211, 'life'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('CHEBI_50904', 'allergen', 266, 'allergen')]
PMC4329404	10/2014	S140-PMC4329404	['ours is the FIRST STUDY TO INVESTIGATE the IMPACT of maternal Vitamin D status on early-Life allergic inflammation.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000104', 'life cycle', 88, 'life')]
PMC4329404	10/2014	S143-PMC4329404	['this CONCURRED with OUR FINDINGS SHOWING Allergen exposure in neonatal Mice with in utero and Postnatal Vitamin D deficiency did not affect Lung function.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 33)]	3	[('CHEBI_50904', 'allergen', 41, 'allergen'), ('NCBITaxon_10088', 'Mus <genus>', 71, 'mice'), ('GO_0007567', 'parturition', 94, 'postnatal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0002048', 'lung', 140, 'lung')]
PMC4329404	10/2014	S148-PMC4329404	['it is CONSISTENT with FINDINGS from epidemiological studies which have FAILED TO SHOW reliable EFFECTS of Vitamin D deficiency or insufficiency on Lung function in children with asthma (6–8,11) ALTHOUGH ASSOCIATIONS are REPORTED in Adults (33).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 22), ('DIFFICULT_TASK', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 220)]	10	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('UBERON_0002048', 'lung', 147, 'lung'), ('UBERON_0007023', 'adult organism', 232, 'adults')]
PMC4329404	10/2014	S149-PMC4329404	['overall, GIVEN OUR FINDINGS in a neonatal Mouse MODEL, and PREVIOUS REPORTS of Vitamin D deficiency in utero through Adulthood not resulting in significantly WORSE ahr, it SEEMS LIKELY that in the context of asthma in early Life, Vitamin D deficiency modifies Immunological Responses To Allergen by the induction of an exaggerated th2 skewed response and eosinophilia.']	[('INCOMPLETE_EVIDENCE', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 158), ('ANOMALY_CURIOUS_FINDING', 172), ('PROBABLE_UNDERSTANDING', 172), ('PROBABLE_UNDERSTANDING', 178)]	10	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mouse'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 117, 'adulthood'), ('UBERON_0000104', 'life cycle', 224, 'life'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 260, 'immunological responses to allergen'), ('CHEBI_50904', 'allergen', 287, 'allergen')]
PMC4329404	10/2014	S156-PMC4329404	['this resulted in lower Eosinophilia, less Airway Remodelling and lower Serum Ige levels compared TO pups that remained on a Vitamin D-deficient diet after weaning.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 97)]	1	[('CL_0000771', 'eosinophil', 23, 'eosinophilia'), ('GO_0003313', 'heart rudiment development', 42, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 42, 'airway'), ('UBERON_0001977', 'blood serum', 71, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 77, 'IgE'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4329404	10/2014	S161-PMC4329404	['that study by agrawal and colleagues HAS SHOWN that the improvement in inflammation is significantly better in Mice that are supplemented with Vitamin D compared TO controls that were vitamin d sufficient (31).']	[('INCOMPLETE_EVIDENCE', 37), ('QUESTION_ANSWERED_BY_THIS_WORK', 162)]	2	[('NCBITaxon_10088', 'Mus <genus>', 111, 'mice'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC4329404	10/2014	S162-PMC4329404	['a mechanism for this FINDING was NOT REPORTED, but IN AGREEMENT with OUR FINDINGS, Vitamin D supplementation in that MODEL also ONLY SHOWED an improvement in allergic inflammation, BUT NOT a complete resolution down to levels in nonallergic Mice, and THUS, the authors conclude Vitamin D supplementation is LIKELY an IMPORTANT adjunct in the treatment of asthma, RATHER than a candidate that will achieve a cure.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 307), ('IMPORTANT_CONSIDERATION', 317), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363)]	12	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 241, 'mice'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D')]
PMC4329404	10/2014	S169-PMC4329404	['it is INTERESTING that in OUR STUDY, dietary Vitamin D in utero was ASSOCIATED with the highest numbers of Il-10-secreting Tregs.']	[('ANOMALY_CURIOUS_FINDING', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 68)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 107, 'IL-10'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 123, 'Tregs')]
PMC4329745	10/2014	S1-PMC4329745	['objectives:\nthe AIM of THIS STUDY was TO DETERMINE the prevalence and ASSESS some risk FACTORS of Vitamin D deficiency among women attending our clinics in tehran, the capital of iran.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('SUPERFICIAL_RELATIONSHIP', 87)]	5	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4329745	10/2014	S7-PMC4329745	['conclusions:\nTHIS study SHOWED a high prevalence of Vitamin D deficiency among iranian women especially in Reproductive ages.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 24)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0000003', 'reproduction', 107, 'reproductive')]
PMC4329745	10/2014	S12-PMC4329745	['IN ORDER to obtain a better estimation of the Vitamin D status in iran, STUDIES encompassing different populations in various age and sex groups ARE REQUIRED.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('FUTURE_WORK', 72), ('FUTURE_WORK', 145), ('IMPORTANT_CONSIDERATION', 149)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4329745	10/2014	S15-PMC4329745	['objectives\nthe AIM of THIS STUDY was TO DETERMINE the prevalence and ASSESS some risk FACTORS of Vitamin D deficiency among women aged 20-80 attending our clinics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('SUPERFICIAL_RELATIONSHIP', 86)]	5	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC4329745	10/2014	S87-PMC4329745	['OUR finding of higher Vitamin D levels in younger ages is IN CONTRAST WITH SOME EXISTING FACTS in the LITERATURE (17).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 80)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4329745	10/2014	S88-PMC4329745	['ALTHOUGH in OUR STUDY the ASSOCIATION between age and Vitamin D deficiency is not substantially.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 26)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC4329745	10/2014	S95-PMC4329745	['THIS STUDY was performed on Vitamin D status specially on women .we did have some LIMITATIONS in our work; detailed diet habits of the participants as well as rates of sun exposure were NOT CONSIDERED in the method BECAUSE of practical DIFFICULTIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 215), ('DIFFICULT_TASK', 236)]	5	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
PMC4329745	10/2014	S98-PMC4329745	['THIS STUDY SHOWS a very high prevalence of Vitamin D deficiency in a sample of iranian women, especially those in Reproductive ages.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0000003', 'reproduction', 114, 'reproductive')]
PMC4221707	11/2014	S183-PMC4221707	['AS IN PREVIOUS STUDIES from sweden in women in Childbearing age [7], THIS STUDY FOUND that early Pregnant women had a low intake of Vitamin D and Folate from Foods.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 80)]	4	[('GO_0007129', 'homologous chromosome pairing at meiosis', 47, 'childbearing'), ('GO_0007565', 'female pregnancy', 97, 'pregnant'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 146, 'folate'), ('CHEBI_33290', 'food', 158, 'foods')]
PMC4256222	12/2014	S25-PMC4256222	['in a prospective cohort with follow up over two decades, we therefore EXAMINED WHETHER the risk of bone fractures during the first 18 years of Life was ASSOCIATED with the maternal status of Vitamin D in Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('SUPERFICIAL_RELATIONSHIP', 152)]	3	[('UBERON_0000104', 'life cycle', 143, 'life'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy')]
PMC4256222	12/2014	S106-PMC4256222	['the PRESENT STUDY is TO OUR KNOWLEDGE the FIRST to INVESTIGATE WHETHER maternal Vitamin D status PREDICTS offspring bone fractures.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('EXPLICIT_QUESTION', 63), ('SUPERFICIAL_RELATIONSHIP', 97)]	7	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4263713	12/2014	S2-PMC4263713	['the PRESENT STUDY AIMS TO TEST WHETHER Vitamin A supplementation CAN restore Lymphocyte pools in Vitamin A-deficient Rats and thereby improve the function of their Intestinal Mucosa; furthermore, the study AIMED TO IDENTIFY the BEST time frame for Vitamin A supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('INCOMPLETE_EVIDENCE', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 206), ('QUESTION_ANSWERED_BY_THIS_WORK', 212), ('IMPORTANT_CONSIDERATION', 228)]	8	[('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('CL_0000542', 'lymphocyte', 77, 'lymphocyte'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 117, 'rats'), ('UBERON_0001242', 'intestinal mucosa', 164, 'intestinal mucosa'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin A')]
PMC4289064	1/2015	S26-PMC4289064	['we FOCUSED our analyses on children and women in developing countries, where high rates of malnutrition and limited access to Nutrient Supplements MAY make Individuals more susceptible to the EFFECTS of pollinator declines, and analyzed five of the most IMPORTANT Nutrients to global nutrition: Vitamin A, zinc, iron, Folate, and Calcium[14],[15](data on Iodine, another globally IMPORTANT Nutrient, were not available in the datasets we analyzed).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 192), ('IMPORTANT_CONSIDERATION', 254), ('IMPORTANT_CONSIDERATION', 380)]	5	[('CHEBI_33284', 'nutrient', 126, 'nutrient'), ('CHEBI_33341', 'titanium atom', 135, 'supplements'), ('NCBITaxon_1', 'root', 156, 'individuals'), ('CHEBI_33284', 'nutrient', 264, 'nutrients'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 318, 'folate'), ('CHEBI_22313', 'alkaline earth metal atom', 330, 'calcium'), ('CHEBI_24859', 'iodine atom', 355, 'iodine'), ('CHEBI_33284', 'nutrient', 390, 'nutrient')]
PMC4289064	1/2015	S88-PMC4289064	['we also TESTED the INFLUENCE of uncertainty in the CONTRIBUTION of pollinators to crop yields on our results for Vitamin A Intake in children and FOUND that WHILE the specific values for the proportion of the population at risk of Nutrient deficiency changed slightly if we used the minimum, midpoint, or maximum percent yield due to pollinators of the categories defined by klein et al.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157)]	5	[('CHEBI_27300', 'vitamin D', 113, 'vitamin A'), ('GO_0007631', 'feeding behavior', 123, 'intake'), ('CHEBI_33284', 'nutrient', 231, 'nutrient')]
PMC4302429	1/2015	S34-PMC4302429	['the AIMS of THIS STUDY were (i) TO INVESTIGATE the immunomodulatory capacity of Vitamin D and (ii) TO EXAMINE the IMPACT of Vitamin D3 supplementation as a preventive or adjuvant therapeutic intervention on the course and mortality of experimental E. Coli meningoencephalitis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 88, 'D'), ('CHEBI_33279', 'vitamin D5', 124, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 124, 'vitamin D3'), ('NCBITaxon_10088', 'Mus <genus>', 248, 'E. coli')]
PMC4302429	1/2015	S160-PMC4302429	['moreover, Vitamin D has anti-inflammatory properties, illustrated in THIS STUDY by increased anti-inflammatory Il-10 and decreased proinflammatory Il-6 concentrations in Brain Tissue.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 69)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 111, 'IL-10'), ('PR_000001470', 'interleukin-28B', 147, 'IL-6'), ('UBERON_0000955', 'brain', 170, 'brain'), ('UBERON_0000479', 'tissue', 176, 'tissue')]
PMC4302429	1/2015	S166-PMC4302429	['TO ASSESS the ROLE of Vitamin D in an in-vivo experimental MODEL of bacterial Cns infection, we analyzed the INFLUENCE of the infection on the survival and Immune Response of Mice Fed a diet containing different amounts of Vitamin D3 after injection of E. Coli directly into the right Frontal Lobe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 78, 'CNS'), ('GO_0006955', 'immune response', 156, 'immune response'), ('UBERON_0002405', 'immune system', 156, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 175, 'mice'), ('GO_0007631', 'feeding behavior', 180, 'fed'), ('CHEBI_33279', 'vitamin D5', 223, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 223, 'vitamin D3'), ('NCBITaxon_10088', 'Mus <genus>', 253, 'E. coli'), ('UBERON_0016525', 'frontal lobe', 285, 'frontal lobe')]
PMC4302429	1/2015	S175-PMC4302429	['we THEREFORE ASKED WHETHER Vitamin D MIGHT Modulate the course of and survival from infection after bacterial meningoencephalitis and WHETHER Vitamin D COULD POTENTIALLY be used therapeutically to alleviate Cns pathology.']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('EXPLICIT_QUESTION', 134), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 158)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 43, 'modulate'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 207, 'CNS')]
PMC4302429	1/2015	S193-PMC4302429	['OTHER mechanisms COULD BE the Regulation of Anti- and proinflammatory Compounds by Vitamin D. for this PURPOSE, we INVESTIGATED the pattern of cytokine and Chemokine Production, a central feature in the development of Neuroinflammation, neurodegeneration, and demyelination in the Cns [46,47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 115)]	5	[('GO_0065007', 'biological regulation', 30, 'regulation'), ('CHEBI_67437', 'Euparin', 44, 'anti-'), ('CHEBI_36357', 'polyatomic entity', 70, 'compounds'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0032602', 'chemokine production', 156, 'chemokine production'), ('GO_0007009', 'plasma membrane organization', 218, 'neuroinflammation'), ('UBERON_0001017', 'central nervous system', 281, 'CNS')]
PMC4303849	1/2015	S7-PMC4303849	['THIS REVIEW provides a current overview on the Regulation Of Vitamin D Metabolism, FOCUSING on Vitamin D deficiency during Gestation and its IMPACT on Pregnancy outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 83), ('SUPERFICIAL_RELATIONSHIP', 141)]	4	[('GO_0019216', 'regulation of lipid metabolic process', 47, 'regulation of vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'gestation'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy')]
PMC4383575	1/2015	S238-PMC4383575	['OTHER POTENTIAL LIMITATIONS of OUR STUDY were the INABILITY to assess the intake of IMPORTANT dietary variables (i.e., Vitamins E, A, and C) (ragin et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 84)]	6	[('CHEBI_27300', 'vitamin D', 119, 'vitamins E'), ('PR_000024090', 'sensor protein TorS', 119, 'vitamins E'), ('PR_000004370', 'asialoglycoprotein receptor 2', 131, 'A'), ('PR_000004900', 'complement C3', 138, 'C')]
PMC4396835	1/2015	S21-PMC4396835	['later, the negative IMPACT of Prenatal Vitamin D deficiency on Brain Development was POSTULATED by mcgrath [17], MAINLY BASED on epidemiological data.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 113), ('QUESTION_ANSWERED_BY_THIS_WORK', 120)]	4	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007420', 'brain development', 63, 'brain development'), ('UBERON_0000955', 'brain', 63, 'brain')]
PMC4396835	1/2015	S30-PMC4396835	['season of Birth findings constitute another LINK between autism and Vitamin D. in europe a MAJOR proportion of the population have CONSIDERABLY lower 25(Oh)D in winter and spring compared TO summer and autumn [36,41].']	[('SUPERFICIAL_RELATIONSHIP', 44), ('IMPORTANT_CONSIDERATION', 91), ('ANOMALY_CURIOUS_FINDING', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 188)]	4	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D')]
PMC4396835	1/2015	S36-PMC4396835	['the AIM of the PRESENT STUDY was TO ADDRESS the EMERGING HYPOTHESIS that low levels of Vitamin D at Birth increase the RISK for asd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007567', 'parturition', 100, 'birth')]
PMC4396835	1/2015	S129-PMC4396835	['seasonal EFFECTS\nOUR FINDING that more children with asd of swedish or other non-african/non-middle east background were Born in the spring than during other seasons - COULD POSSIBLY implicate OTHER aetiological FACTORS THAN Vitamin D levels, such as, for instance, infections.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 168), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('SUPERFICIAL_RELATIONSHIP', 212), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 220)]	7	[('GO_0007567', 'parturition', 121, 'born'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D')]
PMC4396835	1/2015	S130-PMC4396835	['HOWEVER, the LACK OF effect of season of sampling (= season of Birth in OUR STUDY) on 25(Oh)D levels in our african/middle east group, all having low Vitamin D status throughout the year, HAS also BEEN REPORTED in women with african/middle east origin living in norway [59].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 72), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 202)]	5	[('GO_0007567', 'parturition', 63, 'birth'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC4396835	1/2015	S134-PMC4396835	['OUR FINDINGS of lower Vitamin D levels in children with asd, COMPARED TO their siblings, also ACCORD WITH results from a population-based study from the faroe islands, in the north atlantic ocean, of Vitamin D levels in adolescents and young Adults with asd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 61), ('INCOMPLETE_EVIDENCE', 94)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0007023', 'adult organism', 242, 'adults')]
PMC4396835	1/2015	S143-PMC4396835	['strengths and limitations\nthe participants of THIS STUDY represent different ethnic backgrounds, iq levels ranging from intellectual disability to normal intelligence, and highly variable newborn Vitamin D levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46)]	1	[('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC4396835	1/2015	S167-PMC4396835	['HOWEVER, as low Vitamin D is SUGGESTED to CONTRIBUTE to the pathogenesis of autoimmunity [69], OUR FINDINGS COULD BE relevant in this context as well.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 108)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC4396835	1/2015	S168-PMC4396835	['conclusion\nOUR FINDINGS of a low Vitamin D level in a group of newborn children, who later developed asd, provide SUPPORT for the HYPOTHESIS that developmental Vitamin D deficiency during late Pregnancy MAY carry an INCREASED risk of asd in the child, along with several other RISK FACTORS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 216), ('SUPERFICIAL_RELATIONSHIP', 277)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
PMC4396835	1/2015	S169-PMC4396835	['three DIFFERENT independent findings POINT towards a ROLE for Vitamin D in the development of asd: (1) increased risk for asd in offspring of migrants, especially from countries with a dark-skinned population and from cultures where women use covered clothing; (2) low 25(Oh)D levels in groups of newborn children, who later have developed asd, and in groups of children and Adults with asd; and (3) an ASSOCIATION between season of Birth and asd, in OUR STUDY not extending to the high-risk groups of migrants, SUGGESTING that these groups are exposed to suboptimal Vitamin D levels the whole year.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 403), ('QUESTION_ANSWERED_BY_THIS_WORK', 451), ('INCOMPLETE_EVIDENCE', 512)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 269, '25(OH)D'), ('UBERON_0007023', 'adult organism', 375, 'adults'), ('GO_0007567', 'parturition', 433, 'birth'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC4396835	1/2015	S170-PMC4396835	['ALTHOUGH low levels of Vitamin D COULD have a Genetic origin and as SUCH be ASSOCIATED with asd, OUR STUDY is the FIRST TO RULE OUT asd-related lifestyle mechanisms AS EXPLANATION for low 25(Oh)D levels, SINCE the samples were taken in the Newborn Period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 68), ('SUPERFICIAL_RELATIONSHIP', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 165), ('PROBABLE_UNDERSTANDING', 168), ('PROBABLE_UNDERSTANDING', 204)]	10	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('SO_0000704', 'gene', 46, 'genetic'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 194, 'D'), ('UBERON_0007221', 'neonate stage', 240, 'newborn period')]
PMC4383226	2/2015	S44-PMC4383226	['BASED ON this evidence, the PURPOSE of THIS STUDY was TO DETERMINE the risk of plasmodium parasitemia and p. falciparum -specific antigenemia following Vitamin A supplementation and standard vaccination in children under 5 years of age in sub-saharan africa.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 54)]	4	[('CHEBI_27300', 'vitamin D', 152, 'vitamin A')]
PMC4383226	2/2015	S94-PMC4383226	['discussion\nin THIS large, population-BASED STUDY within sub-saharan africa, Vitamin A supplementation was ASSOCIATED with a negative risk of plasmodium parasitemia and p ƒhrp-2 antigenemia among children aged 6–59 months.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 106)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin A')]
PMC4383226	2/2015	S99-PMC4383226	['Vitamin A, dtp and gender\nOUR STUDY EXTENDS PREVIOUS randomized clinical TRIAL EVIDENCE from burkina faso (zeba et al., 2008), papua new guinea (shankar et al., 1999), tanzania (villamor et al., 2002), and uganda (nankabirwa et al., 2011) SHOWING consistent reductions in malaria-induced morbidity and Mortality from Vitamin A.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 239)]	6	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin A'), ('GO_0065007', 'biological regulation', 302, 'mortality'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 325, 'A')]
PMC4383226	2/2015	S106-PMC4383226	['all of the epidemiological EVIDENCE TO SUPPORT the DETRIMENTAL gender-BASED EFFECTS from Vitamin A and dtp on child mortality comes from guinea bissau (benn et al., 2009a,b2009b;fisker et al., 2013).']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('SUPERFICIAL_RELATIONSHIP', 76)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin A')]
PMC4383226	2/2015	S120-PMC4383226	['the breadth and size of the study population enabled us TO EVALUATE the ASSOCIATION between malaria and childhood vaccines/Vitamin A DESPITE high vaccination coverage rates within most of the communities surveyed (desai et al., 2005).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 56), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 133)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin A')]
PMC4383226	2/2015	S150-PMC4383226	["we FOCUSED on standard dhs surveys carried out since january 2010, which tested children for malaria using Blood films (gold standard malaria test) and documented children's use of standard vaccines and Vitamin A supplements."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	1	[('UBERON_0000178', 'blood', 107, 'blood'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin A')]
PMC4340999	3/2015	S95-PMC4340999	['low Vitamin D during the second or third Trimester of Pregnancy HAS BEEN SUGGESTED to be ASSOCIATED with Adult obesity.31,33in THE CURRENT STUDY, spring and early summer peaks and winter troughs for bmi and wc were evident.']	[('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 127)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 41, 'trimester'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('UBERON_0007023', 'adult organism', 105, 'adult')]
PMC4340999	3/2015	S98-PMC4340999	['up to now, a FEW STUDIES have EXAMINED the ASSOCIATION between lower maternal Vitamin D levels in later Pregnancy and offspring adiposity at age 6 years34; at birth, age 9 months and age 9 years35; at ages 5 and 9.5 years36; and at age 35 years,37and shown INCONSISTENT results.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy')]
PMC4340999	3/2015	S102-PMC4340999	['ll in the PRESENT STUDY followed an opposite seasonal TREND to that of Adult adiposity measures, for which maternal uvb exposure (and HENCE Vitamin D status) is STILL a reasonable EXPLANATION.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 134), ('IMPORTANT_CONSIDERATION', 161), ('PROBABLE_UNDERSTANDING', 180)]	5	[('UBERON_0007023', 'adult organism', 71, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4340999	3/2015	S109-PMC4340999	['results in the PRESENT STUDY IMPLY that Prenatal Vitamin D status MIGHT be a POTENTIAL pathway LINKING ll with Adult risks of obesity39,40and a range of chronic diseases.8–10HOWEVER, seasonal variation in ll DEPENDING ON region SUGGESTS that ll CAN ONLY be used as anthropometric BIOMARKER of Prenatal Vitamin D status in SOME geographic regions.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 29), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 245), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 280), ('INCOMPLETE_EVIDENCE', 322)]	12	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 293, 'prenatal'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC4340999	3/2015	S112-PMC4340999	['ALTHOUGH THE CURRENT STUDY is UNABLE TO precisely determine the REASON for mob variation in Adult measures of ll, general adiposity, and central adiposity, the study improves our current understanding of a POTENTIAL ASSOCIATION of Prenatal low exposure to Vitamin D during late second and early third trimesters with short ll and adiposity in later Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('DIFFICULT_TASK', 30), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('UBERON_0007023', 'adult organism', 92, 'adult'), ('GO_0007565', 'female pregnancy', 231, 'prenatal'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0000104', 'life cycle', 349, 'life')]
PMC4340999	3/2015	S125-PMC4340999	['this is also the FIRST-ever population-BASED EVIDENCE LINKING low Prenatal sun-RELATED uvb exposure (and lower Vitamin D by PROXY) to ll and the susceptibility to obesity later in Life and also SUGGESTING that late second and early third trimesters MIGHT be a CRITICAL period for the above-mentioned EFFECTS ALTHOUGH such EVIDENCE is non-specific, it WARRANTS FURTHER STUDIES in this AREA.']	[('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 79), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 249), ('IMPORTANT_CONSIDERATION', 260), ('SUPERFICIAL_RELATIONSHIP', 300), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 308), ('INCOMPLETE_EVIDENCE', 322), ('FUTURE_WORK', 351), ('FUTURE_WORK', 360), ('FUTURE_WORK', 384)]	15	[('GO_0007565', 'female pregnancy', 66, 'prenatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
PMC4392553	3/2015	S431-PMC4392553	["[140]\nsamsel and seneff[248249] PROPOSED that the current Vitamin D deficiency EPIDEMIC is caused by Glyphosate, due TO Glyphosate's interference with cyp enzymes."]	[('INCOMPLETE_EVIDENCE', 32), ('IMPORTANT_CONSIDERATION', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 117)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_17754', 'glycerol', 101, 'glyphosate'), ('CHEBI_17754', 'glycerol', 120, 'glyphosate')]
PMC4396888	3/2015	S134-PMC4396888	['HOWEVER, Micronutrient intakes especially of Iron and Vitamin A were lower in a higher proportion of OUR STUDY population as COMPARED TO the study by kapil et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 9, 'micronutrient'), ('CHEBI_24870', 'ion', 45, 'iron'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin A')]
PMC4405493	4/2015	S2-PMC4405493	['the OBJECTIVE of THIS STUDY was TO ANALYZE the RELATIONSHIP between Vitamin D deficiency in the first trimester and subsequent clinical outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('SUPERFICIAL_RELATIONSHIP', 47)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4405493	4/2015	S20-PMC4405493	['RECENT observational and randomized control trials have ATTEMPTED TO investigate THIS ISSUE, but there REMAINS LIMITED GUIDANCE on the management of Vitamin D deficiency during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('DIFFICULT_TASK', 56), ('INCOMPLETE_EVIDENCE', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 86), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 111), ('FUTURE_WORK', 119)]	9	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC4405493	4/2015	S24-PMC4405493	['THUS, we SOUGHT TO DETERMINE IF Vitamin D deficiency in the first trimester of nulliparous patients is ASSOCIATED with clinical outcomes MOST ASSOCIATED with SIGNIFICANT maternal and fetal morbidity and mortality: Preeclampsia, Gestational diabetes, Preterm Delivery, spontaneous abortion, and growth restriction.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('SUPERFICIAL_RELATIONSHIP', 103), ('PROBABLE_UNDERSTANDING', 137), ('SUPERFICIAL_RELATIONSHIP', 142), ('IMPORTANT_CONSIDERATION', 158)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 214, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 228, 'gestational'), ('GO_0007565', 'female pregnancy', 250, 'preterm'), ('GO_0007567', 'parturition', 258, 'delivery')]
PMC4405493	4/2015	S99-PMC4405493	['race was the only statistically different variable among the Vitamin D groups, with significantly more african american, asian, and other unspecified racial groups in the Vitamin D deficient category compared TO the insufficient and sufficient groups (p = 0.03).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 209)]	1	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC4405493	4/2015	S114-PMC4405493	['ALTHOUGH we recruited ONLY young, nulliparous, previously healthy women, the majority of our patients were either Vitamin D deficient (10%, <20 ng/ml) or Vitamin D insufficient (60%, 20–29 ng/ml) according TO the criteria published by the institute for medicine.18of the 235 patients included in the study, 41 of them had a prior Pregnancy which had resulted in a spontaneous First Trimester Miscarriage or elective termination.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 206)]	3	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007565', 'female pregnancy', 330, 'pregnancy'), ('GO_0042733', 'embryonic digit morphogenesis', 376, 'first trimester'), ('GO_0046660', 'female sex differentiation', 392, 'miscarriage')]
PMC4405493	4/2015	S158-PMC4405493	['although Vitamin D has a biologically POSSIBLE ROLE in all the aforementioned disorders, this WAS NOT DEMONSTRATED in our population AS Vitamin D deficiency did not increase the odds for adverse Pregnancy outcome in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 133), ('QUESTION_ANSWERED_BY_THIS_WORK', 216)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy')]
PMC4405493	4/2015	S176-PMC4405493	['HOWEVER, the high percentage of affected Individuals HIGHLIGHTS the prevalence of Vitamin D deficiency and insufficiency in young, healthy Reproductive-aged women in OUR STUDY population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 166)]	3	[('NCBITaxon_1', 'root', 41, 'individuals'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0000003', 'reproduction', 139, 'reproductive')]
PMC4405493	4/2015	S178-PMC4405493	['ALTHOUGH OUR STUDY DID NOT DEMONSTRATE an association of Vitamin D Plasma concentration with select clinical outcomes, the prevalence of sub-optimal Vitamin D concentrations in patient plasma EMPHASIZES THE NEED for CONTINUED RESEARCH on hypovitaminosis d in Pregnancy and Reproductive health.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 192), ('INCOMPLETE_EVIDENCE', 203), ('FUTURE_WORK', 207), ('FUTURE_WORK', 216)]	10	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 67, 'plasma'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnancy'), ('GO_0000003', 'reproduction', 273, 'reproductive')]
PMC4417995	4/2015	S3-PMC4417995	['in THIS PAPER, we review the EXISTING LITERATURE on the ASSOCIATION between ad and Vitamin D levels, FOCUSING on childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 101)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC4417995	4/2015	S136-PMC4417995	['based on this RATIONALE and comforted by the data obtained from observational studies, the following clinical trials INVESTIGATED the therapeutic ROLE of Vitamin D supplementation in the treatment of ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 146)]	3	[('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC4417995	4/2015	S169-PMC4417995	['heliotherapy\ndifferent studies FOCUSED on the EFFECT of heliotherapy on both Vitamin D levels and ad severity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4427001	4/2015	S1-PMC4427001	['the AIMS of the PRESENT STUDY were TO DETERMINE Midgestational and early Postpartum Vitamin D status in Pregnant women with and without gdm and to describe the RELATIONSHIP between Midgestational and Postpartum Vitamin D status and parallel changes of Glucose tolerance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('GO_0007507', 'heart development', 48, 'midgestational'), ('GO_0007565', 'female pregnancy', 73, 'postpartum'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnant'), ('GO_0007507', 'heart development', 181, 'midgestational'), ('GO_0007565', 'female pregnancy', 200, 'postpartum'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_17234', 'glucose', 252, 'glucose')]
PMC4427001	4/2015	S40-PMC4427001	['THEREFORE, the AIMS of the PRESENT STUDY were (1) TO DETERMINE Midgestational and early Postpartum Vitamin D status by measuring 25(Oh)D Plasma levels in Pregnant women with and without gdm to CONFIRM the hypothetical deficiency in gdm in central european population and (2) to describe the RELATIONSHIP between Midgestational and Postpartum Vitamin D status and parallel changes of parameters characterising Glucose tolerance.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 291)]	6	[('GO_0007507', 'heart development', 63, 'midgestational'), ('GO_0007565', 'female pregnancy', 88, 'postpartum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 132, 'OH ... D'), ('UBERON_0001969', 'blood plasma', 137, 'plasma'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('GO_0007507', 'heart development', 312, 'midgestational'), ('GO_0007565', 'female pregnancy', 331, 'postpartum'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D'), ('CHEBI_17234', 'glucose', 409, 'glucose')]
PMC4427001	4/2015	S83-PMC4427001	["in OUR STUDY, we have FOUND that Midgestational Vitamin D deficiency (i.e., 25(Oh)D levels < 50\u2009nmol/l) was present in majority of the study sample, that is, 45 of 47 (95.7%) women with gdm and 27 of 29 (93.1%) healthy Pregnant women ( p = ns, fisher's exact test)."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 22)]	2	[('GO_0007507', 'heart development', 33, 'midgestational'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('GO_0007565', 'female pregnancy', 219, 'pregnant')]
PMC4427001	4/2015	S97-PMC4427001	['ALTHOUGH there is NO GENERAL CONSENSUS on the criteria for Vitamin D deficiency in Pregnant women, in OUR STUDY we have FOUND high prevalence of deficiency (when using cut-off < 50\u2009nmol/l) in overall study sample: 95.7% of women with gdm and 93.1% of controls were Vitamin D deficient during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('INCOMPLETE_EVIDENCE', 120)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0007565', 'female pregnancy', 292, 'pregnancy')]
PMC4448820	5/2015	S154-PMC4448820	['● THIS REVIEW includes information on the ROLE of specific case study Nutrients (Vitamin A, Vitamin D, zinc, iron, Selenium, Folic Acid) in DEPENDENT pathways.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 2), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('CHEBI_33284', 'nutrient', 70, 'nutrients'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27568', 'selenium atom', 115, 'selenium'), ('CHEBI_30751', 'formic acid', 125, 'folic acid')]
PMC4448820	5/2015	S273-PMC4448820	['for the PURPOSE of this overview, the general molecular actions of 4 Micronutrients (Vitamins A and d, zinc, Folic Acid) will be the primary focus, including their specific points of convergence on the Regulation of 2 major regulators of inflammation: Nf-Κb activity and the induction, and maintenance, of Treg cells.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 202)]	2	[('CHEBI_33839', 'macromolecule', 69, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 85, 'vitamins A'), ('CHEBI_30751', 'formic acid', 109, 'folic acid'), ('GO_0065007', 'biological regulation', 202, 'regulation'), ('GO_0005883', 'neurofilament', 252, 'NF-'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 252, 'NF-κB'), ('CL_0000901', 'Tr1 cell', 306, 'Treg')]
PMC4448820	5/2015	S525-PMC4448820	['caption (boxed-text): text box 19\u2003\nwg 2 summary and conclusions\n\n● the review uses data on 3 Micronutrients (Vitamin A, zinc, and iron), anthropometrically defined undernutrition (stunting, wasting, and underweight), and obesity TO EVALUATE the EFFECT on the following:\n○ Immune function,\n○ recovery of immune function in response to nutritional interventions,\n○ RELATED health outcomes (e.g., risk of infection), and\n○ MARKERS of inflammation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('SUPERFICIAL_RELATIONSHIP', 245), ('SUPERFICIAL_RELATIONSHIP', 363), ('SUPERFICIAL_RELATIONSHIP', 420)]	4	[('CHEBI_33839', 'macromolecule', 93, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('UBERON_0002405', 'immune system', 272, 'immune')]
PMC4448820	5/2015	S538-PMC4448820	['THIS REVIEW includes examples of undernutrition, including undernutrition defined by poor growth (i.e., underweight, stunting, and wasting) and deficiencies of specific Micronutrients (Vitamin A, zinc, and iron) as well as overnutrition, focusing on obesity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0)]	1	[('CHEBI_33839', 'macromolecule', 169, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin A')]
PMC4448820	5/2015	S593-PMC4448820	['HOWEVER, the EFFECTS of Vitamin A supplementation on the Immune System MAY lead TO variable clinical outcomes, DEPENDING ON the nature of the Immune Response NEEDED to combat the infecting pathogens.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('GO_0006955', 'immune response', 142, 'immune response'), ('UBERON_0002405', 'immune system', 142, 'immune')]
PMC4448820	5/2015	S1193-PMC4448820	['THIS STUDY, which was followed by numerous others, HIGHLIGHTS an IMPORTANT and underappreciated ROLE for Vitamin D in Drug Metabolism through the induction of Gene Expression of key Drug-Metabolizing enzymes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 51), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 96)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_23888', 'drug', 118, 'drug'), ('GO_0042737', 'drug catabolic process', 118, 'drug metabolism'), ('GO_0010467', 'gene expression', 159, 'gene expression'), ('SO_0000704', 'gene', 159, 'gene'), ('CHEBI_23888', 'drug', 182, 'drug'), ('GO_0016540', 'protein autoprocessing', 182, 'drug-metabolizing')]
PMC4448820	5/2015	S1392-PMC4448820	['the Nutrients included below are those that have been addressed in the previous wg reviews, with a particular FOCUS on the 6 Nutrients that were covered under the bond project: iron, zinc, Iodine, Vitamin A, Folate, and Vitamin B-12.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 110)]	1	[('CHEBI_33284', 'nutrient', 4, 'nutrients'), ('CHEBI_33284', 'nutrient', 125, 'nutrients'), ('CHEBI_24859', 'iodine atom', 189, 'iodine'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 208, 'folate'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin B'), ('PR_000000037', 'BMP receptor type-2', 228, 'B')]
PMC4488777	5/2015	S30-PMC4488777	['since 2013, the database of the us national library of medicine national institutes of health (pubmed) has gained 2050 NEW publications about Vitamin D and contains 62,427 articles regarding THIS subject.']	[('FULL_UNKNOWN', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 191)]	2	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC4488777	5/2015	S81-PMC4488777	['up to this moment, researchers were FOCUSED on immunomodulating EFFECT of Vitamin D on Endometriosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('UBERON_0010230', 'eyeball of camera-type eye', 87, 'endometriosis')]
PMC4452099	6/2015	S0-PMC4452099	['Gestational and early infancy exposure to margarine fortified with Vitamin D through a national danish programme and the risk of type 1 diabetes: the d-tect study\n\nabstract\nthe OBJECTIVE of the study was TO ASSESS WHETHER Gestational and early Infancy exposure to low dose Vitamin D from a mandatory Margarine fortification programme in denmark INFLUENCED the risk of developing type 1 diabetes (t1d) before age of 15 years.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('QUESTION_ANSWERED_BY_THIS_WORK', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('SUPERFICIAL_RELATIONSHIP', 345)]	4	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_28384', 'vitamin K', 67, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 67, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 222, 'gestational'), ('UBERON_0000023', 'wing', 244, 'infancy'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_6784', 'mestranol', 300, 'margarine')]
PMC4452099	6/2015	S28-PMC4452099	['the AIM of THIS STUDY was TO ASSESS WHETHER Gestational and early Infancy exposure to small extra doses of Vitamin D coming from fortified Margarine INFLUENCED the risk of developing t1d later in Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('SUPERFICIAL_RELATIONSHIP', 149)]	5	[('GO_0007565', 'female pregnancy', 44, 'gestational'), ('UBERON_0000023', 'wing', 66, 'infancy'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_6784', 'mestranol', 139, 'margarine'), ('UBERON_0000104', 'life cycle', 196, 'life')]
PMC4452099	6/2015	S81-PMC4452099	['in the PRESENT STUDY, we INVESTIGATED Early Life exposure to fortification, and its ASSOCIATION with the later t1d risk, and utilized the fact that the mandatory danish Vitamin D fortification regimen was abandoned at a distinct time point.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 84)]	3	[('UBERON_0001847', 'lobule of pinna', 38, 'early life'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC4466139	6/2015	S17-PMC4466139	['the AIM of THIS STUDY was TO ASSESS the Vitamin D status in a population of mothers, living in novara (piedmont, north italy, 45° parallel of latitude), at the time of Delivery and in their newborns two days after Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 168, 'delivery'), ('GO_0007567', 'parturition', 214, 'birth')]
PMC4466139	6/2015	S89-PMC4466139	['in OUR STUDY, north african mothers and newborns had the lowest 25Ohd values; this FINDING is IN LINE WITH PREVIOUS DATA SUGGESTING that ethnic origin is a risk FACTOR for Vitamin D deficiency [23–24].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 161)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 64, '25OHD'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC4466139	6/2015	S117-PMC4466139	['OUR FINDINGS also underline the IMPORTANCE of certain RISK FACTORS in causing Vitamin D deficiency such as immigration, dark skin, and lack of Vitamin D supplementation during the Third Trimester of Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0042793', 'plastid transcription', 180, 'third trimester'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC4516377	6/2015	S1-PMC4516377	['abstract\n\nobjective:\nTO EVALUATE the ASSOCIATION between Calcium intake and Serum Vitamin D levels and childhood obesity by an integrative review.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_22313', 'alkaline earth metal atom', 57, 'calcium'), ('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC4516377	6/2015	S14-PMC4516377	['GIVEN the above, THIS integrative REVIEW AIMED TO EVALUATE the ASSOCIATION between calcium intake and Serum Vitamin D levels with body fat (bf) accumulation in children.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	6	[('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4516377	6/2015	S43-PMC4516377	['Serum levels of Vitamin D were significantly ASSOCIATED with higher bmi, waist circumference and Serum Triacylglycerols, as well as lower hdl levels.20the authors of this study used the same categorization of Vitamin D levels of the iom, BUT cited another reference.22finally, a longitudinal study in the brazilian amazon region, followed children from 2007 to 2012 with the OBJECTIVE of evaluating the EFFECT of the Fto Gene on bmi modifications during childhood, as well as verifying WHETHER the Vitamin D status COULD modify this EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('QUESTION_ANSWERED_BY_THIS_WORK', 375), ('SUPERFICIAL_RELATIONSHIP', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 486), ('INCOMPLETE_EVIDENCE', 515), ('SUPERFICIAL_RELATIONSHIP', 533)]	7	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_17075', '6-hydroxyhexano-6-lactone', 103, 'triacylglycerols'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 417, 'FTO'), ('SO_0000704', 'gene', 421, 'gene'), ('CHEBI_27300', 'vitamin D', 498, 'vitamin D')]
PMC4516377	6/2015	S65-PMC4516377	['THUS, the active transport becomes the main mechanism of calcium absorption when its Ingestion is low.34\nit can be OBSERVED that many of the mechanisms that explain adiposity and its ASSOCIATION with the assessed Micronutrients DEMONSTRATE the close ASSOCIATION between Calcium and the Vitamin D present in the Metabolic events of Adipogenesis, and the fact that the presence or absence of one of them CAN bring damage not only to bone, but health as a whole.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 183), ('QUESTION_ANSWERED_BY_THIS_WORK', 228), ('SUPERFICIAL_RELATIONSHIP', 250), ('INCOMPLETE_EVIDENCE', 402)]	6	[('GO_0007631', 'feeding behavior', 85, 'ingestion'), ('CHEBI_33839', 'macromolecule', 213, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 270, 'calcium'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0008152', 'metabolic process', 311, 'metabolic'), ('GO_0060612', 'adipose tissue development', 331, 'adipogenesis')]
PMC4877864	6/2015	S87-PMC4877864	['WHILE, the results of THIS STUDY SHOWED that Vitamin C and Folate contents were ranged between borderline and inadequate Intake in both groups (group 1 and group 2) COMPARED TO their rdas (p<0.005), HOWEVER Vitamin A was ON THE OTHER HAND adequate.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 33), ('ANOMALY_CURIOUS_FINDING', 165), ('QUESTION_ANSWERED_BY_THIS_WORK', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 199), ('ANOMALY_CURIOUS_FINDING', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	8	[('CHEBI_27300', 'vitamin D', 45, 'vitamin C'), ('CHEBI_30863', '5-azaorotic acid', 59, 'folate'), ('GO_0007631', 'feeding behavior', 121, 'intake'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4499946	7/2015	S10-PMC4499946	['THIS TRIAL is expected to contribute unique INSIGHTS into the EFFECTS of improving maternal-infant Vitamin D status in a low-income setting where stunting and adverse Perinatal outcomes represent SIGNIFICANT PUBLIC HEALTH BURDENS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 196), ('IMPORTANT_CONSIDERATION', 208)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0036268', 'swimming', 167, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 167, 'perinatal')]
PMC4499946	7/2015	S42-PMC4499946	['the primary AIM is TO INVESTIGATE the EFFECT of maternal Vitamin D supplementation on infant length at 1 year of age, but the trial also provides an OPPORTUNITY to study a range of OTHER POTENTIAL Vitamin D–responsive outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('FUTURE_WORK', 149), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('INCOMPLETE_EVIDENCE', 187)]	6	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC4499946	7/2015	S46-PMC4499946	['objectives\nthe primary AIMS of the trial are to estimate (1) the effect of maternal Prenatal oral Vitamind3Supplementation (4200 iu/wk, 16,800 iu/wk, or 28,000 iu/wk administered as weekly doses) versus placebo on infant length at 1 year of age in dhaka, bangladesh; and (2) the EFFECT of maternal Postpartum oral Vitamin D3Supplementation (28,000 iu/wk) versus placebo on length at 1 year of age among infants Born to women who received Vitamin D 28,000 iu/wk during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 279)]	2	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 98, 'vitaminD3supplementation'), ('GO_0007565', 'female pregnancy', 298, 'postpartum'), ('CHEBI_52915', 'phosphatediyl group', 314, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 314, 'vitamin D3supplementation'), ('GO_0007567', 'parturition', 411, 'born'), ('CHEBI_27300', 'vitamin D', 438, 'vitamin D'), ('GO_0007565', 'female pregnancy', 468, 'pregnancy')]
PMC4499946	7/2015	S77-PMC4499946	['TO ASSESS the EFFECT of Prenatal Vitamin D, we PLAN TO perform five primary between-group analyses, comprising each Vitamin D dose versus placebo (three comparisons) and comparisons between adjacent doses (two comparisons).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('FUTURE_WORK', 47)]	3	[('GO_0007565', 'female pregnancy', 24, 'prenatal'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4499946	7/2015	S94-PMC4499946	['interventions and control\n\nVitamin D doses\nthe primary OBJECTIVE of the mdig trial is to establish evidence of a causal RELATIONSHIP between maternal-infant Vitamin D status and infant stature.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 120)]	2	[('CHEBI_28384', 'vitamin K', 27, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4499946	7/2015	S229-PMC4499946	['TO ASSESS the EFFECT of Prenatal Vitamin D on mean Laz at 1 year of age, we PLAN TO perform five primary between-group analyses: each Prenatal Vitamin D dose versus placebo (three pairwise comparisons), as well as comparisons between all adjacent Vitamin D doses (two pairwise comparisons).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('FUTURE_WORK', 76)]	3	[('GO_0007565', 'female pregnancy', 24, 'prenatal'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('PR_000009655', 'laminin subunit beta-2', 51, 'LAZ'), ('GO_0007565', 'female pregnancy', 134, 'prenatal'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D')]
PMC4499946	7/2015	S271-PMC4499946	['HOWEVER, this test is non-specific and frequently led TO the need for repeat testing that was burdensome but uninformative; in no cases did an isolated ca:cr ratio indicate Vitamin D toxicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 54)]	2	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC4499946	7/2015	S296-PMC4499946	['the trial is primarily DESIGNED and powered TO EVALUATE the dose–response EFFECTS of Vitamin D on infant length, an outcome that is directly ALIGNED with the classical ROLE of Vitamin D in Mineral Metabolism and bone health BUT MAY also be interpreted as a SURROGATE marker for Organ (including Brain) Growth and Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 224), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 257)]	8	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('CHEBI_46662', 'mineral', 189, 'mineral'), ('GO_0008152', 'metabolic process', 197, 'metabolism'), ('UBERON_0000062', 'organ', 278, 'organ'), ('GO_0007420', 'brain development', 295, 'brain ... growth ... development'), ('UBERON_0000955', 'brain', 295, 'brain')]
PMC4586450	10/2015	S252-PMC4586450	['WHETHER fortification of Foods COULD BE the answer to THIS problem was EXAMINED; the THEORETICAL intakes from DIFFERENT fortification regimens tested SUGGESTED that milk fortified at 2 µg vitamin d/100 g would provide MOST preschool children with adequate but not excessive intakes.24later work in the alspac looking at Plasma concentrations in mid-childhood of Vitamin D (25-Hydroxyvitamin-D2And 25-Hydroxyvitamin-D3) in RELATION to Cortical bone measures FOUND positive ASSOCIATIONS with D3Only, SUGGESTING that in supplementation OR fortification, d3should be used in PREFERENCE to d2.25these 2 PAPERS give valuable INSIGHTS into HOW the lack of Vitamin D in the diets of the majority of uk residents COULD BE TACKLED.iron\niron is a Nutrient that is ESSENTIAL to a child’s growth and development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 71), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('INCOMPLETE_EVIDENCE', 150), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 422), ('INCOMPLETE_EVIDENCE', 457), ('SUPERFICIAL_RELATIONSHIP', 472), ('INCOMPLETE_EVIDENCE', 498), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 533), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 571), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 619), ('EXPLICIT_QUESTION', 633), ('INCOMPLETE_EVIDENCE', 704), ('FUTURE_WORK', 713), ('IMPORTANT_CONSIDERATION', 753)]	20	[('CHEBI_33290', 'food', 25, 'foods'), ('UBERON_0001969', 'blood plasma', 320, 'plasma'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin D'), ('CHEBI_66469', 'senegin III', 373, '25-hydroxyvitamin-D2and'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 373, '25'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 390, '-D2and'), ('CHEBI_65129', '2-hydroxy-AMP', 397, '25-hydroxyvitamin-D3'), ('PR_000000037', 'BMP receptor type-2', 414, '-D3'), ('UBERON_0001851', 'cortex', 434, 'cortical'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 490, 'D3only'), ('CHEBI_27300', 'vitamin D', 649, 'vitamin D'), ('CHEBI_33284', 'nutrient', 736, 'nutrient')]
PMC4586450	10/2015	S442-PMC4586450	['diet and growth in relation to biochemical outcomes\n\niron status\niron status was INVESTIGATED in RELATION to Food and Nutrient intakes at 1.5 years in the cif subsample (n = 796).60ferritin concentration (a measure of stored iron) was more sensitive to Nutrient intakes (energy-adjusted) than hemoglobin; calcium intake was negatively RELATED to ferritin ( r = −0.22; p< 0.001), and iron, Vitamin C, and fiber intakes were positively RELATED (all p< 0.05).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 335), ('SUPERFICIAL_RELATIONSHIP', 434)]	4	[('CHEBI_33290', 'food', 109, 'food'), ('CHEBI_33284', 'nutrient', 118, 'nutrient'), ('CHEBI_33284', 'nutrient', 253, 'nutrient'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin C')]
PMC4595656	10/2015	S121-PMC4595656	['this constitutes a MAJOR lacuna in our overall understanding of the ROLE of Vitamin D in the early development of the hippocampus and is an AVENUE RIPE for EXPLORATION.']	[('IMPORTANT_CONSIDERATION', 19), ('SUPERFICIAL_RELATIONSHIP', 68), ('FUTURE_WORK', 140), ('IMPORTANT_CONSIDERATION', 147), ('QUESTION_ANSWERED_BY_THIS_WORK', 156)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4598849	10/2015	S6-PMC4598849	['THIS STUDY PROVIDES the FIRST epidemiological EVIDENCE that there was an inverted u shaped RELATIONSHIP between neonatal Vitamin D status and fetal growth, and the risk of sga reduced at moderate concentration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4598849	10/2015	S56-PMC4598849	['in THIS STUDY with a large sample, adjustment for more confounders and using non-linear models, we FOUND that there was an inverted u-shaped RELATIONSHIP between Cord Blood 25(Oh)D and Birth weight, SUGGESTING that the newborn with low or high levels of fetal Vitamin D are both in INCREASED risk of growth restriction and higher levels of fetal Vitamin D HAVE not been shown to confer greater BENEFITS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 199), ('IMPORTANT_CONSIDERATION', 282), ('IMPORTANT_CONSIDERATION', 356), ('IMPORTANT_CONSIDERATION', 394)]	7	[('UBERON_0002240', 'spinal cord', 162, 'cord'), ('UBERON_0000178', 'blood', 167, 'blood'), ('CHEBI_71657', 'versiconol acetate', 173, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 173, '25(OH)D'), ('GO_0007567', 'parturition', 185, 'birth'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D')]
PMC4598849	10/2015	S59-PMC4598849	['the FINDING that Vitamin D levels in the upper range increased the health RISK in THIS STUDY was CONSISTENT with PREVIOUS STUDIES examining the risk of fetal growth restriction11, Allergic Response3031, lower-extremity function32, frailty status33, as well as Cardiovascular disease3435.']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0019267', 'asparagine biosynthetic process from cysteine', 180, 'allergic response3031'), ('UBERON_0004535', 'cardiovascular system', 260, 'cardiovascular')]
PMC4598849	10/2015	S61-PMC4598849	['THEREFORE, the inverted u shaped RELATIONSHIP in THIS STUDY MAYBE SUGGESTED that Gestational Vitamin D MAY have dual biological EFFECTS on the fetal growth.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 128)]	7	[('GO_0007565', 'female pregnancy', 81, 'gestational'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4598849	10/2015	S79-PMC4598849	['in CONCLUSION, THIS STUDY PROVIDES the FIRST epidemiological EVIDENCE that there was an inverted u shaped RELATIONSHIP between neonatal Vitamin D status and fetal growth.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 106)]	6	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4600246	10/2015	S5-PMC4600246	['Plasma Phylloquinone concentrations fluctuate BASED on recent dietary intakes.213DESPITE the fact that a high percentage of undercarboxylated osteocalcin INDICATES poor Vitamin K status, this value can also vary based on recent Vitamin K intake and supplementation214and MAY not INDICATE chronic Vitamin K status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 271), ('INCOMPLETE_EVIDENCE', 279)]	5	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_26124', 'phytosteroid', 7, 'phylloquinone'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin K')]
PMC4600246	10/2015	S37-PMC4600246	['Vitamin K administration HAS BEEN SHOWN to significantly delay the progression of cac and, in addition, it HAS also BEEN shown to significantly delay the deterioration of Arterial elasticity.37in another 3-year, double-blind, placebo-controlled trial, Vitamin D and Vitamin K were INVESTIGATED.']	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 107), ('QUESTION_ANSWERED_BY_THIS_WORK', 281)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('UBERON_0001637', 'artery', 171, 'arterial'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin K')]
PMC4624803	10/2015	S19-PMC4624803	['AIM\nthe AIM of the STUDY was TO TEST the HYPOTHESIS that low levels of Vitamin D in the child during Pregnancy are a risk FACTOR for adhd in the offspring.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 122)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC4624803	10/2015	S56-PMC4624803	['a POSSIBLE linear relationship between Vitamin D levels and the risk of adhd was INVESTIGATED using logistic regression analysis.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 81)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4624803	10/2015	S85-PMC4624803	['adjustment was made for the covariates age of mother, smoking of mother, season of Birth january to march and season of Birth july to september.all childrenchildren with mothers Born in swedenestimate95% confidence limitsp-valueestimate95% confidence limitsp-valuemodel 1-0.77-2.32, 0.770.32-1.11-2.76, 0.530.18model 2-0.77-2.25, 0.700.30-1.08-2.77, 0.620.21model 3-1.00-2.40, 0.390.16-1.00-2.47, 0.460.18model 4-0.99-2.34, 0.360.15-1.11-2.66, 0.440.16\n\ndiscussion\nOUR STUDY FAILS to SUPPORT the HYPOTHESIS that low levels of Vitamin D during Pregnancy are a risk FACTOR for adhd in the offspring.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 465), ('PROBLEM_COMPLICATION', 475), ('INCOMPLETE_EVIDENCE', 484), ('INCOMPLETE_EVIDENCE', 496), ('SUPERFICIAL_RELATIONSHIP', 564)]	5	[('GO_0007567', 'parturition', 83, 'birth'), ('GO_0007567', 'parturition', 120, 'birth'), ('GO_0007567', 'parturition', 178, 'born'), ('CHEBI_27300', 'vitamin D', 526, 'vitamin D'), ('GO_0007565', 'female pregnancy', 543, 'pregnancy')]
PMC4624803	10/2015	S107-PMC4624803	['such lifestyle FACTORS COULD lead to lower levels of Vitamin D.\n\nlimitations\nTHIS is a medium- sized STUDY and a WEAK ASSOCIATION with the risk of developing adhd with Vitamin D deficiency COULD NOT BE EXCLUDED.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4632418	10/2015	S1-PMC4632418	['thus, we FOCUSED on EVALUATING the ASSOCIATION of Vitamin D deficiency with gdm by conducting a meta-analysis of observed studies.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4632418	10/2015	S25-PMC4632418	['THEREFORE, we CONDUCTED THIS meta-analysis to present the EFFECT of maternal Vitamin D level on gdm.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4632418	10/2015	S111-PMC4632418	['OUR FINDINGS for increased risk of Gestational diabetes with Vitamin D deficiency are biologically PLAUSIBLE.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 99)]	2	[('GO_0007565', 'female pregnancy', 35, 'gestational'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4632418	10/2015	S132-PMC4632418	['conclusions\nin CONCLUSION, the EVIDENCE from THIS ARTICLE INDICATES a CONSISTENT ASSOCIATION between Vitamin D deficiency and an INCREASED RISK of Gestational diabetes mellitus.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 129)]	7	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'gestational')]
PMC4934634	11/2015	S6-PMC4934634	['the EFFECT of Vitamin D supplementation during Pregnancy and early Life on maternal and infant outcomes will be of particular FOCUS in this review.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 126)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('UBERON_0000104', 'life cycle', 67, 'life')]
PMC4934634	11/2015	S19-PMC4934634	['rickets will not be discussed in this review (readers are referred to a review on this topic by elder and bishop, 2014 [5]) as this paper is FOCUSED on RECENT LITERATURE regarding the IMPORTANCE of maternal Vitamin D status on Pregnancy and infant outcomes, with an EMPHASIS on supplementation trials.healthcare-03-01097-t001_table 1\n\ncaption (table-wrap): table 1\n\ndesignation of Vitamin D status based on circulating Vitamin D levels by the u.s. institute of medicine (iom) and the Endocrine society.Vitamin D statusiomendocrine societydeficiency<12 ng/ml (30 nmol/l)<20 ng/ml (50 nmol/l)insufficiency12–20 ng/ml (30–50 nmol/l)21–29 ng/ml (52.5–72.5 nmol/l)sufficiency>20 ng/ml (50 nmol/l)>30 ng/ml (75 nmol/l)toxicity>50 ng/ml (125 nmol/l)>150 ng/ml (375 nmol/l)\n\n2.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 141), ('INCOMPLETE_EVIDENCE', 152), ('IMPORTANT_CONSIDERATION', 184), ('IMPORTANT_CONSIDERATION', 266)]	4	[('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('GO_0007565', 'female pregnancy', 227, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 484, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 502, 'Vitamin D')]
PMC4934634	11/2015	S47-PMC4934634	['THE CURRENT REVIEW is FOCUSED on the EFFECTS of Vitamin D on numerous aspects of Reproduction including Male and Female Fertility, Pregnancy, and infant outcomes as well as childhood and Adult disease (figure 1).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 37)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0000003', 'reproduction', 81, 'reproduction'), ('GO_0007618', 'mating', 104, 'male ...'), ('GO_0007567', 'parturition', 113, 'female fertility'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('UBERON_0007023', 'adult organism', 187, 'adult')]
PMC4934634	11/2015	S94-PMC4934634	['these data FURTHER ILLUSTRATE HOW DIFFERENT cut-offs used by the iom vs. endocrine society for defining Vitamin D status (table 1) INFLUENCES the reporting of Vitamin D deficiency PREVALENCE in the population.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 131), ('IMPORTANT_CONSIDERATION', 180)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4934634	11/2015	S126-PMC4934634	[', INVESTIGATED the EFFECTS of Vitamin D co-supplemented with Calcium on Metabolic parameters in women diagnosed with Gestational diabetes starting in their 24th–28th week of Gestation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 2), ('SUPERFICIAL_RELATIONSHIP', 19)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 61, 'calcium'), ('GO_0008152', 'metabolic process', 72, 'metabolic'), ('GO_0007565', 'female pregnancy', 117, 'gestational'), ('GO_0007565', 'female pregnancy', 174, 'gestation')]
PMC4934634	11/2015	S129-PMC4934634	['IN AGREEMENT WITH ANOTHER STUDY by the same group [45], Vitamin D plus calcium supplementation improved fasting Plasma Glucose, serum Insulin, homa-ir, hdl, and ldl in women with Gestational diabetes compared TO placebo.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 209)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 112, 'plasma'), ('CHEBI_17234', 'glucose', 119, 'glucose'), ('PR_000045358', 'insulin family protein', 134, 'insulin'), ('GO_0007565', 'female pregnancy', 179, 'gestational')]
PMC4934634	11/2015	S145-PMC4934634	[', INVESTIGATED the ASSOCIATION of circulating maternal 1,25(Oh)2D levels on Preeclampsia and the EFFECT of Vitamin D supplementation on Placental Cytokine Production in Rats [57].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 2), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_82784', 'PVP38-Ag NP', 55, '1,25(OH)2D'), ('GO_0007128', 'meiotic prophase I', 76, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0001987', 'placenta', 136, 'placental'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 146, 'cytokine production'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 169, 'rats')]
PMC4934634	11/2015	S149-PMC4934634	['TO INVESTIGATE the EFFECT of Vitamin D supplementation on Blood pressure and Circulating T Cells, the Rats induced by reduced Uterine perfusion pressure (rupp), a MODEL of preeclampsia, were administered Vitamin D2Or Vitamin D3On Gestation days 14–18 [57].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 163)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CL_0000080', 'circulating cell', 77, 'circulating'), ('CL_0000084', 'T cell', 89, 'T cells'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 102, 'rats'), ('UBERON_0000995', 'uterus', 126, 'uterine'), ('CHEBI_27329', 'xanthosine phosphate', 204, 'vitamin D2or'), ('PR_000017209', 'utrophin', 204, 'vitamin D2or'), ('CHEBI_63460', 'parkeol', 217, 'vitamin D3on'), ('PR_000017209', 'utrophin', 217, 'vitamin D3on'), ('GO_0007565', 'female pregnancy', 230, 'gestation')]
PMC4934634	11/2015	S180-PMC4934634	['if women PLAN to exclusively Breast Feed their baby, it is IMPORTANT for mothers to have adequate Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('IMPORTANT_CONSIDERATION', 59)]	2	[('GO_0007596', 'blood coagulation', 29, 'breast feed'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4934634	11/2015	S192-PMC4934634	['one randomized controlled trial INVESTIGATED the EFFECTS of Prenatal Vitamin D supplementation on Respiratory outcomes in children at three years of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('GO_0007565', 'female pregnancy', 60, 'prenatal'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 98, 'respiratory')]
PMC4934634	11/2015	S199-PMC4934634	['ALTHOUGH Cord Blood 25(Oh)D levels were significantly higher in the supplemented children compared TO the control group, ONLY a small percentage of offspring receiving daily Vitamin D (13%) or bolus Vitamin D (3%) had Cord Blood Vitamin D levels ≥ 50 nmol/l.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 99), ('ANOMALY_CURIOUS_FINDING', 121)]	3	[('UBERON_0009472', 'axilla', 9, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 20, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 218, 'cord'), ('UBERON_0000178', 'blood', 223, 'blood'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D')]
PMC4934634	11/2015	S207-PMC4934634	['it is anticipated that THIS STUDY will provide valuable NEW information on the EFFECTS of maternal Vitamin D status and offspring allergy/asthma outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('FULL_UNKNOWN', 56), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4934634	11/2015	S212-PMC4934634	['SINCE THE study LOOKED AT the number of visits RATHER than confirmed diagnosis of infection, THIS STUDY SUGGESTS infant Vitamin D supplementation in addition to Prenatal supplementation MIGHT be BENEFICIAL in reducing health care visits for acute Respiratory infections.']	[('PROBLEM_COMPLICATION', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('INCOMPLETE_EVIDENCE', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 93), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 186), ('SUPERFICIAL_RELATIONSHIP', 195)]	8	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'prenatal'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory')]
PMC4934634	11/2015	S253-PMC4934634	['also, studies powered TO DETERMINE the EFFECT of separate ethnic groups’ varying baseline Vitamin D levels on 25(Oh)D levels after different Vitamin D supplementation doses will provide more concrete INFORMATION for individualized RECOMMENDATIONS during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 200), ('FUTURE_WORK', 231)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 112, '(OH)D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy')]
PMC4934634	11/2015	S269-PMC4934634	[', designed a study TO DETERMINE an oral dosage of Vitamin D that would achieve a 25(Oh)D level of 75 nmol/l or greater in 97.5% of newborn, Breastfed infants by three months of age [93].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 19)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('GO_0007567', 'parturition', 140, 'breastfed')]
PMC4684854	12/2015	S2-PMC4684854	['THIS PAPER provides a brief review of POTENTIAL health outcomes RECENTLY LINKED to Gestational Vitamin D deficiency, including Preterm Birth, cesarean Delivery, and Gestational diabetes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 73)]	4	[('GO_0007565', 'female pregnancy', 83, 'gestational'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'preterm birth'), ('GO_0007567', 'parturition', 151, 'delivery'), ('GO_0007565', 'female pregnancy', 165, 'gestational')]
PMC4684854	12/2015	S39-PMC4684854	['THIS PAPER is DESIGNED to review the literature FINDINGS about the enduring IMPACT of Gestational Vitamin D sufficiency on Maternal and pediatric health and Well-Being.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('GO_0007565', 'female pregnancy', 86, 'gestational'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007618', 'mating', 123, 'maternal'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 157, 'well-being')]
PMC4684854	12/2015	S84-PMC4684854	['obesity presents a CONFOUNDING INFLUENCE in THIS discussion, however, AS a greater bmi is ASSOCIATED with lower Vitamin D levels as well as greater Insulin resistance and risk for Gestational diabetes.']	[('PROBLEM_COMPLICATION', 19), ('SUPERFICIAL_RELATIONSHIP', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 90)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('PR_000045358', 'insulin family protein', 148, 'insulin'), ('GO_0007565', 'female pregnancy', 180, 'gestational')]
PMC4684854	12/2015	S110-PMC4684854	['a RECENT body of work has begun TO SUGGEST that lower Gestational Vitamin D levels MAY also be ASSOCIATED with higher rates of pediatric atopic disease [77], food sensitivities [78], atopic dermatitis [79], eczema [80], asthma [81], impaired Lung function [82], allergic disease [83], and other conditions frequently characterized by a hypersensitive Immune state.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 95)]	5	[('GO_0007565', 'female pregnancy', 54, 'gestational'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0002048', 'lung', 242, 'lung'), ('UBERON_0002405', 'immune system', 351, 'immune')]
PMC4684854	12/2015	S132-PMC4684854	['it is APPARENT that training is REQUIRED to establish clinical competency in (i) understanding of the ROLE of various Nutrients in Human health, (ii) HOW TO ASSESS nutritional biochemistry in patients, and (iii) and HOW to intervene to secure Nutrient sufficiency for Individuals and population groups\nwith the MOUNTING EVIDENCE of several health sequelae ASSOCIATED with Gestational Vitamin D deficiency, the VALUE of Preconception education and care by health providers and PUBLIC HEALTH bodies to secure Vitamin D sufficiency throughout Gestation is EVIDENT.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 102), ('EXPLICIT_QUESTION', 150), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('EXPLICIT_QUESTION', 216), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 356), ('IMPORTANT_CONSIDERATION', 410), ('IMPORTANT_CONSIDERATION', 476), ('PROBABLE_UNDERSTANDING', 553)]	12	[('CHEBI_33284', 'nutrient', 118, 'nutrients'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('CHEBI_33284', 'nutrient', 243, 'nutrient'), ('NCBITaxon_1', 'root', 268, 'individuals'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('GO_0007565', 'female pregnancy', 419, 'preconception'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('GO_0007565', 'female pregnancy', 540, 'gestation')]
PMC4684854	12/2015	S136-PMC4684854	['one researcher has SUGGESTED that the dietary REQUIREMENT during Pregnancy and Lactation MAY actually be as high as 6000\u2009iu/day [108], BUT most researchers have concluded, with OUR CURRENT KNOWLEDGE, that a supplemental Vitamin D intake of 4000\u2009iu/day is OPTIMAL [30].']	[('INCOMPLETE_EVIDENCE', 19), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('INCOMPLETE_EVIDENCE', 181), ('FUTURE_WORK', 189), ('IMPORTANT_CONSIDERATION', 255)]	8	[('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('GO_0007595', 'lactation', 79, 'lactation'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC4689556	12/2015	S39-PMC4689556	['women were given instructions to swallow the tablets whole and to avoid other multivitamin supplements containing Vitamin D. this trial was CONDUCTED before national guidance on routinely providing advice on Vitamin D intake during Pregnancy was introduced in march 2008 [26].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 140)]	1	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('GO_0007565', 'female pregnancy', 232, 'pregnancy')]
PMC4689556	12/2015	S131-PMC4689556	['HERE we found no difference in the number of prescriptions issued for medicated skin creams (median 1.0 iqr 0.0, 2.0 combined Vitamin d versus 0.0 (0.0, 2.0) controls; p = 0.27) or wheezing Medications (median 0.0 iqr 0.0, 1.0 combined Vitamin D versus 0.0 (0.0, 0.0) controls; p = 0.42).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0)]	1	[('CHEBI_33229', 'vitamin (role)', 126, 'vitamin'), ('CHEBI_25441', 'mycothiols', 190, 'medications'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC4689556	12/2015	S141-PMC4689556	['discussion\nwe EVALUATED WHETHER two specific dosing regimens of Prenatal Vitamin D supplementation COULD reduce health care utilisation in the first three years of Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 99)]	3	[('GO_0007565', 'female pregnancy', 64, 'prenatal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0000104', 'life cycle', 164, 'life')]
PMC4690051	12/2015	S74-PMC4690051	['BASED ON supplemental studies of Vitamin D during Pregnancy, a 10 ng/ml increase in 25(Oh)D has resulted in a PROTECTIVE odds ratio for healthy Pregnancy outcomes [37]; THUS, we ASSESSED such EFFECTS on Cognitive and language scaled scores.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 110), ('PROBABLE_UNDERSTANDING', 169), ('QUESTION_ANSWERED_BY_THIS_WORK', 178), ('SUPERFICIAL_RELATIONSHIP', 192)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 84, '25(OH)D'), ('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0050890', 'cognition', 203, 'cognitive')]
PMC4691762	12/2015	S2-PMC4691762	['with the AIM of determining the clinical and cost-effectiveness of daily Vitamin D supplementation in breastfed infants from age 6–8\u2005weeks to 12\u2005months of age, we have started a double-blind, randomised, placebo-controlled trial of daily 400\u2005iu Vitamin D supplementation during the first year of Life, vitality.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9)]	1	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('UBERON_0000104', 'life cycle', 296, 'life')]
PMC4691762	12/2015	S20-PMC4691762	['objectives\nwith the ultimate GOAL of developing improved PUBLIC HEALTH GUIDELINES for Vitamin D supplementation of infants, we AIM TO DETERMINE IF Vitamin D supplementation in infants from 6 to 8\u2005weeks of age LEADS to a reduction in the following during the first year of Life:\nchallenge-proven Food allergy\nlower Respiratory infections\nFood sensitisation\ndoctor diagnosed eczema\nvitamin D deficiency\n\nmethods and analysis\n\ndesign\nvitality is a double-blind, randomised, placebo-controlled trial of Vitamin D supplementation during the first year of Life.']	[('IMPORTANT_CONSIDERATION', 29), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 71), ('FUTURE_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('SUPERFICIAL_RELATIONSHIP', 209)]	8	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0000104', 'life cycle', 272, 'life'), ('CHEBI_33290', 'food', 295, 'food'), ('UBERON_0001004', 'respiratory system', 314, 'respiratory'), ('CHEBI_33290', 'food', 337, 'Food'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 388, 'D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('UBERON_0000104', 'life cycle', 550, 'life')]
PMC4691762	12/2015	S111-PMC4691762	['furthermore we are uniquely placed internationally TO ASSESS the ROLE of Vitamin D in Early Life development since australia does not currently RECOMMEND universal infant Vitamin D supplementation and is one of the few countries where there is no routine fortification of the Food chain supply.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 65), ('FUTURE_WORK', 144)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001847', 'lobule of pinna', 86, 'early life'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_33290', 'food', 276, 'food')]
PMC4719746	1/2016	S0-PMC4719746	['Vitamin D deficiency and supplementation in Pregnancy in a multiethnic population-based cohort\n\nabstract\n\nbackground\nTO INVESTIGATE ethnic DIFFERENCES in Vitamin D levels during Pregnancy, assess RISK factors for Vitamin D deficiency and explore the EFFECT of Vitamin D supplementation in women with deficiency in early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('SUPERFICIAL_RELATIONSHIP', 196), ('SUPERFICIAL_RELATIONSHIP', 250)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy')]
PMC4719746	1/2016	S21-PMC4719746	['the AIMS of THIS PAPER were TO INVESTIGATE ethnic DIFFERENCES in Vitamin D levels during Pregnancy, ASSESS RISK FACTORS for Vitamin D deficiency and explore the EFFECT of Vitamin D supplementation in women identified with low values during early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 100), ('SUPERFICIAL_RELATIONSHIP', 107), ('SUPERFICIAL_RELATIONSHIP', 161)]	7	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 171, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 179, 'D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
PMC4719746	1/2016	S38-PMC4719746	['in THIS PAPER, Vitamin D deficiency was DEFINED AS 25(Oh) D <50\xa0nmol/l, and severe Vitamin D deficiency was DEFINED as 25(Oh) D <25\xa0nmol/l, IN ACCORDANCE WITH RELEVANT LITERATURE [20].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 48), ('PROBABLE_UNDERSTANDING', 108), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 159), ('INCOMPLETE_EVIDENCE', 168)]	7	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 121, '(OH) D')]
PMC4719746	1/2016	S63-PMC4719746	['explanatory linear regression models were performed TO ASSESS the relationship between ethnicity and the concentration of 25(Oh)D, both at inclusion and in Gestational week 28, accounting for the following POTENTIAL CONFOUNDING FACTORS: Gestational week, age, parity, season, education, Vitamin D supplements and pre-Pregnancy bmi.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('INCOMPLETE_EVIDENCE', 206), ('PROBLEM_COMPLICATION', 216)]	3	[('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 128, 'D'), ('GO_0007565', 'female pregnancy', 156, 'gestational'), ('GO_0007565', 'female pregnancy', 237, 'gestational'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('GO_0007565', 'female pregnancy', 317, 'pregnancy')]
PMC4719746	1/2016	S118-PMC4719746	['women with <37\xa0nmol/l at baseline were RECOMMENDED 20\xa0μg or 30\xa0μg Vitamin D daily\n\ndiscussion\n\nmain findings\nin THIS cohort study we FOUND a high prevalence of Vitamin D deficiency (<50\xa0nmol/l) in early Pregnancy among women from south asia, middle east and sub-saharan africa, and severe deficiency (<25\xa0nmol/l) was prevalent among women from these regions.']	[('FUTURE_WORK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('INCOMPLETE_EVIDENCE', 133)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC4719746	1/2016	S131-PMC4719746	['INTERPRETATION\nOUR FINDINGS are IN LINE WITH others CONFIRMING widespread Vitamin D deficiency during Pregnancy among ethnic minorities [2,3,11,23,24], although SOME STUDIES from northern europe have FOUND a comparatively higher prevalence and more SEVERE deficiency THAN observed in OUR STUDY [6,25].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 52), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 200), ('IMPORTANT_CONSIDERATION', 249), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 267), ('QUESTION_ANSWERED_BY_THIS_WORK', 284)]	9	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy')]
PMC4719746	1/2016	S132-PMC4719746	['RECENT STUDIES from the same part of oslo MAY have increased AWARENESS of Vitamin D deficiency among health personnel [26–28], which MAY have CONTRIBUTED to the SOMEWHAT lower prevalence of Vitamin D deficiency in ethnic minorities in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 61), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 161), ('QUESTION_ANSWERED_BY_THIS_WORK', 235)]	7	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC4729160	1/2016	S87-PMC4729160	['62(0.24–1.62)–\u2003general rural areas72840.94(0.42–2.13)–\u2003poor rural areas332383.48(1.72–7.03)a4.73(2.67–8.41)acollege or university\u2003no527802.03(1.07–3.85)a3.17 (1.51–6.67)a\u2003yes1236511income\u2003\u2009<\u200910,000141854.60(1.30–16.24)a4.91 (1.31–18.46)a\u200310,000–20,000223174.21(1.24–14.26)a4.33 (1.18–15.90)a\u200320,000–30,000254613.29(0.98–11.03)a3.64 (1.01–13.16)a\u2003\u2009>\u2009=30,000318211drinking\u2003yes201184.00(2.26–6.94)a3.10 (1.65–5.81)a\u2003no44102711smoking\u2003non-smoker without passive smoking2452911\u2003non-smoker with passive smoking315941.15(0.67–1.99)–\u2003smokers9229.02(3.75–21.67)a5.68 (2.23–14.49)agestational age\u2003first trimester1046111\u2003second trimester182743.03(1.38–6.66)a2.40(1.05–5.46)a\u2003third trimester364104.05(1.98–8.26)a2.82(1.34–5.93)a\nastatistically significant at 0.05 level of significance\n\ndiscussion\nOUR STUDY FIRST REPORTED about the Vitamin A nutritional status in a large group of chinese Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 786), ('INCOMPLETE_EVIDENCE', 796), ('INCOMPLETE_EVIDENCE', 802)]	3	[('CHEBI_27300', 'vitamin D', 821, 'vitamin A'), ('GO_0007565', 'female pregnancy', 878, 'pregnant')]
PMC4729160	1/2016	S94-PMC4729160	['in THE CURRENT STUDY, Pregnant women age and va status were negatively ASSOCIATED and the level of Vitamin A decreased with age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('GO_0007565', 'female pregnancy', 22, 'pregnant'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A')]
PMC4729160	1/2016	S100-PMC4729160	['the PRESENT STUDY SHOWED that Retinol concentrations of anemia and Pregnant women with Vitamin A supplements were higher than no anemia and Pregnant women without Vitamin A supplements.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 18)]	2	[('CHEBI_26536', 'retinoic acid', 30, 'retinol'), ('GO_0007565', 'female pregnancy', 67, 'pregnant'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin A'), ('GO_0007565', 'female pregnancy', 140, 'pregnant'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin A')]
PMC4729160	1/2016	S129-PMC4729160	['conclusions\nIN SUMMARY, THE CURRENT STUDY REPORTED the prevalence of Vitamin A among chinese Pregnant women and the prevalence of vad was 5.3\xa0%, which was a MILD PUBLIC-HEALTH ISSUE in china.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 42), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 162), ('IMPORTANT_CONSIDERATION', 176)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('GO_0007565', 'female pregnancy', 93, 'pregnant')]
PMC4764019	1/2016	S7-PMC4764019	['the barker HYPOTHESIS HAS BEEN ELABORATED and evaluated in several reviews,2–4BUT TO THE BEST OF MY KNOWLEDGE, there HAS BEEN NO ATTEMPT to evaluate the HYPOTHESIS specifically for Vitamin D. THUS, what i PROPOSE TO explore in THIS very brief REVIEW is the EVIDENCE RELATING UNRECOGNIZED, Perinatal Vitamin D inadequacy to increased risk of certain chronic diseases later in Life, that is, to ascertain WHETHER any such EFFECTS MIGHT be an instance of the “barker HYPOTHESIS.”\ni deliberately avoid use of labels such as “deficient” or “insufficient” in characterizing Vitamin D status, AS these terms are OFTEN LINKED to specific values for serum 25-Hydroxyvitamin D [25(Oh)D], about which there is considerable CONTROVERSY.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 153), ('PROBABLE_UNDERSTANDING', 192), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 243), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 266), ('INCOMPLETE_EVIDENCE', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('SUPERFICIAL_RELATIONSHIP', 420), ('INCOMPLETE_EVIDENCE', 428), ('INCOMPLETE_EVIDENCE', 464), ('PROBABLE_UNDERSTANDING', 586), ('PROBABLE_UNDERSTANDING', 605), ('SUPERFICIAL_RELATIONSHIP', 611), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 712)]	25	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('GO_0036268', 'swimming', 289, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 289, 'perinatal'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000104', 'life cycle', 375, 'life'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 647, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 668, '25(OH)D')]
PMC4764019	1/2016	S12-PMC4764019	['INSTEAD, where i FOCUS HERE is on the nonskeletal CONSEQUENCES both of untreated rickets and of lesser degrees of Vitamin D inadequacy, OFTEN not clinically apparent and occurring at critical periods during maturation, in some instances well before the Life Stages when rickets is typically manifest.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('PROBLEM_COMPLICATION', 50), ('PROBABLE_UNDERSTANDING', 136)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('UBERON_0000104', 'life cycle', 253, 'life stages')]
PMC4764019	1/2016	S37-PMC4764019	['schizophrenia\nmcgrath et al9have EVALUATED the ASSOCIATION between Vitamin D status at Birth and the development of schizophrenia later in Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 87, 'birth'), ('UBERON_0000104', 'life cycle', 139, 'life')]
PMC4764019	1/2016	S82-PMC4764019	['in closing, it would SEEM IMPORTANT TO EMPHASIZE that the LIKELY Vitamin D status values (and the corresponding daily intakes) ASSOCIATED with protection from the delayed outcomes DISCUSSED HERE are entirely physiological, not Pharmacological (ie, in the range of 40–60 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 21), ('IMPORTANT_CONSIDERATION', 26), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	6	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 227, 'pharmacological')]
PMC4764019	1/2016	S83-PMC4764019	['african nationals living under ancestral conditions exhibit Vitamin D status values in the middle of this range (ie, approximately 46 ng/ml).16\nin conclusion, WHILE one cannot say that the barker HYPOTHESIS HAS BEEN definitively ESTABLISHED for each of the delayed Vitamin D inadequacy outcomes DESCRIBED HERE, it would SEEM that the PRUDENT course, both for oneself as an Individual and for one’s patients and clients, is to assume the applicability of the HYPOTHESIS and, accordingly, to ensure a Vitamin D status approximating that of ancestral Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 295), ('QUESTION_ANSWERED_BY_THIS_WORK', 305), ('ANOMALY_CURIOUS_FINDING', 320), ('FUTURE_WORK', 334), ('INCOMPLETE_EVIDENCE', 458)]	9	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('NCBITaxon_1', 'root', 373, 'individual'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 548, 'humans')]
PMC4770602	1/2016	S1-PMC4770602	['the AIM of the PRESENT STUDY was TO INVESTIGATE the ASSOCIATION between Vitamin D supplement and Preeclampsia in Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 97, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 113, 'pregnant')]
PMC4770602	1/2016	S26-PMC4770602	['THUS, THIS STUDY was AIMED TO EXAMINE the IMPACT of Vitamin D supplementation in reduction of RISK of Preeclampsia in nulliparous women in a randomized controlled trial.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 94)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 102, 'preeclampsia')]
PMC4770602	1/2016	S58-PMC4770602	['cases included 68 pregnant women who received supplementation contain Vitamin D (600 iu/d) and control group included 70 pregnant women who received supplementation without Vitamin D. differences between both groups were not statistically significant ( p -value = 0.84)\n\ndiscussion\nEVIDENCE TO EVALUATE the effectiveness of Vitamin D in Pregnancy is no enough and much of what we KNOW comes from observational RATHER than experimental design, THEREFORE, AT PRESENT Vitamin D supplementation is NOT routinely offered to all pregnant women.']	[('INCOMPLETE_EVIDENCE', 282), ('QUESTION_ANSWERED_BY_THIS_WORK', 291), ('INCOMPLETE_EVIDENCE', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 410), ('PROBABLE_UNDERSTANDING', 443), ('INCOMPLETE_EVIDENCE', 454), ('ANOMALY_CURIOUS_FINDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D'), ('GO_0007565', 'female pregnancy', 337, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D')]
PMC4770602	1/2016	S59-PMC4770602	['[19] in the PRESENT STUDY, we ASSESSED the EFFECT of Vitamin D supplementation in reduction of risk of Preeclampsia in nulliparous women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 103, 'preeclampsia')]
PMC4770602	1/2016	S70-PMC4770602	['[23] in the PRESENT STUDY infant Birth weight in women who received Vitamin D supplementation, was significantly more than control group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12)]	1	[('GO_0007567', 'parturition', 33, 'birth'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4770602	1/2016	S72-PMC4770602	['authors in THIS STUDY SHOWED that the Birth weights of infants Born to women with low milk consumption, observed AS those least LIKELY to consume a daily Vitamin D Intake of 200 iu, was lower compared with those Born to women who did not limit their Consumption of milk.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 113), ('PROBABLE_UNDERSTANDING', 128)]	4	[('GO_0007567', 'parturition', 38, 'birth'), ('GO_0007567', 'parturition', 63, 'born'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007631', 'feeding behavior', 164, 'intake'), ('GO_0007567', 'parturition', 212, 'born'), ('GO_0007631', 'feeding behavior', 250, 'consumption')]
PMC4770602	1/2016	S76-PMC4770602	['level of calcium in studied women was an IMPORTANT unmeasured covariate in OUR STUDY, WHEREAS, low calcium intake MAY BE ASSOCIATED with Vitamin D deficiency and MAY be a RISK FACTOR for Preeclampsia.']	[('IMPORTANT_CONSIDERATION', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 121), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 171)]	7	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 187, 'preeclampsia')]
PMC4770602	1/2016	S79-PMC4770602	['in CONCLUSION, results of the PRESENT STUDY DEMONSTRATED that Vitamin D supplementation during the third Trimester of Pregnancy; reduce the RISK of Preeclampsia HOWEVER, this was not statistically significant.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 44), ('IMPORTANT_CONSIDERATION', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 161)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 105, 'trimester'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 148, 'preeclampsia')]
PMC5115165	1/2016	S14-PMC5115165	['introduction\npotatoes are the third most commonly Consumed Food crop in the world, after rice and wheat.1in the united states, about 35% of women of Reproductive Age (that is, aged 19-50) Consume potatoes daily, accounting FOR 8% of daily total energy intake.2the health EFFECTS of potatoes are INCONCLUSIVE,13and there HAVE BEEN longstanding DEBATES on the appropriate placement of potatoes in dietary guidance.456nonetheless, the dietary guidelines for americans continue to include potatoes in the vegetable Food group and encourage Consumption.7THOUGH potatoes are rich in Vitamin C, Potassium, dietary fiber, and some Phytochemicals,6unlike other vegetables they CAN have DETRIMENTAL EFFECTS on Glucose Metabolism because they contain large amounts of rapidly absorbable Starch.3indeed, SEVERAL epidemiologic STUDIES have LINKED higher potato Consumption to increased concentrations of fasting Plasma Glucose,8insulin resistance,8and an increased risk of type 2 diabetes mellitus.910\nGestational diabetes mellitus (gdm) is a common COMPLICATION of Pregnancy characterized by Glucose intolerance with onset or first recognition during Pregnancy.11gdm is not only ASSOCIATED with adverse Perinatal outcomes,12it is also RELATED to increased long term Cardiometabolic risk in both mothers and their offspring.1113it is THEREFORE CRUCIAL to identify modifiable RISK FACTORS that COULD CONTRIBUTE to the PREVENTION of gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 223), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 320), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('ANOMALY_CURIOUS_FINDING', 548), ('INCOMPLETE_EVIDENCE', 668), ('IMPORTANT_CONSIDERATION', 677), ('SUPERFICIAL_RELATIONSHIP', 689), ('INCOMPLETE_EVIDENCE', 792), ('SUPERFICIAL_RELATIONSHIP', 827), ('PROBLEM_COMPLICATION', 1037), ('SUPERFICIAL_RELATIONSHIP', 1167), ('SUPERFICIAL_RELATIONSHIP', 1223), ('PROBABLE_UNDERSTANDING', 1321), ('IMPORTANT_CONSIDERATION', 1331), ('SUPERFICIAL_RELATIONSHIP', 1362), ('INCOMPLETE_EVIDENCE', 1380), ('SUPERFICIAL_RELATIONSHIP', 1386), ('SUPERFICIAL_RELATIONSHIP', 1404)]	20	[('GO_0007631', 'feeding behavior', 50, 'consumed'), ('CHEBI_33290', 'food', 59, 'food'), ('GO_0000003', 'reproduction', 149, 'reproductive age'), ('GO_0007631', 'feeding behavior', 188, 'consume'), ('CHEBI_33290', 'food', 511, 'food'), ('GO_0007631', 'feeding behavior', 536, 'consumption'), ('CHEBI_27300', 'vitamin D', 577, 'vitamin C'), ('CHEBI_22314', 'alkali metal atom', 588, 'potassium'), ('CHEBI_26254', 'prenylnaphthoquinone', 623, 'phytochemicals'), ('CHEBI_17234', 'glucose', 700, 'glucose'), ('GO_0006006', 'glucose metabolic process', 700, 'glucose metabolism'), ('CHEBI_28017', 'starch', 776, 'starch'), ('GO_0007631', 'feeding behavior', 848, 'consumption'), ('UBERON_0001969', 'blood plasma', 899, 'plasma'), ('CHEBI_17234', 'glucose', 906, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('GO_0007565', 'female pregnancy', 1053, 'pregnancy'), ('CHEBI_17234', 'glucose', 1080, 'glucose'), ('GO_0007565', 'female pregnancy', 1139, 'pregnancy'), ('GO_0036268', 'swimming', 1191, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1191, 'perinatal'), ('GO_0007599', 'hemostasis', 1254, 'cardiometabolic')]
PMC4778858	3/2016	S100-PMC4778858	['HOWEVER, CAUTION for too much Vitamin D supplementation SHOULD BE raised AS ONE STUDY DETERMINED higher concentrations of neonatal 25-Ohd are POSSIBLY ASSOCIATED with an elevated risk of becoming overweight in Adult Life [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 56), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 131, '25-OHD'), ('UBERON_0000113', 'post-juvenile adult stage', 210, 'adult life')]
PMC4778858	3/2016	S101-PMC4778858	['the results of THIS STUDY INDICATE that mothers with higher bmi are AT RISK for lower Vitamin D levels, and CONSEQUENTLY, lower Vitamin D levels in their neonates.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC4778858	3/2016	S124-PMC4778858	['a MAJOR strength of THIS PLANNED STUDY was its design to reduce POTENTIAL CONFOUNDERS of ASSOCIATIONS between maternal and Cord Blood Vitamin D levels and maternal bmi.']	[('IMPORTANT_CONSIDERATION', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 64), ('PROBLEM_COMPLICATION', 74), ('SUPERFICIAL_RELATIONSHIP', 89)]	6	[('UBERON_0002240', 'spinal cord', 123, 'cord'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC4784858	3/2016	S61-PMC4784858	['in this STUDY, the updated pandiet score for the french sample was composed of 27 probabilities of adequacy (protein, total Carbohydrate, dietary fibre, total fat, la, ala, dha, epa+Dha, Vitamin A, Thiamin, riboflavin, Niacin, Pantothenic Acid, Vitamin B6, Folate, Vitamin B12, Vitamin C, Vitamin D, Vitamin E, calcium, Iodine, iron, magnesium, Phosphorus, Potassium, Selenium and zinc) in the as and of seven probabilities of adequacy (protein, total Carbohydrate, Free Sugars, total fat, Saturated Fatty Acids, Cholesterol and Sodium) plus 14 POTENTIAL penalties (Retinol, niacin, Vitamin B6, Folate, Vitamin C, Vitamin D, Vitamin E, Calcium, Iodine, iron, magnesium, Phosphorus, Selenium and zinc) in the ms.\ndietary reference values used to calculate the pandiet for the french sample were those emitted by the french agency for Food, environmental and occupational health (anses), (s1 table) [25,26], except for iron for which the probability of adequacy was determined using values published by the institute of medicine [27,28].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 545)]	2	[('CHEBI_16730', 'chloramphenicol 3-acetate', 124, 'carbohydrate'), ('CHEBI_17874', 'dihydrozeatin', 182, 'DHA'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin A'), ('CHEBI_26948', 'vitamin B1', 198, 'thiamin'), ('CHEBI_7542', 'neurotensin', 219, 'niacin'), ('CHEBI_7916', 'pantothenic acid', 227, 'pantothenic acid'), ('CHEBI_33237', 'vitamin D4', 245, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 257, 'folate'), ('CHEBI_33279', 'vitamin D5', 265, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin E'), ('CHEBI_24859', 'iodine atom', 320, 'iodine'), ('CHEBI_35885', 'secondary phosphine', 345, 'phosphorus'), ('CHEBI_22314', 'alkali metal atom', 357, 'potassium'), ('CHEBI_27568', 'selenium atom', 368, 'selenium'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 452, 'carbohydrate'), ('CHEBI_37958', 'dye', 466, 'free'), ('CHEBI_26822', 'sulfide', 471, 'sugars'), ('CHEBI_26604', 'santonin', 490, 'saturated fatty acids'), ('CHEBI_16113', 'cholesterol', 513, 'cholesterol'), ('CHEBI_52632', 'potassium-39 atom', 529, 'sodium'), ('CHEBI_26536', 'retinoic acid', 566, 'retinol'), ('CHEBI_33237', 'vitamin D4', 583, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 595, 'folate'), ('CHEBI_27300', 'vitamin D', 603, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 614, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 625, 'vitamin E'), ('CHEBI_22313', 'alkaline earth metal atom', 636, 'calcium'), ('CHEBI_24859', 'iodine atom', 645, 'iodine'), ('CHEBI_35885', 'secondary phosphine', 670, 'phosphorus'), ('CHEBI_27568', 'selenium atom', 682, 'selenium'), ('CHEBI_33290', 'food', 833, 'Food')]
PMC4784858	3/2016	S67-PMC4784858	['in THIS STUDY, the updated pandiet score for the us population was composed of 25 probabilities of adequacy in the as (protein, total Carbohydrate, total fat, la, ala, dha, epa+dha, dietary fibre, Vitamin A, Thiamin, riboflavin, niacin, Vitamin B6, Folate, Vitamin B12, Vitamin C, Vitamin D and Vitamin E, calcium, iron, magnesium, Phosphorus, Potassium, Selenium and zinc) and five probabilities of adequacy (total Carbohydrate, total fat, saturated Fatty Acids, Cholesterol and Sodium) plus 12 POTENTIAL penalties (Retinol, niacin, Vitamin B6, Folate, Vitamin C, Vitamin D and Vitamin E, calcium, iron, Phosphorus, Selenium and zinc) in the ms.\ndietary reference intakes used to calculate the pandiet for the us population were those given by the institute of medicine (s2 table) [27,28], except for Dha and Epa+Dha.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 496)]	2	[('CHEBI_16730', 'chloramphenicol 3-acetate', 134, 'carbohydrate'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin A'), ('CHEBI_26948', 'vitamin B1', 208, 'thiamin'), ('CHEBI_33237', 'vitamin D4', 237, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 249, 'folate'), ('CHEBI_33279', 'vitamin D5', 257, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin E'), ('CHEBI_35885', 'secondary phosphine', 332, 'phosphorus'), ('CHEBI_22314', 'alkali metal atom', 344, 'potassium'), ('CHEBI_27568', 'selenium atom', 355, 'selenium'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 416, 'carbohydrate'), ('CHEBI_35366', 'fatty acid', 451, 'fatty acids'), ('CHEBI_16113', 'cholesterol', 464, 'cholesterol'), ('CHEBI_52632', 'potassium-39 atom', 480, 'sodium'), ('CHEBI_26536', 'retinoic acid', 517, 'retinol'), ('CHEBI_33237', 'vitamin D4', 534, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 546, 'folate'), ('CHEBI_27300', 'vitamin D', 554, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 579, 'vitamin E'), ('CHEBI_35885', 'secondary phosphine', 605, 'phosphorus'), ('CHEBI_27568', 'selenium atom', 617, 'selenium'), ('CHEBI_17874', 'dihydrozeatin', 802, 'DHA'), ('CHEBI_34733', 'EPN', 810, 'EPA'), ('CHEBI_17874', 'dihydrozeatin', 814, 'DHA')]
PMC4785305	3/2016	S16-PMC4785305	['caption (boxed-text)\nstrengths and limitations of this study\n\nTHIS is the FIRST randomised controlled trial (rct) in the middle east directly addressing the applicability of the institute of medicine RECOMMENDATIONS in this specific population, and assessing the EFFECT of Vitamin D supplementation on neonatal bone Mineral content.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('INCOMPLETE_EVIDENCE', 74), ('FUTURE_WORK', 200), ('SUPERFICIAL_RELATIONSHIP', 263)]	4	[('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_46662', 'mineral', 316, 'mineral')]
PMC4785305	3/2016	S24-PMC4785305	["ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially."]	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
PMC4785305	3/2016	S35-PMC4785305	['these latter studies AIM at assessing the EFFECT of Vitamin D supplementation on offspring calcium status, maternal and infant Vitamin D status and bone status (by quantitative ultrasound) at 1\u2005year.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4785305	3/2016	S38-PMC4785305	['they ASSESSED the EFFECT of various doses of Vitamin D on the 25(Oh)D level, Immune function and Periodontal disease.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 18)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('UBERON_0002405', 'immune system', 77, 'immune'), ('UBERON_0001758', 'periodontium', 97, 'periodontal')]
PMC4785305	3/2016	S40-PMC4785305	['objectives\nthe two primary OBJECTIVES of this trial, comparing the effect of high-dose versus low-dose Vitamin D, are as follows:\nthe proportion of women who will reach the iom defined desirable 25(Oh)D level ≥50\u2005nmol/l at Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27)]	1	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 195, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 195, '25(OH)D'), ('GO_0007567', 'parturition', 223, 'delivery')]
PMC4785305	3/2016	S42-PMC4785305	['the secondary OBJECTIVES are to compare the EFFECT of high-dose versus low-dose Vitamin D on:\nmaternal outcomes:\nmean maternal 25(Oh)D level at Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('PR_000011594', 'inositol polyphosphate 5-phosphatase OCRL', 130, 'OH ...'), ('GO_0007567', 'parturition', 144, 'delivery')]
PMC4785305	3/2016	S169-PMC4785305	['we will conduct this rct TO TEST the IMPACT of two different doses of Vitamin D replacement on clinically RELEVANT maternal and neonatal outcomes in middle eastern women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 106)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC4811107	3/2016	S97-PMC4811107	['EXAMINED WHETHER Prepregnancy obesity PREDICTED POOR Vitamin D status in neonates in their study of 400 women in pittsburgh, pennsylvania [7].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 48)]	4	[('GO_0007565', 'female pregnancy', 17, 'prepregnancy'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
PMC4811441	3/2016	S39-PMC4811441	['the primary outcome of the study was TO INVESTIGATE the ASSOCIATION between Vitamin D status and hypertensive disorders in Pregnancy and pe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy')]
PMC4843009	4/2016	S120-PMC4843009	['the present OBSERVATIONS underscore the powerful direct or indirect INFLUENCE of 1,25(Oh)2D3On the Brain, which PRESUMABLY accounts FOR the various Cerebral EFFECTS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 112), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('CHEBI_37958', 'dye', 81, '1,'), ('CHEBI_35448', '1,2-phenylene group', 83, '25(OH)2D3on'), ('UBERON_0000955', 'brain', 99, 'brain'), ('UBERON_0001893', 'telencephalon', 148, 'cerebral'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4896250	4/2016	S3005-PMC4896250	['the PRESENT STUDY AIMED TO EXAMINE the regional DIFFERENCES in incidence of Food-induced anaphylaxis (fia) and Serum Vitamin D level in korea.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48)]	4	[('CHEBI_33290', 'food', 76, 'food'), ('UBERON_0001977', 'blood serum', 111, 'serum'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC4896250	4/2016	S3009-PMC4896250	['we EXAMINED the differences in incidence of fia and Serum Vitamin D levels between 2 regions after adjusting for age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	1	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4896250	4/2016	S3551-PMC4896250	['objectives\nTHIS STUDY AIMED TO DETERMINE the prevalence of Vitamin D deficiency in exclusively Breastfed infants and TO EVALUATE its RELATIONSHIP between pth in this population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 133)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007567', 'parturition', 95, 'breastfed')]
PMC4896250	4/2016	S3696-PMC4896250	['THIS STUDY SOUGHT TO EVALUATE WHETHER Genetic variants in the Vitamin D pathway-related Genes are ASSOCIATED with allergic rhinitis in a han chinese population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('SO_0000704', 'gene', 38, 'genetic'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007601', 'visual perception', 62, 'vitamin D'), ('SO_0000704', 'gene', 88, 'genes')]
PMC4896250	4/2016	S4151-PMC4896250	['we INVESTIGATED the ASSOCIATION between Vitamin D levels and hdm sensitization ACCORDING TO ad severity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4896250	4/2016	S4159-PMC4896250	['conclusions: our results DEMONSTRATE that low Vitamin D levels MAY LINK to high hdm sensitization in patients with the SEVERE ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('IMPORTANT_CONSIDERATION', 119)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC4896250	4/2016	S4485-PMC4896250	['the PURPOSE of THIS STUDY was TO EXAMINE the ASSOCIATION of Serum Vitamin D levels with the prevalence of pediatric asthma in korea.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('UBERON_0001977', 'blood serum', 60, 'serum'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4896250	4/2016	S4488-PMC4896250	['moreover, the RELATIONSHIP between Serum 25-Oh Vitamin D levels and Pulmonary function test and environmental FACTORS for sunshine were EXAMINED in asthmatic patients.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 110), ('QUESTION_ANSWERED_BY_THIS_WORK', 136)]	3	[('UBERON_0001977', 'blood serum', 35, 'serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 41, '25-OH'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002048', 'lung', 68, 'pulmonary')]
PMC4896250	4/2016	S4493-PMC4896250	['for PREVENTION and treatment of asthma, an intervention study in asthmatic children with low serum Vitamin D level, and a Vitamin D study ASSESSED the OPTIMAL delivery and safety of its supplementation IS NEEDED.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 138), ('IMPORTANT_CONSIDERATION', 151), ('FUTURE_WORK', 202)]	4	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4896250	4/2016	S5531-PMC4896250	['in the medical professional institute metylovice located 410 meters above sea level found in štramberk highlands during a 4-week stay for treatment with Vitamin D, we INVESTIGATED the EFFECT of climate on the parameters of bronchial asthma and changes of physical parameters by modified cooperœ test in asthmatic children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('SUPERFICIAL_RELATIONSHIP', 184)]	2	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4896250	4/2016	S5537-PMC4896250	['c) results\nthe object was TO EVALUATE the EFFECTIVENESS and benefits of long term stay for asthmatic children after the continuous treatment with Vitamin D and physical exercises.the evaluation was done by the comparison of laboratory examination of Blood and physical parameters in the beginning of the stay and in the end of the stay.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('UBERON_0000178', 'blood', 250, 'blood')]
PMC4896250	4/2016	S5545-PMC4896250	['vitamin a, Vitamin D, Vitamin E, Folic Acid and Vitamin B12 levels were INVESTIGATED.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 72)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('CHEBI_30751', 'formic acid', 33, 'folic acid'), ('CHEBI_33279', 'vitamin D5', 48, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 56, 'B12')]
PMC4896250	4/2016	S6121-PMC4896250	['we AIMED to systematically review observational studies investigating the level of Vitamin D on the prevalence of the current allergic rhinitis (ar) and the development of ar.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC4896250	4/2016	S6211-PMC4896250	['a438 Vitamin D level and the CORRELATION with Ige in children with allergic Respiratory diseases in guangzhou china\n\nhuimin huang1, baoqing sun2, yun chen3, peiyan zheng2, nili wei1, wenting luo4\n\n1the first affiliated hospital of guangzhou medical university, china;2first affiliated hospital guangzhou medical university;3guangzhou yuexiu district maternal and child health care hospital;4first affiliated hospital of guangzhou medical university, guangzhou institute of respiratory diseases\n\ncorrespondence: huimin huang – the first affiliated hospital of guangzhou medical university, china\nobjective: TO EXPLORE the Vitamin D(vit D) level and analyse the CORRELATION with Immunoglobulin e (Ige) in children with allergic Respiratory diseases in guangzhou china.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 606), ('SUPERFICIAL_RELATIONSHIP', 660)]	3	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 46, 'IgE'), ('UBERON_0001004', 'respiratory system', 76, 'Respiratory'), ('CHEBI_27300', 'vitamin D', 621, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 635, 'D'), ('GO_0019814', 'immunoglobulin complex', 677, 'immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 695, 'IgE'), ('UBERON_0001004', 'respiratory system', 726, 'respiratory')]
PMC4896250	4/2016	S6528-PMC4896250	['we SOUGHT TO DETERMINE WHETHER the immunomodulatory properties of Vitamin D MIGHT have beneficial EFFECTS on crs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4896250	4/2016	S7523-PMC4896250	['the AIM of THIS STUDY was TO INVESTIGATE the ASSOCIATION between concentration of Serum Vitamin D levels and recent symptoms of allergic diseases in elementary schoolchildren.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC4896250	4/2016	S8292-PMC4896250	['objective\nwe AIMED TO INVESTIGATE WHETHER Vitamin D insufficiency in asthmatic Adults ASSOCIATES with atopy, poor asthma Control, and more frequent Respiratory Tract infections, and WHETHER these patients CAN BENEFIT from Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 209)]	7	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('GO_0065007', 'biological regulation', 121, 'control'), ('UBERON_0000065', 'respiratory tract', 148, 'respiratory tract'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]
PMC4896250	4/2016	S8300-PMC4896250	['these patients had poorer asthma Control as indicated by act scores, and had a significantly higher rate of allergic sensitization, compared TO the Vitamin D sufficient asthmatics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 141)]	1	[('GO_0065007', 'biological regulation', 33, 'control'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4896250	4/2016	S9520-PMC4896250	['Epidermal barrier injury and Dysregulatory of Immune System COULD BE induced by Vitamin D. the AIM of STUDY was TO REVEAL RELATION in between of Serum level of 25-hydroxyvitamin d with atopic dermatitis occurrence and severity in children.']	[('INCOMPLETE_EVIDENCE', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 122)]	6	[('UBERON_0007376', 'outer epithelium', 0, 'Epidermal'), ('GO_0007631', 'feeding behavior', 29, 'dysregulatory'), ('UBERON_0002405', 'immune system', 46, 'immune system'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 53, 'system'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum')]
PMC4998950	4/2016	S1-PMC4998950	['AIMS\nto clarify the RELATIONSHIP between maternal Vitamin D deficiency and offspring risk of asd with and without intellectual disability.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4998950	4/2016	S11-PMC4998950	['we report HERE on the RELATIONSHIP between secondary care diagnosis of lifetime maternal Vitamin D deficiency and offspring risk of asd with and without intellectual disability, while addressing the INFLUENCE of ethnicity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4998950	4/2016	S23-PMC4998950	['lastly, we EVALUATED WHETHER lifetime maternal Vitamin D deficiency was DIFFERENTLY ASSOCIATED with asd among children with and without maternal histories of migration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4998950	4/2016	S33-PMC4998950	['discussion\nTHIS STUDY is, TO OUR KNOWLEDGE, the FIRST population-based study to ESTIMATE the RELATIONSHIP between maternal Vitamin D deficiency and the RISK of asd in a child.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 152)]	6	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC5035678	4/2016	S9-PMC5035678	['conclusions\nALTHOUGH the high Vitamin D supplementation dose in the PRESENT STUDY (compared to the 400 iu/day dose USUALLY recommended for Pregnancy) SAFELY increases the Serum 25Ohd, in gdm cases, the higher dose does not affect the plasma Glucose level or Insulin resistance at short term follow-up after Delivery.']	[('ANOMALY_CURIOUS_FINDING', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('INCOMPLETE_EVIDENCE', 115), ('IMPORTANT_CONSIDERATION', 150)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'pregnancy'), ('UBERON_0001977', 'blood serum', 171, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD'), ('CHEBI_17234', 'glucose', 241, 'glucose'), ('PR_000045358', 'insulin family protein', 258, 'insulin'), ('GO_0007567', 'parturition', 307, 'delivery')]
PMC5035678	4/2016	S26-PMC5035678	['objectives\nwe THEREFORE SOUGHT TO EXPLORE the EFFECT of Vitamin D supplementation in women with gdm and hypovitaminosis D, both on post-Partum Glucose levels and Insulin resistance, in a randomized clinical trial.']	[('PROBABLE_UNDERSTANDING', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 120, 'D'), ('GO_0007567', 'parturition', 136, 'partum'), ('CHEBI_17234', 'glucose', 143, 'glucose'), ('PR_000045358', 'insulin family protein', 162, 'insulin')]
PMC5035678	4/2016	S109-PMC5035678	['discussion\nTO OUR KNOWLEDGE, THIS is the FIRST STUDY TO EVALUATE the EFFECTS of Vitamin D supplementation during Pregnancy on Glucose Metabolism shortly after Delivery.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 69)]	6	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_17234', 'glucose', 126, 'glucose'), ('GO_0006006', 'glucose metabolic process', 126, 'glucose metabolism'), ('GO_0007567', 'parturition', 159, 'delivery')]
PMC5035678	4/2016	S110-PMC5035678	['OUR STUDY DEMONSTRATES that high dose Vitamin D supplementation during Pregnancy in women with gdm and impairment of 25Ohd concentration has no effect on post-Partum Plasma Glucose and Insulin resistance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 117, '25OHD'), ('GO_0007567', 'parturition', 159, 'partum'), ('UBERON_0001969', 'blood plasma', 166, 'plasma'), ('CHEBI_17234', 'glucose', 173, 'glucose'), ('PR_000045358', 'insulin family protein', 185, 'insulin')]
PMC5035678	4/2016	S129-PMC5035678	['IN CONTRAST WITH OUR STUDY, in which all patients were evaluated for basal Vitamin D insufficiency or deficiency, the proportion of the patients with initial hypovitaminosis was not clarified in the asemi study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5035678	4/2016	S133-PMC5035678	['in OUR STUDY, over a median interval of 26 weeks between commencement of Vitamin D supplements and ogtt measurements, high dose Vitamin D LED TO maternal and neonatal 25Ohd level increases, but not to the predicted EFFECTS on Glucose level and Insulin resistance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 215)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 167, '25OHD'), ('CHEBI_17234', 'glucose', 226, 'glucose'), ('PR_000045358', 'insulin family protein', 244, 'insulin')]
PMC5035678	4/2016	S144-PMC5035678	['in THIS STUDY, application of a proper dose and duration of Vitamin D supplementation LED TO a rapid increase in 25Ohd, up to near 70 ng/ml, which was maintained for the duration of the study.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 113, '25OHD')]
PMC5035678	4/2016	S150-PMC5035678	['the study was DESIGNED to detect any EFFECTS of Vitamin D on Insulin resistance by allowing for adequate time between the start of supplementation and the measurement of outcomes, and with the FEWEST number of patients lost to follow up.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 193)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('PR_000045358', 'insulin family protein', 61, 'insulin')]
PMC5035678	4/2016	S160-PMC5035678	['IN SPITE of these LIMITATIONS, THIS is currently the ONLY study in the literature that evaluates the INFLUENCE of Vitamin D supplementation during Pregnancy on Postpartum dysglycemia.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy'), ('GO_0007565', 'female pregnancy', 160, 'postpartum')]
PMC4800340	5/2016	S13-PMC4800340	["we FOCUS on selective common Food Allergens (Peanuts and Tree nuts, Cow's Milk, and egg) and Nutrients (Vitamin D and n-3 Fatty Acids) that HAVE BEEN RATHER widely studied."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150)]	3	[('CHEBI_33290', 'food', 29, 'food'), ('CHEBI_33663', 'cyclic hydrocarbon', 34, 'allergens'), ('NCBITaxon_10088', 'Mus <genus>', 45, 'peanuts'), ('NCBITaxon_1', 'root', 57, 'tree'), ('NCBITaxon_33208', 'Metazoa', 68, 'cow'), ('UBERON_0001913', 'milk', 74, 'milk'), ('CHEBI_33284', 'nutrient', 93, 'nutrients'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_35366', 'fatty acid', 122, 'fatty acids')]
PMC4800340	5/2016	S25-PMC4800340	["THIS STUDY SUGGESTS that low sunlight and PRESUMABLY suboptimal Vitamin D status at Birth is ASSOCIATED with Food Allergy Development in childhood.30a large scale population-based study in australia SHOWED that infants with low Serum 25-Hydroxyvitamin (Oh) D3Levels (≤50 nmol/l) had almost 12 times and 4 times higher risk of developing Peanut and egg allergies, respectively, in the first year of Life THAN infants with adequate Serum Vitamin D level.31HOWEVER, ANOTHER STUDY conducted in germany DEMONSTRATED that 25(Oh)D3Concentration in Pregnant women's Serum and in Cord Blood were positively ASSOCIATED with increased risk of Food Allergy Development among children in the first 2 years.32a RECENT randomized double-blind controlled TRIAL SHOWED that maternal Vitamin D3Supplementation for 6 weeks during Lactation increased the risk of Food allergy diagnosis by 3.42 times [95% confidence interval (ci)=1.02–11.77] among children of supplementation group compared to control group by 2 years of age.33due to lack OF robustly designed studies, a causal ASSOCIATION between Vitamin D status during Prenatal and Neonatal Period and Food allergy Development In Children remains INCONCLUSIVE."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 452), ('INCOMPLETE_EVIDENCE', 463), ('INCOMPLETE_EVIDENCE', 498), ('SUPERFICIAL_RELATIONSHIP', 598), ('INCOMPLETE_EVIDENCE', 697), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 745), ('ANOMALY_CURIOUS_FINDING', 1020), ('SUPERFICIAL_RELATIONSHIP', 1059), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1181)]	16	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'birth'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0048467', 'gynoecium development', 109, 'food allergy development'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('CHEBI_60346', 'alpha-Kdo-(2->8)-alpha-Kdo-OAll', 234, '25-hydroxyvitamin (OH) D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'peanut'), ('UBERON_0000104', 'life cycle', 398, 'life'), ('UBERON_0001977', 'blood serum', 430, 'serum'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 516, '25(OH)D3concentration'), ('GO_0007565', 'female pregnancy', 541, 'pregnant'), ('UBERON_0001977', 'blood serum', 558, 'serum'), ('UBERON_0009472', 'axilla', 571, 'cord blood'), ('CHEBI_33290', 'food', 632, 'food'), ('GO_0048467', 'gynoecium development', 632, 'food allergy development'), ('CHEBI_52915', 'phosphatediyl group', 766, 'vitamin D3supplementation'), ('GO_0007595', 'lactation', 811, 'lactation'), ('CHEBI_33290', 'food', 843, 'food'), ('CHEBI_27300', 'vitamin D', 1079, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1103, 'prenatal'), ('UBERON_0007221', 'neonate stage', 1116, 'neonatal period'), ('CHEBI_33290', 'food', 1136, 'food'), ('GO_0030163', 'protein catabolic process', 1149, 'development in children')]
PMC4800340	5/2016	S56-PMC4800340	['THIS STUDY SHOWED that Prenatal Vitamin D-mediated epigenetic Regulation in Tslp increased the RISK of wheezing in children.77more Human STUDIES ARE NEEDED to substantiate the ROLE of epigenetic Regulation by Nutrients in the growing epidemic of Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 137), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0007565', 'female pregnancy', 23, 'prenatal'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'regulation'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 76, 'TSLP'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('GO_0065007', 'biological regulation', 195, 'regulation'), ('CHEBI_33284', 'nutrient', 209, 'nutrients'), ('CHEBI_33290', 'food', 246, 'food')]
PMC4859539	5/2016	S1-PMC4859539	['THIS STUDY SOUGHT TO DETERMINE IF circulating Cathelicidin concentrations in healthy children are RELATED to the age of the child, body composition and Vitamin D status at Birth and at the time of the study visit.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('PR_000006009', 'alpha-catulin', 46, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC4859539	5/2016	S10-PMC4859539	['the LACK OF association between Vitamin D status and Cathelicidin in THIS STUDY MAY BE DUE TO the NARROW RANGE in OBSERVED 25(Oh)D values and WARRANTS ADDITIONAL STUDIES for further observation.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 80), ('PROBLEM_COMPLICATION', 87), ('PROBLEM_COMPLICATION', 98), ('INCOMPLETE_EVIDENCE', 114), ('FUTURE_WORK', 142), ('FUTURE_WORK', 151)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 53, 'cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D')]
PMC4859539	5/2016	S14-PMC4859539	['additionally, WHILE ONE STUDY examined the levels of maternal and neonatal Vitamin D and Cathelicidin concentrations in healthy children at Delivery, there is a LACK OF research TO DETERMINE CORRELATIONS between Vitamin D status and cathelicidin among healthy children over time [20], as well as WHICH FACTORS such as age of the child, gender, and body composition MAY INDEPENDENTLY IMPACT Cathelicidin concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 161), ('QUESTION_ANSWERED_BY_THIS_WORK', 178), ('SUPERFICIAL_RELATIONSHIP', 191), ('EXPLICIT_QUESTION', 296), ('SUPERFICIAL_RELATIONSHIP', 302), ('INCOMPLETE_EVIDENCE', 365), ('SUPERFICIAL_RELATIONSHIP', 369), ('SUPERFICIAL_RELATIONSHIP', 383)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 89, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 89, 'cathelicidin'), ('GO_0007567', 'parturition', 140, 'delivery'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 390, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 390, 'cathelicidin')]
PMC4859539	5/2016	S15-PMC4859539	['to address this GAP in the literature, the AIM of THIS follow-up STUDY was TO DETERMINE IF maternal Vitamin D status during Pregnancy and/or a child’s current Vitamin D status AFFECT the circulating concentration of Cathelicidin in healthy children years after Delivery.']	[('FULL_UNKNOWN', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 216, 'cathelicidin'), ('GO_0007567', 'parturition', 261, 'delivery')]
PMC4859539	5/2016	S16-PMC4859539	['a second AIM was TO DETERMINE IF the concentration of cathelicidin and Vitamin D CORRELATE with the number of infections a child experiences during childhood and as a function of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4859539	5/2016	S47-PMC4859539	['four multivariable regressions were performed TO ASSESS WHETHER any significant ASSOCIATIONS existed between the natural logarithm of each subject’s cathelicidin concentration and each of the following Vitamin D measurements: (1) child’s current 25(Oh)D at time of follow-up, (2) child’s 25(Oh)d at Birth, (3) maternal 25(Oh)D throughout Pregnancy (visits 3 to 7 as area under the curve), and (4) maternal 25(Oh)D one month before Delivery; all analyses controlled for race/ethnicity, age, gender, and percent fat.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 246, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 246, '25(OH)D'), ('CHEBI_37972', 'phosphorus-32 atom', 288, '25'), ('CHEBI_17792', 'organohalogen compound', 291, 'OH'), ('GO_0007567', 'parturition', 299, 'birth'), ('CHEBI_71657', 'versiconol acetate', 319, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 319, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 338, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 406, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 406, '25(OH)D'), ('GO_0007567', 'parturition', 431, 'delivery')]
PMC4859539	5/2016	S97-PMC4859539	["in MODELS 1 and 4, there was also a TREND NOTED with the child’s percent fat being positively ASSOCIATED with Cathelicidin (beta = 0.028, p = 0.052 and beta = 0.025, p = 0.087).10.1371/journal.pone.0152711.t003\n\ncaption (table-wrap): table 3\nmultivariable linear regression models assessing factors associated with natural logarithm for Cathelicidin.model 1 \xa0\xa0independent variablesbetase1p valuerace/ethnicity\xa0\xa0black-0.0390.230.864white---------hispanic-0.1490.2000.459genderfemale---------male0.3180.16 0.047 age0.1450.065 0.028 percent fat0.0280.0140.052child's current 25(Oh)D-0.0050.010.598 model 2 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicityblack0.0350.210.868white---------hispanic-0.1490.210.470genderfemale---------male0.2750.170.104age0.2120.07 0.004 percent fat0.0250.020.087child's 25(Oh)D at Birth-0.0030.010.748 model 3 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0410.180.821white---------hispanic-0.1220.160.458genderfemale---------male0.0910.140.507age0.1550.07 0.023 percent fat0.0120.010.359maternal 25(Oh)D throughout Pregnancy<-0.000100.999 model 4 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0460.1990.816white---------hispanic-0.0800.1850.669genderfemale---------male0.3180.158 0.047 age0.1510.064 0.021 percent fat0.0260.010.069maternal 25(Oh)D 1-month before Delivery0.0030.010.606\n1se represents standard error\n\ndiscussion\nin THIS STUDY of healthy children whose mothers had participated in a Vitamin D supplementation trial during Pregnancy, DESPITE DIFFERENCES in both maternal and childhood Vitamin D status, there were no significant differences in Cathelicidin concentration between the three racial/ethnic groups studied."]	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 36), ('ANOMALY_CURIOUS_FINDING', 42), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 1391), ('ANOMALY_CURIOUS_FINDING', 1508), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1516)]	7	[('CHEBI_3364', 'Canthiumine', 110, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 110, 'cathelicidin'), ('CHEBI_3461', 'Casuarictin', 337, 'Cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 572, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 572, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 801, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 807, 'D'), ('GO_0007567', 'parturition', 812, 'birth'), ('CHEBI_71657', 'versiconol acetate', 1042, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1048, 'D'), ('GO_0007565', 'female pregnancy', 1061, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 1300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1300, '25(OH)D'), ('GO_0007567', 'parturition', 1323, 'delivery0'), ('CHEBI_27300', 'vitamin D', 1458, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1497, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1559, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 1618, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 1618, 'cathelicidin')]
PMC4859539	5/2016	S103-PMC4859539	['OF NOTE, most of the children in THIS STUDY were not Vitamin D deficient and the Vitamin D ranges were relatively narrow.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 33)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4889866	5/2016	S1-PMC4889866	['the AIM of THIS STUDY was TO INVESTIGATE the ROLE of maternal and Cord Blood Vitamin D level in tlr-RELATED Innate Immunity and its EFFECT on infectious outcome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 100), ('SUPERFICIAL_RELATIONSHIP', 132)]	6	[('UBERON_0002240', 'spinal cord', 66, 'cord'), ('UBERON_0000178', 'blood', 71, 'blood'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0045087', 'innate immune response', 108, 'innate immunity')]
PMC4889866	5/2016	S9-PMC4889866	['in CONCLUSION, OUR STUDY HAD SHOWN that maternal Vitamin D, BUT NOT cord Vitamin D level, was ASSOCIATED with Viral tlr-triggered Il-10 response.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 94)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('NCBITaxon_1', 'root', 110, 'viral'), ('PR_000001470', 'interleukin-28B', 130, 'IL-10')]
PMC4889866	5/2016	S21-PMC4889866	['because of the APPARENT IMPORTANCE of Vitamin D in Immune Development, we AIMED TO INVESTIGATE the EFFECT of maternal and/or cord Vitamin D level on tlr-triggered cytokine response in neonates at time of Birth and disease outcome in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 99)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0001822', 'kidney development', 51, 'immune development'), ('UBERON_0002405', 'immune system', 51, 'immune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007567', 'parturition', 204, 'birth')]
PMC4889866	5/2016	S23-PMC4889866	['in addition, we SOUGHT TO INVESTIGATE WHETHER maternal Blood and Cord Blood Vitamin D CORRESPOND in their ASSOCIATION with tlr-related Innate Immunity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('EXPLICIT_QUESTION', 38), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 106)]	6	[('UBERON_0000178', 'blood', 55, 'blood'), ('UBERON_0002240', 'spinal cord', 65, 'cord'), ('UBERON_0000178', 'blood', 70, 'blood'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0045087', 'innate immune response', 135, 'innate immunity')]
PMC4889866	5/2016	S84-PMC4889866	['analysis was made to INVESTIGATE WHETHER maternal or Cord Blood Vitamin D status was ASSOCIATED with Lower Respiratory Tract infection (bronchiolitis, pneumonia, and croup), infectious enteritis, and Urinary Tract infection at 1 year of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('UBERON_0002240', 'spinal cord', 53, 'cord'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0004905', 'articulation', 101, 'lower respiratory tract'), ('UBERON_0001553', 'medial tarsal artery', 200, 'urinary tract')]
PMC4889866	5/2016	S88-PMC4889866	['discussion\nthe result from OUR STUDY SHOWED that maternal, BUT NOT Cord Blood Vitamin D level, was ASSOCIATED with Tlr-3 and Tlr7-8 triggered il-10 response.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 99)]	4	[('UBERON_0002240', 'spinal cord', 67, 'cord'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('PR_000001959', 'tumor necrosis factor receptor superfamily member 1B', 115, 'TLR-3'), ('PR_000001155', 'Toll-like receptor 4', 125, 'TLR7')]
PMC4889866	5/2016	S89-PMC4889866	['TO OUR KNOWLEDGE, THIS is the FIRST cohort STUDY TO simultaneously ASSESS the EFFECT of both maternal and Cord Blood Vitamin D status on tlr-RELATED immune response and various infectious diseases during Infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 67), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 141)]	8	[('UBERON_0002240', 'spinal cord', 106, 'cord'), ('UBERON_0000178', 'blood', 111, 'blood'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007631', 'feeding behavior', 204, 'infancy')]
PMC4889866	5/2016	S92-PMC4889866	['our result SUGGESTED that the latter MIGHT be an IMPORTANT ISSUE to CONSIDER, BECAUSE DESPITE a strong CORRELATION between maternal and Cord Vitamin D level, OUR study had OBSERVED a distinction between maternal and cord Vitamin D status in their ASSOCIATION with tlr-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 49), ('PROBLEM_COMPLICATION', 59), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 68), ('PROBLEM_COMPLICATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 247)]	13	[('UBERON_0002240', 'spinal cord', 136, 'cord'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC4889866	5/2016	S102-PMC4889866	['the DIFFERENCE between OUR FINDINGS and those of published reports MIGHT BE EXPLAINED by distinctive study design, AS ours assessed cytokine response to tlr ligands under different Vitamin D concentrations, and not cytokine response to direct Vitamin D stimulation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 67), ('ANOMALY_CURIOUS_FINDING', 73), ('PROBABLE_UNDERSTANDING', 76), ('PROBABLE_UNDERSTANDING', 115)]	6	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4889866	5/2016	S108-PMC4889866	['SINCE one POTENTIAL source of Il-10 is Treg, it was SPECULATED that higher Vitamin D level would be ASSOCIATED with less Treg Cells to respond to tlr stimulation, THUS resulting in lower Il-10 response as SEEN in OUR STUDY.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 100), ('PROBABLE_UNDERSTANDING', 163), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213)]	7	[('PR_000001470', 'interleukin-28B', 30, 'IL-10'), ('CL_0000901', 'Tr1 cell', 39, 'Treg'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CL_0000960', 'T3 B cell', 121, 'Treg cells'), ('PR_000001470', 'interleukin-28B', 187, 'IL-10')]
PMC4889866	5/2016	S121-PMC4889866	['first, the predominantly low Serum level of 25(Oh)D in THIS STUDY has LIMITED our ability TO DETERMINE WHETHER there is an ASSOCIATION between higher concentration of Vitamin D and infection.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 70), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 123)]	5	[('UBERON_0001977', 'blood serum', 29, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC4889866	5/2016	S127-PMC4889866	['finally, ALTHOUGH PRESENT STUDY had OBSERVED an ASSOCIATION between Prenatal Vitamin D status and Viral tlrs-triggered response (Tlr3 and Tlr7/8, both of which recognize Viral rna), the EFFECT of Vitamin D on cpg Double Stranded dna motif (Tlr9) of the Viral Genome also DEMANDS FURTHER EXPLORATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 186), ('IMPORTANT_CONSIDERATION', 271), ('FUTURE_WORK', 279)]	7	[('GO_0007565', 'female pregnancy', 68, 'prenatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('NCBITaxon_1', 'root', 98, 'viral'), ('PR_000001155', 'Toll-like receptor 4', 129, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 138, 'TLR7'), ('NCBITaxon_1', 'root', 170, 'viral'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('SO_0000985', 'double', 213, 'double stranded'), ('PR_000001155', 'Toll-like receptor 4', 240, 'TLR9'), ('NCBITaxon_1', 'root', 253, 'viral'), ('SO_0001026', 'genome', 259, 'genome')]
PMC4889866	5/2016	S130-PMC4889866	['in CONCLUSION, OUR STUDY HAD SHOWN that maternal Vitamin D level, BUT NOT cord Vitamin D, was ASSOCIATED with Tlr3 and Tlr7-8 triggered il-10 response.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('SUPERFICIAL_RELATIONSHIP', 94)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 110, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 119, 'TLR7')]
PMC4889866	5/2016	S131-PMC4889866	['THIS STUDY EMPHASIZED that EVEN THOUGH Cord Vitamin D level was STRONGLY CORRELATED with maternal Vitamin D status, the extent of IMPACT on fetal Immune Cytokine Response MIGHT be distinctive.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 11), ('IMPORTANT_CONSIDERATION', 11), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 64), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 171)]	9	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0002250', 'adaptive immune response', 146, 'immune cytokine response'), ('UBERON_0002405', 'immune system', 146, 'immune')]
PMC4889866	5/2016	S132-PMC4889866	['ALTHOUGH OUR study DID NOT SHOW maternal Vitamin D concentration to have a significant IMPACT on the magnitude or functional capacity of the young infant to defend against infection, we BELIEVE OUR STUDY MAY contribute to a BETTER understanding of the EFFECT of Prenatal Vitamin D status on neonatal Innate Immunity and infectious disease during early Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 252)]	9	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 262, 'prenatal'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0045087', 'innate immune response', 300, 'innate immunity'), ('UBERON_0000104', 'life cycle', 352, 'life')]
PMC4903143	5/2016	S92-PMC4903143	['THE literature has discussed that Vitamin D insufficiency MAY BE ASSOCIATED with first Trimester Pregnancy loss [85,86], Gestational diabetes [103,104], Preeclampsia [89,105], Preterm Birth [92,93], higher rates of primary and emergency caesarean Delivery [94,106], small for Gestational age infants [95], and maternal Postpartum depression [96].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 65)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 87, 'trimester'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('GO_0007565', 'female pregnancy', 121, 'gestational'), ('GO_0007128', 'meiotic prophase I', 153, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 176, 'preterm birth'), ('GO_0007567', 'parturition', 247, 'delivery'), ('GO_0007565', 'female pregnancy', 276, 'gestational'), ('GO_0007565', 'female pregnancy', 319, 'postpartum')]
PMC4923982	5/2016	S64-PMC4923982	['we also ASSESSED the POSSIBILITY that bmi (<25 = referent vs. ≥25), smoking (never = referent vs. ever), dietary Vitamin C intake (below median = referent vs. median or above) and dietary Calcium Intake (below median = referent vs. median or above) MAY have synergistic or antagonistic EFFECTS on the ASSOCIATION between dietary iron intake and gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 286), ('SUPERFICIAL_RELATIONSHIP', 301)]	5	[('CHEBI_27300', 'vitamin D', 113, 'vitamin C'), ('CHEBI_22313', 'alkaline earth metal atom', 188, 'calcium'), ('GO_0007631', 'feeding behavior', 196, 'intake')]
PMC4923982	5/2016	S114-PMC4923982	['IN LIGHT OF this PROPOSED oxidative pathway, we EXAMINED the POSSIBILITY that the antioxidant Vitamin C modified the ASSOCIATION between iron and gdm, but we FOUND that dietary Intake of Vitamin C above the median had no measurable effect on gdm.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 158)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin C'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin C')]
PMC4908484	6/2016	S38-PMC4908484	['the PRESENT research was planned TO study the EFFECTS of Vitamin D on iron accumulation after 6\xa0days of stimulation in be(2)m17 neuroblastoma cells.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4930210	7/2016	S0-PMC4930210	['the current recommended Vitamin D intake guideline for diet and supplements during Pregnancy is not adequate to achieve Vitamin D sufficiency for most Pregnant women\n\nabstract\n\nbackground\nthe aims of THIS STUDY were TO DETERMINE IF Pregnant women consumed the RECOMMENDED Vitamin D through diet alone or through diet and supplements, and if they achieved the current reference range Vitamin D status when their reported dietary intake met the current RECOMMENDATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229), ('FUTURE_WORK', 260), ('FUTURE_WORK', 451)]	5	[('CHEBI_28384', 'vitamin K', 24, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 120, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'Pregnant'), ('GO_0007565', 'female pregnancy', 232, 'pregnant'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D')]
PMC4930210	7/2016	S22-PMC4930210	['THIS REVIEW HIGHLIGHTED the extremely HETEROGENEOUS evidence in regards to definition of Serum Vitamin D concentration THRESHOLD and the LACK OF high-quality interventional studies [10].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('DIFFICULT_TASK', 38), ('PROBABLE_UNDERSTANDING', 119), ('INCOMPLETE_EVIDENCE', 137), ('ANOMALY_CURIOUS_FINDING', 142)]	6	[('UBERON_0001977', 'blood serum', 89, 'serum'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4930210	7/2016	S28-PMC4930210	['our AIMS in the CURRENT STUDY were TO DETERMINE: a) if Pregnant women were Consuming the RECOMMENDED Vitamin D through diet alone or through diet and supplements, and b) IF Pregnant women can achieve the current reference range Vitamin D status when their reported dietary intake of Vitamin D met the current RECOMMENDATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('FUTURE_WORK', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('FUTURE_WORK', 309)]	6	[('GO_0007565', 'female pregnancy', 55, 'pregnant'), ('GO_0007631', 'feeding behavior', 75, 'consuming'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnant'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC4930210	7/2016	S42-PMC4930210	['maternal supplement intake questionnaire (siq)\nfollowing enrollment, the maternal supplement intake questionnaire (siq) was administered by a trained nutrition professional to each participant once during each trimester of Pregnancy and once at 3 months Postpartum to determine current natural health product (nhp) use including Vitamin D. the siq was designed specifically for the apron study and was initially used in a pilot study that included of fifty women in the apron study who completed the questionnaire during their first and second visits TO assess efficacy and the detail of information obtained [15].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 551)]	1	[('GO_0007565', 'female pregnancy', 223, 'pregnancy'), ('GO_0007565', 'female pregnancy', 254, 'postpartum'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D')]
PMC4930210	7/2016	S126-PMC4930210	['discussion\nTO OUR KNOWLEDGE, THIS is the largest STUDY TO date to SHOW 44% of Pregnant women with a higher socioeconomic status reported Vitamin D intake (diet and supplements) not meeting the dietary reference intakes (dri) recomendations.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 66)]	5	[('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4930210	7/2016	S133-PMC4930210	['in THE CURRENT STUDY, we SHOWED that Pregnant women are taking small amounts of Vitamin D from Food and beverages in their diet (<200 iu/day), and they are relying on supplemental sources of Vitamin D to meet the current dris.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 25)]	2	[('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_33290', 'food', 95, 'food'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4930210	7/2016	S135-PMC4930210	['OUR FINDINGS are SUPPORTIVE of a GROWING body of LITERATURE SUGGESTING that the RECOMMENDED dose of Vitamin D during Pregnancy is INADEQUATE in preventing Vitamin D deficiency/insufficiency [26].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 60), ('FUTURE_WORK', 80), ('IMPORTANT_CONSIDERATION', 130), ('PROBLEM_COMPLICATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4930210	7/2016	S139-PMC4930210	['one STRENGTH of THE CURRENT STUDY is its use of a quantification method capable of ACCURATELY measuring 25(Oh)D (separating epimer) and adding the potential CONTRIBUTION of dietary Vitamin D to the total intake ESTIMATE.']	[('IMPORTANT_CONSIDERATION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 211)]	5	[('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 104, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4930210	7/2016	S142-PMC4930210	['ALTHOUGH PREVIOUS STUDIES HAVE SHOWN FACTORS like age, season, and Vitamin D supplementation AFFECT 3-Epi-25(Oh)D3[29,30], in OUR STUDY the ONLY FACTOR positively CORRELATED with level of the 3-Epi-25(Oh)D3Was Vitamin D intake.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 145), ('SUPERFICIAL_RELATIONSHIP', 163)]	10	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_76629', '2-lysophosphatidic acid', 100, '3-epi-25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 112, 'D3'), ('CHEBI_73839', 'D-Leu-D-Leu', 192, '3-epi-25(OH)D3was'), ('PR_000012979', 'DNA-directed DNA/RNA polymerase mu', 204, 'D3was'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
PMC4930210	7/2016	S154-PMC4930210	['the lower rate of Vitamin D insufficiency in OUR STUDY COULD BE RELATED to the cohort characteristics involving very educated, high socio-economic status Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 64)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant')]
PMC4944244	7/2016	S100-PMC4944244	['this is IN LINE WITH OUR STUDY, where the PREVALENCE of hypovitaminosis D (25 (Oh) D Serum <50\xa0nmol/l) in the first trimester was high (90.4\xa0%) and only 11.1\xa0% took supplements containing Vitamin D. moreover, most of them had just started the Supplements and the results MAY not have AFFECTED their Vitamin D status yet.']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('IMPORTANT_CONSIDERATION', 42), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 284)]	5	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 72, 'D'), ('CHEBI_71657', 'versiconol acetate', 75, '25 (OH) D'), ('PR_000003010', 'moesin isoform 1', 78, '(OH ... D'), ('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 243, 'supplements'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC4944244	7/2016	S106-PMC4944244	['ethnic chinese in THIS STUDY had better Vitamin D results COMPARED TO malays and indians which CONTRIBUTE to the decrease of the overall measure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4944244	7/2016	S142-PMC4944244	['the significant predictive factors after multivariable analysis in OUR STUDY were ethnic group, educational status and dietary intake of Vitamin D. HOWEVER, the study by chailurkit et al.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148)]	2	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4944244	7/2016	S203-PMC4944244	['OUR STUDY SHOWED SIMILAR results where fair skin such as chinese had a higher level of Serum 25(Oh) D. initially, by using simple logistic regression analysis, the skin color type, Melanin index measurement and sun protection score SHOWED CORRELATION with Vitamin D status ( p \u2009<\u20090.05).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 232), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('UBERON_0001977', 'blood serum', 87, 'serum'), ('CHEBI_71657', 'versiconol acetate', 93, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 93, '25(OH) D'), ('CHEBI_25179', 'melanins', 181, 'melanin'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC4944244	7/2016	S230-PMC4944244	['FURTHER STUDIES NEED TO BE conducted among health care staff to assess the level of knowledge RELATED to Vitamin D. in addition, THIS RESEARCH AIMED to create the AWARENESS on the IMPORTANCE of Vitamin D to patient.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 129), ('QUESTION_ANSWERED_BY_THIS_WORK', 143), ('IMPORTANT_CONSIDERATION', 163), ('IMPORTANT_CONSIDERATION', 180)]	7	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC4976416	7/2016	S5-PMC4976416	['the AIM of THIS ARTICLE is to review the cosmetic as well as clinical IMPLICATIONS of Vitamin E in dermatology.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('IMPORTANT_CONSIDERATION', 70)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin E')]
PMC4976416	7/2016	S69-PMC4976416	['[50]\n\nrecommended dose of Vitamin E\nin case of Vitamin E, the RECOMMENDED intake (6–10 mg of Α-Tocopherol or the equivalent) is BASED SOLELY ON an ESTIMATE of how much Tocopherol the average Person Consumes.']	[('FUTURE_WORK', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 147)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin E'), ('CHEBI_27725', 'butin', 93, 'α-tocopherol'), ('CHEBI_27013', 'tocopherol', 168, 'tocopherol'), ('NCBITaxon_10088', 'Mus <genus>', 191, 'person'), ('GO_0007631', 'feeding behavior', 198, 'consumes')]
PMC4969253	8/2016	S86-PMC4969253	['conclusions\noverall, the OBSERVATIONS HERE underscore the IMPORTANCE of dietary Vitamin A/Retinoids, a SIGNIFICANT challenge in developing countries.']	[('INCOMPLETE_EVIDENCE', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('IMPORTANT_CONSIDERATION', 58), ('IMPORTANT_CONSIDERATION', 103)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('CHEBI_26537', 'retinoid', 90, 'retinoids')]
PMC4971719	8/2016	S1-PMC4971719	['we performed THIS STUDY TO EVALUATE WHETHER low maternal Vitamin D levels are ASSOCIATED with depressive symptoms in Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy')]
PMC4971719	8/2016	S7-PMC4971719	['using regression analyses, we EVALUATED the RELATIONSHIP between Vitamin D levels with bdi scores as well as with mini diagnoses of major depressive disorder and generalized anxiety disorder.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4971719	8/2016	S31-PMC4971719	['the more RECENT huang et al., STUDY EXAMINED the ASSOCIATION 25 Oh Vitamin D levels measured at 15\xa0weeks Gestation with depression and anxiety symptoms measured at that same time point [25].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 49)]	5	[('CHEBI_63058', '(2R,3S)-EHNA', 61, '25 OH'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'gestation')]
PMC4971719	8/2016	S38-PMC4971719	['we CONDUCTED THIS STUDY TO EVALUATE WHETHER Plasma Vitamin D levels, measured in early and late Pregnancy were ASSOCIATED with depression symptom scores at 3 time points during Pregnancy and at 6–8 weeks Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('UBERON_0001969', 'blood plasma', 44, 'plasma'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'postpartum')]
PMC4971719	8/2016	S44-PMC4971719	['the primary AIM of this secondary analysis was TO DETERMINE WHETHER low Vitamin D during Pregnancy is ASSOCIATED with depressive symptoms as assessed by the beck depression inventory score at three time points during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 102)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy')]
PMC4971719	8/2016	S45-PMC4971719	['as a secondary AIM of THIS STUDY, we EVALUATED WHETHER Vitamin D levels were ASSOCIATED with mini international neuropsychiatric interview diagnoses of major depressive disorder (mdd), generalized anxiety disorder (gad), or anxiety symptoms (mini anxiety subtest, question 1a) [34].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('SUPERFICIAL_RELATIONSHIP', 77)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4971719	8/2016	S86-PMC4971719	['we used the t -test procedure TO EVALUATE the relationship between Vitamin D 1 at enrollment and seasonality, with “winter” being defined as “december through february”.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 67, 'vitamin D 1')]
PMC4971719	8/2016	S87-PMC4971719	['in our primary analysis, we ASSESSED the relationship between Vitamin D as a continuous variable and bdi scores at 12–20 weeks, 34–36 weeks and the 6–8 week Postpartum visits.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'postpartum')]
PMC4971719	8/2016	S127-PMC4971719	['standard deviation\nfor our primary outcome, we EVALUATED the RELATIONSHIP between Vitamin D levels at two time points and bdi scores at 12–20 weeks, 34–36 weeks and 6–8 weeks Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 175, 'postpartum')]
PMC4971719	8/2016	S137-PMC4971719	['BECAUSE our study participants were drawn from a parent study looking at Omega-3 Fatty Acids (Dha and Epa) and their RELATIONSHIP to depression, and to adjust for other POTENTIAL CONFOUNDERS, we CONDUCTED a stepwise linear regression to BETTER UNDERSTAND the ASSOCIATION of Vitamin D with the bdi score.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 169), ('PROBLEM_COMPLICATION', 179), ('QUESTION_ANSWERED_BY_THIS_WORK', 195), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 259)]	7	[('CHEBI_75862', 'alpha-D-rhamnofuranose', 73, 'omega-3 fatty acids'), ('CHEBI_17874', 'dihydrozeatin', 94, 'DHA'), ('CHEBI_34733', 'EPN', 102, 'EPA'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4971719	8/2016	S145-PMC4971719	['discussion\n\nmain findings\nTHIS STUDY presents EVIDENCE that low Vitamin D levels in early Pregnancy (12–20 weeks) are significantly ASSOCIATED with higher depression symptom scores at in early and late Pregnancy in a group of women AT RISK for depression.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 132), ('IMPORTANT_CONSIDERATION', 232)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC4971719	8/2016	S149-PMC4971719	['another strength of THIS STUDY is that we were able to measure Vitamin D longitudinally as well, both in early and late Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20)]	1	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007565', 'female pregnancy', 120, 'pregnancy')]
PMC4971719	8/2016	S160-PMC4971719	['an additional LIMITATION of OUR STUDY was that we were unable to explore the POTENTIALLY modulatory EFFECTS of inflammatory cytokines on the RELATIONSHIP between Vitamin D and depressive symptoms [23].']	[('INCOMPLETE_EVIDENCE', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 100), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC4971719	8/2016	S161-PMC4971719	['OUR STUDY FOUND an ASSOCIATION between low Vitamin D levels in early Pregnancy and depressive symptoms during Pregnancy BUT NOT Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('GO_0007565', 'female pregnancy', 128, 'postpartum')]
PMC4971719	8/2016	S163-PMC4971719	['the main finding of OUR STUDY is that there exists a RELATIONSHIP between low early-Pregnancy Vitamin D levels and depression symptoms in early and late Pregnancy in women AT risk for depression.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 172)]	3	[('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 153, 'pregnancy')]
PMC4971719	8/2016	S168-PMC4971719	['conclusions\nOUR FINDINGS SUGGEST that lower Vitamin D levels in early Pregnancy are ASSOCIATED with depressive symptoms in early and late Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 84)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy')]
PMC4973215	8/2016	S0-PMC4973215	['racial DISPARITIES in Cord Blood Vitamin D levels and its ASSOCIATION with small-for-Gestational-age infants\n\nabstract\n\nobjective:\nTO EXAMINE the RELATIONSHIP of race and maternal characteristics and their ASSOCIATION with Cord Blood Vitamin D levels and small-for-Gestational-age (sga) status.']	[('IMPORTANT_CONSIDERATION', 7), ('SUPERFICIAL_RELATIONSHIP', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 206)]	5	[('UBERON_0002240', 'spinal cord', 22, 'cord'), ('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'gestational'), ('UBERON_0002240', 'spinal cord', 223, 'cord'), ('UBERON_0000178', 'blood', 228, 'blood'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 265, 'gestational')]
PMC4973215	8/2016	S15-PMC4973215	['THUS, the primary PURPOSE of THIS STUDY was to EXAMINE the RELATIONSHIP between race, maternal characteristics, Cord Blood Vitamin D levels and sga status among infants during one winter season in a midwestern us population.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 59)]	5	[('UBERON_0002240', 'spinal cord', 112, 'cord'), ('UBERON_0000178', 'blood', 117, 'blood'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4973215	8/2016	S16-PMC4973215	['in particular, we wanted TO EVALUATE the additive EFFECTS of race and maternal characteristics such as obesity on Vitamin D deficiency and sga.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4973215	8/2016	S17-PMC4973215	['our GOAL was TO IDENTIFY specific high-risk subsets of Pregnant women who MAY BENEFIT from Vitamin D supplementation IN ORDER TO mitigate adverse Perinatal outcomes such as sga.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 74), ('IMPORTANT_CONSIDERATION', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 117)]	5	[('GO_0007565', 'female pregnancy', 55, 'pregnant'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0036268', 'swimming', 146, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 146, 'perinatal')]
PMC4973215	8/2016	S29-PMC4973215	['to explore RELATIONSHIPS between race, Vitamin D levels and sga, we first EVALUATED race as a PREDICTOR of Vitamin D levels (sufficient or deficient) in cord Blood and ASSESSED for POTENTIAL CONFOUNDERS: medicaid status, bmi at Delivery, hypertension, maternal age and Prenatal Vitamin use.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 168), ('INCOMPLETE_EVIDENCE', 181), ('PROBLEM_COMPLICATION', 191)]	6	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0000178', 'blood', 158, 'blood'), ('GO_0007567', 'parturition', 228, 'delivery'), ('GO_0007565', 'female pregnancy', 269, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 278, 'vitamin')]
PMC4973215	8/2016	S50-PMC4973215	['AS Vitamin D levels also DIFFERED by race, we stratified the models predicting sga by race and EXAMINED Vitamin D deficiency, smoking, pre-eclampsia, maternal age, medicaid status and bmi at Delivery as covariates (table 3).']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 95)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007567', 'parturition', 191, 'delivery')]
PMC4973215	8/2016	S61-PMC4973215	['discussion\nin OUR STUDY population, we FOUND that compared with white infants, black infants had significantly lower Cord Blood Vitamin D levels and a greater proportion of vitamin d deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 39)]	2	[('UBERON_0009472', 'axilla', 117, 'cord blood'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC4973215	8/2016	S62-PMC4973215	['ALTHOUGH the prevalence of Vitamin D deficiency in black mothers and neonates is WELL KNOWN, DEBATE exists as to the RELATIONSHIP between race, Vitamin D deficiency and sga.12,14,15,17,18we EXAMINED this RELATIONSHIP in conjunction with additional maternal characteristics in order TO IDENTIFY groups of Pregnant women who could BENEFIT MOST from Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 190), ('SUPERFICIAL_RELATIONSHIP', 204), ('QUESTION_ANSWERED_BY_THIS_WORK', 282), ('IMPORTANT_CONSIDERATION', 329), ('PROBABLE_UNDERSTANDING', 337)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 304, 'pregnant'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
PMC4973215	8/2016	S78-PMC4973215	['furthermore, this study was CONDUCTED in hamilton county, ohio, an area with worse Perinatal outcomes THAN national averages, including higher infant mortality, Preterm Birth and low Birth weight rates, as well as CONSIDERABLE racial DISPARITIES in infant mortality and Perinatal outcomes.34all of Cord Blood samples were collected over one winter season, THUS negating seasonal variations in Vitamin D levels that MAY have been SEEN in OTHER STUDIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('IMPORTANT_CONSIDERATION', 214), ('IMPORTANT_CONSIDERATION', 234), ('PROBABLE_UNDERSTANDING', 356), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 429), ('INCOMPLETE_EVIDENCE', 437)]	8	[('GO_0036268', 'swimming', 83, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 83, 'perinatal'), ('GO_0007565', 'female pregnancy', 161, 'preterm birth'), ('GO_0007567', 'parturition', 183, 'birth'), ('GO_0036268', 'swimming', 270, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 270, 'perinatal'), ('UBERON_0002240', 'spinal cord', 298, 'cord'), ('UBERON_0000178', 'blood', 303, 'blood'), ('CHEBI_27300', 'vitamin D', 393, 'vitamin D')]
PMC4973215	8/2016	S81-PMC4973215	['concurrently, we also EXAMINED maternal variables KNOWN to POTENTIALLY AFFECT Vitamin D levels and sga in an effort to BETTER UNDERSTAND the ROLE of these RISK FACTORS in vitamin d levels and risk of sga.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 141), ('SUPERFICIAL_RELATIONSHIP', 155)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4973215	8/2016	S87-PMC4973215	['IMPORTANTLY, OUR STUDY ILLUSTRATES the ADDITIVE EFFECT of maternal RISK FACTORS and their PREDICTIVE probabilities for Vitamin D deficiency and sga.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 90)]	7	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4979151	8/2016	S35-PMC4979151	['there is NO standard classification of Vitamin D status based on 25(Oh)D3Concentrations in Cord Blood; THUS, for the PURPOSE of the PRESENT STUDY we stratified the participants into four groups based on Serum 25(Oh)D concentrations as done earlier [20] :(1) ≥76\xa0nmol/l (high); (2) 50–75\xa0nmol/l (moderate); (3) 30–49\xa0nmol/l (low); (4) <30\xa0nmol/l (very low).']	[('FULL_UNKNOWN', 9), ('PROBABLE_UNDERSTANDING', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 132)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_73735', 'gadoterate', 65, '25(OH)D3concentrations'), ('PR_000029608', 'DISP complex protein LRCH3', 65, '25 ... OH ... D3concentrations'), ('UBERON_0002240', 'spinal cord', 91, 'cord'), ('UBERON_0000178', 'blood', 96, 'blood'), ('UBERON_0001977', 'blood serum', 203, 'serum'), ('CHEBI_71657', 'versiconol acetate', 209, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 209, '25(OH)D')]
PMC4982007	8/2016	S39-PMC4982007	['THIS SYSTEMATIC REVIEW FOCUSSES on studies LINKING Cognitive function in children to the following indices of maternal nutritional status: a) anthropometry (body mass index (bmi), height and weight); b) status or Intake of selected single Micronutrients (Vitamins D, b1, b6, b12 and Folate) and iron and c) dietary Intake of Macronutrients (Carbohydrate, protein and fat).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('GO_0050890', 'cognition', 51, 'cognitive'), ('GO_0007631', 'feeding behavior', 213, 'intake'), ('CHEBI_33839', 'macromolecule', 239, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 255, 'vitamins D'), ('CHEBI_30863', '5-azaorotic acid', 283, 'folate'), ('GO_0007631', 'feeding behavior', 315, 'intake'), ('CHEBI_33839', 'macromolecule', 325, 'macronutrients'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 341, 'carbohydrate')]
PMC4989298	8/2016	S334-PMC4989298	['Vitamin D\nthe PURPOSE of THIS document is to CONSIDER the administration of Vitamin D for the primary prevention of allergies on the basis of the AVAILABLE SCIENTIFIC EVIDENCE.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('FUTURE_WORK', 45), ('INCOMPLETE_EVIDENCE', 146)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4989298	8/2016	S348-PMC4989298	['state of knowledge\na recent meta-analysis INVESTIGATED the RELATIONSHIP between alterations of Vitamin D status and a number OF pathological conditions [121].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('SUPERFICIAL_RELATIONSHIP', 59), ('ANOMALY_CURIOUS_FINDING', 125)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4990268	8/2016	S39-PMC4990268	['the interventions considered by this review are outlined intable 1(numbered to correspond to the sections of the paper where they are addressed).10.1371/journal.pone.0160562.t001\n\ncaption (table-wrap): table 1\ninterventions addressed in THIS review.Nutritioninfectionobstetrical and other• immediate & exclusive breastfeeding• deworming• advance distribution of Misoprostol for use immediately after Childbirth for preventing post-Partum hemorrhage• antenatal Iron supplementation & anemia screening & treatment• intermittent presumptive treatment of malaria & use of Insecticide-treated nets• pre-eclampsia screening & treatment• multi-Micronutrient supplementation• Tetanus Toxoid• clean Delivery practices• Calcium supplementation• advance distribution of Chlorhexidine for application to the Umbilical Cord Stump• thermal care• antenatal Vitamin A supplementation• syphilis screening & treatment• Birth preparedness & complication readiness• advance distribution of Vitamin A for administration to the newborn• hiv screening/ pmtct• tobacco, alcohol use• Iodized Salt use• Family Planning• balanced protein-energy supplementation\n\neffects modified by context\nfor each of these INTERVENTIONS, the review addresses: 1) EVIDENCE on EFFECTS with regard to mortality and other IMPORTANT endpoints and 2) variation in expected EFFECTS by context.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 237), ('SUPERFICIAL_RELATIONSHIP', 1181), ('INCOMPLETE_EVIDENCE', 1221), ('SUPERFICIAL_RELATIONSHIP', 1233), ('IMPORTANT_CONSIDERATION', 1276), ('SUPERFICIAL_RELATIONSHIP', 1325)]	6	[('GO_0012501', 'programmed cell death', 249, 'NutritionInfectionObstetrical'), ('CHEBI_63610', 'misoprostol', 362, 'misoprostol'), ('GO_0007623', 'circadian rhythm', 400, 'childbirth'), ('GO_0007567', 'parturition', 431, 'partum'), ('UBERON_0001013', 'adipose tissue', 431, 'partum'), ('CHEBI_24870', 'ion', 460, 'iron'), ('CHEBI_24852', 'insecticide', 568, 'insecticide'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 637, 'micronutrient'), ('CHEBI_32848', 'serine residue', 668, 'Tetanus'), ('CHEBI_29238', 'tritium atom', 676, 'toxoid'), ('GO_0007567', 'parturition', 690, 'delivery'), ('CHEBI_31341', 'calcium dihydroxide', 710, 'Calcium'), ('CHEBI_3647', 'chlorpromazine', 759, 'chlorhexidine'), ('UBERON_0010270', 'filum terminale externum', 796, 'umbilical cord stump'), ('CHEBI_27300', 'vitamin D', 842, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 850, 'A'), ('GO_0007567', 'parturition', 901, 'Birth'), ('CHEBI_27300', 'vitamin D', 970, 'vitamin A'), ('CHEBI_31721', 'Irsogladine maleate', 1059, 'Iodized salt'), ('GO_0006437', 'tyrosyl-tRNA aminoacylation', 1077, 'Family Planning')]
PMC4990268	8/2016	S315-PMC4990268	['meta-analyses do not SUPPORT this intervention as a Maternal survival strategy[101,108] HOWEVER the most RECENT such analysis NOTED significant heterogeneity in trial outcomes (i2 = 52%, p = 0.04) MOST LIKELY due TO VARIATIONS in underlying population levels of Vitamin A deficiency between studies[101].']	[('INCOMPLETE_EVIDENCE', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('INCOMPLETE_EVIDENCE', 105), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 197), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('DIFFICULT_TASK', 216)]	7	[('GO_0007618', 'mating', 52, 'maternal'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin A')]
PMC4990280	8/2016	S154-PMC4990280	['a study in nepal DEMONSTRATED that maternal Vitamin A supplementation enhanced natural Antibody concentrations in children at preadolescent age (9 to 13 years); the authors POSTULATED that pre-Natal supplementation lead TO a higher reservoir and sustained natural immunity in these children [37].']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 173), ('QUESTION_ANSWERED_BY_THIS_WORK', 220)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('GO_0042571', 'immunoglobulin complex, circulating', 87, 'antibody'), ('GO_0007567', 'parturition', 193, 'natal')]
PMC4992225	8/2016	S177-PMC4992225	['caption (table-wrap): table 4\n\n25(Oh)D concentrations and depression scores in nulliparous and multiparous subgroupsvariables mean (sd)nulliparousmultiparousvitamin D groupcontrol groupn p -valuevitamin D groupcontrol groupn p -value*25(Oh)D at baseline (ng/ml)13.13(6.91)13.25 (6.55)41/510.9312.49 (9.08)9.31 (5.34)34/270.1525(Oh)D at Delivery (ng/ml)18.40 (11.38)12.49 (6.29)33/430.0116.58 (8.54)11.36 (5.47)28/250.02depression score at baseline8.41(3.52)8.73 (3.57)41/510.678.47 (4.35)8.48 (4.30)34/270.99depression score at 38-40w Gestation6.47(3.43)7.98 (3.74)38/460.065.80 (3.62)7.44 (4.28)30/270.12depression score at Postpartum (4w)4.59(3.24)7.27 (4.04)34/450.0024.60 (3.40)7.52 (4.70)30/270.01depression score at Postpartum (8w)4.18(3.79)7.24 (3.79)34/450.0014.20 (3.79)7.07 (4.37)30/270.01\n*mann–whitney u test\nwe EXAMINED the CORRELATION between change in Vitamin D concentrations and change in depression scores at 38–40 weeks of Gestation, 4 and 8 weeks Postpartum.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 824), ('SUPERFICIAL_RELATIONSHIP', 837)]	2	[('CHEBI_71657', 'versiconol acetate', 31, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 31, '25(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 165, 'D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 203, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 203, 'D'), ('CHEBI_71657', 'versiconol acetate', 234, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 240, 'D'), ('CHEBI_33010', 'chromide(1-)', 327, '(OH)D'), ('GO_0007567', 'parturition', 336, 'delivery'), ('GO_0007565', 'female pregnancy', 535, 'gestation6'), ('GO_0007565', 'female pregnancy', 625, 'postpartum'), ('GO_0007565', 'female pregnancy', 722, 'postpartum'), ('CHEBI_27300', 'vitamin D', 867, 'vitamin D'), ('GO_0007565', 'female pregnancy', 942, 'gestation'), ('GO_0007565', 'female pregnancy', 967, 'postpartum')]
PMC4992225	8/2016	S194-PMC4992225	['in the PRESENT STUDY, the mean Vitamin D concentrations in Vitamin D group were significantly higher after taking 2000\xa0iu of Vitamin D supplementation per day for AT LEAST 8 weeks.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('PROBABLE_UNDERSTANDING', 163)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4992225	8/2016	S197-PMC4992225	['in those studies, Vitamin D supplementations started at the end of the first trimester or at the beginning of the second Trimester and their participants had higher initial 25-hydroxyvitamin d concentrations COMPARED TO the participants in OUR STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('QUESTION_ANSWERED_BY_THIS_WORK', 240)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 121, 'trimester')]
PMC4992225	8/2016	S207-PMC4992225	['THEREFORE, it is JUSTIFIABLE that in OUR STUDY, Vitamin D group had lower 25-Hydroxyvitamin D concentration compared to those were in the study by taheri et al.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 37)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 74, '25-hydroxyvitamin D')]
PMC4992225	8/2016	S235-PMC4992225	['NONETHELESS, in OUR STUDY, the Vitamin D group had significantly lower depression scores after intervention.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC4992225	8/2016	S263-PMC4992225	['it was INTERESTING TO INVESTIGATE TREND of Vitamin D EFFECTIVENESS in the two primiparous and multiparous subgroups.']	[('ANOMALY_CURIOUS_FINDING', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 53)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC4993554	8/2016	S175-PMC4993554	['although Liver is a rich source of key Nutrients such as Iron and Folate, avoiding it in Pregnancy is RECOMMENDED as it contains a high level of Vitamin A and the upper safer limit is UNCERTAIN.52a high dose of Vitamin A in Pregnancy poses a SERIOUS risk of Birth defects.53ALTHOUGH our study DID NOT provide information on HOW this low awareness of Vitamin A-rich source Food COULD AFFECT Pregnant women’s Food choices, written comments (open text sections of the survey) in the PRESENT STUDY INDICATED that SOME women MAY BE INFLUENCED by some of nonevidence-based information.']	[('FUTURE_WORK', 102), ('FULL_UNKNOWN', 184), ('IMPORTANT_CONSIDERATION', 242), ('ANOMALY_CURIOUS_FINDING', 272), ('INCOMPLETE_EVIDENCE', 293), ('EXPLICIT_QUESTION', 324), ('INCOMPLETE_EVIDENCE', 377), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 480), ('INCOMPLETE_EVIDENCE', 494), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 520), ('SUPERFICIAL_RELATIONSHIP', 527)]	13	[('UBERON_0002107', 'liver', 9, 'liver'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CHEBI_24870', 'ion', 57, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 66, 'folate'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin A'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007567', 'parturition', 258, 'birth'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin A'), ('CHEBI_33290', 'food', 372, 'food'), ('GO_0007565', 'female pregnancy', 390, 'pregnant'), ('CHEBI_33290', 'food', 407, 'food')]
PMC4997421	8/2016	S23-PMC4997421	['THEREFORE, the OBJECTIVE of THIS STUDY was to use nhanes data to EXAMINE the Retinol status of women of Childbearing age in the united states, and TO ASSESS the IMPACT of poverty and race, as well as OTHER INDICATORS that have NOT previously BEEN EXAMINED in this population, including Food security and use of supplemental nutrition assistance programs (snap), on Vitamin A status.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 147), ('SUPERFICIAL_RELATIONSHIP', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('SUPERFICIAL_RELATIONSHIP', 206), ('FULL_UNKNOWN', 227)]	9	[('CHEBI_26536', 'retinoic acid', 77, 'retinol'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 104, 'childbearing'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin A')]
PMC4997421	8/2016	S90-PMC4997421	['OUR STUDY SHOWS that lower poverty status and race increase the risk of suboptimal Vitamin A stores in women of Childbearing age in the united states.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 112, 'childbearing')]
PMC4997421	8/2016	S93-PMC4997421	['FOUND a significantly increased RISK of spontaneous Preterm Delivery, maternal anemia, and Pregnancy-induced hypertension when Retinol levels were below 0.70 µmol/l, and BASED ON those functional EFFECTS RECOMMEND a level of 0.70 µmol/l to define Vitamin A deficiency in Pregnancy [3].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 170), ('QUESTION_ANSWERED_BY_THIS_WORK', 170), ('SUPERFICIAL_RELATIONSHIP', 196), ('FUTURE_WORK', 204)]	6	[('GO_0007565', 'female pregnancy', 52, 'preterm'), ('GO_0007567', 'parturition', 60, 'delivery'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 127, 'retinol'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin A'), ('GO_0007565', 'female pregnancy', 271, 'pregnancy')]
PMC4997421	8/2016	S99-PMC4997421	['our analysis used the most recent nhanes cycles containing Serum Retinol information, and OUR FINDINGS also SUPPORT an overall low prevalence of Vitamin A deficiency and insufficiency during this time period.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('INCOMPLETE_EVIDENCE', 108)]	2	[('UBERON_0001977', 'blood serum', 59, 'serum'), ('CHEBI_26536', 'retinoic acid', 65, 'retinol'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A')]
PMC4997421	8/2016	S123-PMC4997421	['we also INVESTIGATED the IMPACT of OTHER socioeconomic indicators on Vitamin A status that have not been WELL explored, including Food insecurity and Snap use.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('FUTURE_WORK', 105)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('CHEBI_33290', 'food', 130, 'food'), ('PR_000015329', 'stannin', 150, 'SNAP')]
PMC4997421	8/2016	S138-PMC4997421	['conclusions\nour results DEMONSTRATE IT IS POSSIBLE that Vitamin A deficiency is a PUBLIC HEALTH CONCERN in nutritionally disadvantaged populations of industrialized societies.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 82)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin A')]
PMC4997567	8/2016	S11-PMC4997567	['the risk factors contributing to Vitamin D deficiency rickets in the egyptian children include the low socioeconomic status, the limited exposure to sunlight due TO housing conditions and cultural practices, and the exclusive or prolonged Breast-feeding without Vitamin D supplements.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 162)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0000310', 'breast', 239, 'breast'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D')]
PMC4997567	8/2016	S15-PMC4997567	['the study was DESIGNED to compare affected versus unaffected children in egypt taking into CONSIDERATION the socioeconomic status, housing and nutritional history, clinical examination, laboratory biochemical serum calcium, phosphorus, alkaline phosphatase, and active Vitamin D 1,25(Oh)2D levels, and radiographic findings.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('IMPORTANT_CONSIDERATION', 91)]	2	[('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 281, '25(OH)2D')]
PMC4997567	8/2016	S54-PMC4997567	['as regards to the maternal Gestational conditions, the mothers of 175 cases (70%) had more than 3 Pregnancies, compared TO the mothers of 23 controls (9.2%); of 140 cases (56%) has less than 2-year interval between the Pregnancies, compared TO those of 14 controls (5.6%); of 200 cases (80%) exposed to less than half an hour a day, compared to the mothers of 50 controls (20%); of 155 (62%) with no Food rich in Vitamin D, nor calcium, nor Vitamin D supplementation during Pregnancy, compared TO those of 10 controls (4%).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 120), ('QUESTION_ANSWERED_BY_THIS_WORK', 241), ('QUESTION_ANSWERED_BY_THIS_WORK', 494)]	3	[('GO_0007565', 'female pregnancy', 27, 'gestational'), ('GO_0007565', 'female pregnancy', 98, 'pregnancies'), ('GO_0007565', 'female pregnancy', 219, 'pregnancies'), ('CHEBI_33290', 'food', 400, 'food'), ('CHEBI_27300', 'vitamin D', 413, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 441, 'vitamin D'), ('GO_0007565', 'female pregnancy', 474, 'pregnancy')]
PMC5014971	8/2016	S37-PMC5014971	['the PURPOSE of THIS STUDY was TO ASSESS the practice, knowledge, and opinions of practicing obstetrician-gynecologists regarding screening for Vitamin D status and Vitamin D supplementation of their Pregnant patients.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	3	[('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 199, 'pregnant')]
PMC5014971	8/2016	S94-PMC5014971	['discussion\nthe results of THIS STUDY SUGGEST that practicing obstetrician-gynecologists GENERALLY are SOMEWHAT CONCERNED about the Vitamin D status of their Pregnant patients and consider Vitamin D supplementation during Pregnancy to be SAFE.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 111), ('IMPORTANT_CONSIDERATION', 237)]	6	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnant'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy')]
PMC5024513	9/2016	S156-PMC5024513	['the pooled mean for Vitamin D status as reflected in Blood 25 (Oh)D in THIS REVIEW was significantly below recommended levels across all trimesters.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 71)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0000178', 'blood', 53, 'blood'), ('CHEBI_71657', 'versiconol acetate', 59, '25 (OH)D'), ('PR_000008838', 'serine protease HTRA1', 59, '25 (OH ... D')]
PMC5051327	9/2016	S2-PMC5051327	['in THIS PILOT STUDY, we HYPOTHESISED that low maternal Vitamin D levels are over-represented in Pregnancies with fetal distress/Birth asphyxia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 24)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancies'), ('GO_0007567', 'parturition', 128, 'birth')]
PMC5051327	9/2016	S11-PMC5051327	['IF OUR FINDINGS are SUPPORTED by FURTHER STUDIES, PREFERABLY on SEVERE Birth asphyxia, Vitamin D supplementation/sun exposure in Pregnancy MAY lower the risk of subsequent Birth asphyxia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 20), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 64), ('INCOMPLETE_EVIDENCE', 139)]	7	[('GO_0007567', 'parturition', 71, 'birth'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC5051327	9/2016	S12-PMC5051327	['caption (boxed-text)\nstrengths and limitations of THIS STUDY\nTHIS is the FIRST STUDY to SHOW that women who underwent an emergency caesarean section due to suspected fetal distress had lower Vitamin D levels in early Pregnancy as compared to those in a control group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('INCOMPLETE_EVIDENCE', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('INCOMPLETE_EVIDENCE', 88)]	5	[('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy')]
PMC5051327	9/2016	S20-PMC5051327	['the primary AIM of this PILOT STUDY was TO INVESTIGATE 25-Oh Vitamin D, the main MARKER of Vitamin D status, in women who underwent caesarean section DUE to suspected fetal distress COMPARED TO those who did not.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	6	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 55, '25-OH'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC5051327	9/2016	S45-PMC5051327	['TO STUDY the EFFECT of Vitamin D levels in early Pregnancy and the risk for Birth asphyxia, we divided the study population into two groups: those with vitamin d deficiency (25-Oh Vitamin D <50\u2005nmol/l, n=95) and those who were non-deficient (25-Oh Vitamin d ≥50\u2005nmol/l, n=78) (table 2).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 13)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('GO_0007567', 'parturition', 76, 'birth'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 174, '25-OH'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_82341', 'Methylazoxymethanol acetate', 242, '25-OH vitamin')]
PMC5051327	9/2016	S52-PMC5051327	['discussion\nTHIS PILOT STUDY is the FIRST to SHOW that women who underwent emergency caesarean section due to suspected fetal asphyxia had lower Vitamin D levels in early Pregnancy as COMPARED TO a control group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183)]	5	[('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
PMC5051327	9/2016	S54-PMC5051327	['IN FACT, the ONLY study PREVIOUSLY addressing THIS topic was performed in southern china, where Vitamin D deficiency is relatively UNCOMMON and no RELATION to Birth asphyxia was FOUND.19two randomised controlled studies of Antenatal Vitamin D supplementation REPORTED lower apgar score at 1 and 5\u2005min, respectively.2021in addition, in the latter study REPORTED, 13% of Vitamin D deficient newborn had apgar score at 5\u2005min <7, as compared TO 1.1% among those who were sufficient.21our observational study design disables us from investigating a causal RELATION between Vitamin D levels and fetal distress/Birth asphyxia.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 259), ('INCOMPLETE_EVIDENCE', 352), ('QUESTION_ANSWERED_BY_THIS_WORK', 438), ('SUPERFICIAL_RELATIONSHIP', 551)]	11	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007567', 'parturition', 159, 'birth'), ('GO_0007567', 'parturition', 223, 'antenatal'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('GO_0007567', 'parturition', 604, 'birth')]
PMC5051327	9/2016	S56-PMC5051327	['Vitamin D deficiency was ASSOCIATED with a significantly shorter Gestational age at Delivery, which is IN LINE WITH OTHER DATA.23furthermore, there SEEMS TO be an inverse RELATION between low active Vitamin D (1,25-Dihydroxy Vitamin D) and meconium-stained Amniotic Fluid, a sign of fetal distress, in Pregnancies complicated by Intrahepatic cholestasis.24\nthe FINDINGS that more than two-third of mothers were Vitamin D deficient during winter/spring season and one-third at summer are CONSISTENT with PREVIOUS reports.2526in THIS STUDY, we used the LIMITS of 25-Oh Vitamin D SUGGESTED by the iom,17BUT the discussion of WHAT levels SHOULD BE CONSIDERED deficient is ONGOING.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('ANOMALY_CURIOUS_FINDING', 148), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 361), ('INCOMPLETE_EVIDENCE', 487), ('INCOMPLETE_EVIDENCE', 503), ('QUESTION_ANSWERED_BY_THIS_WORK', 527), ('INCOMPLETE_EVIDENCE', 551), ('INCOMPLETE_EVIDENCE', 577), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 598), ('EXPLICIT_QUESTION', 622), ('FUTURE_WORK', 634), ('FUTURE_WORK', 644), ('IMPORTANT_CONSIDERATION', 668)]	16	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational'), ('GO_0007567', 'parturition', 84, 'delivery'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 210, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000173', 'amniotic fluid', 257, 'amniotic fluid'), ('GO_0007565', 'female pregnancy', 302, 'pregnancies'), ('UBERON_0001226', 'major calyx', 329, 'intrahepatic'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 561, '25-OH'), ('CHEBI_27300', 'vitamin D', 567, 'vitamin D')]
PMC5085625	9/2016	S18-PMC5085625	['HERE, it is hydroxylated to 25(Oh)D, a major form of Vitamin D found in the Blood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0)]	1	[('CHEBI_71657', 'versiconol acetate', 28, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000178', 'blood', 76, 'blood')]
PMC5085625	9/2016	S22-PMC5085625	['according TO the Endocrine society, insufficiency and deficiency of Vitamin D are DEFINED as concentrations of 25(Oh)D equal to 20–30 ng/ml and <20 ng/ml, respectively.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('PROBABLE_UNDERSTANDING', 82)]	2	[('UBERON_0005063', 'left ventricular compact myocardium', 17, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 111, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 117, 'D')]
PMC5085625	9/2016	S67-PMC5085625	['OUR FINDINGS are CONSISTENT with the results of ANOTHER STUDY conducted in a central european population, which also DOCUMENTED a high prevalence of Vitamin D deficiency [23].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 117)]	4	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC5085625	9/2016	S68-PMC5085625	['taking into account INCONCLUSIVE results of cross-sectional and cohort studies analyzing the ASSOCIATION between Vitamin D status and occurrence of Pregnancy pathologies [28,29], the AIM of OUR STUDY was to asses 25(Oh)D status in women with Gestational hypertension (gh).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('SUPERFICIAL_RELATIONSHIP', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 183), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('GO_0007565', 'female pregnancy', 242, 'gestational')]
PMC5085625	9/2016	S76-PMC5085625	['SIMILAR TO OUR STUDY, they FOUND no association between Vitamin D status, prevalence of gh, Blood pressure at early Gestation and mid-Pregnancy decrease in this parameter [30].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 27)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0000178', 'blood', 92, 'blood'), ('GO_0007565', 'female pregnancy', 116, 'gestation'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
PMC5085625	9/2016	S84-PMC5085625	['HENCE, we POSTULATE to conduct a well-designed randomized study TO ASSESS the ROLE of Vitamin D in the etiopathogenesis of gh.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 64), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5085625	9/2016	S92-PMC5085625	['in OUR STUDY, we determined Vitamin D status at a single time point, shortly before Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'delivery')]
PMC5085625	9/2016	S169-PMC5085625	['conclusions\nin CONCLUSION, both the results of PREVIOUS STUDIES and OUR FINDINGS PRESENTED HERE, documenting the LINK between Maternal deficiency of Vitamin D and the INCREASED RISK of Preeclampsia, POINT TO the IMPORTANT ROLE of an appropriate level and adequate Metabolism Of this Vitamin in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 91), ('SUPERFICIAL_RELATIONSHIP', 113), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 199), ('IMPORTANT_CONSIDERATION', 212), ('SUPERFICIAL_RELATIONSHIP', 222)]	10	[('GO_0007618', 'mating', 126, 'maternal'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 185, 'preeclampsia'), ('GO_0006583', 'melanin biosynthetic process from tyrosine', 264, 'metabolism of ... vitamin'), ('CHEBI_33229', 'vitamin (role)', 283, 'vitamin'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy')]
PMC5028238	10/2016	S85-PMC5028238	['this HAS BEEN used TO EXPLAIN WHY northern populations have a higher prevalence of slos.11\ncarriers also are HYPOTHESIZED to have a Reproductive advantage because of the reduced fetal death due to Rachitic Cephalopelvic disproportion.11,35this is again RELATED to increased Vitamin D Production causing improved bone formation.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('PROBABLE_UNDERSTANDING', 22), ('EXPLICIT_QUESTION', 30), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 253)]	6	[('GO_0000003', 'reproduction', 132, 'reproductive'), ('UBERON_0001286', "Bowman's space", 197, 'rachitic cephalopelvic'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 284, 'production')]
PMC5045784	10/2016	S87-PMC5045784	['there are several LIMITATIONS in OUR STUDY, including its SMALL sample size, risk of selection bias and lack of data on Prenatal Vitamin D supplementation and maternal 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('INCOMPLETE_EVIDENCE', 58)]	3	[('GO_0007565', 'female pregnancy', 120, 'prenatal'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 170, '(OH)D')]
PMC5062906	10/2016	S13-PMC5062906	['conclusions\nTHESE FINDINGS DEMONSTRATE that maternal Vitamin D status plays a ROLE in determining Dna Methylation state in the germline and Soma.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0006306', 'DNA methylation', 98, 'DNA methylation'), ('GO_0044297', 'cell body', 140, 'soma')]
PMC5062906	10/2016	S55-PMC5062906	['we INVESTIGATED both maternally and paternally methylated dmrs and compared methylation changes in offspring Liver and Sperm to characterize Vitamin D-dependent Regulation of epigenetic state in Soma and germline over two generations.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	1	[('UBERON_0002107', 'liver', 109, 'liver'), ('CL_0000019', 'sperm', 119, 'sperm'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0065007', 'biological regulation', 161, 'regulation'), ('GO_0044297', 'cell body', 195, 'soma')]
PMC5062906	10/2016	S59-PMC5062906	['we utilized reciprocal crosses between cc001/unc and cc011/unc (cross 1: cc001 female\u2009×\u2009cc011 male and cross 2: cc011 female\u2009×\u2009cc001 male) TO ASSESS the presence of parent of origin EFFECTS on phenotypic and epigenetic response to Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 139), ('SUPERFICIAL_RELATIONSHIP', 182)]	2	[('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
PMC5062906	10/2016	S63-PMC5062906	['HERE, we ASSESS (1) overall dietary EFFECTS (diet, maternal, or grandmaternal Vitamin D-deficient diet compared to control diet); (2) diet-independent parent/grandparent of origin EFFECTS (po/gpo, cross 1 compared to cross 2, samples from different diets combined); and (3) diet-dependent parent/grandparent of origin EFFECTS (diet\u2009×\u2009po/gpo, both diet and cross differences assessed in an interactive model).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 180), ('SUPERFICIAL_RELATIONSHIP', 318)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5062906	10/2016	S71-PMC5062906	['results\n\ndietary depletion of circulating Plasma 25(Oh)D is DEPENDENT on Genetic background\nTO DETERMINE the extent of Vitamin D depletion in g0dams Fed diet lacking Vitamin d (lvd) compared with dams on control diet (con) (fig.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 92)]	2	[('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('SO_0000704', 'gene', 73, 'genetic'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007631', 'feeding behavior', 149, 'fed'), ('CHEBI_33229', 'vitamin (role)', 166, 'vitamin')]
PMC5062906	10/2016	S89-PMC5062906	['panel above the graph lists all statistically significant ( p value <0.05) comparisons determined by regression analysis for overall diet-dependent effects (diet) and diet\u2009×\u2009strain INTERACTIVE EFFECTS (diet\u2009×\u2009strain)\n\nmaternal Vitamin D depletion alters g1and g2offspring developmental outcomes in a parent and grandparent of origin-DEPENDENT manner\nwe next ASSESSED WHETHER maternal Vitamin D depletion AFFECTS offspring developmental outcomes in a parent and grandparent of origin-DEPENDENT manner across multiple generations.']	[('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 193), ('SUPERFICIAL_RELATIONSHIP', 333), ('QUESTION_ANSWERED_BY_THIS_WORK', 358), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('SUPERFICIAL_RELATIONSHIP', 404), ('SUPERFICIAL_RELATIONSHIP', 483)]	7	[('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D')]
PMC5062906	10/2016	S153-PMC5062906	['maternal Vitamin D depletion alters Dna Methylation in Soma and germline of Adult g1and g2males in a parent and grandparent of origin-DEPENDENT manner\nwe INVESTIGATED WHETHER Vitamin D depletion AFFECTS Dna Methylation state at Imprinted Genes in g1and g2males and WHETHER these differences are LINKED to the developmental changes described above.']	[('SUPERFICIAL_RELATIONSHIP', 134), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('SUPERFICIAL_RELATIONSHIP', 195), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0006306', 'DNA methylation', 36, 'DNA methylation'), ('GO_0044297', 'cell body', 55, 'soma'), ('UBERON_0007023', 'adult organism', 76, 'adult'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0006306', 'DNA methylation', 203, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 228, 'imprinted'), ('SO_0000704', 'gene', 238, 'genes')]
PMC5062906	10/2016	S219-PMC5062906	['TO DETERMINE WHETHER the Vitamin D-dependent epigenetic perturbation REPORTED HERE results in transcriptional perturbation, we measured relative levels of igf2 , H19 , snrpn , and Grb10 in g2neonatal Liver.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 69), ('QUESTION_ANSWERED_BY_THIS_WORK', 78)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 162, 'H19'), ('PR_000008210', 'glutathione peroxidase 1', 180, 'Grb10'), ('UBERON_0002107', 'liver', 200, 'liver')]
PMC5062906	10/2016	S239-PMC5062906	['discussion\nthese data DEMONSTRATE that maternal Vitamin D depletion leads to perturbation of Dna Methylation at Imprinted domains in offspring Soma and germline over two successive generations.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0006306', 'DNA methylation', 93, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 112, 'imprinted'), ('GO_0044297', 'cell body', 143, 'soma')]
PMC5062906	10/2016	S249-PMC5062906	['THIS STUDY highlights the IMPORTANCE of maternal Vitamin D intake in determining molecular and phenotypic Birth outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 26)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth')]
PMC5062906	10/2016	S264-PMC5062906	['THEREFORE, the Vitamin D-dependent parent of origin EFFECTS REPORTED HERE MAY BE INFLUENCED by EITHER epigenetic mechanisms OR Genetic DIFFERENCES in cis or trans .']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	8	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic')]
PMC5062906	10/2016	S269-PMC5062906	['the grandmaternal dietary INFLUENCE on g2phenotype and epigenetic outcome we report HERE DEMONSTRATES inheritance of Vitamin D-induced epigenetic perturbation.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 84), ('INCOMPLETE_EVIDENCE', 89)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5062906	10/2016	S283-PMC5062906	['these observations SUGGEST that Vitamin D-induced changes in methylation are MOST LIKELY the result of sporadic epimutations due TO global dysregulation of epigenetic maintenance and that disruption of epigenetic Regulatory mechanisms is MOST LIKELY the causal FACTOR.']	[('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 77), ('PROBABLE_UNDERSTANDING', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 129), ('PROBABLE_UNDERSTANDING', 238), ('PROBABLE_UNDERSTANDING', 243), ('SUPERFICIAL_RELATIONSHIP', 261)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 213, 'regulatory')]
PMC5064894	10/2016	S21-PMC5064894	['Vitamin D HAS BEEN SHOWN to Modulate the Innate Immune Response in Lung Epithelial Cells [6,7], and Antimicrobial peptides induced by Vitamin D MAY have antiviral EFFECTS BASED on observed activity against Herpes Simplex Virus-1 (Hsv-1) [8], adenovirus [9], human immunodeficiency virus (hiv) [10] and vaccinia [11].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 163), ('QUESTION_ANSWERED_BY_THIS_WORK', 171)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0065007', 'biological regulation', 28, 'modulate'), ('GO_0045087', 'innate immune response', 41, 'innate immune response'), ('UBERON_0002405', 'immune system', 48, 'immune'), ('CL_0000082', 'epithelial cell of lung', 67, 'lung epithelial cells'), ('UBERON_0000115', 'lung epithelium', 67, 'lung epithelial'), ('CHEBI_65381', 'albizoside C', 100, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000008476', 'orexin', 206, 'herpes simplex virus'), ('NCBITaxon_10088', 'Mus <genus>', 230, 'HSV'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 230, 'HSV-1')]
PMC5064894	10/2016	S42-PMC5064894	['THIS STUDY is integrated into a randomized clinical trial of maternal Vitamin D supplementation for which the primary outcome is length at one year of age (maternal Vitamin D for infant Growth (mdig) trial, clinicaltrials.org identifier nct01924013), currently underway in dhaka, bangladesh and funded by the bill and melinda gates foundation (achieving health growth platform grant opp1066764) [30].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0)]	1	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 165, 'Vitamin D'), ('GO_0006099', 'tricarboxylic acid cycle', 186, 'Growth')]
PMC5064894	10/2016	S45-PMC5064894	['we AIM to quantify the EFFECT of maternal Vitamin D supplementation on the relative incidence of, a) microbiologically confirmed ari (primary outcome); b) ari due to influenza (a&b) and Rsv; c) clinical ari; and, d) s. pneumococcus nasal carriage density.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 23)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 186, 'RSV')]
PMC5064894	10/2016	S163-PMC5064894	['THIS will TEST the core mechanistic HYPOTHESIS that IMPROVEMENTS in Vitamin D status via maternal Vitamin D supplementation reduce the RISK of ari among infants in dhaka.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 52), ('IMPORTANT_CONSIDERATION', 135)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC5064894	10/2016	S168-PMC5064894	['we thus maintain 80\xa0% power to address the QUESTION of WHETHER maternal Vitamin D supplementation CAN reduce the rate of microbiologically-confirmed acute Respiratory infections, while simultaneously being able to address WHETHER lower doses are also EFFECTIVE, and TO INVESTIGATE WHETHER a dose–response RELATIONSHIP exists, thereby SUPPORTING the biological PLAUSIBILITY and robustness of inferences.']	[('EXPLICIT_QUESTION', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 55), ('EXPLICIT_QUESTION', 55), ('INCOMPLETE_EVIDENCE', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 222), ('SUPERFICIAL_RELATIONSHIP', 251), ('QUESTION_ANSWERED_BY_THIS_WORK', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('SUPERFICIAL_RELATIONSHIP', 305), ('INCOMPLETE_EVIDENCE', 334), ('INCOMPLETE_EVIDENCE', 360)]	11	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 155, 'respiratory')]
PMC5064894	10/2016	S185-PMC5064894	['a specific pairwise comparison between the 28,000\xa0iu/week Prenatal\u2009+\u2009Postpartum group (group e) will be compared to 28,000\xa0iu/week without Postpartum supplementation (group d) TO IDENTIFY the IMPACT of continuing Vitamin D supplementation in the Postpartum period.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 176), ('SUPERFICIAL_RELATIONSHIP', 192)]	2	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('GO_0007565', 'female pregnancy', 69, 'postpartum'), ('GO_0007565', 'female pregnancy', 139, 'postpartum'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'postpartum')]
PMC5064894	10/2016	S193-PMC5064894	['discussion\nthe mdari study in dhaka, bangladesh leverages the infrastructure of a large randomized placebo controlled, dose-ranging trial of maternal Vitamin D supplementation during Pregnancy and Lactation in bangladesh TO TEST the HYPOTHESIS that maternal Vitamin D supplementation CAN decrease infant Respiratory infections during the HIGH RISK first 6\xa0months of infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 221), ('INCOMPLETE_EVIDENCE', 233), ('INCOMPLETE_EVIDENCE', 284), ('IMPORTANT_CONSIDERATION', 338)]	4	[('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnancy'), ('GO_0007595', 'lactation', 197, 'lactation'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 304, 'respiratory')]
PMC5084041	10/2016	S1-PMC5084041	['the AIM was TO STUDY the DETERMINANTS of change in Vitamin D status during Pregnancy and of Vitamin D deficiency (<30 nmol/l) in early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy')]
PMC5084041	10/2016	S37-PMC5084041	['materials and methods\nthe gravid study was DESIGNED TO INVESTIGATE the ASSOCIATION of Vitamin D status during Pregnancy with Preeclampsia and Pregnancy-induced hypertension.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 125, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy')]
PMC5084041	10/2016	S110-PMC5084041	['discussion\noverall, OUR FINDINGS SHOW that the prevalence of Vitamin D deficiency is low among Pregnant women in sweden.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 33)]	2	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant')]
PMC5084041	10/2016	S113-PMC5084041	['OUR FINDINGS SHOW that the prevalence of Vitamin D deficiency is 10% overall and 2% among women Born in north europe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'born')]
PMC5084041	10/2016	S124-PMC5084041	['in OUR STUDY, the proportion of women using Vitamin D supplements was SIMILAR at t1 and t3, but IT IS POSSIBLE that supplement use CONTRIBUTED to the increase in 25(Oh)D if supplementation was initiated shortly before t1.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 131)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 162, '25(OH)D')]
PMC5084041	10/2016	S138-PMC5084041	['moon et al SHOWED that Vitamin D supplementation is RELATED to changes in 25(Oh)D between the first and the third trimester, which SUPPORTS OUR FINDINGS [12].']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 140)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 74, '25(OH)D')]
PMC5084041	10/2016	S143-PMC5084041	['a LIMITATION of THIS STUDY is that sampling was overrepresented during autumn and spring, when Vitamin D status is highest and lowest, respectively.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5129897	10/2016	S22-PMC5129897	['diseases included in THIS STUDY along with a brief overview of the mechanisms of Vitamin D for each disease and a listing of a few observational studies and clinical trials in support.diseasemechanismsobservational studiesclinical trialscancereffects on cells, Angiogenesis, and metastasis10breast and Colorectal cancer incidence11; survival12breast and all-cancer incidence13cvdeffects on Serum Cholesterol levels, Arterial stiffness, Insulin resistance, hyperglycemia, and increased incident Metabolic syndrome are POTENTIALLY PLAUSIBLE mediators8refs.14,15effect on cvd risk factors16dementiaregulation of Calcium Homeostasis, clearance of Amyloid-Β peptide, antioxidant and anti-inflammatory EFFECTS, and POSSIBLE protection against the neurodegenerative mechanisms ASSOCIATED with ad17incidence18\xa0dmimproves Insulin sensitivity and secretion, mainly via its anti-inflammatory properties19incidence20; meta-analysis21\xa0falls and fracturesreduces bone mass loss by reducing inflammation22; maintains cognition23; helps maintain muscle mass24ref.25ref.26mseffects on Regulatory T and B Cells27Ref.28\xa0respiratory infectionsinduction of Cathelicidin and defensins29; strengthens Adaptive and innate Immune System30Pneumonia31Influenza32,33; ari34\nad, alzheimer disease; ari, acute Respiratory Tract infection; cvd, Cardiovascular disease; dm, diabetes mellitus; ms, multiple sclerosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 517), ('INCOMPLETE_EVIDENCE', 529), ('SUPERFICIAL_RELATIONSHIP', 696), ('INCOMPLETE_EVIDENCE', 709), ('SUPERFICIAL_RELATIONSHIP', 770)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0001525', 'angiogenesis', 261, 'angiogenesis'), ('UBERON_0012652', 'colorectum', 302, 'colorectal'), ('UBERON_0001977', 'blood serum', 390, 'serum'), ('CHEBI_16113', 'cholesterol', 396, 'cholesterol'), ('UBERON_0001637', 'artery', 416, 'arterial'), ('PR_000045358', 'insulin family protein', 436, 'insulin'), ('GO_0008152', 'metabolic process', 494, 'metabolic'), ('GO_0055073', 'cadmium ion homeostasis', 609, 'calcium homeostasis'), ('PR_000004519', 'autism susceptibility gene 2 protein', 643, 'amyloid-β'), ('PR_000045358', 'insulin family protein', 813, 'insulin'), ('CL_0000815', 'regulatory T cell', 1068, 'regulatory T ...'), ('GO_0065007', 'biological regulation', 1068, 'regulatory'), ('CL_0000960', 'T3 B cell', 1085, 'B cells27Ref'), ('PR_000006009', 'alpha-catulin', 1136, 'cathelicidin'), ('GO_0051886', 'negative regulation of timing of anagen', 1178, 'adaptive ...'), ('UBERON_0003822', 'forelimb stylopod', 1198, 'immune system30Pneumonia31Influenza32'), ('UBERON_0000065', 'respiratory tract', 1280, 'respiratory tract'), ('UBERON_0004535', 'cardiovascular system', 1314, 'cardiovascular')]
PMC5129897	10/2016	S23-PMC5129897	['the PURPOSE of THIS NEW STUDY is to revisit Vitamin D concentrations of canadians and to ESTIMATE the economic BENEFIT of increasing 25(Oh)D concentrations, with the knowledge that overall 25(Oh)D concentrations have gone down since our PREVIOUS STUDY.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('FULL_UNKNOWN', 20), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 111), ('INCOMPLETE_EVIDENCE', 237)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 139, 'D'), ('CHEBI_71657', 'versiconol acetate', 189, '25(OH)D')]
PMC5129897	10/2016	S134-PMC5129897	['the total economic BURDEN of the Vitamin D–sensitive diseases CONSIDERED HERE is ESTIMATED at $79.1\xa0billion in 2016 (table\xa08).']	[('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 73), ('INCOMPLETE_EVIDENCE', 81)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5129897	10/2016	S161-PMC5129897	['those ESTIMATES are SIMILAR TO those in the PREVIOUS PAPER on THIS topic, which ESTIMATED that if the 25(Oh)D concentration of all canadians were raised from a mean value of 67\xa0nmol/l to 105\xa0nmol/l, the death rate could fall by 37,000 (22,300–52,300 deaths), REPRESENTING 16.1% (9.7%–22.7%) of annual deaths, and the economic BURDEN could fall by 6.9% (3.8%–10.0%), or $14.4\xa0billion ($8.0\xa0billion–$20.1\xa0billion).89that paper CONSIDERED HOW Vitamin D AFFECTS cancer, cvd, dm, falls and fractures, Heart disease, influenza and pneumonia, ms, and septicemia as well as Pregnancy and Birth outcomes.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 259), ('IMPORTANT_CONSIDERATION', 326), ('INCOMPLETE_EVIDENCE', 425), ('EXPLICIT_QUESTION', 436), ('SUPERFICIAL_RELATIONSHIP', 450)]	11	[('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D'), ('UBERON_0000948', 'heart', 496, 'heart'), ('GO_0007565', 'female pregnancy', 566, 'pregnancy'), ('GO_0007567', 'parturition', 580, 'birth')]
PMC5133057	10/2016	S116-PMC5133057	['[42], where the authors assessed the nutritional status of 75 Pregnant adolescents in venezuela, using the same cutoff points as in OUR STUDY and FOUND low weight in 34.6% of the sample, which also presented insufficient Intake of energy, protein, zinc, Calcium, and Vitamin A.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('INCOMPLETE_EVIDENCE', 146)]	2	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('GO_0007631', 'feeding behavior', 221, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 254, 'calcium'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin A')]
PMC5133057	10/2016	S128-PMC5133057	['moreover, considering the high prevalence of vad OBSERVED in THIS STUDY, as well as its IMPACT on the Pregnancy process, there is a NEED FOR regular assessment of the nutritional status of Prenatal Vitamin A in teens in order to achieve early diagnosis and proper management of this nutritional deficiency.']	[('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('SUPERFICIAL_RELATIONSHIP', 88), ('FUTURE_WORK', 132)]	4	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 189, 'prenatal'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin A')]
PMC5095257	11/2016	S83-PMC5095257	['TO EXPLORE the POSSIBLE EFFECT of uvb radiation exposure, which IS KNOWN to INFLUENCE Vitamin D status, on the seasonality pattern OBSERVED in aad, we compared monthly ors (supplemental figure 1) dividing the cohort into 2 groups according to geographical latitude.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 131)]	6	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5387760	11/2016	S188-PMC5387760	['the advantage of Ca Intake to the Human body also DEPENDS ON OPTIMAL levels of Vitamin D. OUR STUDY’s ability TO DETERMINE multiple INTERACTION EFFECTS among different Micronutrients and Vitamins in RELATION to Birth outcomes and early child survival was LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('QUESTION_ANSWERED_BY_THIS_WORK', 110), ('SUPERFICIAL_RELATIONSHIP', 132), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 199), ('INCOMPLETE_EVIDENCE', 255)]	8	[('CHEBI_32588', 'potassium chloride', 17, 'Ca'), ('GO_0007631', 'feeding behavior', 20, 'intake'), ('NCBITaxon_9606', 'Homo sapiens', 34, 'human'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_33839', 'macromolecule', 168, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 187, 'vitamins'), ('GO_0007567', 'parturition', 211, 'birth')]
PMC5118763	12/2016	S23-PMC5118763	['in THIS ARTICLE, our AIMS were to compare the effectiveness of different Prenatal Food and Micronutrient regimens as well as the efficacy per Micronutrient capsule in women’s Vitamin B-12, Folate, ferritin, and zinc status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 21)]	2	[('GO_0007565', 'female pregnancy', 73, 'prenatal'), ('CHEBI_33290', 'food', 82, 'food'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 91, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 142, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 175, 'vitamin B-12'), ('CHEBI_30863', '5-azaorotic acid', 189, 'folate')]
PMC5118763	12/2016	S151-PMC5118763	['discussion\nin THIS STUDY, women who were assigned to the mmn regimen had higher concentrations of Plasma Vitamin B-12 at week 30 of Pregnancy, but no other differences between Food and Micronutrient regimens were OBSERVED.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 213)]	2	[('UBERON_0001969', 'blood plasma', 98, 'plasma'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 105, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 132, 'pregnancy'), ('CHEBI_33290', 'food', 176, 'food'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 185, 'micronutrient')]
PMC5118763	12/2016	S161-PMC5118763	['DESPITE supplementation, Plasma Vitamin B-12 decreased from early to late Gestation for all 3 Micronutrient types in OUR STUDY.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 117)]	2	[('UBERON_0001969', 'blood plasma', 25, 'plasma'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 32, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 94, 'micronutrient')]
PMC5146866	12/2016	S0-PMC5146866	['prevalence and RISK factors for Vitamin D insufficiency and deficiency at Birth and ASSOCIATED outcome\n\nabstract\n\nbackground\noccurrence and consequence of Cord Blood (Cb) Vitamin D insufficiency/deficiency has not BEEN ADEQUATELY explored DESPITE rising CONCERN regarding THIS topic in pediatrics.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 84), ('INCOMPLETE_EVIDENCE', 214), ('ANOMALY_CURIOUS_FINDING', 239), ('PROBLEM_COMPLICATION', 254), ('QUESTION_ANSWERED_BY_THIS_WORK', 272)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007567', 'parturition', 74, 'birth'), ('UBERON_0002240', 'spinal cord', 155, 'cord'), ('UBERON_0000178', 'blood', 160, 'blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 167, 'CB'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5146866	12/2016	S1-PMC5146866	['THIS STUDY was DESIGNED TO DETERMINE the rate, maternal RISK FACTORS, and clinical outcomes in infants in ASSOCIATION with Vitamin D insufficient/deficient status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007567', 'parturition', 166, 'birth')]
PMC5146866	12/2016	S3-PMC5146866	['we used descriptive statistics and multiple regression models TO IDENTIFY the rate and factors associated with Vitamin D deficiency/insufficiency and RELATED outcomes in the enrolled mother-infant pairs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('SUPERFICIAL_RELATIONSHIP', 150)]	2	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC5146866	12/2016	S10-PMC5146866	['OUR FINDINGS RAISE a QUESTION regarding the adequacy of the aap RECOMMENDED Vitamin D supplementation REQUIREMENTS without knowing the infant’s Vitamin D status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('EXPLICIT_QUESTION', 13), ('EXPLICIT_QUESTION', 21), ('FUTURE_WORK', 64), ('IMPORTANT_CONSIDERATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007567', 'parturition', 164, 'birth')]
PMC5146866	12/2016	S16-PMC5146866	['SEVERAL STUDIES were designed TO IDENTIFY the rates of Vitamin D insufficiency in cb of infants Born to different maternal populations.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'born')]
PMC5146866	12/2016	S26-PMC5146866	['TO THE BEST OF OUR KNOWLEDGE, OUR STUDY is the FIRST that in addition to identifying the rate, also ESTIMATES the risk of Vitamin D deficiency/insufficiency in the cb and ASSOCIATED outcome in a diverse population of infants.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 171)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC5146866	12/2016	S41-PMC5146866	['THEREFORE, the total level of cb Vitamin D measured in THIS STUDY is equal to [25(Oh)D3] levels, which is the main contributor to the [25(Oh)D] pool.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 55)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_62946', 'ammonium sulfate', 79, '25(OH)D3'), ('CHEBI_71657', 'versiconol acetate', 135, '25(OH)D')]
PMC5146866	12/2016	S82-PMC5146866	['OUR FINDINGS confirmed PREVIOUS reports SHOWING an INCREASED RISK for Vitamin D deficiency in infants Born to mothers of non-white race/ethnicity [11,14,15,28].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 40), ('IMPORTANT_CONSIDERATION', 51)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'born')]
PMC5146866	12/2016	S95-PMC5146866	['in the PRESENT STUDY, evaluation of the neonatal clinical data did NOT reveal any obvious association between cb Vitamin D levels and neonatal health status during the short period of Birth hospitalization.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('ANOMALY_CURIOUS_FINDING', 67)]	2	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007567', 'parturition', 184, 'birth')]
PMC5146866	12/2016	S105-PMC5146866	['we would like to highlight the strengths of the PRESENT report that include: (i) prospective observation of a sufficient number and diverse population of mother-infant pairs, (ii) use of 95% confidence intervals to present the POTENTIAL variability in prevalence of Vitamin D deficiency/ insufficiency in cb, (iii) use of regression models for identifying maternal FACTORS that increase the risk for Vitamin D deficiency/insufficiency in infant at Birth, and (iv) reporting clinical characteristics of the neonates in ASSOCIATION with their Vitamin D status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 365), ('SUPERFICIAL_RELATIONSHIP', 518)]	4	[('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 400, 'vitamin D'), ('GO_0007567', 'parturition', 448, 'birth'), ('CHEBI_27300', 'vitamin D', 541, 'vitamin D'), ('GO_0007567', 'parturition', 561, 'birth')]
PMC5155676	12/2016	S24-PMC5155676	['we THEREFORE undertook THIS STUDY TO DETERMINE maternal characteristics ASSOCIATED with achieved 25(Oh)D after Antenatal Vitamin D supplementation in the context of a double-blind, randomized, placebo-controlled trial.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 103, 'D'), ('GO_0007567', 'parturition', 111, 'antenatal'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC5155676	12/2016	S125-PMC5155676	['ALTHOUGH OUR FINDINGS are NOVEL, and MAY enable the development of individualized ADVICE for Antenatal Vitamin D supplementation, there are a NUMBER OF LIMITATIONS which SHOULD BE CONSIDERED in the INTERPRETATION of this study.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FULL_UNKNOWN', 26), ('INCOMPLETE_EVIDENCE', 37), ('FUTURE_WORK', 82), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 152), ('PROBLEM_COMPLICATION', 152), ('FUTURE_WORK', 170), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 198)]	11	[('GO_0007567', 'parturition', 93, 'antenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC5155676	12/2016	S136-PMC5155676	['FUTURE STUDIES SHOULD AIM to determine appropriate doses to enable consistent repletion of 25(Oh)D during Pregnancy, and OUR FINDINGS SUPPORT the NOTION that clinical approaches to Vitamin D repletion MAY BE informed by individual characteristics.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 121), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 201)]	6	[('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 93, '(OH ... D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC5223368	12/2016	S144-PMC5223368	['THEREFORE, the positive ASSOCIATION between high temperature at the third Trimester and increased Birth length in THIS STUDY MIGHT be PARTLY EXPLAINED by Vitamin D status of mothers [31].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 114), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 134), ('PROBABLE_UNDERSTANDING', 141)]	6	[('GO_0009294', 'DNA mediated transformation', 74, 'trimester'), ('GO_0007567', 'parturition', 98, 'birth'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5223368	12/2016	S185-PMC5223368	['one of the LIMITATIONS of THIS STUDY was that FACTORS which COULD AFFECT Birth size such as maternal dietary information and maternal Vitamin D status during Pregnancy were NOT available.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 173)]	6	[('GO_0007567', 'parturition', 73, 'birth'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
PMC5318550	2/2017	S5-PMC5318550	['we EXPLORED how adjusting for socioeconomic status and maternal iq, Childbirth outcomes, Pregnancy Vitamin D status, nutritional intake, exposure to infections, and child age relative to peers in class changed the RELATION between season of Birth and child iq.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 214)]	2	[('GO_0007623', 'circadian rhythm', 68, 'childbirth'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007567', 'parturition', 241, 'birth')]
PMC5332602	3/2017	S182-PMC5332602	['this is IN AGREEMENT with the uniform suppression of the various innate Immune parameters evaluated in THIS STUDY and ASSOCIATED with protein deficiency versus concurrent up- or downregulation of those in Vitamin A-deficient Pigs (31).']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('SUPERFICIAL_RELATIONSHIP', 118)]	3	[('UBERON_0002405', 'immune system', 72, 'immune'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 225, 'pigs')]
PMC5332602	3/2017	S233-PMC5332602	['Serum samples collected at the end of the experiment were submitted to marshfield labs (marshfield, wi) and the diagnostic center for population and Animal health (michigan state university, east lansing, mi) TO ASSESS levels of protein/albumin/Glucose and Vitamin A/Vitamin E/Selenium, respectively.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 209)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('NCBITaxon_33208', 'Metazoa', 149, 'Animal'), ('CHEBI_17234', 'glucose', 245, 'glucose'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 277, 'selenium')]
PMC5340372	3/2017	S2-PMC5340372	['the AIM of THIS STUDY was TO INVESTIGATE the IMPACT of Perinatal Vitamin D levels on Respiratory function and disease outcome in infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 45)]	4	[('GO_0036268', 'swimming', 55, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 55, 'perinatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 85, 'respiratory')]
PMC5340372	3/2017	S26-PMC5340372	['the primary PURPOSE of this study was TO INVESTIGATE the EFFECT of Perinatal Vitamin D levels on the performance of Respiratory function in infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('GO_0036268', 'swimming', 67, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 67, 'perinatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 116, 'respiratory')]
PMC5340372	3/2017	S117-PMC5340372	['in THIS STUDY, infants with low 25(Oh)D had higher rrs BUT SIMILAR vmaxfrc, which IMPLIES that low Perinatal Vitamin D levels MIGHT be ASSOCIATED with a higher resistance of the Extrathoracic Airway.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ANOMALY_CURIOUS_FINDING', 55), ('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135)]	6	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('GO_0036268', 'swimming', 99, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 99, 'perinatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0001601', 'extra-ocular muscle', 178, 'extrathoracic airway')]
PMC5340372	3/2017	S136-PMC5340372	['second, our PREVIOUS report CONCLUDED that relatively low Vitamin D levels were COMMON in the patch population sample of children and young Adults with an inverse CORRELATION between 25(Oh)D level and age being SHOWN HERE [51].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 80), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 211), ('QUESTION_ANSWERED_BY_THIS_WORK', 217)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0007023', 'adult organism', 140, 'adults'), ('CHEBI_33010', 'chromide(1-)', 185, '(OH)D')]
PMC5340372	3/2017	S143-PMC5340372	['last, the sample size was rather SMALL, and the Vitamin D levels of the participants were GENERALLY SUBOPTIMAL in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 90), ('IMPORTANT_CONSIDERATION', 100), ('QUESTION_ANSWERED_BY_THIS_WORK', 114)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5340372	3/2017	S148-PMC5340372	['we BELIEVE that THIS STUDY PROVIDES a CLEARER UNDERSTANDING of the EFFECT of Perinatal Vitamin D levels on Respiratory function and Respiratory outcome in infancy.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('PROBABLE_UNDERSTANDING', 27), ('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 67)]	5	[('GO_0036268', 'swimming', 77, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 77, 'perinatal'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory'), ('UBERON_0001004', 'respiratory system', 132, 'respiratory')]
PMC5351212	3/2017	S4-PMC5351212	['in addition, given the KNOWN immunomodulatory and neuroprotective EFFECTS of Vitamin D, we also INVESTIGATED WHETHER the co-administration of Vitamin D COULD block mia-induced asd-related behaviors.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109), ('INCOMPLETE_EVIDENCE', 152)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5351212	3/2017	S5-PMC5351212	['we co-administered the hormonally active form of Vitamin D, 1Α,25 Dihydroxy Vitamin D3 (1,25Ohd), simultaneously with Poly(I:c) and EXAMINED (i) social interaction, stereotyped behavior, Emotional Learning and Memory, and innate anxiety-like behavior in juveniles and (ii) the levels of the pro-inflammatory cytokines Il-1Β, Il-6 and Tnf-Α in maternal Plasma and fetal Brains.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 132)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_50049', 'D-cystyl group', 60, '1α,25 dihydroxy'), ('CHEBI_33279', 'vitamin D5', 76, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 76, 'vitamin D3'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 90, '25OHD'), ('CHEBI_37311', 'einsteinium molecular entity', 118, 'poly'), ('CHEBI_51686', 'haematoxylin', 123, 'I'), ('GO_0007566', 'embryo implantation', 187, 'emotional'), ('GO_0007612', 'learning', 197, 'learning'), ('GO_0007613', 'memory', 210, 'memory'), ('PR_000001383', 'interleukin-22', 318, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 325, 'IL-6'), ('PR_000000134', 'tumor necrosis factor alpha', 334, 'TNF-α'), ('UBERON_0001969', 'blood plasma', 352, 'plasma'), ('UBERON_0000955', 'brain', 369, 'brains')]
PMC5351212	3/2017	S39-PMC5351212	['(b) GIVEN the anti-inflammatory properties of Vitamin D, the PRESENT STUDY was DESIGNED TO INVESTIGATE WHETHER use of Calcitriol, [1α, 25-Dihydroxy Vitamin D3 (1,25Ohd)], the hormonally active form of Vitamin D, COULD prevent Poly(I:C)-induced behavioral dysfunctions RELEVANT TO asd, including deficits in Social Interaction, stereotyped behavior, innate anxiety, and Emotional Learning.']	[('PROBABLE_UNDERSTANDING', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 212), ('SUPERFICIAL_RELATIONSHIP', 268)]	7	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 118, 'calcitriol'), ('CHEBI_43176', 'hydroxy group', 138, 'dihydroxy'), ('CHEBI_33279', 'vitamin D5', 148, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 148, 'vitamin D3'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 162, '25OHD'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('CHEBI_77358', 'CDP-dipalmitoyl-sn-glycerol', 226, 'poly(I:C'), ('GO_0019417', 'sulfur oxidation', 307, 'social interaction'), ('GO_0050959', 'echolocation', 369, 'emotional learning')]
PMC5351212	3/2017	S262-PMC5351212	['HOWEVER, the fact that mia with poly(I:c) has induced abnormalities in Social Interaction and Cognition at a more translationally RELEVANT age, i.e., juveniles, together with the presence of behavioral abnormalities not normally associated with schizophrenia such as altered digging behavior SUGGEST to us that this Animal MODEL MAY have greater relevance to asd\n\nvitddoes not alter maternal or fetal inflammatory Cytokine Production\nin VIEW OF the KNOWN immunomodulatory EFFECTS of Vitamin D, an obvious neuroprotective mechanism explored HERE was the POSSIBILITY that vitdameliorates the inflammatory response induced by Poly(I:c).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 292), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 329), ('INCOMPLETE_EVIDENCE', 437), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 472), ('QUESTION_ANSWERED_BY_THIS_WORK', 540), ('INCOMPLETE_EVIDENCE', 553)]	10	[('CHEBI_51686', 'haematoxylin', 37, 'I'), ('GO_0019417', 'sulfur oxidation', 71, 'social interaction'), ('GO_0050890', 'cognition', 94, 'cognition'), ('NCBITaxon_33208', 'Metazoa', 316, 'animal'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 414, 'cytokine production'), ('CHEBI_27300', 'vitamin D', 483, 'vitamin D'), ('CHEBI_37311', 'einsteinium molecular entity', 623, 'poly'), ('CHEBI_51686', 'haematoxylin', 628, 'I')]
PMC5351212	3/2017	S304-PMC5351212	['finally, GIVEN that mia and maternal Vitamin D deficiency are both risk-modifying factors for autism and GIVEN that the distinct OVERLAP in behavioral phenotypes produced in the Animal MODELS of these environmental RISK FACTORS, we ADDRESSED the issue of WHETHER mia induces Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 215), ('QUESTION_ANSWERED_BY_THIS_WORK', 232), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 178, 'animal'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC5359891	3/2017	S53-PMC5359891	['taken TOGETHER, there is strong SUPPORT for NEW intervention studies commencing before Pregnancy to provide myo-inositol and Probiotics, and to improve maternal Vitamin B6, Vitamin B12, Vitamin D and zinc status, AIMED at optimising maternal glycaemia and Glucose supply to the Feto-Placental Unit to promote healthy offspring growth and body composition.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 44), ('QUESTION_ANSWERED_BY_THIS_WORK', 213)]	4	[('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_26346', 'prostaglandins J', 125, 'probiotics'), ('CHEBI_33237', 'vitamin D4', 161, 'vitamin B6'), ('CHEBI_33229', 'vitamin (role)', 173, 'vitamin'), ('CHEBI_27778', 'abequose', 181, 'B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 181, 'B12'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_17234', 'glucose', 256, 'glucose'), ('UBERON_0000981', 'femur', 278, 'feto'), ('UBERON_0013765', 'digestive system element', 283, 'placental unit')]
PMC5372327	3/2017	S47-PMC5372327	['BASED ON epidemiological studies, low maternal Intake of Vitamin D at Pregnancy and low Cord Blood 25-Ohd concentration HAVE BEEN ASSOCIATED with a higher risk for asthma, allergic rhinitis and atopic eczema in the offspring, as assessed at 5\xa0years of age [35–38].']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 130)]	4	[('GO_0007631', 'feeding behavior', 47, 'intake'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_72765', 'verruculogen', 99, '25-OHD')]
PMC5372327	3/2017	S66-PMC5372327	['overall AIMS and research questions\nthe AIM of the STUDY is TO INVESTIGATE long-term health benefits of early Vitamin D supplementation with a dose ensuring effective concentration of 25-Ohd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 40), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 60)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 184, '25-OHD')]
PMC5372327	3/2017	S68-PMC5372327	['we HYPOTHESISE that a higher Vitamin D supplementation to infants between 2\xa0weeks and 24\xa0months of age will increase bone strength and decrease the frequency of infections.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5372327	3/2017	S122-PMC5372327	['discussion\nTO THE BEST OF OUR KNOWLEDGE, THIS is the largest and MOST COMPREHENSIVE randomised intervention STUDY TO ASSESS the EFFECTS of Vitamin D supplementation on Skeletal and extra Skeletal outcomes in infants.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('PROBABLE_UNDERSTANDING', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 108), ('QUESTION_ANSWERED_BY_THIS_WORK', 114), ('SUPERFICIAL_RELATIONSHIP', 128)]	6	[('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0004288', 'skeleton', 168, 'skeletal'), ('UBERON_0004288', 'skeleton', 187, 'skeletal')]
PMC5385921	4/2017	S2-PMC5385921	['AIMS\nTO DETERMINE the ASSOCIATION between Gestational Vitamin D status and asd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 22)]	3	[('GO_0007565', 'female pregnancy', 42, 'gestational'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5385921	4/2017	S15-PMC5385921	['THIS STUDY REPORTED lower 25-Hydroxyvitamin D (25Ohd) concentrations in neonatal samples from the asd cases compared with their unaffected siblings.6RECENTLY, a chinese asd case–control study ( n =68 cases) compared first trimester (11–13 weeks) maternal 25Ohd concentrations and REPORTED significantly lower concentrations of 25Ohd in the asd cases compared with their gender- and age-matched controls.12\nwe RECENTLY REPORTED an ASSOCIATION between developmental Vitamin D deficiency and a measure of social impairment within the autism spectrum, based on a large dutch Birth cohort.13in this study, Vitamin D was measured at two occasions: at mid-Gestation and at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 148), ('INCOMPLETE_EVIDENCE', 280), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 430)]	7	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 26, '25-hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 47, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 255, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 327, '25OHD'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('GO_0007567', 'parturition', 571, 'birth'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0007565', 'female pregnancy', 649, 'gestation'), ('GO_0007567', 'parturition', 666, 'birth')]
PMC5385921	4/2017	S121-PMC5385921	['the FINDING from THIS STUDY LENDS weight to the GROWING BODY of epidemiological and Animal MODEL-based research LINKING Gestational Vitamin D deficiency and altered Brain Development.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 112)]	6	[('NCBITaxon_33208', 'Metazoa', 84, 'animal'), ('GO_0007565', 'female pregnancy', 120, 'gestational'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007420', 'brain development', 165, 'brain development'), ('UBERON_0000955', 'brain', 165, 'brain')]
PMC5405075	4/2017	S11-PMC5405075	['several OBSERVATIONAL STUDIES explored THIS issue and SUGGESTED a PUTATIVE PROTECTIVE ROLE of Prenatal Vitamin D sufficiency in the development Of Wheezing and Asthma in the offspring [reviewed in ref.']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 66), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 86)]	6	[('GO_0007565', 'female pregnancy', 94, 'prenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0001503', 'ossification', 144, 'of wheezing'), ('GO_0006953', 'acute-phase response', 160, 'asthma')]
PMC5405075	4/2017	S14-PMC5405075	['in THIS mini-REVIEW ARTICLE, we AIM to present the CURRENT KNOWLEDGE as it EMERGES from studies FOCUSED on the IMPACT of maternal Vitamin D status and Vitamin d supplementation on the Development Of Asthma in early childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 75), ('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 111)]	7	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 151, 'vitamin'), ('GO_0009602', 'detection of symbiont', 184, 'development of asthma')]
PMC5405075	4/2017	S38-PMC5405075	['CONSEQUENTLY, longitudinal studies measuring 25(Oh)D levels, a POSSIBLE more objective INDICATOR of Vitamin D status, were DESIGNED TO explore the POSSIBLE IMPACT of Vitamin D on asthma-like symptoms or asthma.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 87), ('QUESTION_ANSWERED_BY_THIS_WORK', 123), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 156)]	7	[('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 47, '('), ('PR_000006444', 'diacylglycerol kinase delta', 51, 'D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC5426325	4/2017	S1-PMC5426325	['by means of a nationwide mandatory Vitamin D fortification programme, we EXAMINED the risk of fractures among 10–18-year-old children from proximate birth cohorts Born around the date of the termination of the programme.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 73)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007567', 'parturition', 163, 'born')]
PMC5426325	4/2017	S5-PMC5426325	['we ADDRESSED the POTENTIAL modification of the EFFECT of Vitamin D availability by season of Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007567', 'parturition', 93, 'birth')]
PMC5426325	4/2017	S17-PMC5426325	['we used this historical change in fortification legislation TO EXAMINE the INFLUENCE of extra Prenatal Vitamin D exposure from fortified Margarine on the risk of fractures during Pubertal-related Growth Spurts, which has the highest fracture incidence(4).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('GO_0007565', 'female pregnancy', 94, 'prenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_6784', 'mestranol', 137, 'margarine'), ('GO_0007567', 'parturition', 179, 'pubertal'), ('UBERON_0002445', 'ulnare', 196, 'growth spurts')]
PMC5426325	4/2017	S116-PMC5426325	['discussion\nTHIS STUDY ASSESSED the long-term risk of childhood fractures from the natural experiment of terminating a mandatory Margarine fortification programme that until 1 june 1985 fortified all Margarine with Vitamin D in denmark.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 22)]	2	[('CHEBI_6784', 'mestranol', 128, 'margarine'), ('CHEBI_6784', 'mestranol', 199, 'margarine'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC5418719	5/2017	S6-PMC5418719	['conclusion\nCONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu/day MAY enhance Vitamin D status during early hospitalization in vlbw infants with 25 Ohd concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('PROBABLE_UNDERSTANDING', 11), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 40), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('INCOMPLETE_EVIDENCE', 122)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 201, '25 OHD'), ('GO_0007567', 'parturition', 237, 'birth')]
PMC5418719	5/2017	S14-PMC5418719	['ALTHOUGH the incidence of Vitamin D insufficiency in preterm infants varies according TO DIFFERENT geographical locations, mean Serum 25(Oh)D levels during 1–3 days after Birth in preterm infants ranges from 9.5 to 25\xa0ng/ml in both europe and western world [4–7].']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('CHEBI_71657', 'versiconol acetate', 134, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 134, '25(OH ... D'), ('GO_0007567', 'parturition', 171, 'birth')]
PMC5418719	5/2017	S16-PMC5418719	['WHILE Breast Milk Feeding is currently RECOMMENDED as a source of early nutrition in full and preterm infants, an infant diet with Breast Milk alone does not contain enough Vitamin D. the definition of Vitamin D sufficiency in preterm infants is STILL CONTROVERSIAL; optimal Vitamin D status is BASED ON the Vitamin D concentrations for multiple health outcomes in Adults with a target value for 25(Oh)D levels >30\xa0ng/ml [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 39), ('IMPORTANT_CONSIDERATION', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('QUESTION_ANSWERED_BY_THIS_WORK', 295), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('UBERON_0001348', 'brown adipose tissue', 6, 'breast milk'), ('GO_0007614', 'short-term memory', 13, 'milk'), ('GO_0007631', 'feeding behavior', 18, 'feeding'), ('UBERON_0001348', 'brown adipose tissue', 131, 'breast milk'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('UBERON_0007023', 'adult organism', 365, 'adults'), ('CHEBI_71657', 'versiconol acetate', 396, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 396, '25(OH ... D')]
PMC5418719	5/2017	S19-PMC5418719	['the AIM of THIS STUDY was TO DETERMINE WHETHER daily Vitamin D supplementation with a high dose of 800\xa0iu is SAFE and EFFECTIVE to increase the proportion of vlbw infants with 25(Oh)D\u2009>\u200930\xa0ng/ml, from 2\xa0weeks of age until hospital discharge.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 39), ('IMPORTANT_CONSIDERATION', 109), ('SUPERFICIAL_RELATIONSHIP', 118)]	6	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 176, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 176, '25(OH)D')]
PMC5418719	5/2017	S41-PMC5418719	['TO EVALUATE the EFFECT of the course of prematurity on Vitamin D status, we EVALUATED Respiratory Distress syndrome (rds), patent Ductus Arteriosus (pda), necrotizing enterocolitis (nec\u2009≥\u2009grade 2), sepsis (clinical or proven), bronchopulmonary dysplasia (bpd, ≥ moderate), retinopathy of prematurity, Intraventricular hemorrhage (ivh\u2009≥\u2009grade 2), type of infant formula, ventilation days, hospital days and total parenteral nutrition days.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 76)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0003495', 'respiratory system arteriole', 86, 'respiratory distress'), ('UBERON_0002254', 'thyroglossal duct', 130, 'ductus arteriosus'), ('UBERON_0006250', 'infundibular recess of 3rd ventricle', 301, 'intraventricular')]
PMC5418719	5/2017	S89-PMC5418719	['discussion\nTHIS PROSPECTIVE STUDY was PLANNED TO DETERMINE WHETHER 800\xa0iu Vitamin D supplementation from 2\xa0weeks of age is SAFE and EFFECTIVE to reach sufficient Vitamin D levels at 36\xa0weeks pma in vlbw infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('IMPORTANT_CONSIDERATION', 123), ('SUPERFICIAL_RELATIONSHIP', 132)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC5418719	5/2017	S104-PMC5418719	['ALTHOUGH a number of Vitamin D deficiency was significantly lower after supplementation than before supplementation in the PRESENT STUDY, supplementation with 800\xa0iu MIGHT not be sufficient to achieve optimal Vitamin D levels in preterm infants with UNDERLYING level of Vitamin D deficiency from Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 123), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 250)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007567', 'parturition', 296, 'birth')]
PMC5418719	5/2017	S119-PMC5418719	['a RECENT STUDY REVEALING a high prevalence of SEVERE Vitamin D deficiency in the middle east prompted us TO INVESTIGATE the OPTIMAL Vitamin D REQUIREMENT of preterm infants in different geographical locations [7].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 15), ('IMPORTANT_CONSIDERATION', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 105), ('IMPORTANT_CONSIDERATION', 124), ('IMPORTANT_CONSIDERATION', 142)]	6	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5418719	5/2017	S125-PMC5418719	['SIMILAR TO PREVIOUS REPORTS [34,35], in the PRESENT STUDY, women with gdm had a significantly INCREASED RISK of deficient Vitamin D status with cord 25(Oh)D concentrations\u2009≤\u200910\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('IMPORTANT_CONSIDERATION', 94)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 151, '(OH)D')]
PMC5418719	5/2017	S137-PMC5418719	['conclusion\nTHIS STUDY FOCUSED on SAFETY and response to the early initiation of oral Vitamin D supplementation followed by underlying level of Vitamin D at Birth in vlbw infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('IMPORTANT_CONSIDERATION', 33)]	3	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0007567', 'parturition', 156, 'birth')]
PMC5418719	5/2017	S138-PMC5418719	['CONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu per day MAY optimize Vitamin D levels during early hospitalization in vlbw infants.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('INCOMPLETE_EVIDENCE', 115)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5418719	5/2017	S139-PMC5418719	['relatively SMALL number of cases and absence of information on maternal Vitamin D and dietary habits for analysis are POTENTIAL limitations of PRESENT STUDY.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 118), ('QUESTION_ANSWERED_BY_THIS_WORK', 143)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC5474873	6/2017	S40-PMC5474873	['given the LIMITED RESEARCH, the AIM of THIS STUDY is TO INVESTIGATE the ASSOCIATION between Adult Life sun exposure (AS a PROXY for Vitamin D status) and later pes.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 72), ('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 122)]	7	[('UBERON_0000113', 'post-juvenile adult stage', 92, 'adult life'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5474873	6/2017	S145-PMC5474873	['the CONFLICTING FINDING of the PRESENT STUDY COULD POSSIBLY BE ATTRIBUTED to any of the following: (1) DIFFERENT measures were used as PROXIES for Vitamin D—the present study ONLY CONSIDERED the sun exposure variables (and not diet) as a main source for Vitamin D levels (9,13,14); (2) the FOCUS of the PRESENT STUDY was detailed assessment of the entire distribution of the cape scale WHEREAS hedelin et al.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 290), ('QUESTION_ANSWERED_BY_THIS_WORK', 303), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 386)]	13	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC5474873	6/2017	S165-PMC5474873	['THE CURRENT STUDY was BASED ON multiple exposure factors (several sun exposure VARIABLES) AS PROXIES for Vitamin D level and their RELATIONSHIP with pes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 22), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 79), ('PROBABLE_UNDERSTANDING', 90), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 131)]	7	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 113, 'D')]
PMC5489519	6/2017	S29-PMC5489519	['in THIS STUDY, we IDENTIFIED that Milk samples collected from Vitamin D deficient mothers contain elevated levels of Trail compared TO the Vitamin D replete group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 132)]	3	[('UBERON_0001913', 'milk', 34, 'milk'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 117, 'TRAIL'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5489519	6/2017	S84-PMC5489519	['discussion\nTHIS STUDY DEMONSTRATED that Breast Milk from Vitamin D deficient mothers contains high levels of Trail (Α and β) proteins compared to sufficient mother group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 22)]	3	[('UBERON_0001348', 'brown adipose tissue', 40, 'breast milk'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 109, 'TRAIL'), ('PR_000006000', 'carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2', 116, 'α')]
PMC5489519	6/2017	S91-PMC5489519	['THUS, OUR FINDINGS that Vitamin D is ASSOCIATED with altered Trail Expression in Breast Milk MAY BE an IMPORTANT LINK to the mother and infant Immune System.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 93), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 113)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 61, 'TRAIL'), ('GO_0010467', 'gene expression', 67, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 81, 'breast milk'), ('UBERON_0002405', 'immune system', 143, 'immune system')]
PMC5510234	7/2017	S76-PMC5510234	['the fifth study FOCUSED on post-Natal Vitamin A supplementation and enrolled 4495 hiv-infected women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	1	[('GO_0007567', 'parturition', 32, 'natal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin A')]
PMC5513133	7/2017	S2-PMC5513133	['evidence of the ROLE of Vitamin D status and supplementation in the etiology and PREVENTION of pe is reviewed in THIS ARTICLE along with identification of research gaps to inform FUTURE STUDIES.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 113), ('FUTURE_WORK', 179)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5513133	7/2017	S4-PMC5513133	['these sources were retrieved, collected, indexed, and ASSESSED for availability of Pregnancy-related data on pe and Vitamin D.\n\nresults\nseveral case-control studies and cross-sectional studies HAVE SHOWN an ASSOCIATION between Vitamin D status and pe, ALTHOUGH EVIDENCE HAS BEEN INCONSISTENT.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 279)]	7	[('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC5513133	7/2017	S52-PMC5513133	['additionally, Vitamin D LIKELY plays a KEY ROLE in the pathology of pre-eclamptic conditions by AFFECTING Blood pressure through Calcium Homeostasis and/or Modulating inflammation and Immunity, which are examined further in THIS review.']	[('PROBABLE_UNDERSTANDING', 24), ('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 96), ('QUESTION_ANSWERED_BY_THIS_WORK', 224)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000178', 'blood', 106, 'blood'), ('GO_0055073', 'cadmium ion homeostasis', 129, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 156, 'modulating'), ('GO_0007566', 'embryo implantation', 184, 'immunity')]
PMC5513133	7/2017	S91-PMC5513133	['given the ROLE of Vitamin D in Modulation of inflammation and Immune function, Placental Implantation, Angiogenesis and adverse Birth outcomes such as low Birth weight and sga, we EXAMINED the EVIDENCE that Vitamin D MAY play a ROLE in the etiology and PREVENTION of pe in this manuscript.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 180), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 217), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 253)]	6	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0065007', 'biological regulation', 31, 'modulation'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('GO_0007565', 'female pregnancy', 79, 'placental'), ('UBERON_0001987', 'placenta', 79, 'placental'), ('GO_0007566', 'embryo implantation', 89, 'implantation'), ('GO_0001525', 'angiogenesis', 103, 'angiogenesis'), ('GO_0007567', 'parturition', 128, 'birth'), ('GO_0007567', 'parturition', 155, 'birth'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5513133	7/2017	S100-PMC5513133	['selected journal articles were then retrieved, collected, indexed, and ASSESSED for availability of Pregnancy-related data on pe and Vitamin D by jp and pg.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 71)]	1	[('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC5513133	7/2017	S132-PMC5513133	['germany, 2–14 [85]↓ 25(Oh)D levels in pe in summer compared to controls, 1,25(Oh)2D ↓ only in winter25(Oh)D: pe:18.2\xa0±\xa017.1; control: 49.2\xa0±\xa029.2\xa0ng/ml, ( p \xa0<\xa00.001); 1,25(Oh)2D: 291\xa0±\xa0217 vs 612.3\xa0±\xa0455\xa0pmol/ml ( p \xa0<\xa00.05)mohaghegh et al., iran, 2015 [89]↓ mean 25(Oh)D in pe compared to Pregnant controls without pe25(Oh)D:Pe: 37.9\xa0±\xa033.9\xa0nmol/lcontrols: 58.2\xa0±\xa038.2\xa0nmol/l( p \xa0=\xa00.001)powe, usa, 2010 [86]↔ women with pe and controls with 25(Oh)D\xa0<\xa015.0\xa0nmol/ladjusted or: 1.3595% ci: 0.40 to 4.50robinson et al., usa, 2010 [25]↑ eospe in women with maternal 25(Oh)D levels <=19.6\xa0nmol/l compared to levels >19.6\xa0nmol/lor: 3.6095% ci: 1.71–7.58( p \xa0<\xa00.001)schneuer et al., australia, 2014 [114]↔ pe or eospe and low 25(Oh)D (< 25\xa0nmol/l)adjusted or- all pe: 0.4695% ci: 0.19–1.10adjusted or- eospe: 1.4095% ci: 0.20 to 9.89singla et al., india, 2015 [87]↓ mean Serum Vitamin D in women with pe vs controlspe: 24.2\xa0±\xa012.4\xa0nmol/l controls: 36.9\xa0±\xa016.7\xa0nmol/l;( p \xa0=\xa00.0001)ullah et al., bangladesh, 2013 [82]↑ pe per 25\xa0nmol/l decrease in 25(Oh)D leveladjusted or: 1.6695% ci: 1.05–3.02wetta et al., uk, 2013 [96]↔ between pe and 25-Oh D\xa0<\xa030\xa0ng/ml and <37.4\xa0nmol/l<30\xa0ng/ml adjusted or: 1.195% ci: 0.6–2.0adjusted or: 1.4 (<37.4\xa0nmol/l)95% ci: 0.7–3.0woodham et al., usa, 2011 [15]↓ severe pe in women with 10\xa0nmol/l increase in maternal 25(Oh)D leveladjusted or: 0.6295% ci: 0.51–0.76xu et al., usa, 2014 [53]↑ pe in women with Vitamin D deficiency (<37.5\xa0nmol/l)or: 4.495% ci: 1.8–10.8yu et al., uk, 2012 [115]↔ Serum Vitamin D raw values in pe and controls25(Oh)D levels: controls: 46.8\xa0nmol/l (27.8–70.0;)early pe: 32.2\xa0nmol/l (22.7–50.4); late pe: 39.2\xa0nmol/l (22.1–63.0) ( p \xa0=\xa00.231)alvarez-fernandez et al., spain, 2014 [90]↑ pe in women with 25(Oh)D levels <50\xa0nmol/l compared TO levels >50\xa0nmol/l after 20\xa0weeks of Gestationor: 4.695% ci:1.4–15( p \xa0=\xa00.010)scholl et al., usa, 2013 [78]↑ pe in women with 25(Oh)D\xa0<\xa049.9\xa0nmol/l and hyperparathyroidismadjusted or: 2.8695% ci: 1.28–6.41burris et al., usa, 2014 [94]↔ Pe and 25(Oh)D levels compared at each 25\xa0nmol/l increase in 25 (Oh)Dadjusted or: 1.1495% ci: 0.77–1.67haugen et al., norway, 2000 [77]↓ pe in women taking 10–15 mcg/d as compared with no supplementsadjusted or: 0.7395% ci: 0.58–0.92shand et al., canada, 2010 [37]↔ pe and 25(Oh)D levels <37.5\xa0nmol/ladjusted or: 0.9195% ci: 0.31–2.62wei et al., canda 2012 [60]↔ Pe and 25(Oh)D\xa0<\xa050\xa0nmol/ladjusted or: 1.2495% ci: 0.58–2.67( p \xa0=\xa00.58)wei, canada, 2013 [14]↑ pe and women with ↓ pigf levels and maternal 25(Oh)d\xa0<\xa050\xa0nmol/ladjusted or: 2.9795% ci: 1.23–7.20zhou, china, 2014 [116]↔ pe and 25(Oh)D levels25(Oh)D levelsgroup a ( n \xa0=\xa013): 41.4\xa0±\xa06.5\xa0nmol/l; group b ( n \xa0=\xa036): 62.1\xa0±\xa07.0\xa0nmol/l; group c ( n \xa0=\xa025): 89.6\xa0±\xa013.0\xa0nmol/l; ( p \xa0=\xa00.900)\na case-cohort study of women from 12 different united states (us) sites whose vitamin D levels were measured at ≤26\xa0weeks of Gestation SHOWED that 25(Oh)D levels greater than 50\xa0nmol/l were ASSOCIATED with a 40% reduction in risk for severe pe (0.65 [95% ci 0.43 to 0.98]), although there was no reduction in absolute and relative risk for the milder clinical subtypes of pe when 25(Oh)D levels were greater than 50\xa0nmol/l [79].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 1791), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2293), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2609), ('INCOMPLETE_EVIDENCE', 2914), ('SUPERFICIAL_RELATIONSHIP', 2969)]	5	[('CHEBI_71657', 'versiconol acetate', 20, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 26, 'D'), ('CHEBI_73285', "3-iodo-4-aminobenzyl-5'-N-methylcarboxamidoadenosine", 75, '25(OH)2D ↓'), ('CHEBI_33010', 'chromide(1-)', 102, '(OH)D'), ('CHEBI_82784', 'PVP38-Ag NP', 168, '1,25(OH)2D'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 265, '25'), ('PR_000011614', 'opioid growth factor receptor', 268, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 271, 'D'), ('GO_0007565', 'female pregnancy', 291, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 322, 'OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 327, 'PE'), ('CHEBI_71657', 'versiconol acetate', 444, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 444, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 566, '(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 725, 'OH)D'), ('UBERON_0001977', 'blood serum', 867, 'serum'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1043, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1043, '25(OH ... D'), ('CHEBI_72765', 'verruculogen', 1134, '25-OH D'), ('CHEBI_71657', 'versiconol acetate', 1343, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1343, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1434, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1519, 'serum'), ('CHEBI_27300', 'vitamin D', 1525, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 1566, '(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1759, 'OH)D'), ('GO_0007565', 'female pregnancy', 1830, 'gestationOR'), ('CHEBI_71657', 'versiconol acetate', 1920, '25(OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 2030, 'PE'), ('CHEBI_71657', 'versiconol acetate', 2037, '25(OH)D'), ('CHEBI_982', '2-Aceto-2-hydroxybutanoate', 2091, '25 (OH)DAdjusted'), ('CHEBI_71657', 'versiconol acetate', 2303, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 2303, '25(OH)D'), ('CHEBI_51383', 'hydridocarbon(3.)', 2393, 'PE'), ('CHEBI_71657', 'versiconol acetate', 2400, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 2534, '25(OH'), ('CHEBI_71657', 'versiconol acetate', 2619, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 2635, '(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 2865, 'D'), ('GO_0007565', 'female pregnancy', 2904, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 2926, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 3159, '25(OH)D')]
PMC5513133	7/2017	S240-PMC5513133	['DESPITE EVIDENCE that low Vitamin D levels increase RISK for pe early in Pregnancy, VERY FEW STUDIES have tried TO RELATE this EFFECT with the Regulation Of Angiogenic or anti-Angiogenic factors.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 84), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 143)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('GO_0006110', 'regulation of glycolytic process', 143, 'regulation of angiogenic'), ('GO_0001525', 'angiogenesis', 176, 'angiogenic')]
PMC5513133	7/2017	S247-PMC5513133	['RECENTLY, participants in the Vitamin D for antenatal asthma (vdaart) randomized double-blind placebo controlled trial took a daily dose of 4000\xa0iu Vitamin D supplementation plus a multivitamin with 400\xa0iu Vitamin D or placebo (placebo pill plus a multi-Vitamin with 400\xa0iu Vitamin D daily) TO ASSESS the EFFECT of Vitamin D supplementation on the frequency of pe among Pregnant women with a high risk for atopic disease [110].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 291), ('SUPERFICIAL_RELATIONSHIP', 305)]	3	[('CHEBI_28384', 'vitamin K', 30, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 254, 'vitamin'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('GO_0007565', 'female pregnancy', 370, 'pregnant')]
PMC5513133	7/2017	S264-PMC5513133	['WHILE SOME STUDIES HAVE BEEN able to capture an adequate representation of african american women [96], there is a NEED FOR FURTHER RESEARCH on populations with very low Vitamin D levels to understand THIS OBSERVATION and IDENTIFY FACTORS that PREDISPOSE high-risk groups to pe and its more THREATENING clinical subtypes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 115), ('FUTURE_WORK', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206), ('QUESTION_ANSWERED_BY_THIS_WORK', 222), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 244), ('IMPORTANT_CONSIDERATION', 291)]	11	[('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5513133	7/2017	S265-PMC5513133	['DESPITE the clear ASSOCIATION of Serum deficiency with pe, a better understanding of the variable IMPACT of supplementation IS NEEDED to identify POTENTIAL of Genetic and environmental INTERACTIONS, as well as pre-Conception data TO IDENTIFY the CRITICAL time window for therapeutic potential of Vitamin D, if any.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 98), ('FUTURE_WORK', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 230), ('IMPORTANT_CONSIDERATION', 246)]	8	[('UBERON_0001977', 'blood serum', 33, 'serum'), ('SO_0000704', 'gene', 159, 'genetic'), ('GO_0007620', 'copulation', 214, 'conception'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D')]
PMC5521778	7/2017	S5-PMC5521778	['CONSEQUENTLY, we INVESTIGATED IF gcs counteract Retinoid EFFECTS in Alveolar Epithelial Cells by mechanisms involving Bco1-dependent local Vitamin A Metabolism.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_26537', 'retinoid', 48, 'retinoid'), ('CL_0000322', 'pneumocyte', 68, 'alveolar epithelial cells'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 68, 'alveolar epithelial'), ('PR_000004693', 'Bcl-2-like protein 10', 118, 'BCO1'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 139, 'vitamin A metabolism')]
PMC5521778	7/2017	S47-PMC5521778	['THIS STUDY PROVIDES the FIRST EVIDENCE that Gcs antagonize Vitamin A Signaling through suppression of Bco1 Expression and defines a Pparα-dependent transcriptional mechanism.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 24)]	3	[('CL_0000740', 'retinal ganglion cell', 44, 'GCs'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('GO_0038092', 'nodal signaling pathway', 59, 'vitamin A signaling'), ('PR_000004693', 'Bcl-2-like protein 10', 102, 'BCO1'), ('GO_0010467', 'gene expression', 107, 'expression'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 132, 'PPARα')]
PMC5524288	7/2017	S127-PMC5524288	['a LIMITATION of THIS STUDY was that nearly two-thirds of the women (63%) had ONLY one 25(Oh)D test during Pregnancy, which PROHIBITED assessment by Trimester and a more thorough analysis of Vitamin D BENEFIT among those with low initial levels.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 77), ('DIFFICULT_TASK', 123), ('IMPORTANT_CONSIDERATION', 200)]	5	[('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 148, 'trimester'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC5537904	7/2017	S1-PMC5537904	['we EXAMINED ASSOCIATIONS between Prenatal Vitamin D intake, 25-Hydroxyvitamin D (25(Oh)D) in Cord Blood, and offspring size and body composition at Birth and 5 months.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 12)]	2	[('GO_0007565', 'female pregnancy', 33, 'prenatal'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 60, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 93, 'cord'), ('UBERON_0000178', 'blood', 98, 'blood'), ('GO_0007567', 'parturition', 148, 'birth')]
PMC5537904	7/2017	S23-PMC5537904	['in addition, FEW STUDIES EXAMINED WHETHER Gestational weight gain OR body mass index (bmi) modify the ASSOCIATIONS between Prenatal Vitamin D intake, neonatal Vitamin D status, and offspring adiposity.']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 102)]	4	[('GO_0007565', 'female pregnancy', 42, 'gestational'), ('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC5537904	7/2017	S25-PMC5537904	['THUS, the PURPOSE of THIS analysis was TO EXAMINE the ASSOCIATIONS between Prenatal Vitamin D intake, neonatal Vitamin D status, and early Life body composition.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 54)]	5	[('GO_0007565', 'female pregnancy', 75, 'prenatal'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 139, 'life')]
PMC5537904	7/2017	S151-PMC5537904	['OUR finding that the ASSOCIATION between Cord Blood 25(Oh)D and Birthweight varies according to maternal bmi MUST BE REPLICATED in OTHER studies, including intervention trials, TO DETERMINE IF Vitamin D supplementation RECOMMENDATIONS to modify Birthweight SHOULD BE bmi-specific.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 117), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('FUTURE_WORK', 219), ('FUTURE_WORK', 257)]	9	[('UBERON_0009472', 'axilla', 41, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 52, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 52, '25(OH)D'), ('GO_0007596', 'blood coagulation', 64, 'birthweight'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007596', 'blood coagulation', 245, 'birthweight')]
PMC5540678	7/2017	S49-PMC5540678	['IN ORDER TO ASSESS CONFOUNDING arising from OTHER dimensions of diet, we additionally adjusted separately for maternal Intake of Vitamin E, zinc, Selenium, n -3 Polyunsaturated Fatty Acids (Pufas), N -6 Pufas, and total fruits and vegetables in Pregnancy [1,29–31].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('PROBLEM_COMPLICATION', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44)]	4	[('GO_0007631', 'feeding behavior', 119, 'intake'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 146, 'selenium'), ('CHEBI_26203', 'polyprenol triphosphate', 161, 'polyunsaturated'), ('CHEBI_35366', 'fatty acid', 177, 'fatty acids'), ('CHEBI_86926', 'S a S b S', 190, 'PUFAs'), ('CHEBI_73643', 'Phe-Phe-Asp', 198, 'n -6 PUFAs'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC5539754	8/2017	S159-PMC5539754	['OUR FINDINGS SUGGEST that women at risk of Vitamin D deficiency in early Pregnancy have altered Glucose Metabolism in later Gestation, BUT the evidence is NOT CONSISTENT for Insulin resistance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_17234', 'glucose', 96, 'glucose'), ('GO_0006006', 'glucose metabolic process', 96, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'gestation'), ('PR_000045358', 'insulin family protein', 174, 'insulin')]
PMC5546866	8/2017	S12-PMC5546866	['abstract:teaser\nASSOCIATIONS between Snps in the Vitamin D Metabolism pathway and 25(Oh)D were ASSESSED before and after Antenatal Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 95)]	2	[('SO_0000694', 'SNP', 37, 'SNPs'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 49, 'vitamin D metabolism'), ('PR_000006444', 'diacylglycerol kinase delta', 57, 'D'), ('CHEBI_71657', 'versiconol acetate', 82, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 88, 'D'), ('GO_0007567', 'parturition', 121, 'antenatal'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5546866	8/2017	S27-PMC5546866	['we THEREFORE undertook THIS STUDY TO DETERMINE WHETHER Snps within the Vitamin D Metabolism pathway KNOWN to modify Vitamin D status are also ASSOCIATED with the response to Antenatal Vitamin d supplementation.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('SO_0000694', 'SNP', 55, 'SNPs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 71, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 174, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 184, 'vitamin')]
PMC5546866	8/2017	S118-PMC5546866	['discussion\nTHIS STUDY ASSESSED the RELATIONSHIPS between common Genetic variants and the response to Vitamin D supplementation in Pregnancy; rs12785878 in dhcr7 was ASSOCIATED with 25(Oh)D status in early Pregnancy prior to Vitamin D supplementation, WHEREAS rs10741657 in Cyp2R1 and rs2282679 in gc were ASSOCIATED with both the achieved and change in 25(Oh)D concentration following supplementation with 1000 iu/d Cholecalciferol.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 251), ('SUPERFICIAL_RELATIONSHIP', 305)]	6	[('SO_0000704', 'gene', 64, 'genetic'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 181, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 187, 'D'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 273, 'CYP2R1'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 356, 'OH)D'), ('CHEBI_52550', 'theopalauamide', 416, 'cholecalciferol')]
PMC5546866	8/2017	S151-PMC5546866	['OUR FINDINGS SUGGEST that analysis of Snps MAY have an IMPORTANT ROLE in identifying high-risk categories of Individuals who are LIKELY to REQUIRE higher doses of Vitamin D to achieve repletion, and STUDIES ARE NEEDED to establish clinical approaches to Vitamin D supplementation that are centered on individual characteristics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 129), ('IMPORTANT_CONSIDERATION', 139), ('FUTURE_WORK', 199)]	8	[('SO_0000694', 'SNP', 38, 'SNPs'), ('NCBITaxon_1', 'root', 109, 'individuals'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC5638722	8/2017	S2-PMC5638722	['in THIS STUDY, we AIMED TO EVALUATE the EFFECTS of low Vitamin D levels in Cord Blood on neonatal sepsis in preterm infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 40)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 75, 'cord'), ('UBERON_0000178', 'blood', 80, 'blood')]
PMC5638722	8/2017	S4-PMC5638722	['in the PRESENT STUDY, severe Vitamin D deficiency (group 1) was DEFINED AS a 25-Hydroxyvitamin D (25(Oh)D) concentration <5 ng/ml; Vitamin D insufficiency (group 2), 25(Oh)D concentration ≥5 ng/ml and <15 ng/ml; and Vitamin D sufficiency (group 3), 25(Oh)D concentration ≥15 ng/ml.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('PROBABLE_UNDERSTANDING', 64), ('PROBABLE_UNDERSTANDING', 72)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 77, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 166, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 172, 'D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 255, 'D')]
PMC5638722	8/2017	S29-PMC5638722	['we SOUGHT TO EVALUATE the EFFECT of lower Vitamin D levels in Cord Blood on neonatal sepsis in preterm infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('SUPERFICIAL_RELATIONSHIP', 26)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood')]
PMC5638722	8/2017	S77-PMC5638722	['the association between the Cord Vitamin D levels and neonatal sepsis rates were EVALUATED.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 81)]	1	[('UBERON_0002240', 'spinal cord', 28, 'cord'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC5638722	8/2017	S81-PMC5638722	['the association between the presence of Vitamin D deficiency and culture-proven sepsis was also EVALUATED.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 96)]	1	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC5638722	8/2017	S88-PMC5638722	['discussion\nthe AIM of OUR STUDY was TO BETTER EVALUATE the EFFECT of Cord-Blood Vitamin D levels on sepsis, by excluding the babies with known RISK factors for infection and who underwent resuscitation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 143)]	6	[('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC5638722	8/2017	S97-PMC5638722	['with the results of OUR STUDY, we SHOWED that Vitamin D insufficiency is not an independent risk factor for sepsis in premature infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 34)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC5638722	8/2017	S101-PMC5638722	['BECAUSE of this, it is NOT SURPRISING that the results of OUR STUDY DID not SHOW Vitamin D level AS an INDEPENDENT risk FACTOR for neonatal sepsis.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 58), ('ANOMALY_CURIOUS_FINDING', 68), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 97), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 120)]	8	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5638722	8/2017	S111-PMC5638722	['BUT with the results of OUR STUDY, no relation between the Cord-Blood Vitamin D levels and Gestational diabetes incidence is FOUND.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 125)]	3	[('UBERON_0002240', 'spinal cord', 59, 'cord'), ('UBERON_0000178', 'blood', 64, 'blood'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'gestational')]
PMC5638722	8/2017	S116-PMC5638722	['in OUR STUDY which included only premature infants, the number of patients with <5 ng/dl Vitamin D levels was more than the OTHER 2 groups.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5638722	8/2017	S117-PMC5638722	['with OUR STUDY, we FOUND that 70% of the infants had deficient Vitamin D levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5638722	8/2017	S127-PMC5638722	['in THE literature, Cord-Blood Vitamin D levels are REPORTED to be MAINLY 20% lower than the maternal Blood levels25).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 51), ('PROBABLE_UNDERSTANDING', 66)]	3	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('UBERON_0000178', 'blood', 24, 'blood'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000178', 'blood', 101, 'blood')]
PMC5638722	8/2017	S132-PMC5638722	['as a CONCLUSION; OUR STUDY is the FIRST to INVESTIGATE the RELATIONSHIP between the Cord-Blood Vitamin D levels and neonatal sepsis in preterm infants.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 34), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('SUPERFICIAL_RELATIONSHIP', 59)]	5	[('UBERON_0002240', 'spinal cord', 84, 'cord'), ('UBERON_0000178', 'blood', 89, 'blood'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5623264	9/2017	S73-PMC5623264	['twenty-two studies ASSESSED the EFFECT of the INTERVENTIONS on ptb.24–43 45 46all systematic reviews included individually\xa0rcts,24–469 cluster-rcts24 30–32 35 36 38 42 45and 10\xa0both rcts and quasi-rcts.24 26 29–32 43–46the number of included trials per review ranged from 241to 61 trials.30the number of included participants in the reviews ranged from 603 participants41to over 310\u2009000 participants.24supplementation with Vitamins was reported in five reviews,24–26 45 46supplementation with Minerals in eight reviews27–34and mmn supplementation was assessed in three reviews.35–37there was one review on protein supplementation and nutritional education38and two reviews REPORTED on marine oil and Fatty Acid supplementation.39 40one review evaluated reduced Salt intake,41one deworming42and two reviews preventive Antimalarial drugs.43 44\n\nmethodological quality of the included reviews\nsixteen reviews were of high quality.24–26 28–33 36 38 39 42 43 45 46six reviews were assessed to be of moderate quality.27 34 37 40 41 44only one included review had a score of three and, therefore, was judged to be of low methodological quality (table 1).35\n\neffects of interventions\n\noral supplementation with Vitamins alone or in combination\nfive systematic reviews INVESTIGATED the EFFECT of oral supplementation with Vitamin A,24vitamin C45Or Vitamin E during Pregnancy46And oral Folic Acid supplementation25 26during the Periconceptional period and Pregnancy (see\xa0onlinesupplementary table 6).']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 673), ('QUESTION_ANSWERED_BY_THIS_WORK', 1260), ('SUPERFICIAL_RELATIONSHIP', 1277)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 423, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 493, 'minerals'), ('CHEBI_35366', 'fatty acid', 700, 'fatty acid'), ('CHEBI_24866', 'salt', 761, 'salt'), ('CHEBI_67261', '(Z)-2,3-dehydroadipyl-CoA(5-)', 817, 'antimalarial'), ('CHEBI_33277', 'gamma-tocotrienol', 1203, 'vitamins'), ('CHEBI_27300', 'vitamin D', 1313, 'vitamin A'), ('CHEBI_528968', '1-O-(alpha-D-galactopyranosyl)-N-(8-phenyloctanoyl)phytosphingosine', 1333, 'C45or'), ('PR_000001309', 'CD70 molecule', 1333, 'C45or'), ('CHEBI_27300', 'vitamin D', 1339, 'vitamin E'), ('GO_0006412', 'translation', 1356, 'pregnancy46and'), ('CHEBI_30751', 'formic acid', 1376, 'folic acid'), ('UBERON_0001844', 'cochlea', 1418, 'periconceptional'), ('GO_0007565', 'female pregnancy', 1446, 'pregnancy')]
PMC5664622	9/2017	S0-PMC5664622	['Vitamin D concentration in Maternal and Umbilical Cord Blood by season\n\nabstract\nsummer is generally considered to be the season when the body is well-supplied with Vitamin D. the AIM of THIS STUDY was to compare maternal and Umbilical Cord Blood concentrations of Vitamin D during two extreme seasons of the year in poland—winter and summer.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 187)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('UBERON_0000976', 'humerus', 27, 'Maternal'), ('UBERON_0002331', 'umbilical cord', 40, 'Umbilical Cord'), ('UBERON_0000178', 'blood', 55, 'Blood'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 226, 'umbilical cord'), ('UBERON_0000178', 'blood', 241, 'blood'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC5664622	9/2017	S17-PMC5664622	['the AIM of the study was TO EVALUATE maternal and Umbilical Cord Blood Vitamin D concentrations and DETERMINE the extent to which the season of the year (summer) improves these levels in poland.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 100)]	3	[('UBERON_0002331', 'umbilical cord', 50, 'umbilical cord'), ('UBERON_0000178', 'blood', 65, 'blood'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC5664622	9/2017	S39-PMC5664622	['statistical analysis\na multivariate regression analysis was used TO INVESTIGATE the relationship between maternal Vitamin D concentration and selected baseline characteristics (Vitamin D consumption, use of dietary supplements, season, maternal age and education, gravidity, bmi, weight gain, diabetes, hypertension, smoking, use of sun screen, exposure to sun).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 65)]	1	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC5664622	9/2017	S88-PMC5664622	['in OUR STUDY, the high number of women with Vitamin D deficiency MIGHT result from avoidance of sun exposure between 10:00 a.m. and 3:00 p.m. and using sunscreen, which was reported by 46% and 26% of the women from the summer group, respectively.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 65)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5664622	9/2017	S107-PMC5664622	['in OUR STUDY, we FOUND that maternal Vitamin D concentration of >15.3 ng/ml, i.e., half the recommended dose, would be sufficient to meet the DEMANDS of the developing fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 142)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5664622	9/2017	S110-PMC5664622	['in OUR STUDY, we CONFIRMED DETRIMENTAL EFFECTS of excessive weight gain in Pregnancy which results in diminished Vitamin D concentration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 27), ('SUPERFICIAL_RELATIONSHIP', 39)]	4	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC5664622	9/2017	S121-PMC5664622	['the ASSOCIATION between Vitamin D consumption and financial status WAS NOT INVESTIGATED, which is one of the LIMITATIONS of OUR STUDY BECAUSE that FACTOR MIGHT have AFFECTED the diet of the investigated population.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 67), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('INCOMPLETE_EVIDENCE', 109), ('QUESTION_ANSWERED_BY_THIS_WORK', 124), ('PROBLEM_COMPLICATION', 134), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 165)]	9	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5664622	9/2017	S129-PMC5664622	['also, it is VITAL TO BEAR IN MIND that in OUR STUDY the analysis of Vitamin D level was conducted on the day of the Delivery, which does not signify that the concentration was typical for the entire course of Pregnancy or at least its significant part.']	[('IMPORTANT_CONSIDERATION', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 42)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007567', 'parturition', 116, 'delivery'), ('GO_0007565', 'female pregnancy', 209, 'pregnancy')]
PMC5664622	9/2017	S132-PMC5664622	['conclusions\nON THE BASIS OF the FINDINGS of OUR STUDY, conducted among polish Pregnant women, it SEEMS SAFE to conclude that significantly low levels of Vitamin D concentration among Pregnant women in poland MAY in FACT be a common occurrence.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 97), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 208), ('ANOMALY_CURIOUS_FINDING', 215)]	7	[('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnant')]
PMC5664622	9/2017	S135-PMC5664622	['in OUR STUDY, we FOUND that the lowest maternal Vitamin D level should be ≥15.3 ng/ml in order to meet the demands of the fetus.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5634602	10/2017	S18-PMC5634602	['this RECOMMENDATION is BASED, IN PART, off of work by priemel et al evaluating bone mineralization defects and Vitamin D deficiency in Iliac Crest bone of Adults [3].']	[('FUTURE_WORK', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 30)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_4300127', 'nuchal crest', 135, 'iliac crest'), ('UBERON_0007023', 'adult organism', 155, 'adults')]
PMC5634602	10/2017	S19-PMC5634602	['the authors of THIS PAPER HOWEVER, CONCLUDE that doses of supplementation of Vitamin D SHOULD ensure 25(Oh)D levels of 75 nmol/l to maintain Skeletal health.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 35), ('FUTURE_WORK', 87)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 101, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 107, 'D'), ('UBERON_0004288', 'skeleton', 141, 'skeletal')]
PMC5634602	10/2017	S40-PMC5634602	['additionally, we will EVALUATE response to supplementation in the subset of infants weighing <1200 grams AS there is MINIMAL information available regarding response to Vitamin D supplementation in this specific high-risk group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('PROBABLE_UNDERSTANDING', 105), ('INCOMPLETE_EVIDENCE', 117)]	3	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC5634602	10/2017	S89-PMC5634602	['a notable DIFFERENCE between THIS STUDY and ours is that in natarajan’s intervention the dose of Vitamin D supplementation was reduced to ACCOUNT FOR dietary intake of vitamin D and the total intake of Vitamin D was 400 iu or 800 iu.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('PROBABLE_UNDERSTANDING', 138)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC5634602	10/2017	S90-PMC5634602	['in OUR STUDY supplementation of Vitamin D was in addition to dietary Vitamin D leading to greater total daily intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5659607	10/2017	S2-PMC5659607	['objective\nTO perform a combined analysis of the two trials AND INVESTIGATE whether maternal 25-Hydroxy-Vitamin D (25(Oh)D) level at trial entry modified the intervention effect.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 59)]	2	[('CHEBI_70487', '(-)-sanguinolignan C', 92, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 114, '25(OH)D')]
PMC5659607	10/2017	S67-PMC5659607	['the main PURPOSE of the study was to conduct a combined analysis of the effect estimates and individual patient data from our own two large rcts (copsac2010and vdaart), which are very aligned with respect to Vitamin D dosage, time of intervention during Pregnancy, number of enrolled women, and offspring outcome definition[9,10].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9)]	1	[('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy')]
PMC5659607	10/2017	S113-PMC5659607	['Lower Respiratory Tract infections (lrti) are analyzed by poisson regression model.Vitamin D vs.placeboipdor (95% ci)asthma/ recurrent wheeze0.75 (0.57–0.97)p = 0.03total Ige > median0.93 (0.73–1.18)p = 0.43specific Ige > 0.35ku/l1.05 (0.77–1.43)p = 0.78eczema0.91 (0.71–1.18)p = 0.47lrti0.92 (0.75–1.14)p = 0.44\n\ndiscussion\nin THIS combined analysis of the two largest rcts to date of Vitamin D supplementation during Pregnancy, we SHOWED that the supplementation resulted in a significant and clinically IMPORTANT 26% reduced risk of asthma/recurrent wheeze in the offspring until age 3, with a more pronounced 46% reduced risk if the women had 25(Oh)d level ≥30ng/ml at trial entry.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 328), ('INCOMPLETE_EVIDENCE', 433), ('IMPORTANT_CONSIDERATION', 506)]	3	[('UBERON_0004905', 'articulation', 0, 'Lower respiratory tract'), ('CHEBI_28384', 'vitamin K', 83, 'Vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 171, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 216, 'IgE'), ('CHEBI_27300', 'vitamin D', 386, 'vitamin D'), ('GO_0007565', 'female pregnancy', 419, 'pregnancy'), ('CHEBI_63056', 'zinc cation', 647, '25(OH')]
PMC5659607	10/2017	S151-PMC5659607	['combining this KNOWLEDGE with OUR FINDINGS from THIS combined analysis, SHOWING that Vitamin D supplementation has a PROTECTIVE EFFECT on childhood asthma/recurrent wheeze, makes Vitamin D a very PROMISING Nutrient for FUTURE PREVENTION of Immune-mediated disorders.']	[('FUTURE_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 128), ('PROBABLE_UNDERSTANDING', 196), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 226)]	9	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('UBERON_0002405', 'immune system', 240, 'immune')]
PMC5679631	11/2017	S1-PMC5679631	['we INVESTIGATED WHETHER maternal Vitamin D supplemention, maternal Plasma 25-Hydroxyvitamin D concentration, OR direct supplementation of the infant INFLUENCES key bacterial taxa within microbiota of one month old infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 149)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 67, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 74, '25-hydroxyvitamin D')]
PMC5679631	11/2017	S26-PMC5679631	['GIVEN that Vitamin D status is a MODIFIABLE FACTOR which MAY INFLUENCE Intestinal Microbiotic Homeostasis, which in turn is INDICATED to be IMPORTANT in the prevention of Immune mediated diseases, we INVESTIGATED WHETHER maternal use of multivitamin supplements containing Vitamin D, maternal Vitamin D status (25 Hydroxyvitamin D (25(Oh)D), OR administration of Vitamin D supplement to the baby INFLUENCES the presence and abundance of several key bacterial taxa of the infant Gut microbiota.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 342), ('SUPERFICIAL_RELATIONSHIP', 396)]	11	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 82, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 82, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 171, 'immune'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 311, '25 hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 332, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 478, 'gut')]
PMC5679631	11/2017	S69-PMC5679631	['due TO the study design, we tested for POSSIBLE INTERACTION between Vitamin D exposure and recruitment group (conventional/alternative).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5679631	11/2017	S115-PMC5679631	['discussion\nthe OBJECTIVE of THIS STUDY was TO INVESTIGATE the POTENTIAL of Vitamin D to INFLUENCE the presence and or abundance of several key bacterial taxa within the infant Intestinal microbiota.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 88)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0000160', 'intestine', 176, 'intestinal')]
PMC5679631	11/2017	S132-PMC5679631	['COMPATIBLE with our PRESENT STUDY, the results of these three investigations SUGGEST that Vitamin D MAY play a ROLE in shaping the Intestinal microbiota.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 111)]	5	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('UBERON_0000160', 'intestine', 131, 'intestinal')]
PMC5679631	11/2017	S137-PMC5679631	['HERE we report on an ASSOCIATION between Prenatal Vitamin D exposure and the abundance of several key bacterial taxa in the infant Intestinal microbiota.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 21)]	2	[('GO_0007565', 'female pregnancy', 41, 'prenatal'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0000160', 'intestine', 131, 'intestinal')]
PMC5679631	11/2017	S159-PMC5679631	['TO OUR KNOWLEDGE, THIS is the FIRST report of a large scale observational study INDICATING that Prenatal Vitamin D exposure, AS measured either by maternal use of multivitamin supplements containing Vitamin D, or 25(Oh)D quintiles, INFLUENCES several IMPORTANT bacterial taxa within the infant Gut.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 125), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 251)]	7	[('GO_0007565', 'female pregnancy', 96, 'prenatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('UBERON_0001555', 'digestive tract', 294, 'gut')]
PMC5706533	11/2017	S0-PMC5706533	['Vitamin D supplementation during Pregnancy: state of the evidence from a systematic review of randomised trials\n\nabstract\nobjectives \xa0TO ESTIMATE the EFFECTS of Vitamin D supplementation during Pregnancy on 11 maternal and 27 neonatal/infant outcomes; TO DETERMINE frequencies at which trial outcome data were missing, unreported, or inconsistently reported; and to project the POTENTIAL contributions of registered ongoing or planned trials.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 134), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 150), ('QUESTION_ANSWERED_BY_THIS_WORK', 252), ('INCOMPLETE_EVIDENCE', 378)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 194, 'pregnancy')]
PMC5706533	11/2017	S19-PMC5706533	['given the numerous trials on Prenatal Vitamin D published since 2015 and the RESTRICTED scope of the 2016 cochrane review, we UNDERTOOK an updated systematic review of Vitamin D in Pregnancy TO ASSESS the current and future state of the evidence from randomised controlled trials.']	[('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 191), ('QUESTION_ANSWERED_BY_THIS_WORK', 191), ('QUESTION_ANSWERED_BY_THIS_WORK', 194)]	5	[('GO_0007565', 'female pregnancy', 29, 'prenatal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('GO_0007565', 'female pregnancy', 181, 'pregnancy')]
PMC5706533	11/2017	S20-PMC5706533	['we SPECIFICALLY AIMED to estimate the EFFECTS of Vitamin D supplementation during Pregnancy on maternal, neonatal, and infant outcomes, taking into consideration the quality of AVAILABLE evidence and heterogeneity across studies; determine frequencies at which relevant outcome variable data were missing, unreported, or inconsistently reported among trials that were otherwise eligible for inclusion; and IDENTIFY ONGOING or PLANNED STUDIES of Vitamin D supplementation during Pregnancy to project the state of EVIDENCE that COULD accrue in the next decade.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 177), ('FUTURE_WORK', 406), ('IMPORTANT_CONSIDERATION', 415), ('FUTURE_WORK', 426), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 526)]	10	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 478, 'pregnancy')]
PMC5706533	11/2017	S63-PMC5706533	['we ASSESSED the potential contribution of eligible planned/ongoing Prenatal Vitamin D trials by identifying the number of participants and trials for the same prespecified list of maternal or child outcomes as in the systematic review of completed trials.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	1	[('GO_0007565', 'female pregnancy', 67, 'prenatal'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5706533	11/2017	S163-PMC5706533	['MANY of the REPORTED doses, HOWEVER, DID NOT yield EFFECTS on maternal 25(Oh)D that would be expected BASED ON Vitamin D pharmacokinetics.3637the muted dose-25(Oh)D RELATION COULD BE ATTRIBUTED to high baseline 25(Oh)D, low precision of 25(Oh)D assays, low rates of adherence to supplementation regimens, or lower than labeled Vitamin D content of the Supplements.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('ANOMALY_CURIOUS_FINDING', 108), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 183)]	10	[('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 73, '(OH ... D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 157, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 237, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 352, 'supplements')]
PMC5706533	11/2017	S178-PMC5706533	['what is already known on THIS topic\nnumerous randomised trials and systematic reviews of Vitamin D supplementation during Pregnancy HAVE BEEN published, with CONFLICTING results and conclusions\nrecommendations regarding Vitamin D supplementation vary widely among medical and professional organisations, and who currently RECOMMENDS against routine Prenatal Vitamin D supplementation\n\nwhat THIS STUDY adds\nsystematic review and meta-analyses of 43 trials including 8406 participants SHOWED that Prenatal Vitamin D supplementation was ASSOCIATED with increased maternal and cord Serum 25-Hydroxyvitamin D concentrations, increased mean birth weight, reduced the risk of small for Gestational age, reduced the risk of wheeze in offspring, and increased infant length at one year of age\nthere was a LACK OF EVIDENCE OF benefits of Prenatal Vitamin D supplementation for maternal health conditions RELATED to Pregnancy, no effect on other Birth outcomes of PUBLIC HEALTH IMPORTANCE such as Preterm Birth, and SCANT EVIDENCE on safety outcomes\nFEW of the trials were designed to test the EFFECT of Vitamin D on clinical or functional outcomes, and most trials were SMALL and at overall high or UNCERTAIN risk of bias\nthirty five planned or ongoing Prenatal Vitamin D trials COULD contribute an additional 12\u2009530 participants to FUTURE systematic reviews\n\npubmed central:']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('FUTURE_WORK', 322), ('QUESTION_ANSWERED_BY_THIS_WORK', 390), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 534), ('INCOMPLETE_EVIDENCE', 796), ('SUPERFICIAL_RELATIONSHIP', 894), ('IMPORTANT_CONSIDERATION', 953), ('IMPORTANT_CONSIDERATION', 967), ('INCOMPLETE_EVIDENCE', 1005), ('INCOMPLETE_EVIDENCE', 1039), ('SUPERFICIAL_RELATIONSHIP', 1083), ('INCOMPLETE_EVIDENCE', 1160), ('FULL_UNKNOWN', 1189), ('INCOMPLETE_EVIDENCE', 1269), ('FUTURE_WORK', 1323)]	18	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 228, 'D'), ('GO_0007565', 'female pregnancy', 349, 'prenatal'), ('CHEBI_27300', 'vitamin D', 358, 'vitamin D'), ('GO_0007565', 'female pregnancy', 495, 'prenatal'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 584, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 679, 'gestational'), ('GO_0007565', 'female pregnancy', 828, 'prenatal'), ('CHEBI_27300', 'vitamin D', 837, 'vitamin D'), ('GO_0007565', 'female pregnancy', 905, 'pregnancy'), ('GO_0007567', 'parturition', 935, 'birth'), ('GO_0007565', 'female pregnancy', 986, 'preterm'), ('GO_0007567', 'parturition', 994, 'birth'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1243, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1252, 'vitamin D')]
PMC5707701	11/2017	S164-PMC5707701	['ACCORDING TO the recommendations of the institute of medicine (iom) [62], we ESTIMATED the supply of Vitamin E for infants in the PRESENT STUDY using the average quantity of milk consumed by infants aged 0–6 m (780 ml), and FOUND that the POSSIBLE EFFECT of these milks offered to the infants was 5.0, 3.0, 1.9, 1.6, 1.7, 1.6 mg/day of Vitamin E, respectively.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 130), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 239), ('SUPERFICIAL_RELATIONSHIP', 248)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin E')]
PMC5707701	11/2017	S165-PMC5707701	['OUR FINDINGS SUGGESTED that only Colostrum reached an ai proposal for the infant aged less than six months; therefore, the implementation of procedures to increase Vitamin E concentrations in milk would be IMPORTANT.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('IMPORTANT_CONSIDERATION', 206)]	3	[('UBERON_0001914', 'colostrum', 33, 'colostrum'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin E')]
PMC5707701	11/2017	S170-PMC5707701	['these inverse CORRELATIONS between SOME of the Carotenoids and current bmi MAY BE due TO the underlying mechanism that an excess of body fat increases the consumption of all antioxidant elements in the diet [63], SO that Lactating women with a higher bmi and more body fat consumed more Vitamins A and E than those with lower bmi, resulting in lower Carotenoids in Human Milk.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 75), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('PROBABLE_UNDERSTANDING', 213)]	5	[('CHEBI_50815', 'norgestimate', 47, 'carotenoids'), ('GO_0007594', 'puparial adhesion', 221, 'lactating'), ('CHEBI_27300', 'vitamin D', 287, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 296, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 302, 'E'), ('CHEBI_50815', 'norgestimate', 350, 'carotenoids'), ('NCBITaxon_9606', 'Homo sapiens', 365, 'human'), ('UBERON_0001913', 'milk', 371, 'milk')]
PMC5732505	12/2017	S2-PMC5732505	['our OBJECTIVE was to compare maternal 25-Hydroxy Vitamin D concentrations [25(Oh)D] between mothers with and without gdm, and TO INVESTIGATE IF an ASSOCIATION existed between maternal Vitamin D concentration and infant Birth size.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 38, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 75, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007567', 'parturition', 219, 'birth')]
PMC5732505	12/2017	S132-PMC5732505	['abbreviations: gwg, Gestational weight gain; gdm, Gestational diabetes mellitus; 25(Oh)D, 25-Hydroxy Vitamin D; suboptimal, ucb, Umbilical Cord Blood; 25(Oh)D\u2009<\u200980\xa0nmol/l; optimal 25(Oh)D\u2009≥\u200980\xa0nmol/l\n\ndiscussion\nthe primary FOCUS of this work was TO DETERMINE WHETHER 25(Oh)D concentration differs between mothers with AND without gdm, and WHETHER Vitamin D status AFFECTS Birth size in normal-Birth-weight infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 224), ('QUESTION_ANSWERED_BY_THIS_WORK', 247), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('SUPERFICIAL_RELATIONSHIP', 365)]	5	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('GO_0007565', 'female pregnancy', 50, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 90, '25-hydroxy vitamin D'), ('UBERON_0002331', 'umbilical cord', 129, 'umbilical cord'), ('UBERON_0000178', 'blood', 144, 'blood'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 180, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0007567', 'parturition', 373, 'birth'), ('GO_0007567', 'parturition', 394, 'birth')]
PMC5732505	12/2017	S140-PMC5732505	['in OUR STUDY, maternal Vitamin D concentrations were SIMILAR in non-gdm and gdm mothers, and there was no linear association between Vitamin D concentrations and ogtt results.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC5732505	12/2017	S156-PMC5732505	['IN AGREEMENT with OUR FINDINGS, OTHERS have DISCOVERED that mothers with higher Vitamin D concentration have infants with smaller Head circumference at Birth [36,37].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 44)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0000033', 'head', 130, 'head'), ('GO_0007567', 'parturition', 152, 'birth')]
PMC5738092	12/2017	S14-PMC5738092	['in THIS PAPER, we illustrate the use of partial least squares (pls) regression analysis to quantify ASSOCIATIONS between materno-infant and household socioeconomic characteristics and multiple measures of newborn size, drawing on a large population cohort of infants whose mothers participated in a maternal Vitamin A and Beta-Carotene supplementation in rural, northern bangladesh [6].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 100)]	2	[('CHEBI_27300', 'vitamin D', 308, 'vitamin A'), ('CHEBI_17579', 'beta-carotene', 322, 'beta-carotene')]
PMC5738092	12/2017	S123-PMC5738092	['OUR STUDY REVEALED that all the maternal variables EXAMINED, except Vitamin A and Β- Carotene supplement receipt during Pregnancy, were significantly ASSOCIATED with Birth size.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 82, 'β- carotene'), ('GO_0007565', 'female pregnancy', 120, 'pregnancy'), ('GO_0007567', 'parturition', 166, 'birth')]
PMC5758521	1/2018	S1-PMC5758521	['we ASSESSED WHETHER Vitamin A and Vitamin E nutritional status MAY AFFECT circulating leptin, adiponectin, Insulin-Like Growth Factor (Igf)-I and Igf-Ii levels in early Life in Humans.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('PR_000008929', 'interferon-related developmental regulator 1', 107, 'insulin-like growth factor ...'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 135, 'IGF)-I'), ('PR_000002046', 'interferon regulatory factor 4', 146, 'IGF-II'), ('UBERON_0000104', 'life cycle', 169, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 177, 'humans')]
PMC5758521	1/2018	S21-PMC5758521	['to fill this IMPORTANT research data gap, we SOUGHT TO EVALUATE WHETHER Vitamin A and e nutritional status in neonates are ASSOCIATED with circulating concentrations of leptin, adiponectin, Igf-I and Igf-Ii which are IMPORTANT BIOMARKERS of fetal growth and Metabolic health15,16.']	[('IMPORTANT_CONSIDERATION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 217), ('SUPERFICIAL_RELATIONSHIP', 227)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('PR_000008919', 'interferon alpha-6', 190, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 200, 'IGF-II'), ('GO_0008152', 'metabolic process', 258, 'metabolic')]
PMC5758521	1/2018	S27-PMC5758521	['in the original Birth cohort, we had collected Cord Blood specimens in 255 infants, but 7 without sufficient Plasma specimen (0.5\u2009ml) available for assays of Vitamins A and E. the PRESENT STUDY included all 248 subjects with Cord Plasma specimens available for assays of Vitamins A and e. all newborns are free of Birth defects, infections and Respiratory Distress syndrome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 180)]	1	[('GO_0007567', 'parturition', 16, 'birth'), ('UBERON_0002240', 'spinal cord', 47, 'cord'), ('UBERON_0000178', 'blood', 52, 'blood'), ('UBERON_0001969', 'blood plasma', 109, 'plasma'), ('CHEBI_27300', 'vitamin D', 158, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 158, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 173, 'E'), ('UBERON_0002240', 'spinal cord', 225, 'cord'), ('UBERON_0001969', 'blood plasma', 230, 'plasma'), ('CHEBI_27300', 'vitamin D', 271, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 271, 'vitamins A'), ('GO_0007567', 'parturition', 314, 'birth'), ('UBERON_0003495', 'respiratory system arteriole', 344, 'respiratory distress')]
PMC5758521	1/2018	S147-PMC5758521	['it is NOTEWORTHY that in OUR STUDY, Vitamin A and E measurements were pretty ROBUST (low intra- and inter-assay cvs), and that Birth weight was measured by research nurses using a reliable electronic weighing scale.']	[('ANOMALY_CURIOUS_FINDING', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 50, 'E'), ('GO_0007567', 'parturition', 127, 'birth')]
PMC5784894	1/2018	S2-PMC5784894	['we TESTED the HYPOTHESIS in an Animal MODEL system that Early Life Vitamin D depletion results in abrogation of the response to mechanical loading, with consequent reduction in bone size, mass and strength during both childhood and Adulthood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 38)]	3	[('NCBITaxon_33208', 'Metazoa', 31, 'animal'), ('UBERON_0001847', 'lobule of pinna', 56, 'early life'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 232, 'adulthood')]
PMC5784894	1/2018	S136-PMC5784894	['discussion\nTHIS STUDY REPLICATES the real Life situation of early Life Vitamin D deficiency in the infant who is Born to a Vitamin D deficient mother and then exclusively breast Fed until weaning.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 22)]	2	[('UBERON_0000104', 'life cycle', 42, 'life'), ('UBERON_0000104', 'life cycle', 66, 'life'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007567', 'parturition', 113, 'born'), ('CHEBI_28384', 'vitamin K', 123, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 178, 'fed')]
PMC5784894	1/2018	S137-PMC5784894	['in THIS STUDY we HAVE SHOWN that early Life Vitamin D deficiency LEADS to decreased bone strength and negatively IMPACTS structure in the bone of Growing and mature female Mice.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 113)]	4	[('UBERON_0000104', 'life cycle', 39, 'life'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0040007', 'growth', 146, 'growing'), ('NCBITaxon_10088', 'Mus <genus>', 172, 'mice')]
PMC5784894	1/2018	S147-PMC5784894	['OUR FINDINGS SUGGEST a nutritional programming EFFECT of Vitamin D on Growing and Adult bone.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0040007', 'growth', 70, 'growing'), ('UBERON_0007023', 'adult organism', 82, 'adult')]
PMC5784894	1/2018	S171-PMC5784894	['a further LIMITATION to THIS STUDY is that the diet used creates a MODEL of complete Vitamin D deficiency that is not typical of the Human population.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('INCOMPLETE_EVIDENCE', 67)]	3	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 133, 'human')]
PMC5784894	1/2018	S190-PMC5784894	['THIS is the FIRST STUDY to report the results of mechanical loading of bone in Mice exposed to Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12)]	2	[('NCBITaxon_10088', 'Mus <genus>', 79, 'mice'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC5784894	1/2018	S191-PMC5784894	['THIS work THUS establishes Early Life Vitamin D deficiency as a FACTOR that CAN CONTRIBUTE to Adult osteoporosis; offers a POTENTIAL Solution–supplementation of Vitamin D during Pregnancy and infancy; and presents a MODEL system TO IDENTIFY pathways that COULD BE TARGETED in Adult Life to prevent or treat osteoporosis, a GLOBAL health PROBLEM.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 10), ('SUPERFICIAL_RELATIONSHIP', 64), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 216), ('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('INCOMPLETE_EVIDENCE', 255), ('FUTURE_WORK', 264), ('IMPORTANT_CONSIDERATION', 323), ('IMPORTANT_CONSIDERATION', 337)]	12	[('UBERON_0001847', 'lobule of pinna', 27, 'early life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_75958', 'solution', 133, 'solution'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('UBERON_0000113', 'post-juvenile adult stage', 276, 'adult life')]
PMC5812027	2/2018	S0-PMC5812027	['trajectory of Vitamin D status during Pregnancy in RELATION to neonatal Birth size and fetal survival: a prospective cohort study\n\nabstract\n\nbackground\nwe INVESTIGATED the ASSOCIATIONS between Vitamin D status in early and late Pregnancy with neonatal small for Gestational age (sga), low Birth weight (lbw) and Preterm Delivery.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 155), ('SUPERFICIAL_RELATIONSHIP', 172)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0007567', 'parturition', 72, 'birth'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0007565', 'female pregnancy', 262, 'gestational'), ('GO_0007567', 'parturition', 289, 'birth'), ('GO_0007565', 'female pregnancy', 312, 'preterm'), ('GO_0007567', 'parturition', 320, 'delivery')]
PMC5812027	2/2018	S28-PMC5812027	['lower Vitamin D status HAS also BEEN ASSOCIATED with a medical history of recurrent Miscarriage [12] BUT ONLY two prospective studies have INVESTIGATED this, without finding that lower 25Ohd concentrations increases the risk of Pregnancy Loss [5,13].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 101), ('QUESTION_ANSWERED_BY_THIS_WORK', 139)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0046660', 'female sex differentiation', 84, 'miscarriage'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 185, '25OHD'), ('GO_0006508', 'proteolysis', 228, 'pregnancy loss')]
PMC5812027	2/2018	S33-PMC5812027	['our OBJECTIVES were to study the ASSOCIATIONS between Vitamin D status in both early and late Pregnancy, as well as change in Vitamin D status during Pregnancy with neonatal sga, lbw and Preterm Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0007565', 'female pregnancy', 187, 'preterm'), ('GO_0007567', 'parturition', 195, 'delivery')]
PMC5812027	2/2018	S34-PMC5812027	['ASSOCIATIONS between Vitamin D status in early Pregnancy and Pregnancy loss WERE also STUDIED.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 76)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
PMC5812027	2/2018	S73-PMC5812027	['tobacco use and Vitamin D supplement use were also INVESTIGATED as POTENTIAL CONFOUNDERS BUT did not show any confounding effect and were THUS not included in the final MODELS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('INCOMPLETE_EVIDENCE', 67), ('PROBLEM_COMPLICATION', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('PROBABLE_UNDERSTANDING', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC5812027	2/2018	S152-PMC5812027	['in addition, Vitamin D status among women who Terminated the Pregnancy WAS NOT ASSESSED.']	[('INCOMPLETE_EVIDENCE', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 79)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0042778', 'tRNA end turnover', 46, 'terminated'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
PMC5827025	2/2018	S74-PMC5827025	['discussion\nthe PRESENT STUDY analyzed Vitamin D status among 3598 Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnant')]
PMC5827025	2/2018	S104-PMC5827025	['the PRESENT STUDY analyzed the ASSOCIATION between Vitamin D status during first- and second-Trimester and Preterm Delivery in chinese population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 93, 'trimester'), ('GO_0007565', 'female pregnancy', 107, 'preterm'), ('GO_0007567', 'parturition', 115, 'delivery')]
PMC5838372	3/2018	S1-PMC5838372	['the AIM of THIS STUDY was TO EVALUATE maternal Vitamin D status and its EFFECT on neonatal Vitamin D concentrations after a support programme for Pregnant women was introduced.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant')]
PMC5838372	3/2018	S2-PMC5838372	['a second AIM was TO IDENTIFY risk FACTORS for Vitamin D deficiency in a district of i̇stanbul.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC5838372	3/2018	S27-PMC5838372	['the AIM of THIS STUDY was TO EVALUATE maternal Vitamin D status and its EFFECT on neonatal Vitamin D status, following the introduction of the support programme for pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC5838372	3/2018	S28-PMC5838372	['a second AIM was TO IDENTIFY risk FACTORS for Vitamin D deficiency in the istanbul district of bağcılar, a low socio-economic neighborhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC5838372	3/2018	S99-PMC5838372	['in THIS PRESENT STUDY, mean Vitamin D level was FOUND TO be 14.82±11.45 ng/ml in Pregnant women and 13.16±7.16 ng/ml in their infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('ANOMALY_CURIOUS_FINDING', 48)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 81, 'pregnant')]
PMC5941617	5/2018	S20-PMC5941617	['the main OBJECTIVE is to give RECOMMENDATIONS regarding the PREVENTION and treatment of Vitamin D deficiency in italian children and adolescents (0–18\xa0years), CONSIDERING both the Skeletal and Extra-Skeletal EFFECTS of Vitamin D and POTENTIAL RISK FACTORS in specific subgroups of children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('FUTURE_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 208), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 243)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0004288', 'skeleton', 180, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 193, 'extra-skeletal'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
PMC5941617	5/2018	S103-PMC5941617	['in 2016 the united kingdom scientific advisory committee on nutrition (sacn) reviewed THE EVIDENCE on Vitamin D and health and RECOMMENDED that Serum 25(Oh)D levels of all children and adolescents in the united kingdom SHOULD NOT fall below 10\xa0ng/ml (a so-CALLED “population PROTECTIVE level”) at any time of the year to protect Musculoskeletal health.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('INCOMPLETE_EVIDENCE', 90), ('FUTURE_WORK', 127), ('FUTURE_WORK', 219), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 275)]	6	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('UBERON_0002204', 'musculoskeletal system', 329, 'musculoskeletal')]
PMC5941617	5/2018	S271-PMC5941617	['at PRESENT, SOME UNANSWERED QUESTIONS REMAIN [CRITICAL times during which supplementation MAY BE most EFFECTIVE, regimen and length of supplementation (continuous or intermittent), gender difference] [227], THUS Vitamin D supplementation to optimize bone mass acquisition SHOULD BE reserved for children AT RISK for deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('EXPLICIT_QUESTION', 28), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('PROBABLE_UNDERSTANDING', 207), ('FUTURE_WORK', 272), ('IMPORTANT_CONSIDERATION', 304)]	11	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC5941617	5/2018	S300-PMC5941617	['taken TOGETHER, all these data INDICATE that Vitamin D status MIGHT have SOME INFLUENCE on conditioning the incidence and severity of SOME but not all type of Respiratory infections and that more information are REQUIRED before drawing any firm conclusion on THIS topic.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 134), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('QUESTION_ANSWERED_BY_THIS_WORK', 259)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 159, 'respiratory')]
PMC5941617	5/2018	S333-PMC5941617	['an italian rct was performed TO TEST WHETHER Vitamin D3Supplementation (oral 100000\xa0iu every 3\xa0months for 4 doses) COULD improve Vitamin D status and AFFECT the t-Cell phenotype in hiv-infected patients aged 8 to 26\xa0years with Serum 25(Oh) D\u2009<\u200930\xa0ng/ml.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('CHEBI_52915', 'phosphatediyl group', 45, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CL_0000622', 'acinar cell', 162, '-cell'), ('UBERON_0001977', 'blood serum', 227, 'serum'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 233, '25(OH) D')]
PMC5941617	5/2018	S390-PMC5941617	['the EVIDENCES for a pathogenetic ROLE for Vitamin D in ad are STILL CONFLICTING EVEN THOUGH data in favour of such CORRELATION are increasingly stronger with MORE STUDIES in favour BUT OTHERS OPPOSING THIS HYPOTHESIS.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 115), ('FUTURE_WORK', 158), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('INCOMPLETE_EVIDENCE', 206)]	11	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5941617	5/2018	S539-PMC5941617	['data about Vitamin D intake and status in Pregnant women are relatively SCARCE but CONFIRM THIS scenario.']	[('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 83), ('QUESTION_ANSWERED_BY_THIS_WORK', 91)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnant')]
PMC5941617	5/2018	S594-PMC5941617	['HOWEVER, at PRESENT safety data in both the short- and the long-term of monthly or OTHER Vitamin D regimens LACK DUE TO the nature of the studies, especially in young children.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('INCOMPLETE_EVIDENCE', 108), ('PROBLEM_COMPLICATION', 113)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC5941617	5/2018	S610-PMC5941617	['the PRESENT consensus PAPER AIMS to give practical approach to Vitamin D supplementation for italian infants, children and adolescents.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 28)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5941617	5/2018	S674-PMC5941617	['HOWEVER, as FEW STUDIES SHOWED that Vitamin D supplementation improves clinical parameters in patients with active tuberculosis or hiv infection, MORE rigorous and extensive STUDIES ARE NEEDED to EVALUATE the ROLE of Vitamin D supplementation in infectious diseases, CONSIDERING also the setting of care, children’s age and nutritional status, POTENTIAL co-infections and compliance with Anti-infective therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 146), ('FUTURE_WORK', 174), ('QUESTION_ANSWERED_BY_THIS_WORK', 196), ('SUPERFICIAL_RELATIONSHIP', 209), ('IMPORTANT_CONSIDERATION', 267), ('INCOMPLETE_EVIDENCE', 344)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('CHEBI_59132', 'antigen', 388, 'anti')]
PMC5941617	5/2018	S691-PMC5941617	['at PRESENT, there is NO EVIDENCE that Vitamin D supplementation MAY delay the development of t1dm or MAY ameliorate its clinical features.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 101)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC5941617	5/2018	S716-PMC5941617	['depression\n\nepidemiological studies that evaluated an ASSOCIATION between Vitamin D deficiency and depression are lacking at PRESENT.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 125)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC5941617	5/2018	S729-PMC5941617	['CONSIDERING AVAILABLE EVIDENCE, PARTICULARLY the LACK OF italian studies, at PRESENT we DO NOT RECOMMEND OTHER modalities DIFFERENT from daily or weekly administration of Vitamin D to treat asymptomatic Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 77), ('FULL_UNKNOWN', 88), ('FUTURE_WORK', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	10	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D')]
PMC5952272	5/2018	S143-PMC5952272	['IN fact, it is the most potent Steroid Hormone in the Human body INTERACTING with 2.5% of the Human Genome or some 1000 Genes (a large NUMBER of which AFFECT Brain Development and function) and working like a master on-off switch.35\nthe LINK between Vitamin D and autism are based on 4 observational data:\nthe low concentrations of Serotonin in the Brain and its elevated concentrations in Tissues outside the Blood-Brain Barrier;\nlow Plasma concentrations of the Vitamin D hormone precursor 25-Hydroxyvitamin D (25(Oh) D3);\nhigh male incidence;\npresence of maternal Antibodies to foetal Brain Tissue.35,36\nthe level of Serotonin in the Brain DEPENDS ON the Blood levels of tryptophan, which, UNLIKE Serotonin, crosses the Blood-Brain Barrier.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 643), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 693)]	7	[('CHEBI_26764', 'steroid hormone', 31, 'steroid hormone'), ('NCBITaxon_9606', 'Homo sapiens', 54, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 94, 'human'), ('SO_0001026', 'genome', 100, 'genome'), ('SO_0000704', 'gene', 120, 'genes'), ('GO_0007420', 'brain development', 158, 'brain development'), ('UBERON_0000955', 'brain', 158, 'brain'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_28790', 'serotonin', 332, 'serotonin'), ('UBERON_0000955', 'brain', 349, 'brain'), ('UBERON_0000479', 'tissue', 390, 'tissues'), ('UBERON_0000120', 'blood brain barrier', 410, 'blood-brain barrier'), ('UBERON_0001969', 'blood plasma', 435, 'plasma'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 492, '25-hydroxyvitamin D'), ('CHEBI_62946', 'ammonium sulfate', 513, '25(OH) D3'), ('GO_0042571', 'immunoglobulin complex, circulating', 567, 'antibodies'), ('UBERON_0000955', 'brain', 588, 'brain'), ('UBERON_0000479', 'tissue', 594, 'tissue'), ('CHEBI_28790', 'serotonin', 620, 'serotonin'), ('UBERON_0000955', 'brain', 637, 'brain'), ('UBERON_0000178', 'blood', 658, 'blood'), ('CHEBI_28790', 'serotonin', 700, 'serotonin'), ('UBERON_0000178', 'blood', 723, 'blood'), ('UBERON_0000052', 'fornix of brain', 729, 'brain barrier')]
PMC5956785	5/2018	S4-PMC5956785	['further, we geo-mapped the results of the studies TO IDENTIFY the PATTERNS of the ASSOCIATION between Vitamin D and chronic childhood arthritis across the globe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5956785	5/2018	S30-PMC5956785	['HERE we report the results of a Vitamin D- jia scoping review that summarizes, synthesizes, evaluates, and interprets pertinent EVIDENCE from the literature to address the following research questions: 1) WHAT is the RELATIONSHIP between Vitamin D status and the occurrence of jia?']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 128), ('EXPLICIT_QUESTION', 205), ('SUPERFICIAL_RELATIONSHIP', 217), ('EXPLICIT_QUESTION', 280)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5956785	5/2018	S75-PMC5956785	['THIS PRESENT REVIEW summarizes ACCUMULATED EVIDENCE on Vitamin D and chronic childhood arthritis by disease activity and latitude.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('INCOMPLETE_EVIDENCE', 31)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5956785	5/2018	S238-PMC5956785	['WHILE THIS REVIEW FOCUSED on Vitamin D status in children with jia, Vitamin D MAY BE INVOLVED in both disease development and subsequent disease activity status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 85)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC5956785	5/2018	S251-PMC5956785	['RECENTLY THE IDEA of investigating epistasis (Gene-Gene interactions) amongst Genes in the inflammatory and Vitamin D pathway and HOW their INTERACTIONS CONTRIBUTE to jia risk was explored by ellis et al.']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 13), ('EXPLICIT_QUESTION', 130), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 153)]	6	[('SO_0000704', 'gene', 46, 'gene'), ('SO_0000704', 'gene', 51, 'gene'), ('SO_0000704', 'gene', 78, 'genes'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC5956785	5/2018	S272-PMC5956785	['conclusion\nTHIS is the FIRST scoping review to summarize research RELATING to Vitamin D and jia in the context of Vitamin D status, latitude, disease activity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5995352	6/2018	S39-PMC5995352	['on this background we AIMED TO INVESTIGATE the RELATIONSHIP between early Life Vitamin D exposure and linear growth in children up to three years of age in the large, danish, population-based odense child cohort (occ).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('UBERON_0000104', 'life cycle', 74, 'life'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5995352	6/2018	S152-PMC5995352	['this was IN KEEPING WITH OUR FINDINGS, SUPPORTING that early Pregnancy Vitamin D status does not affect offspring linear growth.']	[('INCOMPLETE_EVIDENCE', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 39)]	3	[('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC6011374	6/2018	S2-PMC6011374	['we AIMED to compare Vitamin D status in two distinct populations of Pregnant women in australia and new zealand and TO INVESTIGATE the RELATIONSHIP between Vitamin D status and Pregnancy outcome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 116), ('SUPERFICIAL_RELATIONSHIP', 135)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC6011374	6/2018	S29-PMC6011374	['using a robust, validated chemiluminescent-based assay to measure Serum 25(Oh)D [27], we AIMED TO INVESTIGATE the DIFFERENCES between Vitamin D status in early Pregnancy in two distinct populations of Nulliparous women from australia and new zealand.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	3	[('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 72, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy'), ('GO_0046662', 'regulation of oviposition', 201, 'nulliparous')]
PMC6011374	6/2018	S30-PMC6011374	['we also AIMED TO EXAMINE the RELATIONSHIP between Serum 25(Oh)D at 15\u2009±\u20091\xa0weeks’ Gestation and the risk of an adverse Pregnancy outcome and included determining the EFFECT modification of fetal sex on the ASSOCIATION between maternal Vitamin D status and Pregnancy outcome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 165), ('SUPERFICIAL_RELATIONSHIP', 205)]	5	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 56, '25(OH)D'), ('GO_0007565', 'female pregnancy', 81, 'gestation'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy')]
PMC6011374	6/2018	S80-PMC6011374	['caption (table-wrap): table 2\n\nadjusted relative risks (arr) of Pregnancy complications from any complication, Preeclampsia (pe), Gestational hypertension (gh), Gestational diabetes mellitus (gdm), spontaneous Preterm Birth (sptb) and small-for-Gestational age (sga) according to Vitamin D status categorised based on standardised quartiles and clinical definitions of Vitamin D statuspregnancy complicationsall womenany complicationpeghgdmsptbsga n (%) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci)standardised quartiles**\u2003low711 (25)328 (46)0.95 (0.85, 1.07)46 (6)1.02 (0.66, 1.57))57 (8)0.97 (0.67, 1.42)28 (4)0.79 (0.47, 1.30)36 (5)0.83 (0.54, 1.29)84 (12)1.02 (0.75, 1.39)\u2003low-moderate755 (27)318 (42)1.00 (0.90, 1.12)42 (6)1.07 (0.69, 1.64)65 (9)1.06 (0.74, 1.52)25 (3)0.67 (0.39, 1.16)33 (4)0.87 (0.56, 1.3572 (10)0.98 (0.73, 1.32)\u2003moderate-high702 (25)309 (44)1.0†37 (5)1.0†50 (7)1.0†28 (4)1.0†39 (6)1.0†81 (12)1.0†\u2003high630 (23)258 (41)0.93 (0.82, 1.06)†35 (6)1.24 (0.78, 1.96)40 (6)0.87 (0.58, 1.30)10 (2) 0.47(0.23, 0.96) 30 (5)0.77 (0.48, 1.25)60 (10)0.80 (0.57, 1.11)Vitamin d status\u2003<25 nmol/l99 (4)51 (52)1.10 (0.89, 1.36)8 (8)1.44 (0.68, 3.03))6 (6)0.70 (0.32, 1.52)5 (5)0.98 (0.38, 2.52)7 (7)1.44 (0.68, 3.04)13 (13)1.15 (0.66, 2.01)\u200325-50 nmol/l673 (24)301 (45)0.93 (0.83, 1.03)45 (7)1.18 (0.80, 1.75)59 (9)0.97 (0.71, 1.34)26 (4)0.89 (0.54, 1.47)29 (4)0.75 (0.48, 1.16)74 (11)0.93 (0.69, 1.24)\u2003>50-75 nmol/l928 (33)428 (46)1.0†48 (5)1.0†80 (9)1.0†35 (4)1.0†52 (6)1.0†107 (12)1.0†\u2003>75 nmol/l1098 (39)435 (40)0.95 (0.86, 1.04)60 (5)1.28 (0.87, 1.87)67 (6)0.82 (0.59, 1.12)†26 (2)0.78 (0.48, 1.28)51 (5)0.86 (0.59, 1.26)104 (9)0.86 (0.67, 1.12)\n*relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non caucasian vs. caucasian), smoking status at 15\u2009±\u20091\xa0weeks’ Gestation (no vs. yes), Alcohol consumption at 15\u2009±\u20091\xa0weeks’ (no vs yes), recreational walking (1-3×/week and\u2009≥\u20094×/week vs. never) and recruitment site (auckland vs. adelaide)\n**Serum 25(Oh)D was standardised for month that Serum was sampled based as previously described [34]\n†reference category\n\nSerum 25(Oh)D, Pregnancy outcome and fetal sex\nas THERE IS EVIDENCE to SUGGEST that Vitamin D Metabolism within the Placenta MAY DIFFER with respect to fetal sex [35] THUS, we ASSESSED the EFFECT of “standardised” Vitamin D status on Pregnancy outcome stratified by fetal sex (table\xa03).']	[('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2251), ('INCOMPLETE_EVIDENCE', 2305), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2309), ('PROBABLE_UNDERSTANDING', 2347), ('QUESTION_ANSWERED_BY_THIS_WORK', 2356), ('SUPERFICIAL_RELATIONSHIP', 2369)]	7	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 111, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('GO_0007565', 'female pregnancy', 161, 'gestational'), ('GO_0007565', 'female pregnancy', 210, 'preterm birth'), ('GO_0007565', 'female pregnancy', 245, 'gestational'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 1141, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1882, 'gestation'), ('CHEBI_30879', 'alcohol', 1906, 'alcohol'), ('UBERON_0001977', 'blood serum', 2060, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 2066, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 2066, '25(OH)D'), ('UBERON_0001977', 'blood serum', 2106, 'serum'), ('UBERON_0001977', 'blood serum', 2180, 'Serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 2189, 'OH)D'), ('GO_0007565', 'female pregnancy', 2195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2264, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 2264, 'vitamin D metabolism'), ('UBERON_0001987', 'placenta', 2296, 'placenta'), ('CHEBI_27300', 'vitamin D', 2394, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2414, 'pregnancy')]
PMC6011374	6/2018	S87-PMC6011374	['it is the largest prospective cohort study TO ASSESS Vitamin D status within the international scope cohort, comparing and combining two distinct populations of Pregnant women living at similar latitude and provides a GREATER UNDERSTANDING of Vitamin D deficiency and the risk of adverse Pregnancy outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 218)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'pregnant'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy')]
PMC6011374	6/2018	S107-PMC6011374	['in THIS STUDY, we observed marginal sex-specific DIFFERENCES between early Pregnancy Vitamin D status and Pregnancy outcome where by high Vitamin D status and carrying a male fetus was moderately ASSOCIATED with decreasing the risk of having any Pregnancy complication.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('SUPERFICIAL_RELATIONSHIP', 196)]	3	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
PMC6011374	6/2018	S119-PMC6011374	['THEREFORE, Vitamin D status MAY BE IMPORTANT in populations where dietary Calcium intake is low which is UNLIKELY in the population of women studied HERE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 35), ('PROBABLE_UNDERSTANDING', 105), ('QUESTION_ANSWERED_BY_THIS_WORK', 149)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 74, 'calcium')]
PMC6043562	7/2018	S117-PMC6043562	['two other Prenatal Nutrients with immunomodulatory potential, N-3 polyunsaturated Fatty Acids and Vitamin D, were also ASSOCIATED with lower Feno levels in OUR STUDY.']	[('SUPERFICIAL_RELATIONSHIP', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 156)]	2	[('GO_0007565', 'female pregnancy', 10, 'prenatal'), ('CHEBI_33284', 'nutrient', 19, 'nutrients'), ('CHEBI_30256', 'thiocarbonyl group', 62, 'n-3'), ('CHEBI_35366', 'fatty acid', 82, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_32035', 'potassium hydroxide', 141, 'FeNO')]
